gene	geneid	associationtype	Original DB	Sentence in the supporting publication	PMID	Protein Class	Gene Full Name	CUI	Disease	HPO Term	CUI	Disease	Semantic Type	mesh	Disease Class	DO Class	Type	omim	Type	Score	PMID Year
IL4	3565	AlteredExpression	BEFREE	Levels of serum IgE and <span class= gene  id= 17563406-15-24-28 >IL-4</span> were considerably higher in <span class= disease  id= 17563406-15-57-67 >asthmatics</span> than non-<span class= disease  id= 17563406-15-77-86 >asthmatic</span> controls.	17563406	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2008
IL4	3565	AlteredExpression	BEFREE	Increased <span class= gene  id= 24450480-0-10-14 >IL-4</span> mRNA expression and poly-aromatic hydrocarbon concentrations from children with <span class= disease  id= 24450480-0-95-101 >asthma</span>.	24450480	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2014
IL4	3565	AlteredExpression	BEFREE	However, the percent of Th2 cells, <span class= gene  id= 23786933-10-35-39 >IL-4</span> levels and expression of GATA-3 mRNA was markedly higher in patients with mild and moderate to severe <span class= disease  id= 23786933-10-142-148 >asthma</span> than in the control group.	23786933	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2014
IL4	3565	AlteredExpression	BEFREE	Our findings suggest a possible mechanism by which IL-13 and <span class= gene  id= 11509632-9-61-65 >IL-4</span> can modulate CysLT(1)R expression on monocytes and macrophages, and consequently their responsiveness to LTD(4), and thus contribute to the pathogenesis of <span class= disease  id= 11509632-9-222-228 >asthma</span> and allergic diseases.	11509632	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2001
IL4	3565	AlteredExpression	BEFREE	In the presence of different concentrations of LPS (10 ng/ml, 1 mug/ml), there was a decrease in <span class= gene  id= 17884733-9-97-101 >IL-4</span>-induced IL-5 expression without differences in both groups, indicating an intact T(H)2 response to bacterial endotoxin LPS in <span class= disease  id= 17884733-9-228-234 >asthma</span>.	17884733	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2007
IL4	3565	AlteredExpression	LHGDN	The interaction between SNPs in IL-4/IL-13 pathway significantly influence genetic control of serum IgE levels and development of childhood asthma.	16461126	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2005
IL4	3565	AlteredExpression	BEFREE	The RT-PCR analysis detected a significantly <span class= gene  id= 11132771-8-45-49 >IL-4</span>-mRNA expression in all <span class= disease  id= 11132771-8-73-82 >asthmatic</span> patients, compared with controls.	11132771	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2001
IL4	3565	AlteredExpression	LHGDN	Activation of T cells and IL-4 production may be involved not only in the basic pathogenesis of childhood asthma but also in its acute exacerbation.	15051937	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2004
IL4	3565	AlteredExpression	BEFREE	We also found that there was an obviously positive correlation between serum IgE and <span class= gene  id= 24970690-11-85-89 >IL-4</span> levels in <span class= disease  id= 24970690-11-100-109 >asthmatic</span> patients.	24970690	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2014
IL4	3565	AlteredExpression	BEFREE	In contrast, 10-6 m PGE2 significantly down-regulated IFN-gamma and <span class= gene  id= 10336593-11-68-72 >IL-4</span> mRNAs (P &lt; 0.05 for both IFN-gamma and <span class= gene  id= 10336593-11-112-116 >IL-4</span>, n = 4) in the control group, whereas this was <span class= negexp >not observed for</span> <span class= gene  id= 10336593-11-181-185 >IL-4</span> mRNA in the <span class= disease  id= 10336593-11-198-204 >asthma</span> group (n = 7).	10336593	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	1999
IL4	3565	AlteredExpression	BEFREE	OVA-challenged WT mice showed allergic inflammation and <span class= disease  id= 21205293-7-56-59 >AHR</span> in the airways along with increased expression of TNF-&alpha;, IFN-&gamma;, <span class= gene  id= 21205293-7-124-128 >IL-4</span> and tenascin-C in the lungs.	21205293	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2011
IL4	3565	AlteredExpression	BEFREE	<span class= gene  id= 12759454-8-0-4 >IL-4</span> mRNA and IL-5 mRNA were significantly higher in the xenografts of <span class= disease  id= 12759454-8-71-80 >asthmatic</span> huPBMC-SCID mice than those in the xenografts of normal huPBMC-SCID mice, but there were no significant differences in the expressions of IL-2 mRNA or IFN-gamma mRNA between them.	12759454	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2003
IL4	3565	AlteredExpression	BEFREE	In the absence of dexamethasone, there was <span class= negexp >no significant difference</span> in the expressions of <span class= gene  id= 11155664-5-91-95 >IL-4</span> and IL-5 mRNA between SR and SS asthmatics, and the numbers of mRNA positive cells for <span class= gene  id= 11155664-5-183-187 >IL-4</span> and IL-5 were also similar between these two groups, however, in the presence of dexamethasone (10(-7) mol/L), expressions of <span class= gene  id= 11155664-5-314-318 >IL-4</span> mRNA (P &lt; 0.01) and IL-5 mRNA (P &lt; 0.05) were significantly inhibited in SS <span class= disease  id= 11155664-5-395-405 >asthmatics</span>, but not in SR <span class= disease  id= 11155664-5-421-431 >asthmatics</span> (P &gt; 0.05).	11155664	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2001
IL4	3565	AlteredExpression	BEFREE	<span class= gene  id= 9949314-0-0-4 >IL-4</span> and IL-5 mRNA expression in induced sputum of <span class= disease  id= 9949314-0-51-60 >asthmatic</span> subjects: comparison with bronchial wash.	9949314	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	1999
IL4	3565	AlteredExpression	BEFREE	<span class= gene  id= 24801457-12-0-4 >IL-4</span> levels in the obese <span class= disease  id= 24801457-12-25-34 >asthmatic</span> group were almost equal to those of the <span class= disease  id= 24801457-12-75-84 >asthmatic</span> group and more than in the other two groups, without significant difference.	24801457	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2014
IL4	3565	AlteredExpression	BEFREE	A common IL4 haplotype defined at 5 loci, which includes the -589T promoter variant, previously shown to be associated with increased interleukin (<span class= gene  id= 12402189-3-147-152 >IL)-4</span> transcriptional activity and predisposition to <span class= disease  id= 12402189-3-200-206 >asthma</span>, was overrepresented in patients with severe RSV disease (odds ratio, 1.63; P=.02).	12402189	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2002
IL4	3565	AlteredExpression	BEFREE	Occasional <span class= gene  id= 7613132-5-11-15 >IL-4</span> and IL-5 mRNA cells were observed in non-<span class= disease  id= 7613132-5-57-66 >asthmatic</span> control subjects, the large majority being CD3+ cells.	7613132	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	1995
IL4	3565	AlteredExpression	BEFREE	It was concluded that PKC might participate in regulating the expression of <span class= gene  id= 12539551-6-76-80 >IL-4</span> and IL-5 in <span class= disease  id= 12539551-6-93-102 >asthmatic</span> T lymphocytes, and the activation of PKC in T lymphocytes might play an important role in the pathogenesis of <span class= disease  id= 12539551-6-213-219 >asthma</span>.	12539551	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2004
IL4	3565	AlteredExpression	BEFREE	In this study, using a ragweed induced mouse asthma model, we studied if BMSCs could be beneficial in an allergic, Th2-dominant environment.When BMSCs were injected i.v. at the time of the antigen challenge, they protected the animals from the majority of <span class= disease  id= 20231466-3-256-262 >asthma</span>-specific pathological changes, including inhibition of eosinophil infiltration and excess mucus production in the lung, decreased levels of Th2 cytokines (<span class= gene  id= 20231466-3-418-422 >IL-4</span>, IL-5, and IL-13) in bronchial lavage, and lowered serum levels of Th2 immunoglobulins (IgG1 and IgE).	20231466	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2010
IL4	3565	AlteredExpression	BEFREE	The latter is a natural antagonist of <span class= gene  id= 15965616-12-38-42 >IL-4</span> and when expressed in an individual at a level higher than <span class= gene  id= 15965616-12-102-106 >IL-4</span>, the person will resist a microbial infection (e.g.Mycobacterium tuberculosis) or <span class= disease  id= 15965616-12-189-195 >asthma</span>.	15965616	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2005
IL4	3565	AlteredExpression	BEFREE	<span class= gene  id= 24980391-0-0-13 >Interleukin-4</span> and interleukin-13 pathway genetics affect disease susceptibility, serum immunoglobulin E levels, and gene expression in <span class= disease  id= 24980391-0-135-141 >asthma</span>.	24980391	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2014
IL4	3565	AlteredExpression	BEFREE	De novo or augmented inhaled glucocorticoid therapy was associated with significant reductions in the percentages of CD4 T cells expressing IL-5 and <span class= gene  id= 11826234-10-149-153 >IL-4</span> mRNA, as well as improvements in lung function, symptom scores, and bronchial hyperresponsiveness to metacholine (PD20) in both the atopic and nonatopic <span class= disease  id= 11826234-10-307-317 >asthmatics</span>.	11826234	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2002
IL4	3565	AlteredExpression	BEFREE	<span class= disease  id= 10550742-0-0-9 >Asthmatic</span> airway biopsy specimens are more likely to express the <span class= gene  id= 10550742-0-65-69 >IL-4</span> alternative splice variant IL-4delta2.	10550742	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	1999
IL4	3565	AlteredExpression	BEFREE	The severity of diseases with eosinophilic inflammation like nasal polyposis, atopic dermatitis and <span class= disease  id= 15144475-3-100-106 >asthma</span>, where Th2-type cytokines (<span class= gene  id= 15144475-3-134-138 >IL-4</span> and IL-13) and TGF-beta are expressed locally, was shown to correlate with bacterial factors such as lipopolysaccharide (LPS) rather than allergen.	15144475	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2004
IL4	3565	AlteredExpression	LHGDN	These data suggest that during a respiratory virus infection activated CD8+ T cells from asthmatic subjects may produce excess type 2 cytokines and may contribute to asthma exacerbation by augmenting allergic inflammation.	16001979	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2005
IL4	3565	AlteredExpression	BEFREE	By contrast, <span class= gene  id= 21468546-5-13-17 >IL-4</span> levels were significantly higher in <span class= disease  id= 21468546-5-54-63 >asthmatic</span> patients than in the control group (P&lt;0.01) and were negatively correlated with the ratio of T-bet/GATA-3.	21468546	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2011
IL4	3565	AlteredExpression	BEFREE	Microarray analysis of the expression profiles of lung tissue in two murine models of <span class= disease  id= 12813015-1-86-92 >asthma</span> revealed high levels of arginase I and arginase II activity, in association with <span class= gene  id= 12813015-1-174-178 >IL-4</span> and IL-13 overexpression, suggesting that arginine pathways are critical in the pathogenesis of <span class= disease  id= 12813015-1-275-281 >asthma</span>.	12813015	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2003
IL4	3565	AlteredExpression	BEFREE	Thus the increase in <span class= gene  id= 9199876-4-21-25 >IL-4</span> expression can be considered as an underlying mechanism of the allergic disease process and <span class= negexp >not so much of the</span> <span class= disease  id= 9199876-4-137-146 >asthmatic</span> state of the children.	9199876	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	1997
IL4	3565	AlteredExpression	BEFREE	GATA3, <span class= gene  id= 25307458-11-7-11 >IL-4</span> mRNA expression levels were upregulated in patients with <span class= disease  id= 25307458-11-69-75 >asthma</span> than the healthy control.	25307458	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2014
IL4	3565	AlteredExpression	BEFREE	The expression of T-bet mRNA and the level of IFN-gamma were lower, but level of serum <span class= gene  id= 17361521-5-87-91 >IL-4</span> was higher in <span class= disease  id= 17361521-5-106-112 >asthma</span> patients when compared with those in healthy subjects respectively.	17361521	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2007
IL4	3565	AlteredExpression	BEFREE	Plasma <span class= gene  id= 26108069-7-7-11 >IL-4</span> level was significantly higher in <span class= disease  id= 26108069-7-46-52 >asthma</span> exacerbation subjects than controls (157.98 &plusmn; 21.57 versus 121.92 &plusmn; 24.37 pg/mL; p &lt; 0.0001), and IFN-&gamma; level was significantly lower in <span class= disease  id= 26108069-7-190-196 >asthma</span> exacerbation subjects (292.73 &plusmn; 152.47 versus 421.78 &plusmn; 145.84 pg/mL; p = 0.0107).	26108069	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2016
IL4	3565	AlteredExpression	BEFREE	In the atopic <span class= disease  id= 8902881-6-14-24 >asthmatics</span>, the expression of IL-13 was significantly greater than that for <span class= gene  id= 8902881-6-90-94 >IL-4</span> (p &lt; .01).	8902881	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	1997
IL4	3565	AlteredExpression	BEFREE	In vitro addition of <span class= gene  id= 11150000-9-21-25 >IL-4</span> induced a dose-dependent increase in Fc epsilon RI alpha-chain expression on BMs from NASs, and this effect was significantly enhanced with BMs from <span class= disease  id= 11150000-9-175-178 >AAP</span>s.	11150000	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2001
IL4	3565	AlteredExpression	BEFREE	There were increased proportions of cells positive for IL-3 (p &lt; 0.05), <span class= gene  id= 8360390-6-72-76 >IL-4</span> (p &lt; 0.005), IL-5 (p &lt; 0.005), and GM-CSF (p &lt; 0.005) mRNA in BAL fluid from patients with symptomatic <span class= disease  id= 8360390-6-180-186 >asthma</span> when compared with that from subjects <span class= negexp >free of</span> symptoms, but <span class= negexp >no difference</span> between the groups in numbers of cells expressing IL-2 and interferon-gamma mRNA.	8360390	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	1993
IL4	3565	AlteredExpression	BEFREE	At the level of MSG protein expression, the 3 cytokines were seen, with a significant increase in <span class= gene  id= 11031339-8-98-102 >IL-4</span> protein expression in steroid-treated <span class= disease  id= 11031339-8-141-150 >asthmatic</span> subjects compared with untreated asthmatic subjects and control subjects, but there were no differences between the groups in IL-5 and IFN-gamma protein expression.	11031339	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2000
IL4	3565	AlteredExpression	BEFREE	In particular, <span class= gene  id= 12589338-4-15-19 >IL-4</span> and IL-13 are produced at elevated levels in the <span class= disease  id= 12589338-4-69-78 >asthmatic</span> lung and are thought to be central regulators of many of the hallmark features of the disease.	12589338	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2003
IL4	3565	AlteredExpression	BEFREE	In <span class= disease  id= 22226971-3-3-9 >asthma</span> there is an overexpression of T(H)2 cytokines, such as <span class= gene  id= 22226971-3-65-69 >IL-4</span>, IL-5 and IL-13.	22226971	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2011
IL4	3565	AlteredExpression	BEFREE	In conclusion, AT-RvD1 demonstrated significant effects on the <span class= gene  id= 26075216-7-63-67 >IL-4</span>-induced activation of bronchial epithelial cells and consequently the potential to modulate neutrophilic and eosinophilic airway inflammation in <span class= disease  id= 26075216-7-213-219 >asthma</span>.	26075216	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2014
IL4	3565	AlteredExpression	BEFREE	In the subjects with <span class= disease  id= 1530827-8-21-27 >asthma</span>, mRNA for <span class= gene  id= 1530827-8-38-51 >interleukin-4</span> and 5 was expressed predominantly by T lymphocytes.	1530827	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	1992
IL4	3565	AlteredExpression	BEFREE	STAT6 links <span class= gene  id= 21814192-0-12-16 >IL-4</span>/IL-13 stimulation with pendrin expression in <span class= disease  id= 21814192-0-62-68 >asthma</span> and chronic obstructive pulmonary disease.	21814192	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2011
IL4	3565	AlteredExpression	BEFREE	Expression of <span class= gene  id= 9120316-0-14-18 >IL-4</span> and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) <span class= disease  id= 9120316-0-176-186 >asthmatics</span>.	9120316	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	1997
IL4	3565	AlteredExpression	BEFREE	We report using p62-/- mice and cells that p62 acts downstream TCR activation, and is important for Th2 polarization and <span class= disease  id= 16874300-4-121-127 >asthma</span>, playing a significant role in the control of the sustained activation of NF-kappaB and late synthesis of GATA3 and <span class= gene  id= 16874300-4-244-248 >IL-4</span> by participating in the activation of the IKK complex.	16874300	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2006
IL4	3565	AlteredExpression	BEFREE	Lung inflammation, IFN-gamma:<span class= gene  id= 18828742-7-29-33 >IL-4</span> mRNA expression ratios, airway obstruction (AO), and <span class= disease  id= 18828742-7-87-109 >airway hyperreactivity</span> (<span class= disease  id= 18828742-7-111-114 >AHR</span>) were significantly increased in mice inoculated with live RSV.	18828742	signaling molecule	interleukin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.440351394001266	2009
TBX21	30009	AlteredExpression	BEFREE	AM could increase the expression of <span class= gene  id= 17361521-9-36-41 >T-bet</span> mRNA and Thl cytokines such as IFN-Y, and might reverse the Th2 predominant status in <span class= disease  id= 17361521-9-128-134 >asthma</span> patients.	17361521	transcription factor; nucleic acid binding	T-box 21	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.431352297717041	2007
TBX21	30009	AlteredExpression	BEFREE	In conclusion, (1) p38MAPK-pathway rather than ERK-pathway may play a more basic role in the regulation of the increased <span class= gene  id= 17127048-7-121-126 >T-bet</span> expression in <span class= disease  id= 17127048-7-141-147 >asthma</span>, and (2) ERK- and p38MAPK-activation modulate IFNgamma expression independently of <span class= gene  id= 17127048-7-231-236 >T-bet</span> and this regulatory role of ERK-1/-2 on IFNgamma release is impaired in <span class= disease  id= 17127048-7-309-315 >asthma</span>.	17127048	transcription factor; nucleic acid binding	T-box 21	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.431352297717041	2006
IL13	3596	AlteredExpression	BEFREE	<span class= gene  id= 21764573-10-0-17 >Allergic rhinitis</span>, chronic rhinitis and chronic rhinosinusitis were associated with different risk factor patterns and symptom expression of <span class= disease  id= 21764573-10-141-147 >asthma</span>.	21764573	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2011
IL13	3596	AlteredExpression	BEFREE	We propose that: (i) IL-4- and <span class= gene  id= 15677460-8-31-36 >IL-13</span>-stimulated SCCA gene expression is mediated via STAT-1 and STAT-6 activation, and (ii) by suppressing the production, and most likely by interfering with the signaling of these cytokines, UG inhibits SCCA gene expression associated with airway inflammation in <span class= disease  id= 15677460-8-297-303 >asthma</span>.	15677460	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2005
IL13	3596	AlteredExpression	BEFREE	iNOS and arginase mRNA (real-time PCR) and protein expression (Western blot and immunofluorescence) as well as iNOS activity (nitrite levels) were measured in ALI epithelial cells cultured from bronchial brushings of normal and <span class= disease  id= 18384429-5-228-237 >asthmatic</span> subjects following <span class= gene  id= 18384429-5-257-262 >IL-13</span> stimulation.	18384429	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2008
IL13	3596	AlteredExpression	LHGDN	<span class=gene id=17418380>IL-13</span> augments TGF-beta 1-induced tissue inhibitor of metalloproteinase-1 expression through increased Smad phosphorylation and may contribute to fibrosis and airway remodeling seen in the presence of T-helper 2 cell inflammation in <span class=disease id=17418380>asthma</span>.	17418380	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2007
IL13	3596	AlteredExpression	BEFREE	The effect of <span class= gene  id= 26074138-10-14-19 >IL-13</span> on ELN expression was significantly correlated with postbronchodilator FEV1/FVC in patients with <span class= disease  id= 26074138-10-117-123 >asthma</span>.	26074138	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2016
IL13	3596	AlteredExpression	BEFREE	To determine whether airway epithelial miRNA expression is altered in <span class= disease  id= 22955319-3-70-76 >asthma</span> and identify <span class= gene  id= 22955319-3-90-95 >IL-13</span>-regulated miRNAs.	22955319	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2013
IL13	3596	AlteredExpression	BEFREE	<span class= gene  id= 7650396-0-0-5 >IL-13</span> expression at the sites of allergen challenge in patients with <span class= disease  id= 7650396-0-69-75 >asthma</span>.	7650396	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	1995
IL13	3596	AlteredExpression	BEFREE	The in vitro increase in response to <span class= gene  id= 25945802-11-37-42 >IL-13</span> suggests that type 2 cytokines regulate BDNF levels and activity in <span class= disease  id= 25945802-11-111-117 >asthma</span>.	25945802	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2016
IL13	3596	AlteredExpression	BEFREE	Further analysis of these mice and mice transgenic for mouse Il4 and <span class= gene  id= 10508526-8-69-73 >Il13</span> demonstrated that moderate changes in Il4 and <span class= gene  id= 10508526-8-120-124 >Il13</span> expression affect <span class= disease  id= 10508526-8-143-149 >asthma</span>-associated phenotypes in vivo.	10508526	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	1999
IL13	3596	AlteredExpression	BEFREE	By using air-liquid interface cultures of airway epithelium from patients with asthma and nonasthmatic control subjects, we compared RV16 replication-induced changes in mRNA expression of <span class= disease  id= 24588727-4-188-194 >asthma</span> candidate genes and eicosanoid production in the epithelium with or without <span class= gene  id= 24588727-4-271-276 >IL-13</span>-induced mucus metaplasia.	24588727	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2014
IL13	3596	AlteredExpression	BEFREE	High levels of IL-5 and <span class= gene  id= 23121677-4-24-29 >IL-13</span> mRNA were detected in sputum cells from <span class= disease  id= 23121677-4-70-76 >asthma</span> patients.	23121677	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2013
IL13	3596	AlteredExpression	BEFREE	IL-4, IL-5, and <span class= gene  id= 24075231-9-16-21 >IL-13</span> transcripts are easily detected in sputum cells from <span class= disease  id= 24075231-9-75-84 >asthmatic</span> patients, and their expression levels can be used to classify <span class= disease  id= 24075231-9-147-153 >asthma</span> into T(H)2-high and T(H)2-low endotypes.	24075231	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2013
IL13	3596	AlteredExpression	BEFREE	To identify how effects of <span class= gene  id= 16083784-5-27-32 >IL-13</span> on airway epithelial cells contribute to gene expression changes in murine <span class= disease  id= 16083784-5-108-114 >asthma</span> models and determine whether similar changes are seen in people with <span class= disease  id= 16083784-5-184-190 >asthma</span>.	16083784	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2005
IL13	3596	AlteredExpression	BEFREE	In the atopic <span class= disease  id= 8902881-6-14-24 >asthmatics</span>, the expression of <span class= gene  id= 8902881-6-44-49 >IL-13</span> was significantly greater than that for IL-4 (p &lt; .01).	8902881	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	1997
IL13	3596	AlteredExpression	LHGDN	The interaction between SNPs in IL-4/<span class=gene id=16461126>IL-13</span> pathway significantly influence genetic control of serum IgE levels and development of childhood <span class=disease id=16461126>asthma</span>.	16461126	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2005
IL13	3596	AlteredExpression	BEFREE	We evaluated IL-1 alpha, -2, -4, -5, -6, -13, and granulocyte-macrophage colony-stimulating factor (GM-CSF), and interferon-gamma (IFN-gamma). mRNAs for IL-1 alpha, -2, -4, -5, and IFN-gamma were detected in all of the atopic subjects; mRNAs for IL-6 and GM-CSF were found in five <span class= disease  id= 9087947-7-281-291 >asthmatics</span>; and mRNA for <span class= gene  id= 9087947-7-306-311 >IL-13</span> was found in one patient only.	9087947	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	1997
IL13	3596	AlteredExpression	BEFREE	NF-kB inhibitor blocked IL-4/<span class= gene  id= 26588817-11-29-34 >IL-13</span>-induced increase in B2R expression in cultured fibroblasts, suggesting a role as potential anti-<span class= disease  id= 26588817-11-131-137 >asthma</span> drug.	26588817	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2015
IL13	3596	AlteredExpression	BEFREE	Using RT-PCR, we examined the expression of IL-4 and <span class= gene  id= 17563406-5-53-58 >IL-13</span> genes in twenty <span class= disease  id= 17563406-5-75-84 >asthmatic</span> cases and twenty normal individuals.	17563406	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2008
IL13	3596	AlteredExpression	BEFREE	Additionally, <span class= gene  id= 24450586-9-14-19 >IL-13</span>, IL-10 and eosinophil major basic protein mRNA levels were greater in patients with asthma exacerbations compared to non-exacerbating patients (P = 0.03, P = 0.06 and P = 0.02, respectively), and <span class= gene  id= 24450586-9-216-221 >IL-13</span> mRNA correlated with the peak <span class= disease  id= 24450586-9-252-258 >Asthma</span> Index (P = 0.006).	24450586	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2014
IL13	3596	AlteredExpression	BEFREE	Using microarray and polymerase chain reaction analyses of airway epithelial brushings from 42 patients with mild-to-moderate <span class= disease  id= 19483109-4-126-132 >asthma</span> and 28 healthy control subjects, we classified subjects with <span class= disease  id= 19483109-4-194-200 >asthma</span> based on high or low expression of <span class= gene  id= 19483109-4-236-241 >IL-13</span>-inducible genes.	19483109	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2009
IL13	3596	AlteredExpression	BEFREE	STAT6 links IL-4/<span class= gene  id= 21814192-0-17-22 >IL-13</span> stimulation with pendrin expression in <span class= disease  id= 21814192-0-62-68 >asthma</span> and chronic obstructive pulmonary disease.	21814192	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2011
IL13	3596	AlteredExpression	BEFREE	These data underline (1) the pivotal role of the gamma c chain, CD40/CD40L, JAK3 and <span class= gene  id= 12207328-10-85-90 >IL-13</span> in the inflammatory-like activation of lung myofibroblasts, (2) the cell-type restraint effects of <span class= gene  id= 12207328-10-190-195 >IL-13</span> on these cells, and (3) the potential usefulness of JAK3 inhibitors in the treatment of <span class= disease  id= 12207328-10-284-290 >asthma</span>.	12207328	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2002
IL13	3596	AlteredExpression	BEFREE	Interleukin-4 and <span class= gene  id= 24980391-0-18-32 >interleukin-13</span> pathway genetics affect disease susceptibility, serum immunoglobulin E levels, and gene expression in <span class= disease  id= 24980391-0-135-141 >asthma</span>.	24980391	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2014
IL13	3596	AlteredExpression	LHGDN	These data suggest that during a respiratory virus infection activated CD8+ T cells from asthmatic subjects may produce excess type 2 cytokines and may contribute to asthma exacerbation by augmenting allergic inflammation.	16001979	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2005
IL13	3596	AlteredExpression	BEFREE	However, IL-19 up-regulated <span class= gene  id= 15557163-7-28-33 >IL-13</span> in <span class= disease  id= 15557163-7-37-46 >asthmatic</span> mice.	15557163	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2005
IL13	3596	AlteredExpression	BEFREE	Squamous cell carcinoma antigen-1 (SCCA1) and SCCA2, the cysteine and serine protease inhibitors, respectively, showed the highest expression by IL-4 and <span class= gene  id= 12421571-3-154-159 >IL-13</span>, and particularly, SCCA1 was significantly increased in the <span class= disease  id= 12421571-3-220-229 >asthmatic</span> cDNA library.	12421571	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2003
IL13	3596	AlteredExpression	LHGDN	Expression of <span class=gene id=17563406>IL-13</span> gene in 70% of patients with allergic <span class=disease id=17563406>asthma</span> was higher than controls (P = 0.01)	17563406	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2008
IL13	3596	AlteredExpression	BEFREE	In this study, using a ragweed induced mouse <span class= disease  id= 20231466-3-45-51 >asthma</span> model, we studied if BMSCs could be beneficial in an allergic, Th2-dominant environment.When BMSCs were injected i.v. at the time of the antigen challenge, they protected the animals from the majority of <span class= disease  id= 20231466-3-256-262 >asthma</span>-specific pathological changes, including inhibition of eosinophil infiltration and excess mucus production in the lung, decreased levels of Th2 cytokines (IL-4, IL-5, and <span class= gene  id= 20231466-3-434-439 >IL-13</span>) in bronchial lavage, and lowered serum levels of Th2 immunoglobulins (IgG1 and IgE).	20231466	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2010
IL13	3596	AlteredExpression	BEFREE	Microarray analysis of the expression profiles of lung tissue in two murine models of asthma revealed high levels of arginase I and arginase II activity, in association with IL-4 and <span class= gene  id= 12813015-1-183-188 >IL-13</span> overexpression, suggesting that arginine pathways are critical in the pathogenesis of <span class= disease  id= 12813015-1-275-281 >asthma</span>.	12813015	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2003
IL13	3596	AlteredExpression	BEFREE	Four polymorphisms SCCA1 promoter that were in linkage disequilibrium were associated with skin test positivity in <span class= disease  id= 23199842-10-115-124 >asthmatic</span> children and showed higher promoter activity and higher binding of GATA-2 and GATA-3 after IL-4 + <span class= gene  id= 23199842-10-223-228 >IL-13</span> stimulation.	23199842	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2012
IL13	3596	AlteredExpression	BEFREE	The amounts of <span class= gene  id= 11703360-6-15-20 >IL-13</span> in supernatant fluids and IFN-gamma mRNA in cells were <span class= negexp >not statistically different among the</span> <span class= disease  id= 11703360-6-114-116 >BA</span> patients, AD patients and non-allergic controls.	11703360	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2001
IL13	3596	AlteredExpression	BEFREE	IL-4 mediates important proinflammatory functions in <span class= disease  id= 11398072-1-53-59 >asthma</span>, including induction of the IgE isotype switch, increased expression of vascular cell adhesion molecule 1 and promotion of eosinophil transmigration across the endothelium, stimulation of mucus production, and T(H)2 lymphocyte differentiation, leading to release of IL-4, IL-5, IL-9, and <span class= gene  id= 11398072-1-348-353 >IL-13</span>.	11398072	signaling molecule	interleukin 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.376242481353674	2001
ADRB2	154	AlteredExpression	BEFREE	Expression of <span class= gene  id= 7680566-0-14-40 >beta 2-adrenergic receptor</span> mRNA in peripheral lung in <span class= disease  id= 7680566-0-68-74 >asthma</span> and chronic obstructive pulmonary disease.	7680566	receptor	adrenoceptor beta 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.354032677964365	1993
ADRB2	154	AlteredExpression	BEFREE	<span class= disease  id= 17415415-2-0-6 >Asthma</span> models show increased ASM G(alphai) expression, considered the basis for the proasthmatic phenotypes of enhanced bronchial hyperreactivity to contraction mediated by M(3)-muscarinic receptors and diminished relaxation mediated by beta(2)-adrenergic receptors (<span class= gene  id= 17415415-2-267-276 >beta(2)AR</span>s).	17415415	receptor	adrenoceptor beta 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.354032677964365	2007
ADRB2	154	AlteredExpression	BEFREE	<span class= gene  id= 16289313-4-0-26 >Beta-2 adrenergic receptor</span> (<span class= gene  id= 16289313-4-28-33 >ADRB2</span>) expressed on bronchial smooth muscle is a well-defined target for <span class= disease  id= 16289313-4-101-107 >asthma</span> treatment that has epidemiological implications in lung cancer development.	16289313	receptor	adrenoceptor beta 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.354032677964365	2005
ADRB2	154	AlteredExpression	BEFREE	These findings suggest that stressful experience diminishes expression of the glucocorticoid and <span class= gene  id= 16567656-11-97-124 >beta(2)-adrenergic receptor</span> genes in children with <span class= disease  id= 16567656-11-148-154 >asthma</span>.	16567656	receptor	adrenoceptor beta 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.354032677964365	2006
ADRB2	154	AlteredExpression	BEFREE	Densitometric scanning of the autoradiograms suggests that there was <span class= negexp >no significant difference</span> in the relative abundance of muscarinic m1 and beta 1- and <span class= gene  id= 8764219-5-154-180 >beta 2-adrenergic receptor</span> mRNA in <span class= disease  id= 8764219-5-189-198 >asthmatic</span> compared with nonasthmatic lungs.	8764219	receptor	adrenoceptor beta 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.354032677964365	1996
ADRB2	154	AlteredExpression	BEFREE	The level of <span class= gene  id= 20394512-9-13-18 >ADRB2</span> gene expression (71.41%, 95% CI 63.54-85.09) was maximal in patients with <span class= disease  id= 20394512-9-93-99 >asthma</span> with persistent airflow limitation.	20394512	receptor	adrenoceptor beta 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.354032677964365	2010
ADRB2	154	AlteredExpression	BEFREE	Homologous and heterologous regulation of <span class= gene  id= 8049696-5-42-51 >beta 2-AR</span>, along with modulation of expression and turnover of the G proteins coupled to adenylyl cyclase, may play an important role in the pathogenesis, evolution, and management of <span class= disease  id= 8049696-5-226-242 >bronchial asthma</span>.	8049696	receptor	adrenoceptor beta 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.354032677964365	1994
ADRB2	154	AlteredExpression	BEFREE	Differential expression of the <span class= gene  id= 22192964-0-31-48 >&beta;2-adrenoreceptor</span> and M3-cholinoreceptor genes in bronchial mucosa of patients with <span class= disease  id= 22192964-0-115-121 >asthma</span> and chronic obstructive pulmonary disease.	22192964	receptor	adrenoceptor beta 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.354032677964365	2011
TNF	7124	AlteredExpression	BEFREE	We hypothesized that COX-2 expression and PGE2 secretion might be elevated in <span class= disease  id= 25180620-2-78-87 >asthmatic</span> hASMCs in response to proinflammatory signals in part due to altered histone acetylation and/or microRNA expression. hASMCs obtained from nonasthmatic and asthmatic human subjects were treated with cytomix (IL-1&beta;, <span class= gene  id= 25180620-2-302-307 >TNF-&alpha;</span>, and IFN-&gamma;).	25180620	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2016
TNF	7124	AlteredExpression	BEFREE	Our findings indicate that high <span class= gene  id= 22502799-7-32-37 >TNF-&alpha;</span> levels correlate with M pneumoniae positivity in human <span class= disease  id= 22502799-7-93-102 >asthmatic</span> patients and that human SP-A inhibits M pneumoniae-stimulated transcription and release of TNF-&alpha; by MCs, implicating a protective role for SP-A.	22502799	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2012
TNF	7124	AlteredExpression	BEFREE	Vitamin D inhibited <span class= gene  id= 26207385-10-20-24 >TNF&alpha;</span>-induced IL8 protein secretion levels to a comparable degree in fatal <span class= disease  id= 26207385-10-94-100 >asthma</span>- and non-<span class= disease  id= 26207385-10-110-116 >asthma</span>-derived ASM even though IL8 had significantly higher baseline levels in fatal <span class= disease  id= 26207385-10-195-201 >asthma</span>-derived ASM.	26207385	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2015
TNF	7124	AlteredExpression	BEFREE	Increased <span class= gene  id= 10923589-2-10-13 >TNF</span>-alpha levels have been found in airway biopsies and bronchoalveolar lavage fluids from <span class= disease  id= 10923589-2-101-110 >asthmatic</span> patients.	10923589	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2000
TNF	7124	AlteredExpression	BEFREE	Airway neutrophils from participants with <span class= disease  id= 19842845-8-42-48 >asthma</span> spontaneously released lower levels of interleukin (IL)-8, IL-1beta and <span class= gene  id= 19842845-8-121-148 >tumor necrosis factor-alpha</span> proteins, and had lower levels of cytokine gene expression compared to healthy controls.	19842845	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2010
TNF	7124	AlteredExpression	BEFREE	Compared to controls, patients with acute exacerbation of <span class= disease  id= 26546898-4-58-74 >bronchial asthma</span> showed significantly lower adiponectin and significantly higher IL-6 and <span class= gene  id= 26546898-4-148-153 >TNF-&alpha;</span> levels (p&lt;0.01).	26546898	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2015
TNF	7124	AlteredExpression	BEFREE	Basal and <span class= gene  id= 22773691-5-10-15 >TNF-&alpha;</span>-induced expression of miR-140-3p was determined in nonasthmatic ASM (NAASM) and <span class= disease  id= 22773691-5-96-105 >asthmatic</span> ASM (AASM) cells.	22773691	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2012
TNF	7124	AlteredExpression	BEFREE	Anti-inflammatory activity of IL-37 in <span class= disease  id= 26454413-0-39-48 >asthmatic</span> children: Correlation with inflammatory cytokines <span class= gene  id= 26454413-0-99-104 >TNF-&alpha;</span>, IL-&beta;, IL-6 and IL-17A.	26454413	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2015
TNF	7124	AlteredExpression	BEFREE	Silencing of p110&alpha; or -&delta;, but not p110&beta;, resulted in comparable attenuation of <span class= gene  id= 22556157-11-79-84 >TNF-&alpha;</span>-induced CD38 expression in <span class= disease  id= 22556157-11-112-121 >asthmatic</span> and nonasthmatic cells.	22556157	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2012
TNF	7124	AlteredExpression	BEFREE	Nonasthmatic and <span class= disease  id= 22268118-6-17-26 >asthmatic</span> ASM cell-associated syndecan-4 protein expression was also increased by <span class= gene  id= 22268118-6-99-104 >TNF-&alpha;</span> or cytomix at 4-8 h, with the highest levels detected in cytomix-stimulated <span class= disease  id= 22268118-6-181-190 >asthmatic</span> cells.	22268118	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2012
TNF	7124	AlteredExpression	BEFREE	We demonstrate enhanced <span class= gene  id= 1696867-3-24-33 >TNF-alpha</span> gene expression in mononuclear cells from these patients compared with healthy subjects and patients with <span class= disease  id= 1696867-3-140-156 >bronchial asthma</span>.	1696867	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	1990
TNF	7124	AlteredExpression	BEFREE	The anti-<span class= gene  id= 18053016-7-9-12 >TNF</span>-alpha reagent, etanercept, restored the functional activity and Foxp3 expression of CD4(+)CD25(high) Treg derived from allergic <span class= disease  id= 18053016-7-141-151 >asthmatics</span>.	18053016	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2008
TNF	7124	AlteredExpression	BEFREE	Higher serum levels of <span class= gene  id= 23376082-6-23-28 >TNF-&alpha;</span> were observed in genotypes G/A and G/G of <span class= disease  id= 23376082-6-71-80 >asthmatic</span> children and wheezy infants than in controls.	23376082	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2013
TNF	7124	AlteredExpression	BEFREE	COPD patients with reversibility had increased sputum neutrophils, IL-8, and <span class= gene  id= 20856828-7-77-82 >TNF-&alpha;</span> levels compared to smoking <span class= disease  id= 20856828-7-110-120 >asthmatics</span>.	20856828	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2010
TNF	7124	AlteredExpression	BEFREE	Our analysis confirmed the prediction that the expression of IL-8, Cox2, and <span class= gene  id= 22679274-8-77-82 >TNF-&alpha;</span> was up-regulated in <span class= disease  id= 22679274-8-103-112 >asthmatic</span> cells, whereas the expression of IL-6 was lower compared with that in healthy control subjects.	22679274	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2012
TNF	7124	AlteredExpression	BEFREE	OVA-challenged WT mice showed allergic inflammation and <span class= disease  id= 21205293-7-56-59 >AHR</span> in the airways along with increased expression of <span class= gene  id= 21205293-7-110-115 >TNF-&alpha;</span>, IFN-&gamma;, IL-4 and tenascin-C in the lungs.	21205293	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2011
TNF	7124	AlteredExpression	BEFREE	The <span class= gene  id= 11207646-9-4-26 >tumour necrosis factor</span> pathway was activated in AN and <span class= disease  id= 11207646-9-59-61 >AA</span> with increased cytokine and receptor levels and increased TRAF2, an intracellular signalling product.	11207646	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2001
TNF	7124	AlteredExpression	BEFREE	<span class= gene  id= 24500711-1-0-3 >TNF</span> expression is elevated in <span class= disease  id= 24500711-1-30-36 >asthma</span> and other inflammatory airway diseases that are commonly treated with glucocorticoid-based therapies, but the impact of glucocorticoids on negative feedback control of <span class= gene  id= 24500711-1-205-208 >TNF</span> is not well understood.	24500711	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	2014
TNF	7124	AlteredExpression	BEFREE	Significant levels of <span class= gene  id= 1374772-2-22-25 >TNF</span> (578 +/- 917 pg/ml versus 24 +/- 29 pg/ml) (p = 0.01), GM-CSF (24 +/- 41 pg/ml versus less than 8 pg/ml) (p = 0.02), and IL-6 (225 +/- 327 pg/ml versus 7 +/- 12 pg/ml) (p = 0.01), but not IL-1 alpha or IL-4, were detected in the bronchoalveolar lavage fluid (BALF) of patients with symptomatic compared with BALF of patients with asymptomatic <span class= disease  id= 1374772-2-369-375 >asthma</span>.	1374772	signaling molecule	tumor necrosis factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.350678535044538	1992
IL5	3567	AlteredExpression	LHGDN	These data suggest that during a respiratory virus infection activated CD8+ T cells from asthmatic subjects may produce excess type 2 cytokines and may contribute to asthma exacerbation by augmenting allergic inflammation.	16001979	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2005
IL5	3567	AlteredExpression	LHGDN	Results show that the expression of interleukin-5 mRNA in mild asthma differed from that in severe and moderate asthma before and after corticosteroid treatment.	12910312	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2004
IL5	3567	AlteredExpression	BEFREE	The effect of Ginkgo Biloba extract on the expression of PKCalpha in the inflammatory cells and the level of <span class= gene  id= 17828490-0-109-113 >IL-5</span> in induced sputum of <span class= disease  id= 17828490-0-135-144 >asthmatic</span> patients.	17828490	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2010
IL5	3567	AlteredExpression	BEFREE	Recently, <span class= gene  id= 7523534-2-10-14 >IL-5</span> mRNA has been identified in eosinophils from patients with celiac disease, eosinophilic heart diseases, and <span class= disease  id= 7523534-2-123-129 >asthma</span>.	7523534	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1994
IL5	3567	AlteredExpression	BEFREE	Recently, however, eosinophil precursors (CD34/IL-5Ralpha+ cells) and <span class= gene  id= 10640772-2-70-74 >IL-5</span> mRNA+ cells have been identified within the lungs of <span class= disease  id= 10640772-2-128-138 >asthmatics</span>, indicating that a population of eosinophils may differentiate in situ.	10640772	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2000
IL5	3567	AlteredExpression	BEFREE	PARP-1 deficiency blocks <span class= gene  id= 21276008-0-25-29 >IL-5</span> expression through calpain-dependent degradation of STAT-6 in a murine <span class= disease  id= 21276008-0-101-107 >asthma</span> model.	21276008	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2011
IL5	3567	AlteredExpression	BEFREE	We examined CD34(+) cell numbers by immunohistochemistry and <span class= gene  id= 9870912-3-61-65 >IL-5</span> receptor alpha (IL-5Ralpha) messenger RNA (mRNA) expression by in situ hybridization in bronchial biopsies from atopic <span class= disease  id= 9870912-3-185-194 >asthmatic</span> patients, and from atopic and nonatopic control subjects.	9870912	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1999
IL5	3567	AlteredExpression	BEFREE	In this study, using a ragweed induced mouse asthma model, we studied if BMSCs could be beneficial in an allergic, Th2-dominant environment.When BMSCs were injected i.v. at the time of the antigen challenge, they protected the animals from the majority of <span class= disease  id= 20231466-3-256-262 >asthma</span>-specific pathological changes, including inhibition of eosinophil infiltration and excess mucus production in the lung, decreased levels of Th2 cytokines (IL-4, <span class= gene  id= 20231466-3-424-428 >IL-5</span>, and IL-13) in bronchial lavage, and lowered serum levels of Th2 immunoglobulins (IgG1 and IgE).	20231466	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2010
IL5	3567	AlteredExpression	BEFREE	Improvement of <span class= disease  id= 12534456-9-15-21 >asthma</span> was observed mostly in patients with a low baseline and non-<span class= gene  id= 12534456-9-82-86 >IL-5</span> inducible expression of LTC4 synthase (LTC4S) mRNA in eosinophils.	12534456	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2003
IL5	3567	AlteredExpression	BEFREE	Effect of bacterial endotoxin LPS on expression of INF-gamma and <span class= gene  id= 17884733-0-65-69 >IL-5</span> in T-lymphocytes from <span class= disease  id= 17884733-0-92-102 >asthmatics</span>.	17884733	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2007
IL5	3567	AlteredExpression	BEFREE	Spirometric parameters and levels of interferon gamma and <span class= gene  id= 22186238-0-58-62 >IL-5</span> in induced sputum from patients with allergic rhinitis or <span class= disease  id= 22186238-0-121-127 >asthma</span>.	22186238	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2012
IL5	3567	AlteredExpression	BEFREE	Occasional IL-4 and <span class= gene  id= 7613132-5-20-24 >IL-5</span> mRNA cells were observed in non-<span class= disease  id= 7613132-5-57-66 >asthmatic</span> control subjects, the large majority being CD3+ cells.	7613132	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1995
IL5	3567	AlteredExpression	BEFREE	Glucocorticoid therapy of <span class= disease  id= 7742019-13-26-36 >asthmatics</span> is associated with a reduction in the percentages of CD4 T-LC expressing IL-3, <span class= gene  id= 7742019-13-116-120 >IL-5</span>, and GM-CSF mRNA and secretion of the corresponding proteins.	7742019	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1995
IL5	3567	AlteredExpression	BEFREE	Uncontrolled <span class= disease  id= 23957336-11-13-23 >asthmatics</span> [Asthma Control Test (ACT) &lt; 20] had higher sputum <span class= gene  id= 23957336-11-75-79 >IL-5</span>, IL-17A and IL-25 mRNA levels compared to controlled <span class= disease  id= 23957336-11-133-143 >asthmatics</span> (P = 0.002; P = 0.002; P = 0.066) and uncontrolled <span class= disease  id= 23957336-11-195-201 >asthma</span> is more common among '<span class= gene  id= 23957336-11-224-228 >IL-5</span>- and IL-17A-high' asthmatics compared to '<span class= gene  id= 23957336-11-271-275 >IL-5</span>-, IL-17A-low' <span class= disease  id= 23957336-11-290-300 >asthmatics</span> (?(2) = 3.7, P = 0.027; relative risk (RR): 1.8, 95% CI = 1.1-3.1).	23957336	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2013
IL5	3567	AlteredExpression	BEFREE	The results of this study provide the first evidence of increased GATA-3 gene expression in association with <span class= gene  id= 9949310-10-109-113 >IL-5</span> mRNA+ cells in <span class= disease  id= 9949310-10-129-138 >asthmatic</span> airways.	9949310	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1999
IL5	3567	AlteredExpression	BEFREE	Interaction with monocytes enhances <span class= gene  id= 12771545-0-36-40 >IL-5</span> gene transcription in peripheral T cells of <span class= disease  id= 12771545-0-85-94 >asthmatic</span> patients.	12771545	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2003
IL5	3567	AlteredExpression	BEFREE	Montelukast inhibits <span class= gene  id= 14619337-0-21-34 >interleukin-5</span> mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with <span class= disease  id= 14619337-0-173-179 >asthma</span>.	14619337	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2004
IL5	3567	AlteredExpression	BEFREE	Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for <span class= gene  id= 8417755-0-84-97 >interleukin-5</span> and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic <span class= disease  id= 8417755-0-219-229 >asthmatics</span>.	8417755	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1993
IL5	3567	AlteredExpression	BEFREE	These results suggest that the suppression of <span class= gene  id= 8006305-12-46-50 >IL-5</span> production through the suppression of <span class= gene  id= 8006305-12-89-93 >IL-5</span> gene expression is one of the most important mechanisms by which glucocorticoids inhibit eosinophil functions in the treatment of atopic diseases, including <span class= disease  id= 8006305-12-251-267 >bronchial asthma</span>.	8006305	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1994
IL5	3567	AlteredExpression	BEFREE	These observations support the view that atopic and nonatopic <span class= disease  id= 8998072-8-62-68 >asthma</span> are associated with combined bronchial mucosal expression of CC chemokines (RANTES and MCP-3), together with eosinophil-active cytokines (<span class= gene  id= 8998072-8-207-211 >IL-5</span>, GM-CSF, and IL-3).	8998072	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1997
IL5	3567	AlteredExpression	BEFREE	Peripheral blood T lymphocytes from <span class= disease  id= 10336593-0-36-45 >asthmatic</span> patients are primed for enhanced expression of interleukin (IL)-4 and <span class= gene  id= 10336593-0-116-120 >IL-5</span> mRNA: associations with lung function and serum IgE.	10336593	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1999
IL5	3567	AlteredExpression	BEFREE	Allergen challenge primes for <span class= gene  id= 10383594-0-30-34 >IL-5</span> mRNA production and abrogates beta-adrenergic function in peripheral blood T lymphocytes from <span class= disease  id= 10383594-0-129-139 >asthmatics</span>.	10383594	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1999
IL5	3567	AlteredExpression	BEFREE	Expression of mRNA for <span class= gene  id= 2022726-0-23-36 >interleukin-5</span> in mucosal bronchial biopsies from <span class= disease  id= 2022726-0-72-78 >asthma</span>.	2022726	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1991
IL5	3567	AlteredExpression	BEFREE	Inhibition of the late <span class= disease  id= 25981191-10-23-32 >asthmatic</span> response by SB010 was associated with attenuation of allergen-induced sputum eosinophilia and with lower levels of tryptase in sputum and lower plasma levels of <span class= gene  id= 25981191-10-194-207 >interleukin-5</span>.	25981191	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2015
IL5	3567	AlteredExpression	BEFREE	De novo or augmented inhaled glucocorticoid therapy was associated with significant reductions in the percentages of CD4 T cells expressing <span class= gene  id= 11826234-10-140-144 >IL-5</span> and IL-4 mRNA, as well as improvements in lung function, symptom scores, and bronchial hyperresponsiveness to metacholine (PD20) in both the atopic and nonatopic <span class= disease  id= 11826234-10-307-317 >asthmatics</span>.	11826234	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2002
IL5	3567	AlteredExpression	BEFREE	Thus, inhibition of <span class= gene  id= 19548628-2-20-24 >IL-5</span> expression seems to be an attractive approach for <span class= disease  id= 19548628-2-75-81 >asthma</span> therapy.	19548628	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2009
IL5	3567	AlteredExpression	BEFREE	Membrane-bound and soluble alpha <span class= gene  id= 9105087-0-33-37 >IL-5</span> receptor mRNA in the bronchial mucosa of atopic and nonatopic <span class= disease  id= 9105087-0-100-110 >asthmatics</span>.	9105087	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1997
IL5	3567	AlteredExpression	BEFREE	<span class= gene  id= 1937868-0-0-13 >Interleukin-5</span> mRNA in mucosal bronchial biopsies from <span class= disease  id= 1937868-0-54-63 >asthmatic</span> subjects.	1937868	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1991
IL5	3567	AlteredExpression	BEFREE	It was concluded that PKC might participate in regulating the expression of IL-4 and <span class= gene  id= 12539551-6-85-89 >IL-5</span> in <span class= disease  id= 12539551-6-93-102 >asthmatic</span> T lymphocytes, and the activation of PKC in T lymphocytes might play an important role in the pathogenesis of <span class= disease  id= 12539551-6-213-219 >asthma</span>.	12539551	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2004
IL5	3567	AlteredExpression	BEFREE	IL-4 and <span class= gene  id= 9949314-0-9-13 >IL-5</span> mRNA expression in induced sputum of <span class= disease  id= 9949314-0-51-60 >asthmatic</span> subjects: comparison with bronchial wash.	9949314	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1999
IL5	3567	AlteredExpression	BEFREE	Eosinophils express <span class= gene  id= 1401075-0-20-33 >interleukin 5</span> and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in <span class= disease  id= 1401075-0-129-139 >asthmatics</span>.	1401075	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1992
IL5	3567	AlteredExpression	BEFREE	Role of activator protein-1 in the transcription of <span class= gene  id= 16116958-0-52-65 >interleukin-5</span> gene regulated by protein kinase C signal in <span class= disease  id= 16116958-0-111-120 >asthmatic</span> human T lymphocytes.	16116958	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2006
IL5	3567	AlteredExpression	BEFREE	<span class= gene  id= 12125504-0-0-13 >Interleukin-5</span> messenger RNA expression in peripheral blood mononuclear cells from patients with <span class= disease  id= 12125504-0-96-112 >bronchial asthma</span> and eosinophilia.	12125504	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2002
IL5	3567	AlteredExpression	BEFREE	Allergen-induced increases in bone marrow T lymphocytes and <span class= gene  id= 12231502-0-60-73 >interleukin-5</span> expression in subjects with <span class= disease  id= 12231502-0-102-108 >asthma</span>.	12231502	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2002
IL5	3567	AlteredExpression	BEFREE	In experiments on isolated ASM tissue segments (a) exogenous administration of IL-2 and IFN-gamma to atopic <span class= disease  id= 10194481-7-108-117 >asthmatic</span> serum-sensitized ASM ablated both their enhanced constrictor responsiveness to acetylcholine (ACh) and their attenuated relaxation responsiveness to beta-adrenoceptor stimulation with isoproterenol, and (b) administration of <span class= gene  id= 10194481-7-343-347 >IL-5</span> and GM-CSF to naive ASM induced significant increases in their contractility to ACh and impaired their relaxant responsiveness to isoproterenol.	10194481	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1999
IL5	3567	AlteredExpression	BEFREE	Collectively, these observations provide new evidence demonstrating that activation of the CAM counterreceptor ligands ICAM-1 and LFA-1, both of which are endogenously expressed in ASM cells, elicits autologously upregulated <span class= gene  id= 10835320-7-225-229 >IL-5</span> release and associated changes in ICAM-1 expression and agonist responsiveness in atopic <span class= disease  id= 10835320-7-319-328 >asthmatic</span> sensitized ASM.	10835320	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2000
IL5	3567	AlteredExpression	BEFREE	Real-time quantitative polymerase chain reaction was adopted to detect TRPV1 mRNA expression level and enzyme-linked immuno sorbent assay was used to detect the serum total IgE level, eosinophil (EOS) number, IL-4, <span class= gene  id= 25715236-5-215-219 >IL-5</span>, and interferon (IFN) gamma levels in peripheral venous blood of children in the healthy control group and <span class= disease  id= 25715236-5-327-333 >asthma</span> group before and after treatment.	25715236	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2015
IL5	3567	AlteredExpression	BEFREE	These novel data on the regions of the human <span class= gene  id= 10651947-8-45-49 >IL-5</span> promoter that are bound by transcription factors should allow dissection of the regulatory mechanisms involved in the transcription of <span class= gene  id= 10651947-8-185-189 >IL-5</span> in the T-helper lymphocytes of <span class= disease  id= 10651947-8-221-231 >asthmatics</span>.	10651947	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2000
IL5	3567	AlteredExpression	BEFREE	The gene expression of IL-4 and <span class= gene  id= 11155664-7-32-36 >IL-5</span> in SR <span class= disease  id= 11155664-7-43-49 >asthma</span> was not inhibited by dexamethasone at the concentration of 10(-7) mol/L.	11155664	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2001
IL5	3567	AlteredExpression	BEFREE	<span class= gene  id= 8648029-0-0-13 >Interleukin-5</span> messenger RNA expression in peripheral blood CD4+ cells in <span class= disease  id= 8648029-0-73-79 >asthma</span>.	8648029	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1996
IL5	3567	AlteredExpression	BEFREE	Expression of IL-4 and <span class= gene  id= 9120316-0-23-27 >IL-5</span> mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) <span class= disease  id= 9120316-0-176-186 >asthmatics</span>.	9120316	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1997
IL5	3567	AlteredExpression	BEFREE	<span class= gene  id= 12910312-0-0-4 >IL-5</span> expression in the sputum of patients with <span class= disease  id= 12910312-0-47-63 >bronchial asthma</span>.	12910312	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2004
IL5	3567	AlteredExpression	BEFREE	Collectively, these findings provide new evidence demonstrating that the altered responsiveness of atopic <span class= disease  id= 11597904-6-106-115 >asthmatic</span> serum-sensitized ASM is largely attributed to activation of an intrinsic T helper type 2-type autocrine mechanism involving IL-10-mediated release and the action of <span class= gene  id= 11597904-6-281-285 >IL-5</span> in the sensitized ASM itself.	11597904	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2001
IL5	3567	AlteredExpression	BEFREE	Chronic cough resembles <span class= disease  id= 9525446-0-24-30 >asthma</span> with <span class= gene  id= 9525446-0-36-40 >IL-5</span> and granulocyte-macrophage colony-stimulating factor gene expression in bronchoalveolar cells.	9525446	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1998
IL5	3567	AlteredExpression	BEFREE	There were increased proportions of cells positive for IL-3 (p &lt; 0.05), IL-4 (p &lt; 0.005), <span class= gene  id= 8360390-6-90-94 >IL-5</span> (p &lt; 0.005), and GM-CSF (p &lt; 0.005) mRNA in BAL fluid from patients with symptomatic <span class= disease  id= 8360390-6-180-186 >asthma</span> when compared with that from subjects <span class= negexp >free of</span> symptoms, but <span class= negexp >no difference</span> between the groups in numbers of cells expressing IL-2 and interferon-gamma mRNA.	8360390	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	1993
IL5	3567	AlteredExpression	BEFREE	IL-4 mRNA and <span class= gene  id= 12759454-8-14-18 >IL-5</span> mRNA were significantly higher in the xenografts of <span class= disease  id= 12759454-8-71-80 >asthmatic</span> huPBMC-SCID mice than those in the xenografts of normal huPBMC-SCID mice, but there were no significant differences in the expressions of IL-2 mRNA or IFN-gamma mRNA between them.	12759454	signaling molecule	interleukin 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.326724320987281	2003
CCL11	6356	AlteredExpression	BEFREE	Eotaxin-3 but not <span class= gene  id= 11415932-0-18-25 >eotaxin</span> gene expression is upregulated in <span class= disease  id= 11415932-0-60-70 >asthmatics</span> 24 hours after allergen challenge.	11415932	signaling molecule	C-C motif chemokine ligand 11	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.318741210136161	2001
CCL11	6356	AlteredExpression	BEFREE	We studied the correlation between the <span class= gene  id= 22846146-6-39-46 >eotaxin</span> gene expression level in the material from nasal brushing and respiratory tests in <span class= disease  id= 22846146-6-130-136 >asthma</span> and COPD patients.	22846146	signaling molecule	C-C motif chemokine ligand 11	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.318741210136161	2012
CCL11	6356	AlteredExpression	BEFREE	These results indicate that Th2 cytokines and TGF-beta may contribute to the pathogenesis of <span class= disease  id= 20214667-14-93-99 >asthma</span> by stimulating expression of <span class= gene  id= 20214667-14-129-134 >CCL11</span>.	20214667	signaling molecule	C-C motif chemokine ligand 11	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.318741210136161	2010
CCL11	6356	AlteredExpression	BEFREE	This study aimed to determine whether pseudotyped AAV2/9 virus carrying the small hairpin RNA targeting <span class= gene  id= 22913580-4-104-109 >CCL11</span> and expressed by CMV/U6 promoter could reduce eosinophilia and <span class= disease  id= 22913580-4-173-182 >asthmatic</span> responses in mite allergen-sensitized mice.	22913580	signaling molecule	C-C motif chemokine ligand 11	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.318741210136161	2013
CCL11	6356	AlteredExpression	LHGDN	Our results suggest that the polymorphisms of the eotaxin gene family are associated with the susceptibility of asthma and Eotaxin-3 might play the critical role for the recruitment of eosinophils and the maintenance of IgE levels.	15207712	signaling molecule	C-C motif chemokine ligand 11	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.318741210136161	2004
CCL11	6356	AlteredExpression	LHGDN	A highly significant association of the newly studied (GAAGGA) (n) hexanucleotide repeat with asthma (p = 3x10 (-6)), log (10) TsIgE (p = 0.006) and eotaxin levels (p = 0.004) was observed.	17220216	signaling molecule	C-C motif chemokine ligand 11	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.318741210136161	2007
CCL11	6356	AlteredExpression	BEFREE	The <span class= gene  id= 26810221-5-4-11 >eotaxin</span> receptor CCR3 was expressed at high levels on submucosal endothelial cells in patients and a murine model of <span class= disease  id= 26810221-5-121-127 >asthma</span>.	26810221	signaling molecule	C-C motif chemokine ligand 11	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.318741210136161	2015
CCL11	6356	AlteredExpression	BEFREE	<span class= disease  id= 23600543-7-0-10 >Asthmatics</span> with glutathione S-transferase P1 Val(105)/Val(105) compared with <span class= disease  id= 23600543-7-77-87 >asthmatics</span> with the glutathione S-transferase P1 Val(105)/Ile(105) and Ile(105)/Ile(105) had greater generation of acute phase cytokines (TNF-&alpha;, IL-6, CXCL8), IL-12, <span class= gene  id= 23600543-7-243-248 >CCL11</span>, thromboxane B2 and immunoglobulin E at 24 h after local allergen challenge.	23600543	signaling molecule	C-C motif chemokine ligand 11	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.318741210136161	2013
GSTP1	2950	AlteredExpression	BEFREE	Three of these genes were previously implicated in both <span class= disease  id= 25895113-10-56-62 >asthma</span> and IBD (ZPBP2 IL1R1, and IL18R1) and 3 in asthma only (PYHIN1, IL2RB, and <span class= gene  id= 25895113-10-138-143 >GSTP1</span>).	25895113	null	glutathione S-transferase pi 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.305203087261019	2016
CD14	929	AlteredExpression	BEFREE	Atopy appears to play a role in the level of <span class= gene  id= 11149987-12-45-49 >CD14</span> expression and may contribute to LPS sensitivity in <span class= disease  id= 11149987-12-102-111 >asthmatic</span> subjects.	11149987	null	CD14 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.298695032323084	2001
CD14	929	AlteredExpression	BEFREE	Our data suggest that PAR-2 -mediated activation of <span class= gene  id= 26658828-10-52-56 >CD14</span>++CD16+ monocytes may play a role in the pathogenesis of severe <span class= disease  id= 26658828-10-120-126 >asthma</span>.	26658828	null	CD14 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.298695032323084	2015
CD14	929	AlteredExpression	BEFREE	<span class= gene  id= 15879416-0-0-4 >CD14</span> tobacco gene-environment interaction modifies <span class= disease  id= 15879416-0-51-57 >asthma</span> severity and immunoglobulin E levels in Latinos with <span class= disease  id= 15879416-0-111-117 >asthma</span>.	15879416	null	CD14 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.298695032323084	2005
CD14	929	AlteredExpression	BEFREE	Finally we showed that human <span class= gene  id= 24358127-9-29-33 >CD14</span>(+)CD16(+) intermediate monocytes, which are found in increased numbers in patients with allergies and <span class= disease  id= 24358127-9-136-152 >bronchial asthma</span>, expressed high levels of miR-124 and exhibited other properties of M2-like cells.	24358127	null	CD14 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.298695032323084	2013
CD14	929	AlteredExpression	BEFREE	Those with <span class= gene  id= 16387800-11-11-15 >CD14</span> -159CC and CC16 38AA had no change in sCD14 and CC16 levels and more severe <span class= disease  id= 16387800-11-92-98 >asthma</span>.	16387800	null	CD14 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.298695032323084	2006
TGFB1	7040	AlteredExpression	BEFREE	TGF-beta(2) expression was observed in both the normal and <span class= disease  id= 17651146-9-59-68 >asthmatic</span> bronchial epithelium, and both real-time PCR and an ELISA showed a significant basal and <span class= gene  id= 17651146-9-158-168 >TGF-beta(1</span>)-induced TGF-beta(2) expression in the bronchial epithelial cell line BEAS2B.	17651146	signaling molecule	transforming growth factor beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.292753357385021	2007
TGFB1	7040	AlteredExpression	BEFREE	<span class= gene  id= 21908588-2-0-30 >Transforming growth factor-&beta;(1</span>) (<span class= gene  id= 21908588-2-33-40 >TGF-&beta;(1</span>)) is upregulated in <span class= disease  id= 21908588-2-61-67 >asthma</span> and COPD and contributes to tissue remodeling in the airways by driving ECM production by structural cells, including airway smooth muscle.	21908588	signaling molecule	transforming growth factor beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.292753357385021	2012
TGFB1	7040	AlteredExpression	BEFREE	Controversy surrounding the increased expression of <span class= gene  id= 17892594-0-52-62 >TGF beta 1</span> in <span class= disease  id= 17892594-0-66-72 >asthma</span>.	17892594	signaling molecule	transforming growth factor beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.292753357385021	2007
TGFB1	7040	AlteredExpression	BEFREE	Urotensin upregulates <span class= gene  id= 22270542-0-22-51 >transforming growth factor-&beta;1</span> expression of <span class= disease  id= 22270542-0-66-72 >asthma</span> airway through ERK-dependent pathway.	22270542	signaling molecule	transforming growth factor beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.292753357385021	2012
TGFB1	7040	AlteredExpression	BEFREE	Eosinophils enhance WNT-5a and <span class= gene  id= 27297409-0-31-37 >TGF-&beta;1</span> genes expression in airway smooth muscle cells and promote their proliferation by increased extracellular matrix proteins production in <span class= disease  id= 27297409-0-174-180 >asthma</span>.	27297409	signaling molecule	transforming growth factor beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.292753357385021	2016
TGFB1	7040	AlteredExpression	LHGDN	activation of TGF-beta1/Smad2 signaling is associated with airway remodeling in asthma	12170265	signaling molecule	transforming growth factor beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.292753357385021	2002
TGFB1	7040	AlteredExpression	LHGDN	Neutrophil derived elastase (NE) upregulates TGF-beta1 gene expression and release via My88/IRAK/NF-kappaB pathway, possibly through activation of TLR4, and shed light on a potential role of neutrophils in the pathogenesis of asthma.	16690986	signaling molecule	transforming growth factor beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.292753357385021	2006
TGFB1	7040	AlteredExpression	BEFREE	While <span class= gene  id= 8202878-11-6-16 >TGF-beta 1</span> mRNA and protein are abundantly expressed in human lungs, there is <span class= negexp >no clear difference</span> in expression between the airways of <span class= disease  id= 8202878-11-141-150 >asthmatic</span> subjects and those of smokers with and without COPD.	8202878	signaling molecule	transforming growth factor beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.292753357385021	1994
TGFB1	7040	AlteredExpression	BEFREE	<span class= gene  id= 8810646-0-0-33 >Transforming growth factor beta 1</span> (<span class= gene  id= 8810646-0-35-45 >TGF beta 1</span>) gene expression by eosinophils in <span class= disease  id= 8810646-0-81-90 >asthmatic</span> airway inflammation.	8810646	signaling molecule	transforming growth factor beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.292753357385021	1996
SCGB1A1	7356	AlteredExpression	BEFREE	We propose that: (i) IL-4- and IL-13-stimulated SCCA gene expression is mediated via STAT-1 and STAT-6 activation, and (ii) by suppressing the production, and most likely by interfering with the signaling of these cytokines, <span class= gene  id= 15677460-8-225-227 >UG</span> inhibits SCCA gene expression associated with airway inflammation in <span class= disease  id= 15677460-8-297-303 >asthma</span>.	15677460	signaling molecule	secretoglobin family 1A member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.261503373982605	2005
SCGB1A1	7356	AlteredExpression	BEFREE	There was a significant further decrease of <span class= gene  id= 19076932-6-44-48 >CC10</span> expression in patients with NPs and <span class= disease  id= 19076932-6-85-91 >asthma</span>.	19076932	signaling molecule	secretoglobin family 1A member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.261503373982605	2009
SCGB1A1	7356	AlteredExpression	LHGDN	<span class=gene id=15677460>Uteroglobin</span> suppresses SCCA gene expression associated with airway inflammation in <span class=disease id=15677460>asthma</span>	15677460	signaling molecule	secretoglobin family 1A member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.261503373982605	2005
SCGB1A1	7356	AlteredExpression	BEFREE	Lower <span class= gene  id= 26439880-11-6-11 >CC-16</span> serum level was associated with impaired lung function and AR, suggesting that serum <span class= gene  id= 26439880-11-97-102 >CC-16</span> level may reflect early damages to the lung epithelium in adults without <span class= disease  id= 26439880-11-176-182 >asthma</span>.	26439880	signaling molecule	secretoglobin family 1A member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.261503373982605	2015
SCGB1A1	7356	AlteredExpression	BEFREE	Serum <span class= gene  id= 21255142-10-6-10 >CC16</span> levels in the children with rhinitis who develop <span class= disease  id= 21255142-10-60-66 >asthma</span> and carry the AA genotype were significantly lower than those who carry the non-AA genotype and those who did <span class= negexp >not develop</span> <span class= disease  id= 21255142-10-189-195 >asthma</span>.	21255142	signaling molecule	secretoglobin family 1A member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.261503373982605	2011
SCGB1A1	7356	AlteredExpression	BEFREE	Those with CD14 -159CC and <span class= gene  id= 16387800-11-27-31 >CC16</span> 38AA had no change in sCD14 and <span class= gene  id= 16387800-11-64-68 >CC16</span> levels and more severe <span class= disease  id= 16387800-11-92-98 >asthma</span>.	16387800	signaling molecule	secretoglobin family 1A member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.261503373982605	2006
CCL5	6352	AlteredExpression	BEFREE	Our data indicate that the suppression of the expression of <span class= gene  id= 10386610-5-60-66 >RANTES</span> can be accomplished by TZD treatment, raising the possibility that TZD might be of therapeutic value in diseases such as <span class= disease  id= 10386610-5-188-194 >asthma</span>.	10386610	signaling molecule	C-C motif chemokine ligand 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.260367665065757	1999
CCL5	6352	AlteredExpression	BEFREE	The presence of increased <span class= gene  id= 22444510-9-26-30 >CCL5</span> levels in nasal epithelia at the time of bronchiolitis or the development of allergic sensitization by age 3 years are associated with increased likelihood of subsequent <span class= disease  id= 22444510-9-201-207 >asthma</span>.	22444510	signaling molecule	C-C motif chemokine ligand 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.260367665065757	2012
CCL5	6352	AlteredExpression	BEFREE	<span class= gene  id= 8534483-6-0-6 >RANTES</span> was also expressed in the bronchial epithelium in vivo, as indicated by positive immunocytochemical staining of bronchial biopsy tissues obtained from mild <span class= disease  id= 8534483-6-163-172 >asthmatic</span> patients before and after treatment with 500 micrograms of inhaled beclomethasone dipropionate (BDP) twice daily or matched placebo for 4 mo.	8534483	signaling molecule	C-C motif chemokine ligand 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.260367665065757	1996
CCL5	6352	AlteredExpression	BEFREE	Expression of <span class= gene  id= 8970374-0-14-20 >RANTES</span> mRNA and protein in airways of patients with mild <span class= disease  id= 8970374-0-71-77 >asthma</span>.	8970374	signaling molecule	C-C motif chemokine ligand 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.260367665065757	1997
CCL5	6352	AlteredExpression	BEFREE	There was a weak and <span class= negexp >negative correlation</span> between T-bet expression and <span class= gene  id= 17302903-8-71-77 >RANTES</span> level in the <span class= disease  id= 17302903-8-91-101 >asthmatics</span> (r=-0 x 29, P=0 x 032).	17302903	signaling molecule	C-C motif chemokine ligand 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.260367665065757	2007
NPSR1	387129	AlteredExpression	LHGDN	Because remodeling of airway epithelium is a feature of chronic asthma, the up-regulation of MMP10 and TIMP3 by NPS-NPSR1 signaling may be of relevance in the pathogenesis of asthma.	16926187	receptor	neuropeptide S receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.259967097348936	2006
NPSR1	387129	AlteredExpression	LHGDN	GPRA might have functional relevance in modulating asthma by increased expression levels in the relevant tissues under diseased state and by potential inhibitory effect of GPRA-A activation on cell growth	15947423	receptor	neuropeptide S receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.259967097348936	2005
ALOX5	240	AlteredExpression	BEFREE	We used in situ PCR in this model of human <span class= disease  id= 11035107-2-43-49 >asthma</span> to detect lung mRNA for <span class= gene  id= 11035107-2-74-88 >5-lipoxygenase</span> (<span class= gene  id= 11035107-2-90-94 >5-LO</span>) and <span class= gene  id= 11035107-2-100-104 >5-LO</span>-activating protein (FLAP), key proteins necessary for leukotriene synthesis.	11035107	oxidoreductase	arachidonate 5-lipoxygenase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.251772945574828	2000
ALOX5	240	AlteredExpression	BEFREE	Leukotrienes (LTs) derived from <span class= gene  id= 20093252-1-32-46 >5-lipoxygenase</span> (<span class= gene  id= 20093252-1-48-52 >5-LO</span>) activity are most widely known for their actions during acute inflammation and <span class= disease  id= 20093252-1-133-139 >asthma</span>.	20093252	oxidoreductase	arachidonate 5-lipoxygenase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.251772945574828	2010
ALOX5	240	AlteredExpression	BEFREE	Expression of <span class= gene  id= 9642160-0-14-28 >5-lipoxygenase</span> and <span class= gene  id= 9642160-0-33-47 >5-lipoxygenase</span>-activating protein mRNAs in the peripheral blood leukocytes of <span class= disease  id= 9642160-0-111-121 >asthmatics</span>.	9642160	oxidoreductase	arachidonate 5-lipoxygenase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.251772945574828	1998
ORMDL3	94103	AlteredExpression	BEFREE	We determined the relationship between expression of <span class= gene  id= 25842287-5-53-59 >ORMDL3</span> and ceramide in epithelial and inflammatory cells and in <span class= disease  id= 25842287-5-117-123 >asthma</span> pathogenesis in mice.	25842287	null	ORMDL sphingolipid biosynthesis regulator 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.249822826062325	2015
ORMDL3	94103	AlteredExpression	BEFREE	A polymorphism controlling <span class= gene  id= 18395550-0-27-33 >ORMDL3</span> expression is associated with <span class= disease  id= 18395550-0-64-70 >asthma</span> that is poorly controlled by current medications.	18395550	null	ORMDL sphingolipid biosynthesis regulator 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.249822826062325	2008
ORMDL3	94103	AlteredExpression	BEFREE	Luciferase assays were used to measure the effect of putative promoter SNPs on expression of the <span class= disease  id= 26483175-7-97-103 >asthma</span>-associated orosomucoid-like 3 gene (<span class= gene  id= 26483175-7-140-146 >ORMDL3</span>).	26483175	null	ORMDL sphingolipid biosynthesis regulator 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.249822826062325	2015
HLA-DQB1	3119	AlteredExpression	BEFREE	In addition, a high proportion of TDI <span class= disease  id= 9351595-7-38-48 >asthmatics</span> express the <span class= gene  id= 9351595-7-61-69 >HLA-DQB1</span>*0503-associated aspartic acid at residue 57, suggesting that HLA-DQ may have a key role in conferring susceptibility.	9351595	defense/immunity protein	major histocompatibility complex, class II, DQ beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.246399665202841	1997
IL1B	3553	AlteredExpression	BEFREE	IL-33 is a nuclear cytokine from the <span class= gene  id= 25278425-1-37-41 >IL-1</span> family constitutively expressed in epithelial barrier tissues and lymphoid organs, which plays important roles in type-2 innate immunity and human <span class= disease  id= 25278425-1-189-195 >asthma</span>.	25278425	signaling molecule	interleukin 1 beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.236143908360939	2014
IL1B	3553	AlteredExpression	BEFREE	All the <span class= disease  id= 1516385-5-8-17 >asthmatic</span> patients had increased numbers of monocytes in their BALF (p less than 0.002) and those cells invariably showed increased expression of <span class= gene  id= 1516385-5-154-172 >interleukin 1 beta</span> (<span class= gene  id= 1516385-5-174-182 >IL1 beta</span>) transcripts.	1516385	signaling molecule	interleukin 1 beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.236143908360939	1992
IL1B	3553	AlteredExpression	BEFREE	Phenotypic features of alveolar monocytes/macrophages and IL-8 gene activation by <span class= gene  id= 10919504-0-82-86 >IL-1</span> and TNF-alpha in <span class= disease  id= 10919504-0-104-113 >asthmatic</span> patients.	10919504	signaling molecule	interleukin 1 beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.236143908360939	2000
IL1B	3553	AlteredExpression	BEFREE	Levels of <span class= gene  id= 1374772-3-10-19 >IL-1 beta</span> (266 +/- 270 pg/ml versus less than 20 pg/ml) (p = 0.001) and IL-2 (1.4 +/- 2.8 ng/ml versus less than 0.3 ng/ml) (p = 0.05) in BALF in patients with symptomatic compared with that in BALF levels in patients with asymptomatic <span class= disease  id= 1374772-3-246-252 >asthma</span> suggested activation of alveolar macrophages and T cells.	1374772	signaling molecule	interleukin 1 beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.236143908360939	1992
IL1B	3553	AlteredExpression	BEFREE	Because <span class= disease  id= 23614732-4-8-14 >asthma</span> exacerbations are associated with elevated concentrations of secreted <span class= gene  id= 23614732-4-85-90 >IL-1&beta;</span>, we addressed whether the NLRP3 inflammasome is activated under in vitro conditions that mimic infectious exacerbations in <span class= disease  id= 23614732-4-214-220 >asthma</span>.	23614732	signaling molecule	interleukin 1 beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.236143908360939	2014
IL1B	3553	AlteredExpression	BEFREE	IL-33 is a recently characterized <span class= gene  id= 20689814-1-34-38 >IL-1</span> family cytokine and found to be expressed in inflammatory diseases, including severe <span class= disease  id= 20689814-1-124-130 >asthma</span> and inflammatory bowl disease.	20689814	signaling molecule	interleukin 1 beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.236143908360939	2010
IL1B	3553	AlteredExpression	BEFREE	Repression of COX-2 and <span class= gene  id= 25217662-8-24-29 >IL-1&beta;</span> expression by miR-146a correlated with reduced abundance of the RNA-binding protein human antigen R. These results demonstrate that miR-146a and miR-146b expression is inducible in hASMCs by proinflammatory cytokines and that miR-146a expression is greater in <span class= disease  id= 25217662-8-290-299 >asthmatic</span> cells.	25217662	signaling molecule	interleukin 1 beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.236143908360939	2014
IL1RN	3557	AlteredExpression	BEFREE	Differences in the genotypes and plasma concentrations of the <span class= gene  id= 10843772-0-62-95 >INTERLEUKIN-1 receptor antagonist</span> in black and white South African <span class= disease  id= 10843772-0-129-139 >asthmatics</span> and control subjects.	10843772	signaling molecule	interleukin 1 receptor antagonist	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.234913976154827	2000
IL12B	3593	AlteredExpression	BEFREE	We also observed additive effects of the risk alleles of <span class= gene  id= 23575353-7-57-62 >IL12B</span> and decreased mRNA levels of C/EBP&alpha; in <span class= disease  id= 23575353-7-102-111 >asthmatic</span> patients.	23575353	signaling molecule	interleukin 12B	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.234690406527927	2014
NOS2	4843	AlteredExpression	BEFREE	<span class= disease  id= 16597326-1-0-6 >Asthma</span> is associated with airway hyperresponsiveness and enhanced T-cell number/activity on one hand and increased levels of exhaled nitric oxide (NO) with expression of <span class= gene  id= 16597326-1-170-191 >inducible NO synthase</span> (<span class= gene  id= 16597326-1-193-197 >iNOS</span>) on the other hand.	16597326	null	nitric oxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.23076604236862	2006
NOS2	4843	AlteredExpression	BEFREE	BNP stimulated the release of acetylcholine (210.7 &plusmn; 11.1%) from BEAS-2B cells that in turn increased MYPT1 and <span class= gene  id= 24074453-10-112-116 >iNOS</span> gene/protein expression and enhanced NO levels in <span class= disease  id= 24074453-10-167-176 >asthmatic</span> ASM supernatant (35.0 &plusmn; 13.0%).	24074453	null	nitric oxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.23076604236862	2014
NOS2	4843	AlteredExpression	LHGDN	Increased expression of iNOS might have a role in the development of allergic inflammation in upper and lower airways and in comorbidity of allergic rhinitis and asthma.	18254476	null	nitric oxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.23076604236862	2008
NOS2	4843	AlteredExpression	BEFREE	They suppress <span class= disease  id= 8541027-5-14-23 >asthmatic</span> inflammation predominantly by reducing transcription of genes coding for inflammatory mediators (particularly cytokines) and enzymes (<span class= gene  id= 8541027-5-158-179 >inducible NO synthase</span>, inducible cyclo-oxygenase).	8541027	null	nitric oxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.23076604236862	1996
NOS2	4843	AlteredExpression	BEFREE	In non-<span class= disease  id= 22590587-6-7-17 >asthmatics</span>, after correction for multiple comparisons, we found significant associations of Fe(NO) levels with three SNPs in NOS3 and <span class= gene  id= 22590587-6-141-145 >NOS2</span> (P &le; 0.002), and of EBC NO2-NO3 level with NOS2 (P = 0.002).	22590587	null	nitric oxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.23076604236862	2012
VEGFA	7422	AlteredExpression	BEFREE	Gene expression of <span class= gene  id= 11398081-0-19-53 >vascular endothelial growth factor</span> and its receptors and angiogenesis in <span class= disease  id= 11398081-0-92-108 >bronchial asthma</span>.	11398081	signaling molecule	vascular endothelial growth factor A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.228405585382312	2001
VEGFA	7422	AlteredExpression	BEFREE	The levels of HIF-1&alpha; and <span class= gene  id= 21517900-9-25-29 >VEGF</span> increased in lung tissue and bronchial fluid of patients with <span class= disease  id= 21517900-9-92-98 >asthma</span> and in the nasal fluid of patients with rhinitis after challenge.	21517900	signaling molecule	vascular endothelial growth factor A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.228405585382312	2011
VEGFA	7422	AlteredExpression	LHGDN	<span class=gene id=16645174>VEGF</span> regulates MMP-9 expression and plays a critical role in initiation and maintenance of <span class=disease id=16645174>asthma</span>.	16645174	signaling molecule	vascular endothelial growth factor A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.228405585382312	2006
VEGFA	7422	AlteredExpression	BEFREE	Allergen treatment and lung-specific <span class= gene  id= 21595947-6-37-71 >vascular endothelial growth factor</span> (<span class= gene  id= 21595947-6-73-77 >VEGF</span>) expression induced <span class= disease  id= 21595947-6-98-104 >asthma</span>-like pathologies in the murine lungs.	21595947	signaling molecule	vascular endothelial growth factor A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.228405585382312	2011
VEGFA	7422	AlteredExpression	LHGDN	The increased expression of sputum VEGF in asthmatic children reinforces the concept that it might have a pathogenetic role in bronchial asthma and may represent a biomarker of airway inflammation.	18298425	signaling molecule	vascular endothelial growth factor A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.228405585382312	2009
VEGFA	7422	AlteredExpression	BEFREE	Relationship between neurokinin 2 receptor gene polymorphisms and serum <span class= gene  id= 16961715-0-72-106 >vascular endothelial growth factor</span> levels in patients with toluene diisocyanate-induced <span class= disease  id= 16961715-0-160-166 >asthma</span>.	16961715	signaling molecule	vascular endothelial growth factor A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.228405585382312	2007
VEGFA	7422	AlteredExpression	BEFREE	<span class= gene  id= 24152156-11-0-4 >VEGF</span> levels were <span class= negexp >not associated</span> with <span class= disease  id= 24152156-11-37-46 >asthmatic</span> symptoms or lung function measures.	24152156	signaling molecule	vascular endothelial growth factor A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.228405585382312	2013
MMP9	4318	AlteredExpression	BEFREE	Taken together, these data demonstrate that TNF-alpha increases <span class= gene  id= 14734780-12-64-69 >MMP-9</span> and tenascin expression in bronchial fibroblasts via the transcription factor Ets-1, and suggest a role for Ets-1 in airway remodeling in <span class= disease  id= 14734780-12-208-214 >asthma</span>.	14734780	null	matrix metallopeptidase 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226878479989308	2004
MMP9	4318	AlteredExpression	BEFREE	To determine whether the expression of key <span class= disease  id= 23804543-1-43-49 >asthma</span> related genes, IL-4, LIGHT, LTBR, MMP-9, CCR-2, and ADAM-33 in mononuclear cells and the plasma concentration of nitric oxide metabolites (NOM) and <span class= gene  id= 23804543-1-198-203 >MMP-9</span> are increased in the obese, obese type 2 diabetics (T2DM) and in morbidly obese patients prior to and after gastric bypass surgery (RYGB).	23804543	null	matrix metallopeptidase 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226878479989308	2013
MMP9	4318	AlteredExpression	BEFREE	These data indicate that HRV-induced activation of the MEK/ERK MAPK pathway and Fra-1 expression are necessary for the upregulation of <span class= gene  id= 22461694-10-135-140 >MMP-9</span> and can be modulated by two distinct but commonly used <span class= disease  id= 22461694-10-196-202 >asthma</span> pharmacotherapies.	22461694	null	matrix metallopeptidase 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226878479989308	2012
TSLP	85480	AlteredExpression	BEFREE	Surprisingly, the IL-1 signaling pathway was also proposed to control the activation of <span class= gene  id= 23953709-4-88-116 >thymic stromal lymphopoietin</span> (<span class= gene  id= 23953709-4-118-122 >TSLP</span>), a cytokine implicated in development of the T(H)2 response in patients with atopic dermatitis (AD) and <span class= disease  id= 23953709-4-228-234 >asthma</span>.	23953709	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2013
TSLP	85480	AlteredExpression	LHGDN	Elevated bronchial mucosal expression of <span class=gene id=15944327>TSLP</span> is implicated in <span class=disease id=15944327>asthma</span> pathogenesis; its action is partly through selective development and retention, or recruitment of T helper type 2, not Th1, receptor-bearing cells.	15944327	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2005
TSLP	85480	AlteredExpression	BEFREE	Excessive expression of <span class= gene  id= 20079130-1-24-52 >thymic stromal lymphopoietin</span> (<span class= gene  id= 20079130-1-54-58 >TSLP</span>) has been demonstrated in <span class= disease  id= 20079130-1-85-94 >asthmatic</span> airway epithelia and in nasal epithelia from animal models of allergic rhinitis (AR), but the evidence of expression of <span class= gene  id= 20079130-1-215-219 >TSLP</span> in nasal epithelial cells (NECs) of patients with AR is lacking.	20079130	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2010
TSLP	85480	AlteredExpression	BEFREE	This role is supported by the finding that <span class= gene  id= 20146705-8-43-47 >TSLP</span> expression is upregulated in keratinocytes of atopic dermatitis skin lesions and in bronchial epithelial cells in <span class= disease  id= 20146705-8-162-168 >asthma</span>.	20146705	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2010
TSLP	85480	AlteredExpression	BEFREE	<span class= gene  id= 25680454-3-0-28 >Thymic stromal lymphopoietin</span> (<span class= gene  id= 25680454-3-30-34 >TSLP</span>) has been found at high levels in patients with <span class= disease  id= 25680454-3-83-89 >asthma</span> and idiopathic pulmonary fibrosis, and TSLP has been proposed as a primary driver of lung fibrotic disease.	25680454	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2014
TSLP	85480	AlteredExpression	BEFREE	Double-stranded RNA induces disproportionate expression of <span class= gene  id= 20627922-0-59-87 >thymic stromal lymphopoietin</span> versus interferon-beta in bronchial epithelial cells from donors with <span class= disease  id= 20627922-0-158-164 >asthma</span>.	20627922	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2010
TSLP	85480	AlteredExpression	LHGDN	There is distinct airways expression of <span class=gene id=18684970>TSLP</span> and chemokines which preferentially attract T helper (Th) type 1- and Th2-type T cells, and influx of T cells bearing their receptors in <span class=disease id=18684970>asthma</span> and chronic obstructive pulmonary disease.	18684970	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2008
TSLP	85480	AlteredExpression	BEFREE	dsRNA-induced expression of <span class= gene  id= 20951221-0-28-56 >thymic stromal lymphopoietin</span> (<span class= gene  id= 20951221-0-58-62 >TSLP</span>) in <span class= disease  id= 20951221-0-67-76 >asthmatic</span> epithelial cells is inhibited by a small airway relaxant.	20951221	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2010
TSLP	85480	AlteredExpression	BEFREE	Increased expression of immunoreactive <span class= gene  id= 21975173-0-39-67 >thymic stromal lymphopoietin</span> in patients with severe <span class= disease  id= 21975173-0-92-98 >asthma</span>.	21975173	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2011
TSLP	85480	AlteredExpression	BEFREE	Expression of sDC OX40L and CCL17 mRNA was increased in <span class= disease  id= 25813919-9-56-65 >asthmatic</span> cases (P = .003 and P = .0001, respectively). sHBEC <span class= gene  id= 25813919-9-118-122 >TSLP</span> mRNA expression was strongly associated with sDC OX40L mRNA expression (R = 0.65, P = .001) and less strongly with sDC CCL17 mRNA expression. sHBEC IL33 mRNA expression was associated with sDC OX40L mRNA expression (R = 0.42, P = .04) but not sDC CCL17 mRNA expression.	25813919	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2014
TSLP	85480	AlteredExpression	BEFREE	Lung-specific <span class= gene  id= 18941246-1-14-42 >thymic stromal lymphopoietin</span> (<span class= gene  id= 18941246-1-44-48 >TSLP</span>) expression is sufficient for the development of an <span class= disease  id= 18941246-1-101-107 >asthma</span>-like chronic airway inflammatory disease.	18941246	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2009
TSLP	85480	AlteredExpression	BEFREE	Consistent with this observation, airway epithelial cells from <span class= disease  id= 22981788-7-63-72 >asthmatic</span> children a produced significantly greater levels of <span class= gene  id= 22981788-7-125-129 >TSLP</span> after RSV infection than cells from healthy children.	22981788	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2012
TSLP	85480	AlteredExpression	BEFREE	<span class= gene  id= 15944327-0-0-28 >Thymic stromal lymphopoietin</span> expression is increased in <span class= disease  id= 15944327-0-56-65 >asthmatic</span> airways and correlates with expression of Th2-attracting chemokines and disease severity.	15944327	null	thymic stromal lymphopoietin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.226134167548616	2005
IL1RL1	9173	AlteredExpression	BEFREE	Patients with positive family history of <span class= disease  id= 27026044-8-41-47 >asthma</span> exhibited more CD203c and <span class= gene  id= 27026044-8-74-78 >ST2L</span> expression (p&lt;0.05).	27026044	receptor	interleukin 1 receptor like 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.225076647812092	2017
RNASE3	6037	AlteredExpression	LHGDN	In the asthma group, there was no correlation between methacholine end-point concentration and the eosinophil counts or serum ECP levels/contrast, AMP end-point concentration correlated with the eosinophil counts and with serum ECP levels.	17573858	enzyme modulator; nucleic acid binding; hydrolase	ribonuclease A family member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.224731822872916	2007
RNASE3	6037	AlteredExpression	BEFREE	Similar results were obtained with serum <span class= gene  id= 8648029-5-41-44 >ECP</span> levels: levels in patients with acute asthma were highest (20.30 +/- 5.31 micrograms/L), followed by levels in patients with stable <span class= disease  id= 8648029-5-177-183 >asthma</span> (2.76 +/- 0.65 micrograms/L) and levels in normal control subjects (1.37 +/- 0.06 micrograms/L; p &lt; 0.01 for all comparisons).	8648029	enzyme modulator; nucleic acid binding; hydrolase	ribonuclease A family member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.224731822872916	1996
RNASE3	6037	AlteredExpression	BEFREE	To examine the relationships between IL-3 and GM-CSF messenger (m) ribonucleic acid (RNA) expression in peripheral blood CD4+ cells and serum levels of <span class= gene  id= 8835120-2-152-179 >eosinophil cationic protein</span> (<span class= gene  id= 8835120-2-181-184 >ECP</span>), a marker of eosinophil activation, and disease activity in <span class= disease  id= 8835120-2-246-252 >asthma</span>.	8835120	enzyme modulator; nucleic acid binding; hydrolase	ribonuclease A family member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.224731822872916	1996
RNASE3	6037	AlteredExpression	BEFREE	Eosinophil numbers, <span class= gene  id= 11097314-3-20-47 >eosinophil cationic protein</span> (<span class= gene  id= 11097314-3-49-52 >ECP</span>), and the expression of eotaxin were examined in induced sputum from atopic <span class= disease  id= 11097314-3-129-139 >asthmatics</span> (AA = 11), nonatopic <span class= disease  id= 11097314-3-161-171 >asthmatics</span> (NAA = 11), and atopic (AC = 12) and normal (NC = 10) controls.	11097314	enzyme modulator; nucleic acid binding; hydrolase	ribonuclease A family member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.224731822872916	2001
RNASE3	6037	AlteredExpression	BEFREE	<span class= gene  id= 26600485-0-0-27 >Eosinophil cationic protein</span> mRNA expression in children with <span class= disease  id= 26600485-0-61-77 >bronchial asthma</span>.	26600485	enzyme modulator; nucleic acid binding; hydrolase	ribonuclease A family member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.224731822872916	2016
RNASE3	6037	AlteredExpression	BEFREE	Levels of <span class= gene  id= 16136454-6-10-37 >eosinophil cationic protein</span> in sputum were also greater in the children with <span class= disease  id= 16136454-6-87-93 >asthma</span> who had higher nasal viral burdens than they were in those who had lower nasal viral burdens.	16136454	enzyme modulator; nucleic acid binding; hydrolase	ribonuclease A family member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.224731822872916	2005
SCGB3A2	117156	AlteredExpression	BEFREE	The secretory protein, <span class= gene  id= 18201431-1-23-52 >uteroglobin-related protein 1</span> (<span class= gene  id= 18201431-1-54-59 >UGRP1</span>), is expressed mainly in the lung and trachea and recently has been implicated in <span class= disease  id= 18201431-1-142-148 >asthma</span>.	18201431	null	secretoglobin family 3A member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.222981147853012	2008
SCGB3A2	117156	AlteredExpression	BEFREE	The secretory protein, <span class= gene  id= 15591807-1-23-52 >uteroglobin-related protein 1</span> (<span class= gene  id= 15591807-1-54-59 >UGRP1</span>), is mainly expressed in the lung and trachea and has recently been implicated in <span class= disease  id= 15591807-1-142-148 >asthma</span>.	15591807	null	secretoglobin family 3A member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.222981147853012	2004
SCGB3A2	117156	AlteredExpression	BEFREE	Also plasma <span class= gene  id= 21503925-5-12-17 >UGRP1</span> levels were shown to be associated both with this polymorphism and the severity of <span class= disease  id= 21503925-5-101-107 >asthma</span>.	21503925	null	secretoglobin family 3A member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.222981147853012	2012
EDN1	1906	AlteredExpression	BEFREE	HRH1 was differentially expressed in adults with <span class= disease  id= 23448392-8-49-55 >asthma</span> vs. controls (p = 0.04), and <span class= gene  id= 23448392-8-85-89 >EDN1</span> was differentially expressed in children with <span class= disease  id= 23448392-8-136-142 >asthma</span> vs. controls 12-18 years old (p = 0.03).	23448392	null	endothelin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.222380537127273	2013
EDN1	1906	AlteredExpression	BEFREE	Furthermore, erythromycin and clarithromycin inhibited <span class= gene  id= 9701415-7-55-59 >ET-1</span> expression in bronchoepithelial cells from patients with chronic, stable <span class= disease  id= 9701415-7-133-139 >asthma</span>.	9701415	null	endothelin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.222380537127273	1998
EDN1	1906	AlteredExpression	BEFREE	Augmented epithelial <span class= gene  id= 17996929-0-21-33 >endothelin-1</span> expression in refractory <span class= disease  id= 17996929-0-59-65 >asthma</span>.	17996929	null	endothelin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.222380537127273	2007
EDN1	1906	AlteredExpression	BEFREE	When hydrocortisone (10(-6)M) was added to the culture medium of <span class= disease  id= 1443891-7-65-74 >asthmatic</span> bronchial epithelial cells for 48 h, the release of immunoreactive endothelin significantly decreased (p &lt; 0.025), but the numbers of cells expressing <span class= gene  id= 1443891-7-226-244 >preproendothelin 1</span> mRNA did not change to the same extent.	1443891	null	endothelin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.222380537127273	1992
SPINK5	11005	AlteredExpression	BEFREE	SPINK5 single-nucleotide polymorphisms (SNPs) and <span class= gene  id= 22570283-4-50-56 >SPINK5</span> expression levels were correlated with CRS without (CRSsNP) and with nasal polyps (CRSwNP), aspirin intolerance, <span class= disease  id= 22570283-4-170-176 >asthma</span>, and allergies.	22570283	enzyme modulator	serine peptidase inhibitor, Kazal type 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.222278222812648	2012
ICAM1	3383	AlteredExpression	BEFREE	<span class= gene  id= 9731032-6-0-6 >ICAM-1</span> expression was significantly increased in bronchial epithelial cells from untreated <span class= disease  id= 9731032-6-91-101 >asthmatics</span>, but ICAM-1 was not expressed in those from steroid-dependent asthmatic patients.	9731032	cell adhesion molecule; signaling molecule	intercellular adhesion molecule 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.218218247963749	1998
ICAM1	3383	AlteredExpression	BEFREE	Collectively, these observations provide new evidence demonstrating that activation of the CAM counterreceptor ligands <span class= gene  id= 10835320-7-119-125 >ICAM-1</span> and LFA-1, both of which are endogenously expressed in ASM cells, elicits autologously upregulated IL-5 release and associated changes in <span class= gene  id= 10835320-7-264-270 >ICAM-1</span> expression and agonist responsiveness in atopic <span class= disease  id= 10835320-7-319-328 >asthmatic</span> sensitized ASM.	10835320	cell adhesion molecule; signaling molecule	intercellular adhesion molecule 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.218218247963749	2000
IL33	90865	AlteredExpression	BEFREE	Serum <span class= gene  id= 26107423-3-6-11 >IL-33</span> levels are increased in various diseases, such as atopic dermatitis, chronic hepatitis C infection, and <span class= disease  id= 26107423-3-116-122 >asthma</span>.	26107423	null	interleukin 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.216836523017323	2016
IL33	90865	AlteredExpression	BEFREE	<span class= gene  id= 25278425-1-0-5 >IL-33</span> is a nuclear cytokine from the IL-1 family constitutively expressed in epithelial barrier tissues and lymphoid organs, which plays important roles in type-2 innate immunity and human <span class= disease  id= 25278425-1-189-195 >asthma</span>.	25278425	null	interleukin 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.216836523017323	2014
IL33	90865	AlteredExpression	BEFREE	<span class= gene  id= 20689814-1-0-5 >IL-33</span> is a recently characterized IL-1 family cytokine and found to be expressed in inflammatory diseases, including severe <span class= disease  id= 20689814-1-124-130 >asthma</span> and inflammatory bowl disease.	20689814	null	interleukin 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.216836523017323	2010
IL33	90865	AlteredExpression	BEFREE	In this study we demonstrate that both ICs and HDM induce expression of <span class= gene  id= 25088053-7-72-77 >IL-33</span>, a critical mediator in <span class= disease  id= 25088053-7-102-108 >asthma</span> pathogenesis and the differentiation of TH2 cells, in DCs.	25088053	null	interleukin 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.216836523017323	2014
IL33	90865	AlteredExpression	BEFREE	Induced sputum levels of <span class= gene  id= 23855553-0-25-30 >IL-33</span> and soluble ST2 in young <span class= disease  id= 23855553-0-56-65 >asthmatic</span> children.	23855553	null	interleukin 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.216836523017323	2014
IL33	90865	AlteredExpression	BEFREE	Expression of sDC OX40L and CCL17 mRNA was increased in <span class= disease  id= 25813919-9-56-65 >asthmatic</span> cases (P = .003 and P = .0001, respectively). sHBEC TSLP mRNA expression was strongly associated with sDC OX40L mRNA expression (R = 0.65, P = .001) and less strongly with sDC CCL17 mRNA expression. sHBEC <span class= gene  id= 25813919-9-271-275 >IL33</span> mRNA expression was associated with sDC OX40L mRNA expression (R = 0.42, P = .04) but not sDC CCL17 mRNA expression.	25813919	null	interleukin 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.216836523017323	2014
IL33	90865	AlteredExpression	BEFREE	Finally, we showed that <span class= gene  id= 19841166-10-24-29 >IL-33</span> was more abundantly expressed in the lung epithelial cells of <span class= disease  id= 19841166-10-92-98 >asthma</span> patients than those from healthy controls, suggesting that <span class= gene  id= 19841166-10-158-163 >IL-33</span> may be involved in lung macrophage activation in clinical <span class= disease  id= 19841166-10-222-228 >asthma</span>.	19841166	null	interleukin 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.216836523017323	2009
IL33	90865	AlteredExpression	BEFREE	Increased expression of <span class= gene  id= 19801525-0-24-29 >IL-33</span> in severe <span class= disease  id= 19801525-0-40-46 >asthma</span>: evidence of expression by airway smooth muscle cells.	19801525	null	interleukin 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.216836523017323	2009
IL33	90865	AlteredExpression	BEFREE	Alternaria-derived serine protease activity drives <span class= gene  id= 24636086-0-51-56 >IL-33</span>-mediated <span class= disease  id= 24636086-0-66-72 >asthma</span> exacerbations.	24636086	null	interleukin 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.216836523017323	2014
HLA-DQA1	3117	AlteredExpression	BEFREE	The cluster analysis of these DEGs showed that 4 genes, including human leukocyte antigen (<span class= gene  id= 24838153-3-91-99 >HLA-DQA1</span>), HLA-DRB4, integrin 3 (ITGB3) and killer cell lectin-like receptor subfamily F member 1 (KLRF1) were all significantly expressed in 3 groups, which were significantly enriched in <span class= disease  id= 24838153-3-280-286 >asthma</span>, T1D and intestinal immune network for IgA production pathway.	24838153	defense/immunity protein	major histocompatibility complex, class II, DQ alpha 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.215592235433893	2015
PTGDR2	11251	AlteredExpression	BEFREE	Considering the fact that eosinophil infiltration is prominent in the upper and lower airways of aspirin exacerbated respiratory disease (AERD) compared to aspirin-tolerant <span class= disease  id= 19796209-3-173-179 >asthma</span> (ATA) patients, we hypothesized that activation of eosinophils via dysregulation of the <span class= gene  id= 19796209-3-268-273 >CRTH2</span> gene may play an important role and be an important marker for AERD.	19796209	receptor	prostaglandin D2 receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.21538302118431	2010
PTGDR2	11251	AlteredExpression	BEFREE	Asthma exacerbations, poor <span class= disease  id= 23506843-11-27-33 >asthma</span> control, and TH2 inflammatory markers were associated with higher PGD2, HPGDS, and <span class= gene  id= 23506843-11-117-122 >CRTH2</span> levels.	23506843	receptor	prostaglandin D2 receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.21538302118431	2013
PTGDR2	11251	AlteredExpression	BEFREE	D prostanoid receptor 2 (<span class= gene  id= 25312757-0-25-92 >chemoattractant receptor-homologous molecule expressed on TH2 cells</span>) protein expression in <span class= disease  id= 25312757-0-116-125 >asthmatic</span> patients and its effects on bronchial epithelial cells.	25312757	receptor	prostaglandin D2 receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.21538302118431	2014
CCL2	6347	AlteredExpression	BEFREE	We demonstrated that <span class= gene  id= 25765592-8-21-25 >CCL2</span> and IL-17 levels and the frequency of Th17 and Tc17 cells in lung tissues and bronchoalveolar lavage fluid increased in the <span class= disease  id= 25765592-8-150-156 >asthma</span> group compared with the normal control mice.	25765592	signaling molecule	C-C motif chemokine ligand 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.214782410458571	2014
CCL2	6347	AlteredExpression	BEFREE	The mean serum <span class= gene  id= 16801146-5-15-20 >MCP-1</span> level was significantly lower in the <span class= disease  id= 16801146-5-58-67 >asthmatic</span> than in the control children.	16801146	signaling molecule	C-C motif chemokine ligand 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.214782410458571	2006
CCL2	6347	AlteredExpression	BEFREE	We conclude that cells contained in the bronchial secretions from <span class= disease  id= 14968124-7-66-76 >asthmatics</span> express higher amounts of mRNA for MMP-1 and TIMP-1, perhaps related to an increased expression of <span class= gene  id= 14968124-7-176-181 >MCP-1</span>, which might contribute to the extracellular matrix changes observed during airway remodelling.	14968124	signaling molecule	C-C motif chemokine ligand 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.214782410458571	2004
CAT	847	AlteredExpression	BEFREE	Although <span class= gene  id= 9038914-2-9-17 >catalase</span> and glutathione peroxidase in bronchial epithelium of <span class= disease  id= 9038914-2-72-82 >asthmatics</span> were similar to control SOD activity in <span class= disease  id= 9038914-2-123-133 >asthmatics</span> not on inhaled corticosteroid (-CS) was lower than <span class= disease  id= 9038914-2-185-195 >asthmatics</span> on inhaled corticosteroid (+CS) and controls.	9038914	oxidoreductase	catalase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.213250719445235	1997
ADA	100	AlteredExpression	LHGDN	The activity of <span class=gene id=12774669>ADA</span> was determined in lymphocytes, esoinophils and blood serum in patients with <span class=disease id=12774669>bronchial asthma</span>.	12774669	hydrolase	adenosine deaminase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.21105290517153	2003
TNC	3371	AlteredExpression	BEFREE	Consistently, <span class= gene  id= 21354146-5-14-24 >tenascin-C</span> expression in vivo was found to correlate with fibrin deposition in several diseases associated with <span class= gene  id= 21354146-5-126-136 >tenascin-C</span> overexpression such as fibrosis, <span class= disease  id= 21354146-5-170-176 >asthma</span> and cancer.	21354146	signaling molecule	tenascin C	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.210345394510833	2011
TNC	3371	AlteredExpression	BEFREE	Taken together, these data demonstrate that TNF-alpha increases MMP-9 and <span class= gene  id= 14734780-12-74-82 >tenascin</span> expression in bronchial fibroblasts via the transcription factor Ets-1, and suggest a role for Ets-1 in airway remodeling in <span class= disease  id= 14734780-12-208-214 >asthma</span>.	14734780	signaling molecule	tenascin C	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.210345394510833	2004
TNC	3371	AlteredExpression	BEFREE	OVA-challenged WT mice showed allergic inflammation and <span class= disease  id= 21205293-7-56-59 >AHR</span> in the airways along with increased expression of TNF-&alpha;, IFN-&gamma;, IL-4 and <span class= gene  id= 21205293-7-133-143 >tenascin-C</span> in the lungs.	21205293	signaling molecule	tenascin C	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.210345394510833	2011
ARG1	383	AlteredExpression	BEFREE	Microarray analysis of the expression profiles of lung tissue in two murine models of <span class= disease  id= 12813015-1-86-92 >asthma</span> revealed high levels of <span class= gene  id= 12813015-1-117-127 >arginase I</span> and arginase II activity, in association with IL-4 and IL-13 overexpression, suggesting that arginine pathways are critical in the pathogenesis of <span class= disease  id= 12813015-1-275-281 >asthma</span>.	12813015	hydrolase	arginase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.210294237353521	2003
ARG1	383	AlteredExpression	BEFREE	The expression of <span class= gene  id= 20382750-1-18-28 >arginase I</span> has been a focus of research into the pathogenesis of experimental <span class= disease  id= 20382750-1-96-102 >asthma</span>, because arginase deprives nitric oxide synthase (NOS) of arginine and therefore participates in the attenuation of bronchodilators such as nitric oxide (NO).	20382750	hydrolase	arginase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.210294237353521	2010
ARG1	383	AlteredExpression	BEFREE	We show here that T(h)2 cell-mediated inflammation in murine <span class= disease  id= 24150243-4-61-67 >asthma</span> models induces the expression of some markers of alternatively activated macrophage such as <span class= gene  id= 24150243-4-160-170 >arginase 1</span> and resistin-like molecule-&alpha; in iDCs by a mechanism depending on the intrinsic expression of STAT6.	24150243	hydrolase	arginase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.210294237353521	2014
HLA-G	3135	AlteredExpression	BEFREE	Abnormal <span class= gene  id= 23732778-2-9-14 >HLA-G</span> expression is present in various diseases, such as renal cell carcinoma, <span class= disease  id= 23732778-2-88-94 >asthma</span> and classical Hodgkin's lymphoma.	23732778	defense/immunity protein; receptor	major histocompatibility complex, class I, G	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.209744783785095	2013
HLA-G	3135	AlteredExpression	BEFREE	Maternal <span class= disease  id= 23534973-0-9-15 >asthma</span> and microRNA regulation of soluble <span class= gene  id= 23534973-0-51-56 >HLA-G</span> in the airway.	23534973	defense/immunity protein; receptor	major histocompatibility complex, class I, G	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.209744783785095	2013
PLAU	5328	AlteredExpression	LHGDN	Constitutive uPA primes, and exogenous uPA can activate, airway eosinophil adhesion following segmental allergen challenge and that increased uPA expression may be a mechanism of increased eosinophil infiltration and function in asthma.	16728704	protease; hydrolase	plasminogen activator, urokinase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.208748190962867	2006
PLAU	5328	AlteredExpression	LHGDN	Induced-sputum innate immune factor levels discriminate inflammatory changes in cystic fibrosis, COPD, and asthma.	16236890	protease; hydrolase	plasminogen activator, urokinase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.208748190962867	2005
ARG2	384	AlteredExpression	BEFREE	The elevated <span class= gene  id= 22712848-12-13-24 >arginase II</span> activity and expression may be a mechanism underlying adverse effects induced by PM exposure in <span class= disease  id= 22712848-12-121-127 >asthma</span> patients.	22712848	hydrolase	arginase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.207286598104494	2012
ARG2	384	AlteredExpression	BEFREE	Microarray analysis of the expression profiles of lung tissue in two murine models of <span class= disease  id= 12813015-1-86-92 >asthma</span> revealed high levels of arginase I and <span class= gene  id= 12813015-1-132-143 >arginase II</span> activity, in association with IL-4 and IL-13 overexpression, suggesting that arginine pathways are critical in the pathogenesis of <span class= disease  id= 12813015-1-275-281 >asthma</span>.	12813015	hydrolase	arginase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.207286598104494	2003
ARG2	384	AlteredExpression	BEFREE	To determine the relationships of iNOS expression/activation and <span class= gene  id= 22092728-3-65-75 >arginase 2</span> expression with <span class= disease  id= 22092728-3-92-98 >asthma</span> severity, FeNO, nitrotyrosine (NT) and eosinophilic inflammation.	22092728	hydrolase	arginase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.207286598104494	2011
ALDH2	217	AlteredExpression	BEFREE	Approximately half the <span class= disease  id= 17590989-6-23-32 >asthmatic</span> subjects developed bronchoconstriction with concomitant increases in blood acetaldehyde and histamine, which was associated with genetically reduced<span class= gene  id= 17590989-6-181-186 >ALDH2</span> activities.	17590989	oxidoreductase	aldehyde dehydrogenase 2 family (mitochondrial)	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.206462417751855	2008
AREG	374	AlteredExpression	BEFREE	<span class= gene  id= 15696083-9-0-12 >Amphiregulin</span> was also expressed in human lung mast cells from patients with <span class= disease  id= 15696083-9-76-82 >asthma</span>, as demonstrated by means of double-immunofluorescence staining.	15696083	signaling molecule	amphiregulin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.204655999954305	2005
AREG	374	AlteredExpression	BEFREE	IL-3 can induce basophils to express high levels of <span class= gene  id= 21036386-14-52-64 >amphiregulin</span>, which may contribute to tissue remodeling during type 2 immune responses such as <span class= disease  id= 21036386-14-147-153 >asthma</span>.	21036386	signaling molecule	amphiregulin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.204655999954305	2010
AREG	374	AlteredExpression	BEFREE	<span class= gene  id= 22247333-4-0-12 >Amphiregulin</span> and HB-EGF were expressed in airway epithelium of patients with <span class= disease  id= 22247333-4-77-83 >asthma</span>.	22247333	signaling molecule	amphiregulin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.204655999954305	2012
PARP1	142	AlteredExpression	BEFREE	In the present study, we provide evidence for the first time that <span class= gene  id= 26205779-10-66-72 >PARP-1</span> is activated in human <span class= disease  id= 26205779-10-95-101 >asthma</span> and that its inhibition is effective in blocking established <span class= disease  id= 26205779-10-163-169 >asthma</span> in mice.	26205779	ligase; nucleic acid binding	poly(ADP-ribose) polymerase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.204604842796993	2015
PARP1	142	AlteredExpression	BEFREE	<span class= gene  id= 21276008-0-0-6 >PARP-1</span> deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine <span class= disease  id= 21276008-0-101-107 >asthma</span> model.	21276008	ligase; nucleic acid binding	poly(ADP-ribose) polymerase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.204604842796993	2011
PDE4D	5144	AlteredExpression	BEFREE	We further elucidated that methylated <span class= gene  id= 26181301-9-38-43 >PDE4D</span> decreased <span class= gene  id= 26181301-9-54-59 >PDE4D</span> expression in <span class= disease  id= 26181301-9-74-83 >asthmatic</span> ASMCs, increased cAMP level, and inhibited the aberrant increase in Ca(2+) level.	26181301	hydrolase	phosphodiesterase 4D	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.204604842796993	2016
NFKB2	4791	AlteredExpression	BEFREE	Peripheral blood mononuclear cell NF-kappaB <span class= gene  id= 17913447-0-44-48 >p105</span> mRNA decreases during <span class= disease  id= 17913447-0-71-80 >asthmatic</span> attacks.	17913447	transcription factor; nucleic acid binding	nuclear factor kappa B subunit 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.202681755307501	2007
BCL2	596	AlteredExpression	BEFREE	Expression of <span class= gene  id= 11422132-7-14-19 >Bcl-2</span> by the CD4+ cell population was significantly reduced in the <span class= disease  id= 11422132-7-81-90 >asthmatic</span> compared with the control group (P = 0.002).	11422132	signaling molecule	BCL2, apoptosis regulator	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.201373633921065	2001
BCL2	596	AlteredExpression	BEFREE	Cyclosporin A, apoptosis of BAL T-cells and expression of <span class= gene  id= 12952249-0-58-63 >Bcl-2</span> in <span class= disease  id= 12952249-0-67-77 >asthmatics</span>.	12952249	signaling molecule	BCL2, apoptosis regulator	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.201373633921065	2004
BCL2	596	AlteredExpression	BEFREE	Activation of <span class= gene  id= 26938720-0-14-19 >Bcl-2</span>-Caspase-9 Apoptosis Pathway in the Testis of <span class= disease  id= 26938720-0-65-74 >Asthmatic</span> Mice.	26938720	signaling molecule	BCL2, apoptosis regulator	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.201373633921065	2016
BCL2	596	AlteredExpression	BEFREE	Apoptosis, proliferation, and expression of <span class= gene  id= 9806739-0-44-49 >Bcl-2</span>, Fas, and Fas ligand in bronchial biopsies from <span class= disease  id= 9806739-0-98-108 >asthmatics</span>.	9806739	signaling molecule	BCL2, apoptosis regulator	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.201373633921065	1998
SOD1	6647	AlteredExpression	BEFREE	<span class= gene  id= 21829032-11-0-3 >SOD</span> and CAT activity may be good tools to differentiate potential <span class= disease  id= 21829032-11-66-72 >asthma</span> sufferers.	21829032	oxidoreductase	superoxide dismutase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.201098907136852	2011
SOD1	6647	AlteredExpression	BEFREE	Decreased Cu,Zn-<span class= gene  id= 9038914-0-16-19 >SOD</span> activity in <span class= disease  id= 9038914-0-32-41 >asthmatic</span> airway epithelium: correction by inhaled corticosteroid in vivo.	9038914	oxidoreductase	superoxide dismutase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.201098907136852	1997
PTEN	5728	AlteredExpression	BEFREE	<span class= gene  id= 21489309-7-0-4 >PTEN</span> protein was found to be expressed at low levels in lung tissues in <span class= disease  id= 21489309-7-72-81 >asthmatic</span> mice; but the expression was restored after treatment with dexamethasone.	21489309	phosphatase; hydrolase	phosphatase and tensin homolog	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.200549453568426	2011
TIMP3	7078	AlteredExpression	BEFREE	Because genetic studies have shown that ADAM-33 gene polymorphisms are associated with asthma, we designed this study to assess mRNA expression profile of several ADAM and ADAMTS proteases in sputum from patients with <span class= disease  id= 17088949-3-218-224 >asthma</span> and to investigate the relationship between expression of these proteases and <span class= disease  id= 17088949-3-303-309 >asthma</span>-associated inflammation and airway obstruction. mRNA expression profile of selected ADAM and ADAMTS proteinases (ADAM-8, -9, -10, -12, -15, -17, and -33; ADAMTS-1, -2, -15, -16, -17, -18, and -19), their physiological inhibitors TIMP-1 and TIMP-3, and RECK, a membrane-anchored MMP activity regulator, was obtained by RT-PCR analysis performed on cells collected by sputum induction from 21 patients with mild to moderate asthma and 17 healthy individuals. mRNA levels of ADAM-8, ADAM-9, ADAM-12, TIMP-1, and <span class= gene  id= 17088949-3-819-825 >TIMP-3</span> were significantly increased, whereas mRNA levels coding for ADAMTS-1, ADAMTS-15, and RECK were significantly decreased in patients with asthma compared with control patients.	17088949	null	TIMP metallopeptidase inhibitor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.200549453568426	2006
TIMP3	7078	AlteredExpression	BEFREE	Because remodeling of airway epithelium is a feature of chronic asthma, the up-regulation of MMP10 and <span class= gene  id= 16926187-8-103-108 >TIMP3</span> by NPS-NPSR1 signaling may be of relevance in the pathogenesis of <span class= disease  id= 16926187-8-175-181 >asthma</span>.	16926187	null	TIMP metallopeptidase inhibitor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.200549453568426	2006
MMP10	4319	AlteredExpression	BEFREE	Because remodeling of airway epithelium is a feature of chronic asthma, the up-regulation of <span class= gene  id= 16926187-8-93-98 >MMP10</span> and TIMP3 by NPS-NPSR1 signaling may be of relevance in the pathogenesis of <span class= disease  id= 16926187-8-175-181 >asthma</span>.	16926187	null	matrix metallopeptidase 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.200274726784213	2006
STAT6	6778	AlteredExpression	BEFREE	We show here that T(h)2 cell-mediated inflammation in murine <span class= disease  id= 24150243-4-61-67 >asthma</span> models induces the expression of some markers of alternatively activated macrophage such as arginase 1 and resistin-like molecule-&alpha; in iDCs by a mechanism depending on the intrinsic expression of <span class= gene  id= 24150243-4-264-269 >STAT6</span>.	24150243	transcription factor; nucleic acid binding	signal transducer and activator of transcription 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.118066995850431	2014
STAT6	6778	AlteredExpression	BEFREE	<span class= gene  id= 11692112-0-0-50 >Signal transducer and activator of transcription 6</span> (<span class= gene  id= 11692112-0-52-58 >STAT-6</span>) expression and function in <span class= disease  id= 11692112-0-87-96 >asthmatic</span> bronchial epithelium.	11692112	transcription factor; nucleic acid binding	signal transducer and activator of transcription 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.118066995850431	2001
STAT6	6778	AlteredExpression	BEFREE	<span class= gene  id= 21814192-0-0-5 >STAT6</span> links IL-4/IL-13 stimulation with pendrin expression in <span class= disease  id= 21814192-0-62-68 >asthma</span> and chronic obstructive pulmonary disease.	21814192	transcription factor; nucleic acid binding	signal transducer and activator of transcription 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.118066995850431	2011
STAT6	6778	AlteredExpression	BEFREE	These data show that targeting the key transcription factor <span class= gene  id= 19494273-11-60-65 >STAT6</span> by siRNA effectively blocks the development of cardinal features of allergic airway disease, like allergen-induced airway inflammation and <span class= disease  id= 19494273-11-205-208 >AHR</span>.	19494273	transcription factor; nucleic acid binding	signal transducer and activator of transcription 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.118066995850431	2009
STAT6	6778	AlteredExpression	BEFREE	Therefore, inhibition of local <span class= gene  id= 19175798-2-31-36 >STAT6</span> expression provides a rationale for therapeutic intervention in <span class= disease  id= 19175798-2-101-117 >bronchial asthma</span>.	19175798	transcription factor; nucleic acid binding	signal transducer and activator of transcription 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.118066995850431	2009
IL4R	3566	AlteredExpression	BEFREE	Our group recently reported that interleukin-13 (IL13), <span class= gene  id= 17883727-3-56-78 >interleukin-4 receptor</span>-alpha and thymus and the activation-regulated chemokine interacted to influence <span class= disease  id= 17883727-3-159-165 >asthma</span> and raised plasma total IgE.	17883727	receptor	interleukin 4 receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.108471097916942	2007
PTGS2	5743	AlteredExpression	BEFREE	We examined whether a decreased activity of nuclear factor(NF)-kappaB), a transcriptional regulator of cyclooxygenase-2 (COX-2), could account for down-regulation of <span class= gene  id= 12622742-1-166-171 >COX-2</span> in nasal polyps of aspirin-sensitive <span class= disease  id= 12622742-1-209-219 >asthmatics</span>.	12622742	oxidoreductase	prostaglandin-endoperoxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.103870840740281	2003
PTGS2	5743	AlteredExpression	BEFREE	COX-1, and not <span class= gene  id= 18753249-0-15-20 >COX-2</span> activity, regulates airway function: relevance to aspirin-sensitive <span class= disease  id= 18753249-0-89-95 >asthma</span>.	18753249	oxidoreductase	prostaglandin-endoperoxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.103870840740281	2008
PTGS2	5743	AlteredExpression	BEFREE	Our aim was to investigate the expression of COX-1 and <span class= gene  id= 17622692-3-55-60 >COX-2</span> mRNA in primary human bronchial epithelial cells (HBEC) isolated from <span class= disease  id= 17622692-3-131-141 >asthmatics</span> and non-<span class= disease  id= 17622692-3-150-160 >asthmatics</span>.	17622692	oxidoreductase	prostaglandin-endoperoxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.103870840740281	2007
PTGS2	5743	AlteredExpression	BEFREE	PAR-2 activation, PGE2, and <span class= gene  id= 12754192-0-28-33 >COX-2</span> in human <span class= disease  id= 12754192-0-43-52 >asthmatic</span> and nonasthmatic airway smooth muscle cells.	12754192	oxidoreductase	prostaglandin-endoperoxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.103870840740281	2003
PTGS2	5743	AlteredExpression	BEFREE	<span class= gene  id= 10390414-0-0-16 >Cyclooxygenase-2</span> mRNA is downexpressed in nasal polyps from aspirin-sensitive <span class= disease  id= 10390414-0-78-88 >asthmatics</span>.	10390414	oxidoreductase	prostaglandin-endoperoxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.103870840740281	1999
PTGS2	5743	AlteredExpression	BEFREE	<span class= gene  id= 25180620-0-0-16 >Cyclooxygenase-2</span> and microRNA-155 expression are elevated in <span class= disease  id= 25180620-0-61-70 >asthmatic</span> airway smooth muscle cells.	25180620	oxidoreductase	prostaglandin-endoperoxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.103870840740281	2016
PTGS2	5743	AlteredExpression	BEFREE	Repression of <span class= gene  id= 25217662-8-14-19 >COX-2</span> and IL-1&beta; expression by miR-146a correlated with reduced abundance of the RNA-binding protein human antigen R. These results demonstrate that miR-146a and miR-146b expression is inducible in hASMCs by proinflammatory cytokines and that miR-146a expression is greater in <span class= disease  id= 25217662-8-290-299 >asthmatic</span> cells.	25217662	oxidoreductase	prostaglandin-endoperoxide synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.103870840740281	2014
ADAM33	80332	AlteredExpression	BEFREE	Because dysregulated expression of <span class= gene  id= 18423563-3-35-41 >ADAM33</span> can contribute to disease pathogenesis, we characterized the mechanism or mechanisms that control its transcription and investigated <span class= gene  id= 18423563-3-175-181 >ADAM33</span> expression in bronchial biopsy specimens and brushings from healthy and <span class= disease  id= 18423563-3-254-263 >asthmatic</span> subjects.	18423563	null	ADAM metallopeptidase domain 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.095566137761782	2008
ADAM33	80332	AlteredExpression	BEFREE	<span class= gene  id= 15709049-0-0-6 >ADAM33</span> expression in <span class= disease  id= 15709049-0-21-30 >asthmatic</span> airways and human embryonic lungs.	15709049	null	ADAM metallopeptidase domain 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.095566137761782	2005
ADAM33	80332	AlteredExpression	LHGDN	ADAM33 is associated with asthma development, and the levels of ADAM protein are related to asthma severity.	16387804	null	ADAM metallopeptidase domain 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.095566137761782	2006
ADAM33	80332	AlteredExpression	BEFREE	<span class= gene  id= 16387804-10-0-6 >ADAM33</span> is associated with <span class= disease  id= 16387804-10-26-32 >asthma</span> development, and the levels of ADAM protein are related to <span class= disease  id= 16387804-10-92-98 >asthma</span> severity.	16387804	null	ADAM metallopeptidase domain 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.095566137761782	2006
ADAM33	80332	AlteredExpression	BEFREE	The expression of <span class= gene  id= 17208589-12-18-24 >ADAM33</span> by ASM cells is increased in patients with <span class= disease  id= 17208589-12-68-74 >asthma</span>, and its expression may be regulated by IFN-gamma.	17208589	null	ADAM metallopeptidase domain 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.095566137761782	2006
ADAM33	80332	AlteredExpression	BEFREE	Increased expression of <span class= gene  id= 17339047-0-24-30 >ADAM33</span> and ADAM8 with disease progression in <span class= disease  id= 17339047-0-69-75 >asthma</span>.	17339047	null	ADAM metallopeptidase domain 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.095566137761782	2006
ADAM33	80332	AlteredExpression	BEFREE	Identification of those isoforms of <span class= gene  id= 14742294-3-36-42 >ADAM33</span> that are expressed in airways is fundamental to dissecting the role of <span class= gene  id= 14742294-3-114-120 >ADAM33</span> in <span class= disease  id= 14742294-3-124-130 >asthma</span>.	14742294	null	ADAM metallopeptidase domain 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.095566137761782	2004
ADAM33	80332	AlteredExpression	BEFREE	The ability of maternal allergy or exogenous IL-13 to suppress Adam33/<span class= gene  id= 19665773-15-70-76 >ADAM33</span> mRNA but enhance <span class= gene  id= 19665773-15-94-100 >Adam33</span> processing suggests a gene-environment interaction that may be relevant for <span class= disease  id= 19665773-15-177-183 >asthma</span> pathogenesis.	19665773	null	ADAM metallopeptidase domain 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.095566137761782	2009
ADAM33	80332	AlteredExpression	BEFREE	TGF-&beta;2, vascular epithelial growth factor (VEGF), <span class= gene  id= 22227417-2-50-86 >a disintegrin and metalloprotease 33</span> (<span class= gene  id= 22227417-2-88-94 >ADAM33</span>), and periostin are hypothesized to be involved in subepithelial remodeling and are overexpressed in adult <span class= disease  id= 22227417-2-202-211 >asthmatic</span> airways.	22227417	null	ADAM metallopeptidase domain 33	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.095566137761782	2011
CD40	958	AlteredExpression	BEFREE	These data underline (1) the pivotal role of the gamma c chain, <span class= gene  id= 12207328-10-64-68 >CD40</span>/CD40L, JAK3 and IL-13 in the inflammatory-like activation of lung myofibroblasts, (2) the cell-type restraint effects of IL-13 on these cells, and (3) the potential usefulness of JAK3 inhibitors in the treatment of <span class= disease  id= 12207328-10-284-290 >asthma</span>.	12207328	receptor	CD40 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.091653515897269	2002
IL22	50616	AlteredExpression	BEFREE	<span class= gene  id= 21535180-0-0-5 >IL-22</span> mRNA in peripheral blood mononuclear cells from allergic rhinitic and <span class= disease  id= 21535180-0-76-85 >asthmatic</span> pediatric patients.	21535180	signaling molecule	interleukin 22	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.085429023149632	2011
IL22	50616	AlteredExpression	BEFREE	IL-17 and <span class= gene  id= 24349168-13-10-15 >IL-22</span> were increased in both normal and <span class= disease  id= 24349168-13-50-59 >asthmatic</span> conditions with a significantly higher amount in <span class= disease  id= 24349168-13-109-119 >asthmatics</span> compared to controls.	24349168	signaling molecule	interleukin 22	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.085429023149632	2013
IL22	50616	AlteredExpression	BEFREE	To identify the most vulnerable population among those children we selected <span class= disease  id= 23330224-5-76-82 >asthma</span> as a typical allergy-related disease, and could show that there are significant differences in the levels of <span class= gene  id= 23330224-5-192-197 >IL-22</span> mRNA expression between IgE negative non-<span class= disease  id= 23330224-5-239-248 >asthmatic</span> subject and <span class= disease  id= 23330224-5-261-270 >asthmatic</span> children showing positive IgE reaction toward egg or milk, again.	23330224	signaling molecule	interleukin 22	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.085429023149632	2013
ESR2	2100	AlteredExpression	BEFREE	In this subnetwork, several receptors (EGFR, EGR1, <span class= gene  id= 27188427-11-51-55 >ESR2</span>, PGR), transcription factors (MYC, JAK), cytokines (IL8, IL6, IL1B), one chemokine (CXCL1), one kinase (SRC) and one cyclooxygenase (PTGS2) were described to be associated with inflammatory environment and steroid resistance in <span class= disease  id= 27188427-11-284-290 >asthma</span>.	27188427	transcription factor; receptor; nucleic acid binding	estrogen receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.080549453568426	2016
PRMT1	3276	AlteredExpression	BEFREE	Thus <span class= gene  id= 26911452-11-5-10 >PRMT1</span> expression in structural lung cells in <span class= disease  id= 26911452-11-50-56 >asthma</span> can be considered as potential target for new therapeutic intervention.	26911452	transferase	protein arginine methyltransferase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.080549453568426	2016
NTRK1	4914	AlteredExpression	BEFREE	Using fluorescence microscopy, we found that Kidins220 and <span class= gene  id= 20934630-7-59-63 >TrkA</span> were co-expressed on the membranes of the BALF cells of <span class= disease  id= 20934630-7-120-129 >asthmatic</span> mice.	20934630	null	neurotrophic receptor tyrosine kinase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.080549453568426	2010
PIN1	5300	AlteredExpression	BEFREE	<span class= gene  id= 17965833-6-0-4 >Pin1</span> also regulates the post-transcriptional level of some cytokines, associated with <span class= disease  id= 17965833-6-86-92 >asthma</span>, that possess 3' untranslated region AU-rich elements (AREs) via interaction withAUF1, the nucleoprotein in the ARE-binding complex.	17965833	isomerase	peptidylprolyl cis/trans isomerase, NIMA-interacting 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.080549453568426	2008
TACR1	6869	AlteredExpression	BEFREE	In summary, bronchial epithelial cell changes in <span class= disease  id= 17392578-7-49-55 >asthma</span> are induced by LIF which promotes the expression of <span class= gene  id= 17392578-7-108-113 >NK-1R</span>, and JAK/STAT pathway and MAPK/ERK pathway may participate in this process.	17392578	receptor	tachykinin receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.080274726784213	2007
IL10	3586	AlteredExpression	BEFREE	Our results support the hypothesis that <span class= gene  id= 11295668-9-40-45 >IL-10</span> overexpression may counterbalance the effects of proinflammatory cytokines and mitigate the inflammatory reaction found in gut mucosa of subjects with <span class= disease  id= 11295668-9-197-203 >asthma</span>.	11295668	signaling molecule	interleukin 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.06930262387553	2001
IL10	3586	AlteredExpression	BEFREE	Additionally, IL-13, <span class= gene  id= 24450586-9-21-26 >IL-10</span> and eosinophil major basic protein mRNA levels were greater in patients with asthma exacerbations compared to non-exacerbating patients (P = 0.03, P = 0.06 and P = 0.02, respectively), and IL-13 mRNA correlated with the peak <span class= disease  id= 24450586-9-252-258 >Asthma</span> Index (P = 0.006).	24450586	signaling molecule	interleukin 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.06930262387553	2014
IL10	3586	AlteredExpression	BEFREE	Most of the <span class= gene  id= 11031340-11-12-17 >IL-10</span> and IL-12 mRNA(+) cells in sputum from <span class= disease  id= 11031340-11-57-66 >asthmatic</span> subjects were macrophages (&gt;80%), with less than 10% of mRNA colocalizing to epithelial cells.	11031340	signaling molecule	interleukin 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.06930262387553	2000
IL10	3586	AlteredExpression	BEFREE	<span class= gene  id= 15894599-0-0-14 >Interleukin-10</span> gene expression in acute virus-induced <span class= disease  id= 15894599-0-54-60 >asthma</span>.	15894599	signaling molecule	interleukin 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.06930262387553	2005
IL10	3586	AlteredExpression	LHGDN	findings suggest that dust mite allergen levels modify the effect of <span class=gene id=18440625>IL10</span> SNPs on allergy and <span class=disease id=18440625>asthma</span> exacerbations	18440625	signaling molecule	interleukin 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.06930262387553	2008
IL10	3586	AlteredExpression	BEFREE	The in vitro effects of budesonide in modulating: TLR4 and TLR2 expression in controls and in <span class= disease  id= 25722071-4-94-104 >asthmatics</span>; <span class= gene  id= 25722071-4-106-111 >IL-10</span> expression and cytokine release (IL-6 and TNF-&alpha; selected by a multiplex assay) in <span class= disease  id= 25722071-4-194-204 >asthmatics</span> were also explored.	25722071	signaling molecule	interleukin 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.06930262387553	2015
IL10	3586	AlteredExpression	BEFREE	Increased <span class= gene  id= 8630259-0-10-24 >interleukin-10</span> messenger RNA expression in atopic allergy and <span class= disease  id= 8630259-0-72-78 >asthma</span>.	8630259	signaling molecule	interleukin 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.06930262387553	1996
IL10	3586	AlteredExpression	BEFREE	Collectively, these findings provide new evidence demonstrating that the altered responsiveness of atopic <span class= disease  id= 11597904-6-106-115 >asthmatic</span> serum-sensitized ASM is largely attributed to activation of an intrinsic T helper type 2-type autocrine mechanism involving <span class= gene  id= 11597904-6-240-245 >IL-10</span>-mediated release and the action of IL-5 in the sensitized ASM itself.	11597904	signaling molecule	interleukin 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.06930262387553	2001
IL10	3586	AlteredExpression	BEFREE	Exhaled levels of IL4, <span class= gene  id= 24393359-10-23-27 >IL10</span>, and IL13 were positively associated with <span class= disease  id= 24393359-10-70-76 >asthma</span> development (p &lt; 0.01).	24393359	signaling molecule	interleukin 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.06930262387553	2013
LTC4S	4056	AlteredExpression	BEFREE	The over-expression of the <span class= gene  id= 21429049-11-27-42 >LTC(4) synthase</span> in a mouse <span class= disease  id= 21429049-11-54-60 >asthma</span> model also replicates the key features of AIA.	21429049	transferase	leukotriene C4 synthase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.067350825631403	2012
LTC4S	4056	AlteredExpression	BEFREE	Enhanced expression of the <span class= gene  id= 10970818-0-27-52 >leukotriene C(4) synthase</span> due to overactive transcription of an allelic variant associated with aspirin-intolerant <span class= disease  id= 10970818-0-142-148 >asthma</span>.	10970818	transferase	leukotriene C4 synthase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.067350825631403	2000
LTC4S	4056	AlteredExpression	BEFREE	We have reported that genetic variability in the expression of <span class= gene  id= 19703064-2-63-78 >LTC(4) synthase</span> is associated with responsiveness to pranlukast in Japanese <span class= disease  id= 19703064-2-139-148 >asthmatic</span> patients.	19703064	transferase	leukotriene C4 synthase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.067350825631403	2009
LTC4S	4056	AlteredExpression	BEFREE	Improvement of <span class= disease  id= 12534456-9-15-21 >asthma</span> was observed mostly in patients with a low baseline and non-IL-5 inducible expression of <span class= gene  id= 12534456-9-111-124 >LTC4 synthase</span> (<span class= gene  id= 12534456-9-126-131 >LTC4S</span>) mRNA in eosinophils.	12534456	transferase	leukotriene C4 synthase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.067350825631403	2003
TLR4	7099	AlteredExpression	BEFREE	And the expression of <span class= gene  id= 20072849-5-22-26 >TLR4</span> on PBMCs and TNF-alpha production stimulated by lipopolysaccharide (LPS), were significantly higher in mild to moderate than in severe <span class= disease  id= 20072849-5-162-172 >asthmatics</span>.	20072849	extracellular matrix protein; receptor	toll like receptor 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.056037549052977	2009
TLR4	7099	AlteredExpression	BEFREE	One reason for this could be a reduced <span class= gene  id= 17884733-13-39-44 >TLR 4</span> expression on CD4(+) T-lymphocytes of <span class= disease  id= 17884733-13-83-92 >asthmatic</span> subjects.	17884733	extracellular matrix protein; receptor	toll like receptor 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.056037549052977	2007
TLR4	7099	AlteredExpression	BEFREE	Therefore, the decreased activation of <span class= gene  id= 19067129-5-39-43 >TLR4</span> and TLR5 in asthmatic patients might contribute to the immunopathological mechanisms of <span class= disease  id= 19067129-5-132-138 >asthma</span> by reducing the release of Th1 and anti-inflammatory cytokines.	19067129	extracellular matrix protein; receptor	toll like receptor 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.056037549052977	2008
CYSLTR1	10800	AlteredExpression	BEFREE	Our findings suggest a possible mechanism by which IL-13 and IL-4 can modulate <span class= gene  id= 11509632-9-79-88 >CysLT(1)R</span> expression on monocytes and macrophages, and consequently their responsiveness to LTD(4), and thus contribute to the pathogenesis of <span class= disease  id= 11509632-9-222-228 >asthma</span> and allergic diseases.	11509632	receptor	cysteinyl leukotriene receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.054557015196954	2001
CYSLTR1	10800	AlteredExpression	BEFREE	Cysteinyl leukotriene 1 (<span class= gene  id= 22871757-1-25-31 >CysLT1</span>) receptor expression is known to be increased in the airway mucosa of patients with <span class= disease  id= 22871757-1-116-122 >asthma</span>, especially during exacerbations; however, nothing is known of its expression in COPD.	22871757	receptor	cysteinyl leukotriene receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.054557015196954	2012
CYSLTR1	10800	AlteredExpression	LHGDN	upregulation of cysteinyl leukotriene-1 receptor is associated with asthma	16123393	receptor	cysteinyl leukotriene receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.054557015196954	2006
CYSLTR1	10800	AlteredExpression	BEFREE	Determination of structure and transcriptional regulation of <span class= gene  id= 16771777-0-61-68 >CYSLTR1</span> and an association study with <span class= disease  id= 16771777-0-99-105 >asthma</span> and rhinitis.	16771777	receptor	cysteinyl leukotriene receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.054557015196954	2006
CYSLTR1	10800	AlteredExpression	BEFREE	Because cysteinyl-leukotrienes (cysLTs) are major protagonists in the pathophysiology of human asthma, and because neutrophils are involved in the more severe form of <span class= disease  id= 16809637-1-167-173 >asthma</span>, we studied the potential for leukotriene (LT) D(4) to induce synthesis of the chemokine IL-8 through activation of the <span class= gene  id= 16809637-1-294-300 >CysLT1</span> receptor.	16809637	receptor	cysteinyl leukotriene receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.054557015196954	2007
IFNG	3458	AlteredExpression	BEFREE	<span class= gene  id= 12061423-11-0-16 >Interferon-gamma</span> was observed at similar levels in <span class= disease  id= 12061423-11-51-57 >asthma</span> patients and healthy controls.	12061423	signaling molecule	interferon gamma	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.039752158335705	2002
IFNG	3458	AlteredExpression	BEFREE	In contrast, the expression of <span class= gene  id= 9870929-5-31-47 >interferon-gamma</span> was observed in a higher proportion of cultured bronchial biopsies from the normal control subjects than in those from <span class= disease  id= 9870929-5-167-176 >asthmatic</span> subjects.	9870929	signaling molecule	interferon gamma	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.039752158335705	1999
IFNG	3458	AlteredExpression	BEFREE	OVA-challenged WT mice showed allergic inflammation and <span class= disease  id= 21205293-7-56-59 >AHR</span> in the airways along with increased expression of TNF-&alpha;, <span class= gene  id= 21205293-7-117-122 >IFN-&gamma;</span>, IL-4 and tenascin-C in the lungs.	21205293	signaling molecule	interferon gamma	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.039752158335705	2011
IFNG	3458	AlteredExpression	BEFREE	Blood was collected from 24 steroid-naive asthmatics, 39 <span class= disease  id= 17302903-4-57-67 >asthmatics</span> on inhaled corticosteroid and 32 age- and sex-matched controls for assay of T-bet expression, specific IgE and chemokines (<span class= gene  id= 17302903-4-191-207 >interferon-gamma</span> inducible protein-10 (IP-10/CXCL10), monokines induced by interferon-gamma (MIG/CXCL9), monocyte chemotactic protein-1 (MCP-1/CCL2), regulated upon activation normal T cell expressed and secreted (RANTES/CCL5) and interleukin-8 (IL-8/CXCL8) levels.	17302903	signaling molecule	interferon gamma	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.039752158335705	2007
IFNG	3458	AlteredExpression	BEFREE	In vitro <span class= gene  id= 11699731-0-9-25 >interferon gamma</span> regulation of CCR-3 mRNA expression in peripheral blood leukocytes from atopic <span class= disease  id= 11699731-0-105-115 >asthmatics</span>.	11699731	signaling molecule	interferon gamma	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.039752158335705	2002
IFNG	3458	AlteredExpression	BEFREE	IFN-&alpha;1, IFN-&beta;1 and <span class= gene  id= 24450586-8-19-24 >IFN-&gamma;</span> mRNA levels correlated with the peak <span class= disease  id= 24450586-8-62-68 >Asthma</span> Index (r = 0.58, P &lt; 0.001; r = 0.57, P = 0.001; and r = 0.51, P = 0.004, respectively).	24450586	signaling molecule	interferon gamma	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.039752158335705	2014
IFNG	3458	AlteredExpression	BEFREE	Level of sB7-H3 in <span class= disease  id= 26108069-10-19-25 >asthma</span> exacerbation subjects was inversely correlated with level of <span class= gene  id= 26108069-10-87-92 >IFN-&gamma;</span> (r(p) = -0.605; p = 0.005) after adjustment.	26108069	signaling molecule	interferon gamma	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.039752158335705	2016
ACE	1636	AlteredExpression	BEFREE	These data suggest that lifelong genetically elevated <span class= gene  id= 19423314-8-54-57 >ACE</span> activity is <span class= negexp >not a major risk factor</span> for <span class= disease  id= 19423314-8-98-104 >asthma</span> or COPD, or for ischemic heart disease, hypertension, and low physical activity in COPD patients.	19423314	null	angiotensin I converting enzyme	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.039728033201403	2009
IL6	3569	AlteredExpression	BEFREE	In conclusion, using both bioinformatics and experimental tools we found a highly relevant potential role for microRNA dysregulation in the control of <span class= gene  id= 25360780-12-151-155 >IL-6</span> and IL-8 expression in <span class= disease  id= 25360780-12-179-185 >asthma</span>.	25360780	signaling molecule	interleukin 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.037726756531588	2014
IL6	3569	AlteredExpression	BEFREE	Dexamethasone's trans-activation of GILZ and trans-repression of NF-kB-driven <span class= gene  id= 23160983-9-78-82 >IL-6</span> expression were both inhibited by IL2?+?4; IL17?+?IL23 antagonized Dex trans-repression in PBMC from <span class= disease  id= 23160983-9-184-194 >asthmatics</span>.	23160983	signaling molecule	interleukin 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.037726756531588	2012
IL6	3569	AlteredExpression	BEFREE	Subjects with an elevation of both hsCRP and <span class= gene  id= 23438328-4-45-49 >IL-6</span> were grouped as <span class= disease  id= 23438328-4-66-76 >asthmatics</span> with systemic inflammation, and those with both hsCRP and <span class= gene  id= 23438328-4-135-139 >IL-6</span> within the normal ranges were grouped as <span class= disease  id= 23438328-4-181-191 >asthmatics</span> without systemic inflammation.	23438328	signaling molecule	interleukin 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.037726756531588	2013
IL6	3569	AlteredExpression	BEFREE	TNFalpha-induced eotaxin, RANTES, and <span class= gene  id= 19465513-6-38-42 >IL-6</span> as well as PDGF-BB-induced <span class= gene  id= 19465513-6-70-74 >IL-6</span> expression was inhibited by DMF and by dexamethasone from <span class= disease  id= 19465513-6-133-142 >asthmatic</span> and nonasthmatic ASMC, but the combination of both drugs showed <span class= negexp >no glucocorticoid sparing effect</span> in either of the two groups.	19465513	signaling molecule	interleukin 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.037726756531588	2009
IL6	3569	AlteredExpression	BEFREE	<span class= disease  id= 26764119-8-0-6 >Asthma</span> was increased in Denmark (9%) compared to Greenland (3.6%, p &lt; 0.0001) and associated with increased adipose tissue <span class= gene  id= 26764119-8-123-127 >IL-6</span> gene expression and increased BMI.	26764119	signaling molecule	interleukin 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.037726756531588	2015
IL18	3606	AlteredExpression	BEFREE	Similarly, constitutive expression of <span class= gene  id= 10543274-9-38-43 >IL-18</span> protein was observed within the airway epithelium of control individuals, with more positive cells found within sarcoidosis tissue (p&lt;0.01) and fewer within <span class= disease  id= 10543274-9-201-210 >asthmatic</span> tissue (p&lt;0.01), compared to controls.	10543274	signaling molecule	interleukin 18	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.034858233377182	1999
IL18	3606	AlteredExpression	BEFREE	In parallel, BALF concentrations of soluble VEGFR1 and <span class= gene  id= 26869672-6-55-60 >IL-18</span> were significantly reduced in severe <span class= disease  id= 26869672-6-98-108 >asthmatics</span> in vivo and inversely correlated with angiogenesis.Activin-A is overexpressed and has anti-angiogenic effects in vitro that are not propagated in vivo, where reduced basal expression of its receptors is observed particularly in severe <span class= disease  id= 26869672-6-344-350 >asthma</span>.	26869672	signaling molecule	interleukin 18	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.034858233377182	2015
IL18	3606	AlteredExpression	BEFREE	There was weak evidence to implicate the following: IL13, IFNGR2, EDN1, and VDR in <span class= disease  id= 19247692-8-83-89 >asthma</span>; <span class= gene  id= 19247692-8-91-95 >IL18</span>, TBXA2R, IFNGR2, and VDR in atopy; TLR9, TBXA2R, VDR, NOD2, and STAT6 in airway hyperresponsiveness; TLR10, IFNGR2, STAT6, VDR, and NPSR1 in atopic asthma.	19247692	signaling molecule	interleukin 18	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.034858233377182	2009
TLR2	7097	AlteredExpression	BEFREE	Upregulation of <span class= gene  id= 21570715-15-16-20 >TLR2</span> and TLR4 on macrophages with increased sensitivity to hyaluronan fragments suggests a novel proinflammatory mechanism by which persistence of hyaluronan fragments could contribute to chronic inflammation and airway remodeling in <span class= disease  id= 21570715-15-250-256 >asthma</span>.	21570715	extracellular matrix protein; receptor	toll like receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.033605854768391	2011
TLR2	7097	AlteredExpression	BEFREE	Budesonide increases TLR4 and <span class= gene  id= 25722071-0-30-34 >TLR2</span> expression in Treg lymphocytes of allergic <span class= disease  id= 25722071-0-78-88 >asthmatics</span>.	25722071	extracellular matrix protein; receptor	toll like receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.033605854768391	2015
TLR2	7097	AlteredExpression	BEFREE	Sputum <span class= gene  id= 21129050-8-7-11 >TLR2</span> mRNA expression was up-regulated in both acute and stable <span class= disease  id= 21129050-8-70-76 >asthma</span> compared with healthy controls and decreased 4-6 weeks after acute exacerbation.	21129050	extracellular matrix protein; receptor	toll like receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.033605854768391	2012
TLR2	7097	AlteredExpression	BEFREE	Decreased <span class= gene  id= 21239529-1-10-30 >Toll-like receptor 2</span> (<span class= gene  id= 21239529-1-32-36 >TLR2</span>) expression has been reported in patients with chronic obstructive pulmonary disease and in a murine <span class= disease  id= 21239529-1-138-144 >asthma</span> model, which may predispose the hosts to bacterial infections, leading to disease exacerbations.	21239529	extracellular matrix protein; receptor	toll like receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.033605854768391	2011
NOS3	4846	AlteredExpression	BEFREE	Our results demonstrate that the <span class= gene  id= 12738608-5-33-66 >endothelial nitric oxide synthase</span>, a nitric oxide synthase constitutively expressed in epithelial cells, plays an important role in determining measured levels of exhaled nitric oxide, a marker of the <span class= disease  id= 12738608-5-234-243 >asthmatic</span> condition.	12738608	null	nitric oxide synthase 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.030202233422876	2003
NOS3	4846	AlteredExpression	LHGDN	eNOS overexpression attenuates both airway inflammation and airway hyperresponsiveness in a transgenic mouse model of allergic asthma.	16597326	null	nitric oxide synthase 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.030202233422876	2006
IL9	3578	AlteredExpression	BEFREE	<span class= gene  id= 10629460-0-0-4 >IL-9</span> and its receptor in allergic and nonallergic lung disease: increased expression in <span class= disease  id= 10629460-0-88-94 >asthma</span>.	10629460	null	interleukin 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.029523433516814	2000
IL9	3578	AlteredExpression	LHGDN	Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes.	12789235	null	interleukin 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.029523433516814	2003
IL9	3578	AlteredExpression	BEFREE	Elevated expression of <span class= gene  id= 12047433-0-23-36 >interleukin-9</span> mRNA in the bronchial mucosa of atopic <span class= disease  id= 12047433-0-76-86 >asthmatics</span> and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes.	12047433	null	interleukin 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.029523433516814	2003
IL9	3578	AlteredExpression	LHGDN	HCLCA1 is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma	11842292	null	interleukin 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.029523433516814	2002
IL9	3578	AlteredExpression	BEFREE	In simple AD patients and AD patients complicated by allergic rhinitis or <span class= disease  id= 24032555-5-74-80 >asthma</span>, there were no significant differences in the Th9 cell percentage, PU.1 and <span class= gene  id= 24032555-5-157-161 >IL-9</span> expression levels between them.	24032555	null	interleukin 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.029523433516814	2013
IL9	3578	AlteredExpression	BEFREE	The constitutive overexpression of <span class= gene  id= 11781348-2-35-39 >IL-9</span> in the lungs of transgenic mice resulted in an <span class= disease  id= 11781348-2-87-93 >asthma</span>-like phenotype.	11781348	null	interleukin 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.029523433516814	2002
IL9	3578	AlteredExpression	BEFREE	The IL12B gene encodes the <span class= gene  id= 15007350-1-27-30 >p40</span> chain of IL-12, a proinflammatory cytokine that antagonizes TH2 expression and hence may play a critical role in the pathogenesis of airway inflammation observed in <span class= disease  id= 15007350-1-196-202 >asthma</span>.	15007350	null	interleukin 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.029523433516814	2004
IL9	3578	AlteredExpression	BEFREE	In the present study, we examined the effect of <span class= gene  id= 17446528-3-48-52 >IL-9</span> overexpression on the subepithelial fibrotic response, a feature of <span class= disease  id= 17446528-3-121-130 >asthmatic</span> remodeling, induced by chronic exposure to Alternaria alternata extract.	17446528	null	interleukin 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.029523433516814	2007
IL9	3578	AlteredExpression	BEFREE	A calcium-activated chloride channel (HCLCA1) is strongly related to <span class= gene  id= 11842292-0-69-73 >IL-9</span> expression and mucus production in bronchial epithelium of patients with <span class= disease  id= 11842292-0-147-153 >asthma</span>.	11842292	null	interleukin 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.029523433516814	2002
DPP10	57628	AlteredExpression	BEFREE	The <span class= gene  id= 25592153-9-4-9 >DPP10</span> level was significantly higher in sera from patients with AERD compared with patients with aspirin-tolerant <span class= disease  id= 25592153-9-118-124 >asthma</span> and control subjects (P = .021 and P &lt; .001, respectively).	25592153	protease; enzyme modulator; hydrolase	dipeptidyl peptidase like 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.028949854814086	2014
MBL2	4153	AlteredExpression	BEFREE	An <span class= gene  id= 18729778-4-3-6 >MBL</span> level below the median concentration was a significant risk factor for infections (<span class= disease  id= 18729778-4-90-96 >asthma</span> status-adjusted odds ratio [OR], 2.5 [95% confidence interval {CI}, 1.4-4.5]).	18729778	defense/immunity protein	mannose binding lectin 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.028726285187186	2008
MBL2	4153	AlteredExpression	BEFREE	Elevated levels of <span class= gene  id= 16487239-0-19-40 >mannan-binding lectin</span> [corrected] (MBL) and eosinophilia in patients of <span class= disease  id= 16487239-0-91-107 >bronchial asthma</span> with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL.	16487239	defense/immunity protein	mannose binding lectin 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.028726285187186	2006
MBL2	4153	AlteredExpression	LHGDN	increased blood levels in asthmatic children; findings indicate that mbl may be implicated in the pathogenesis of asthma by contributing to airway inflammation or by increasing the risk of developing asthma	15853952	defense/immunity protein	mannose binding lectin 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.028726285187186	2005
IL2	3558	AlteredExpression	BEFREE	The <span class= gene  id= 24801457-11-4-8 >IL-2</span> and IFN-gamma levels in the obese <span class= disease  id= 24801457-11-43-52 >asthmatic</span> group were lower than in the other three groups.	24801457	signaling molecule	interleukin 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027692890584963	2014
IL2	3558	AlteredExpression	BEFREE	The smoking history and the presence of atopy or <span class= disease  id= 10228104-3-49-55 >asthma</span> in parents or siblings were recorded and blood mononuclear cell interferon (IFN)-gamma and interleukin (IL)-4 production in response to <span class= gene  id= 10228104-3-192-196 >IL-2</span> were assessed in 32 infants hospitalized for bronchiolitis and in a subgroup (n = 19) in which pulmonary function tests were performed approximately 4.9 mo later.	10228104	signaling molecule	interleukin 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027692890584963	1999
IL2	3558	AlteredExpression	BEFREE	IL-4 mRNA and IL-5 mRNA were significantly higher in the xenografts of <span class= disease  id= 12759454-8-71-80 >asthmatic</span> huPBMC-SCID mice than those in the xenografts of normal huPBMC-SCID mice, but there were <span class= negexp >no significant differences in the expressions of</span> <span class= gene  id= 12759454-8-219-223 >IL-2</span> mRNA or IFN-gamma mRNA between them.	12759454	signaling molecule	interleukin 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027692890584963	2003
IL2	3558	AlteredExpression	BEFREE	Levels of IL-1 beta (266 +/- 270 pg/ml versus less than 20 pg/ml) (p = 0.001) and <span class= gene  id= 1374772-3-82-86 >IL-2</span> (1.4 +/- 2.8 ng/ml versus less than 0.3 ng/ml) (p = 0.05) in BALF in patients with symptomatic compared with that in BALF levels in patients with asymptomatic <span class= disease  id= 1374772-3-246-252 >asthma</span> suggested activation of alveolar macrophages and T cells.	1374772	signaling molecule	interleukin 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027692890584963	1992
IL2	3558	AlteredExpression	BEFREE	PBMC from atopic subjects contained significantly greater quantities of IL-4 mRNA (P = 0.04) but not IL-5, <span class= gene  id= 7812887-10-107-111 >IL-2</span> and IFN gamma mRNA compared with non-atopic subjects regardless of their <span class= disease  id= 7812887-10-185-194 >asthmatic</span> status.	7812887	signaling molecule	interleukin 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027692890584963	1995
CXCL8	3576	AlteredExpression	BEFREE	Positive <span class= gene  id= 10069871-8-9-13 >IL-8</span> gene expression was <span class= negexp >not predicted</span> by history of prior surgery nor by atopic or <span class= disease  id= 10069871-8-93-102 >asthmatic</span> status.	10069871	signaling molecule	C-X-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027116404993526	1999
CXCL8	3576	AlteredExpression	BEFREE	Epithelium from patients with severe asthma produced greater levels of mucin, released more <span class= gene  id= 22409990-9-92-96 >IL-8</span>, and produced lower levels of lipoxin A(4) than that from patients with mild <span class= disease  id= 22409990-9-174-180 >asthma</span>.	22409990	signaling molecule	C-X-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027116404993526	2012
CXCL8	3576	AlteredExpression	BEFREE	Increased levels of bradykinin and <span class= gene  id= 12532104-1-35-39 >IL-8</span> have been detected within the airways of individuals with active symptoms of allergic rhinitis and <span class= disease  id= 12532104-1-139-145 >asthma</span>.	12532104	signaling molecule	C-X-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027116404993526	2003
CXCL8	3576	AlteredExpression	BEFREE	Association of serum levels of polychlorinated biphenyls with <span class= gene  id= 22326254-0-62-66 >IL-8</span> mRNA expression in blood samples from <span class= disease  id= 22326254-0-105-114 >asthmatic</span> and non-<span class= disease  id= 22326254-0-123-132 >asthmatic</span> Japanese children.	22326254	signaling molecule	C-X-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027116404993526	2012
CXCL8	3576	AlteredExpression	BEFREE	Human airway smooth muscle cells from <span class= disease  id= 19734226-0-38-47 >asthmatic</span> individuals have <span class= gene  id= 19734226-0-65-70 >CXCL8</span> hypersecretion due to increased NF-kappa B p65, C/EBP beta, and RNA polymerase II binding to the CXCL8 promoter.	19734226	signaling molecule	C-X-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027116404993526	2009
CXCL8	3576	AlteredExpression	BEFREE	Clarithromycin therapy can modulate <span class= gene  id= 17947611-12-36-40 >IL-8</span> levels and neutrophil accumulation and activation in the airways of patients with refractory <span class= disease  id= 17947611-12-134-140 >asthma</span>.	17947611	signaling molecule	C-X-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027116404993526	2008
CXCL8	3576	AlteredExpression	BEFREE	Vitamin D inhibited TNF&alpha;-induced <span class= gene  id= 26207385-10-33-36 >IL8</span> protein secretion levels to a comparable degree in fatal <span class= disease  id= 26207385-10-94-100 >asthma</span>- and non-<span class= disease  id= 26207385-10-110-116 >asthma</span>-derived ASM even though <span class= gene  id= 26207385-10-141-144 >IL8</span> had significantly higher baseline levels in fatal <span class= disease  id= 26207385-10-195-201 >asthma</span>-derived ASM.	26207385	signaling molecule	C-X-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027116404993526	2015
CXCL8	3576	AlteredExpression	BEFREE	P38 inhibitor significantly enhanced DEX suppression of LPS-induced <span class= gene  id= 26517722-12-68-72 >IL-8</span> mRNA by PBMC of steroid resistant <span class= disease  id= 26517722-12-107-117 >asthmatics</span>.	26517722	signaling molecule	C-X-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027116404993526	2015
CXCL8	3576	AlteredExpression	BEFREE	Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, <span class= gene  id= 15696082-0-94-98 >IL-8</span>, and IFN-gamma-inducible protein 10 expression in <span class= disease  id= 15696082-0-149-158 >asthmatic</span> airway mucosa.	15696082	signaling molecule	C-X-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027116404993526	2005
CXCL8	3576	AlteredExpression	BEFREE	In conclusion, using both bioinformatics and experimental tools we found a highly relevant potential role for microRNA dysregulation in the control of IL-6 and <span class= gene  id= 25360780-12-160-164 >IL-8</span> expression in <span class= disease  id= 25360780-12-179-185 >asthma</span>.	25360780	signaling molecule	C-X-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027116404993526	2014
CXCL8	3576	AlteredExpression	BEFREE	Blood was collected from 24 steroid-naive asthmatics, 39 <span class= disease  id= 17302903-4-57-67 >asthmatics</span> on inhaled corticosteroid and 32 age- and sex-matched controls for assay of T-bet expression, specific IgE and chemokines (interferon-gamma inducible protein-10 (IP-10/CXCL10), monokines induced by interferon-gamma (MIG/CXCL9), monocyte chemotactic protein-1 (MCP-1/CCL2), regulated upon activation normal T cell expressed and secreted (RANTES/CCL5) and interleukin-8 (IL-8/<span class= gene  id= 17302903-4-442-447 >CXCL8</span>) levels.	17302903	signaling molecule	C-X-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.027116404993526	2007
CCR3	1232	AlteredExpression	BEFREE	<span class= gene  id= 16081847-0-0-4 >CCR3</span> expression and function in <span class= disease  id= 16081847-0-32-41 >asthmatic</span> airway smooth muscle cells.	16081847	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-C motif chemokine receptor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.026659495982741	2005
CCR3	1232	AlteredExpression	BEFREE	In vitro interferon gamma regulation of <span class= gene  id= 11699731-0-40-45 >CCR-3</span> mRNA expression in peripheral blood leukocytes from atopic <span class= disease  id= 11699731-0-105-115 >asthmatics</span>.	11699731	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-C motif chemokine receptor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.026659495982741	2002
CCR3	1232	AlteredExpression	BEFREE	<span class= gene  id= 17983872-8-0-4 >CCR3</span> protein expression was higher on eosinophils of <span class= disease  id= 17983872-8-53-62 >asthmatic</span> patients without ht2 than in those with ht2.	17983872	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-C motif chemokine receptor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.026659495982741	2007
CCR3	1232	AlteredExpression	BEFREE	Therefore, we decided to analyze the regulation of <span class= gene  id= 18849613-3-51-55 >CCR3</span> by IFN-gamma in <span class= disease  id= 18849613-3-72-82 >asthmatics</span> and to characterize the dependence of this process on immunoglobulin E (IgE) levels.	18849613	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-C motif chemokine receptor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.026659495982741	2008
CCR3	1232	AlteredExpression	BEFREE	Epithelial <span class= gene  id= 16920975-12-11-15 >CCR3</span> participates in key functions for wound repair, amplifies the expression of profibrogenic and chemokine transcripts, and appears up-regulated in inflamed <span class= disease  id= 16920975-12-170-179 >asthmatic</span> airways.	16920975	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-C motif chemokine receptor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.026659495982741	2006
SERPINE1	5054	AlteredExpression	BEFREE	To characterize the mechanisms of the 4G/5G-dependent <span class= gene  id= 18234320-4-54-59 >PAI-1</span> expression in mast cells (MCs), a major source of <span class= gene  id= 18234320-4-110-115 >PAI-1</span> and key effector cells in <span class= disease  id= 18234320-4-142-148 >asthma</span>.	18234320	enzyme modulator	serpin family E member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.02643592635584	2007
SERPINE1	5054	AlteredExpression	BEFREE	Vitamin D has also been implicated in <span class= disease  id= 22532985-3-38-44 >asthma</span> through its effects on the obesity, bacillus Calmettee Gu&eacute;rin (BCG) vaccination and high vitamin D level, vitamin D supplement, checkpoint protein kinase 1 (Chk1), <span class= gene  id= 22532985-3-209-242 >plasminogen activator inhibitor-1</span> (<span class= gene  id= 22532985-3-244-249 >PAI-1</span>) and gamma delta T cells (gdT).	22532985	enzyme modulator	serpin family E member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.02643592635584	2012
NR3C1	2908	AlteredExpression	BEFREE	An analysis of <span class= gene  id= 25393397-0-15-38 >glucocorticoid receptor</span>-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for <span class= disease  id= 25393397-0-188-194 >asthma</span> therapeutics.	25393397	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2014
NR3C1	2908	AlteredExpression	LHGDN	RNA silencing of GCRbeta mRNA in human BAL macrophages from patients with GC-insensitive asthma resulted in enhanced dexamethasone-induced GCRalpha transactivation.	16387802	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2006
NR3C1	2908	AlteredExpression	BEFREE	DEX-stimulated recruitment of <span class= gene  id= 24418482-11-30-32 >GR</span> and histone H4 acetylation at the glucocorticoid response element 4.6 kbp upstream of the MKP-1 gene were significantly lower in monocytes from patients with SR asthma compared with those from patients with SS <span class= disease  id= 24418482-11-243-249 >asthma</span>.	24418482	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2013
NR3C1	2908	AlteredExpression	BEFREE	We therefore studied <span class= gene  id= 9731032-2-21-23 >GR</span> mRNA and protein levels in bronchial biopsies obtained from seven untreated <span class= disease  id= 9731032-2-100-109 >asthmatic</span> patients, seven control volunteers, and seven patients with chronic bronchitis.	9731032	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	1998
NR3C1	2908	AlteredExpression	BEFREE	<span class= gene  id= 22156779-0-0-23 >Glucocorticoid receptor</span> &beta; and histone deacetylase 1 and 2 expression in the airways of severe <span class= disease  id= 22156779-0-94-100 >asthma</span>.	22156779	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2012
NR3C1	2908	AlteredExpression	BEFREE	In vivo modulation of <span class= gene  id= 10200007-0-22-45 >glucocorticoid receptor</span> mRNA by inhaled fluticasone propionate in bronchial mucosa and blood lymphocytes in subjects with mild <span class= disease  id= 10200007-0-149-155 >asthma</span>.	10200007	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	1999
NR3C1	2908	AlteredExpression	BEFREE	Gene network modeling revealed decreased <span class= gene  id= 25863981-9-41-64 >glucocorticoid receptor</span> signaling and increased activity of the mitogen-activated protein kinase and Jun kinase cascades in patients with <span class= disease  id= 25863981-9-179-181 >SA</span>.	25863981	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2015
NR3C1	2908	AlteredExpression	BEFREE	Secondary steroid resistance in <span class= disease  id= 7633872-5-32-38 >asthma</span> may arise in response to the release of cytokines that activate AP-1 and other transcription factors that bind directly to <span class= gene  id= 7633872-5-162-164 >GR</span>.	7633872	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	1995
NR3C1	2908	AlteredExpression	BEFREE	Inhibition of histone deacetylase 2 expression by elevated <span class= gene  id= 20538962-0-59-82 >glucocorticoid receptor</span> beta in steroid-resistant <span class= disease  id= 20538962-0-109-115 >asthma</span>.	20538962	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2010
NR3C1	2908	AlteredExpression	BEFREE	Sex-specific associations between cortisol and birth weight in pregnancies complicated by <span class= disease  id= 20627904-0-90-96 >asthma</span> are <span class= negexp >not due to differential</span> <span class= gene  id= 20627904-0-125-148 >glucocorticoid receptor</span> expression.	20627904	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2010
NR3C1	2908	AlteredExpression	BEFREE	These <span class= gene  id= 9560836-7-6-9 >GCR</span> changes along with recent evidence for increased transcription factor activation in SR <span class= disease  id= 9560836-7-97-103 >asthma</span> which may inhibit GCR/DNA interactions as well as the selective recruitment of neutrophils into the airways of certain patients with severe <span class= disease  id= 9560836-7-244-250 >asthma</span> contribute to the heterogeneity of mechanisms underlying steroid resistance.	9560836	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	1998
NR3C1	2908	AlteredExpression	BEFREE	To elucidate the regulation of <span class= gene  id= 23593222-1-31-54 >glucocorticoid receptor</span> (GR) signaling under pro-<span class= disease  id= 23593222-1-80-89 >asthmatic</span> conditions, cultured human airway smooth muscle (HASM) cells were treated with proinflammatory cytokines or <span class= gene  id= 23593222-1-198-200 >GR</span> ligands alone and in combination, and then examined for induced changes in ligand-dependent and -independent GR activation and downstream signaling events.	23593222	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2013
NR3C1	2908	AlteredExpression	BEFREE	Expression of c-fos, rather than c-jun or <span class= gene  id= 12400872-0-42-65 >glucocorticoid-receptor</span> mRNA, correlates with decreased glucocorticoid response of peripheral blood mononuclear cells in <span class= disease  id= 12400872-0-163-169 >asthma</span>.	12400872	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2003
NR3C1	2908	AlteredExpression	BEFREE	Life stress and diminished expression of genes encoding <span class= gene  id= 16567656-0-56-79 >glucocorticoid receptor</span> and beta2-adrenergic receptor in children with <span class= disease  id= 16567656-0-127-133 >asthma</span>.	16567656	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2006
NR3C1	2908	AlteredExpression	BEFREE	The <span class= gene  id= 25649164-0-4-9 >NR3C1</span> <span class= gene  id= 25649164-0-10-33 >Glucocorticoid Receptor</span> Gene Polymorphisms May Modulate the TGF-beta mRNA Expression in <span class= disease  id= 25649164-0-98-104 >Asthma</span> Patients.	25649164	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2016
NR3C1	2908	AlteredExpression	BEFREE	Bronchial biopsies from allergen-challenged atopic <span class= disease  id= 21827450-4-51-60 >asthmatic</span> subjects taking inhaled budesonide or placebo were subjected to gene expression analysis using real-time reverse transcriptase-PCR for the corticosteroid-inducible genes (official gene symbols with aliases in parentheses): TSC22D3 [glucocorticoid-induced leucine zipper (GILZ)], dual-specificity phosphatase-1 (MAPK phosphatase-1), both anti-inflammatory effectors, and FKBP5 [FK506-binding protein 51 (FKBP51)], a regulator of <span class= gene  id= 21827450-4-489-491 >GR</span> function.	21827450	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 3 group C member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.023126528299589	2012
IL1A	3552	AlteredExpression	BEFREE	Phenotypic features of alveolar monocytes/macrophages and IL-8 gene activation by <span class= gene  id= 10919504-0-82-86 >IL-1</span> and TNF-alpha in <span class= disease  id= 10919504-0-104-113 >asthmatic</span> patients.	10919504	signaling molecule	interleukin 1 alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.021794281778852	2000
IL1A	3552	AlteredExpression	BEFREE	IL-33 is a nuclear cytokine from the <span class= gene  id= 25278425-1-37-41 >IL-1</span> family constitutively expressed in epithelial barrier tissues and lymphoid organs, which plays important roles in type-2 innate immunity and human <span class= disease  id= 25278425-1-189-195 >asthma</span>.	25278425	signaling molecule	interleukin 1 alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.021794281778852	2014
IL1A	3552	AlteredExpression	BEFREE	Microbial adhesion (virulence) and Proteobacteria abundance were significantly associated with variation in the expression of the upstream regulator <span class= gene  id= 26125632-11-149-153 >IL1A</span>; suggesting that microbiome characteristics modulate host inflammatory and immune systems during <span class= disease  id= 26125632-11-251-257 >asthma</span>.	26125632	signaling molecule	interleukin 1 alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.021794281778852	2015
IL1A	3552	AlteredExpression	BEFREE	IL-33 is a recently characterized <span class= gene  id= 20689814-1-34-38 >IL-1</span> family cytokine and found to be expressed in inflammatory diseases, including severe <span class= disease  id= 20689814-1-124-130 >asthma</span> and inflammatory bowl disease.	20689814	signaling molecule	interleukin 1 alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.021794281778852	2010
IL17A	3605	AlteredExpression	LHGDN	The data suggest that Th17 cell infiltration in asthmatic airways links T cell activity with neutrophilic inflammation in asthma.	17083726	signaling molecule	interleukin 17A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019829806889032	2006
IL17A	3605	AlteredExpression	BEFREE	Recently, <span class= gene  id= 16951370-1-10-16 >IL-17A</span> has been shown to be expressed in higher levels in respiratory secretions from <span class= disease  id= 16951370-1-96-106 >asthmatics</span> and correlated with airway hyperresponsiveness.	16951370	signaling molecule	interleukin 17A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019829806889032	2006
IL17A	3605	AlteredExpression	BEFREE	<span class= gene  id= 24349168-13-0-5 >IL-17</span> and IL-22 were increased in both normal and <span class= disease  id= 24349168-13-50-59 >asthmatic</span> conditions with a significantly higher amount in <span class= disease  id= 24349168-13-109-119 >asthmatics</span> compared to controls.	24349168	signaling molecule	interleukin 17A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019829806889032	2013
IL17A	3605	AlteredExpression	BEFREE	We demonstrated that CCL2 and <span class= gene  id= 25765592-8-30-35 >IL-17</span> levels and the frequency of Th17 and Tc17 cells in lung tissues and bronchoalveolar lavage fluid increased in the <span class= disease  id= 25765592-8-150-156 >asthma</span> group compared with the normal control mice.	25765592	signaling molecule	interleukin 17A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019829806889032	2014
IL17A	3605	AlteredExpression	BEFREE	<span class= gene  id= 17083726-0-0-5 >IL-17</span> mRNA in sputum of <span class= disease  id= 17083726-0-24-33 >asthmatic</span> patients: linking T cell driven inflammation and granulocytic influx?	17083726	signaling molecule	interleukin 17A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019829806889032	2006
IL17A	3605	AlteredExpression	BEFREE	Despite the absence of the mRNA for the <span class= gene  id= 21535180-5-40-46 >IL-17A</span> cytokine, IL-22 expression was found in PBMC from asthmatic patients, with increased IL-22 mRNA levels in patients with chronic severe respect to those with moderate <span class= disease  id= 21535180-5-213-219 >asthma</span>.	21535180	signaling molecule	interleukin 17A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019829806889032	2011
IL17A	3605	AlteredExpression	BEFREE	<span class= gene  id= 24393021-0-0-6 >IL-17A</span> mediates a selective gene expression profile in <span class= disease  id= 24393021-0-55-64 >asthmatic</span> human airway smooth muscle cells.	24393021	signaling molecule	interleukin 17A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019829806889032	2014
IL18R1	8809	AlteredExpression	BEFREE	Three of these genes were previously implicated in both <span class= disease  id= 25895113-10-56-62 >asthma</span> and IBD (ZPBP2 IL1R1, and <span class= gene  id= 25895113-10-89-95 >IL18R1</span>) and 3 in <span class= disease  id= 25895113-10-106-112 >asthma</span> only (PYHIN1, IL2RB, and GSTP1).	25895113	receptor	interleukin 18 receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019698781819772	2016
TLR9	54106	AlteredExpression	BEFREE	In the on-treatment group, TLR1, TLR2, TLR6, and <span class= gene  id= 20072849-4-49-53 >TLR9</span> expressions on PBMCs were significantly different between <span class= disease  id= 20072849-4-112-122 >asthmatics</span> and controls.	20072849	extracellular matrix protein; receptor	toll like receptor 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019372897878247	2009
TLR9	54106	AlteredExpression	BEFREE	Polymorphisms in the identified chitin receptors, NOD2 and <span class= gene  id= 24722226-7-59-63 >TLR9</span>, predispose individuals to inflammatory conditions and dysregulated expression of chitinases and chitinase-like binding proteins, whose activity is essential to generate IL-10-inducing fungal chitin particles in vitro, have also been linked to inflammatory conditions and <span class= disease  id= 24722226-7-336-342 >asthma</span>.	24722226	extracellular matrix protein; receptor	toll like receptor 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019372897878247	2014
TLR9	54106	AlteredExpression	BEFREE	The <span class= gene  id= 18020622-5-4-8 >TLR9</span>-mediated activation of the vertebrate immune system suggests using such <span class= gene  id= 18020622-5-81-85 >TLR9</span> agonists as effective vaccine adjuvants for infectious disease, and for the treatment of cancer and <span class= disease  id= 18020622-5-186-192 >asthma</span>/allergy.	18020622	extracellular matrix protein; receptor	toll like receptor 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019372897878247	2008
TLR9	54106	AlteredExpression	BEFREE	Lung ST2L and <span class= gene  id= 21640974-5-14-34 >toll-like receptor 9</span> protein expression levels concomitantly increased in a time-dependent manner during fungal <span class= disease  id= 21640974-5-126-132 >asthma</span>.	21640974	extracellular matrix protein; receptor	toll like receptor 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.019372897878247	2011
FEV	54738	AlteredExpression	BEFREE	In accord with these murine findings, IL-11 is selectively expressed in eosinophils and epithelial cells in patients with moderate and severe <span class= disease  id= 11590369-7-142-148 >asthma</span> where expression correlates directly with disease severity and inversely with <span class= gene  id= 11590369-7-227-230 >FEV</span>(1).	11590369	transcription factor; signaling molecule; nucleic acid binding	FEV, ETS transcription factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.018681421326491	2001
FEV	54738	AlteredExpression	BEFREE	EDN1 mRNA levels and protein expression in <span class= disease  id= 17996929-6-43-52 >asthmatic</span> patients were negatively correlated with prebronchodilator and postbronchodilator <span class= gene  id= 17996929-6-135-138 >FEV</span>(1) value (r(2) &gt;or= 0.193, P &lt;or= .03), and they were positively related to airway smooth muscle areas (r(2) = 0.253, P = .01 and r(2) = 0.281, P = .005 for EDN1 mRNA and protein expression, respectively).	17996929	transcription factor; signaling molecule; nucleic acid binding	FEV, ETS transcription factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.018681421326491	2007
FEV	54738	AlteredExpression	BEFREE	The mRNA transcripts for MMP-1, TIMP-1 and monocyte chemoattractant protein-1 (MCP-1) were increased in cell pellets of induced sputum from <span class= disease  id= 14968124-4-140-150 >asthmatics</span> when compared to controls (P&lt;0.05), and the intensity of MMP-1 mRNA expression inversely correlated with the <span class= gene  id= 14968124-4-260-263 >FEV</span>(1) in <span class= disease  id= 14968124-4-270-280 >asthmatics</span> (r=-0.49, P&lt;0.05).	14968124	transcription factor; signaling molecule; nucleic acid binding	FEV, ETS transcription factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.018681421326491	2004
CHIA	27159	AlteredExpression	LHGDN	results establish a significant association of <span class=gene id=18602573>CHIA</span> with atopic <span class=disease id=18602573>asthma</span> and serum total IgE levels in the Indian population	18602573	hydrolase	chitinase, acidic	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.018390660433337	2008
CHIA	27159	AlteredExpression	LHGDN	expressed in exaggerated quantities in human asthma	15192232	hydrolase	chitinase, acidic	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.018390660433337	2004
CHIA	27159	AlteredExpression	BEFREE	As a novel target for <span class= disease  id= 19241384-6-22-28 >asthma</span> therapy, structural details of <span class= gene  id= 19241384-6-60-66 >AMCase</span> activity will help guide the future design of specific and potent AMCase inhibitors.	19241384	hydrolase	chitinase, acidic	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.018390660433337	2009
CHIA	27159	AlteredExpression	BEFREE	<span class= gene  id= 18824549-1-0-26 >Acidic mammalian chitinase</span> (<span class= gene  id= 18824549-1-28-34 >AMCase</span>) is expressed in an exaggerated fashion in epithelial cells at sites of pulmonary T helper cell type 2 inflammation and plays important roles in the pathogenesis of anti-parasite and <span class= disease  id= 18824549-1-218-224 >asthma</span>-like responses.	18824549	hydrolase	chitinase, acidic	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.018390660433337	2009
CHIA	27159	AlteredExpression	BEFREE	<span class= gene  id= 18845328-2-0-26 >Acidic mammalian chitinase</span> (<span class= gene  id= 18845328-2-28-34 >AMCase</span>) and chitotriosidase (CHIT1) have chitinolytic activity, but relatively little is known about their expression in human <span class= disease  id= 18845328-2-155-161 >asthma</span>.	18845328	hydrolase	chitinase, acidic	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.018390660433337	2008
CHIA	27159	AlteredExpression	BEFREE	Silencing <span class= gene  id= 19548841-9-10-16 >AMCase</span> expression by shRNA may be a promising therapeutic strategy in <span class= disease  id= 19548841-9-80-86 >asthma</span>.	19548841	hydrolase	chitinase, acidic	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.018390660433337	2010
BDNF	627	AlteredExpression	BEFREE	The current review focuses on 1) the importance of <span class= gene  id= 24560686-3-51-55 >BDNF</span> expression and signaling mechanisms in early airway and lung development, critical to both normal neonatal lung function and also its disruption in prematurity and insults such as inflammation and infection; 2) how <span class= gene  id= 24560686-3-271-275 >BDNF</span>, potentially derived from airway nerves modulate neurogenic control of airway tone, a key aspect of airway reflexes as well as dysfunctional responses to allergic inflammation; 3) the emerging idea that local <span class= gene  id= 24560686-3-485-489 >BDNF</span> production by resident airway cells such as epithelium and airway smooth muscle can contribute to normal airway structure and function, and to <span class= disease  id= 24560686-3-633-655 >airway hyperreactivity</span> and remodeling in diseases such as <span class= disease  id= 24560686-3-691-697 >asthma</span>.	24560686	signaling molecule	brain derived neurotrophic factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.016807812262688	2014
BDNF	627	AlteredExpression	BEFREE	This <span class= gene  id= 11544458-2-5-17 >neurotrophin</span> is found at high levels in the serum of <span class= disease  id= 11544458-2-58-67 >asthmatic</span> individuals, is released during allergic reactions, and is reported to augment in vitro histamine and leukotriene C4 release by human basophils.	11544458	signaling molecule	brain derived neurotrophic factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.016807812262688	2001
BDNF	627	AlteredExpression	BEFREE	<span class= gene  id= 25945802-0-0-33 >Brain-Derived Neurotrophic Factor</span> Expression in <span class= disease  id= 25945802-0-48-54 >Asthma</span>. Association with Severity and Type 2 Inflammatory Processes.	25945802	signaling molecule	brain derived neurotrophic factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.016807812262688	2016
BDNF	627	AlteredExpression	BEFREE	They are a possible source of elevated <span class= gene  id= 12752594-15-39-51 >neurotrophin</span> levels found in allergy and <span class= disease  id= 12752594-15-80-86 >asthma</span>.	12752594	signaling molecule	brain derived neurotrophic factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.016807812262688	2003
FCER1A	2205	AlteredExpression	LHGDN	microarray data identify Lyn as a negative regulator in Ag-stimulated bone marrow-derived mast cells of the expression of genes linked to FcepsilonRI signaling and also to the response pathways that lead to allergy and asthma	16339523	cell adhesion molecule	Fc fragment of IgE receptor Ia	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.016467572943845	2005
FCER1A	2205	AlteredExpression	BEFREE	Peripheral blood and bronchoalveolar lavage (BAL) PMNs from <span class= disease  id= 11292654-7-60-69 >asthmatic</span> subjects also express intracellular <span class= gene  id= 11292654-7-106-125 >Fc epsilon RI alpha</span> and beta chain immunoreactivity.	11292654	cell adhesion molecule	Fc fragment of IgE receptor Ia	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.016467572943845	2001
FCER1A	2205	AlteredExpression	BEFREE	In vitro addition of IL-4 induced a dose-dependent increase in <span class= gene  id= 11150000-9-63-88 >Fc epsilon RI alpha-chain</span> expression on BMs from NASs, and this effect was significantly enhanced with BMs from <span class= disease  id= 11150000-9-175-178 >AAP</span>s.	11150000	cell adhesion molecule	Fc fragment of IgE receptor Ia	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.016467572943845	2001
LTA4H	4048	AlteredExpression	BEFREE	LPS induced significant expression of ANXA1 and <span class= gene  id= 25634111-8-48-53 >LTA4H</span> in <span class= disease  id= 25634111-8-57-67 >asthmatics</span> when compared to COPD patients and healthy subjects.	25634111	protease; hydrolase	leukotriene A4 hydrolase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.016141689002319	2014
CSF2	1437	AlteredExpression	BEFREE	Eosinophils express interleukin 5 and <span class= gene  id= 1401075-0-38-86 >granulocyte macrophage-colony-stimulating factor</span> mRNA at sites of allergic inflammation in <span class= disease  id= 1401075-0-129-139 >asthmatics</span>.	1401075	signaling molecule	colony stimulating factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01567210334584	1992
CSF2	1437	AlteredExpression	BEFREE	Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and <span class= gene  id= 8417755-0-102-150 >granulocyte/macrophage colony-stimulating factor</span> in bronchial biopsies after allergen inhalation challenge in atopic <span class= disease  id= 8417755-0-219-229 >asthmatics</span>.	8417755	signaling molecule	colony stimulating factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01567210334584	1993
CSF2	1437	AlteredExpression	BEFREE	There were increased proportions of cells positive for IL-3 (p &lt; 0.05), IL-4 (p &lt; 0.005), IL-5 (p &lt; 0.005), and <span class= gene  id= 8360390-6-112-118 >GM-CSF</span> (p &lt; 0.005) mRNA in BAL fluid from patients with symptomatic <span class= disease  id= 8360390-6-180-186 >asthma</span> when compared with that from subjects <span class= negexp >free of</span> symptoms, but <span class= negexp >no difference</span> between the groups in numbers of cells expressing IL-2 and interferon-gamma mRNA.	8360390	signaling molecule	colony stimulating factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01567210334584	1993
CSF2	1437	AlteredExpression	BEFREE	Glucocorticoid therapy of <span class= disease  id= 7742019-13-26-36 >asthmatics</span> is associated with a reduction in the percentages of CD4 T-LC expressing IL-3, IL-5, and <span class= gene  id= 7742019-13-126-132 >GM-CSF</span> mRNA and secretion of the corresponding proteins.	7742019	signaling molecule	colony stimulating factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01567210334584	1995
CSF2	1437	AlteredExpression	BEFREE	In experiments on isolated ASM tissue segments (a) exogenous administration of IL-2 and IFN-gamma to atopic <span class= disease  id= 10194481-7-108-117 >asthmatic</span> serum-sensitized ASM ablated both their enhanced constrictor responsiveness to acetylcholine (ACh) and their attenuated relaxation responsiveness to beta-adrenoceptor stimulation with isoproterenol, and (b) administration of IL-5 and <span class= gene  id= 10194481-7-352-358 >GM-CSF</span> to naive ASM induced significant increases in their contractility to ACh and impaired their relaxant responsiveness to isoproterenol.	10194481	signaling molecule	colony stimulating factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01567210334584	1999
CSF2	1437	AlteredExpression	BEFREE	Day-night variation in eosinophil <span class= gene  id= 17225724-9-34-40 >GM-CSF</span> expression is associated with circadian variation in airway function in <span class= disease  id= 17225724-9-113-119 >asthma</span>, a key manifestation of <span class= disease  id= 17225724-9-144-150 >asthma</span> severity.	17225724	signaling molecule	colony stimulating factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01567210334584	2007
CSF2	1437	AlteredExpression	BEFREE	<span class= gene  id= 9731032-7-0-6 >GM-CSF</span> expression was significantly increased in bronchial epithelial cells from untreated and steroid-dependent <span class= disease  id= 9731032-7-113-122 >asthmatic</span> patients.	9731032	signaling molecule	colony stimulating factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01567210334584	1998
CSF2	1437	AlteredExpression	BEFREE	Chronic cough resembles <span class= disease  id= 9525446-0-24-30 >asthma</span> with IL-5 and <span class= gene  id= 9525446-0-45-93 >granulocyte-macrophage colony-stimulating factor</span> gene expression in bronchoalveolar cells.	9525446	signaling molecule	colony stimulating factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01567210334584	1998
CSF2	1437	AlteredExpression	BEFREE	Further assessment made in 15 of the 24 acute <span class= disease  id= 8835120-6-46-56 >asthmatics</span> 7 days after systemic steroid treatment revealed a significant reduction in <span class= gene  id= 8835120-6-133-139 >GM-CSF</span> expression (P &lt; 0.05) but not for IL-3.	8835120	signaling molecule	colony stimulating factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01567210334584	1996
MYLK	4638	AlteredExpression	BEFREE	Myosin, transgelin, and <span class= gene  id= 19011151-0-24-49 >myosin light chain kinase</span>: expression and function in <span class= disease  id= 19011151-0-78-84 >asthma</span>.	19011151	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	myosin light chain kinase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.015434178341623	2009
MYLK	4638	AlteredExpression	LHGDN	Selective overexpression of airway smooth muscle genes in asthmatic airways leads to increased Vmax, thus contributing to the airway hyperresponsiveness observed in asthma.	19011151	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	myosin light chain kinase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.015434178341623	2009
FOXP3	50943	AlteredExpression	BEFREE	Glucocorticoids upregulate <span class= gene  id= 15577848-0-27-32 >FOXP3</span> expression and regulatory T cells in <span class= disease  id= 15577848-0-70-76 >asthma</span>.	15577848	transcription factor; nucleic acid binding	forkhead box P3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.013576603386761	2005
FOXP3	50943	AlteredExpression	LHGDN	Analysis of cd4+ CD25+ regulatory T cells and <span class=gene id=17393103>FOXP3</span> mRNA in the peripheral blood of patients with <span class=disease id=17393103>asthma</span>.	17393103	transcription factor; nucleic acid binding	forkhead box P3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.013576603386761	2007
FOXP3	50943	AlteredExpression	BEFREE	<span class= gene  id= 25048599-9-0-5 >FOXP3</span> protein levels in Tet-On() clones were high after both 2- and 5-day Dox treatment; however, 5-day cells were comparable with T(regs) from patients with <span class= disease  id= 25048599-9-159-165 >asthma</span>, whereas 2-day cells were similar to T(regs) from participants without <span class= disease  id= 25048599-9-237-243 >asthma</span>.	25048599	transcription factor; nucleic acid binding	forkhead box P3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.013576603386761	2014
FOXP3	50943	AlteredExpression	BEFREE	The mRNA expression of <span class= gene  id= 17349011-6-23-38 >forkhead box P3</span> (<span class= gene  id= 17349011-6-40-45 >FoxP3</span>) was increased in moderate-severe versus mild <span class= disease  id= 17349011-6-92-98 >asthma</span> (2 x 93 +/- 0 x 38 versus 1 x 60 +/- 0 x 31, P&lt; 0 x 01).	17349011	transcription factor; nucleic acid binding	forkhead box P3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.013576603386761	2007
FOXP3	50943	AlteredExpression	BEFREE	Decreased <span class= gene  id= 19392991-0-10-15 >FOXP3</span> protein expression in patients with <span class= disease  id= 19392991-0-52-58 >asthma</span>.	19392991	transcription factor; nucleic acid binding	forkhead box P3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.013576603386761	2010
FOXP3	50943	AlteredExpression	BEFREE	Modified <span class= gene  id= 23391720-0-9-14 >Foxp3</span> mRNA protects against <span class= disease  id= 23391720-0-37-43 >asthma</span> through an IL-10-dependent mechanism.	23391720	transcription factor; nucleic acid binding	forkhead box P3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.013576603386761	2012
FOXP3	50943	AlteredExpression	BEFREE	The anti-TNF-alpha reagent, etanercept, restored the functional activity and <span class= gene  id= 18053016-7-77-82 >Foxp3</span> expression of CD4(+)CD25(high) Treg derived from allergic <span class= disease  id= 18053016-7-141-151 >asthmatics</span>.	18053016	transcription factor; nucleic acid binding	forkhead box P3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.013576603386761	2008
FOXP3	50943	AlteredExpression	BEFREE	Therefore, <span class= gene  id= 26409874-11-11-16 >FOXP3</span> expression could serve as an indicator of severe <span class= disease  id= 26409874-11-66-72 >asthma</span> with concomitant atopic conditions such as IgE-dependent FA.	26409874	transcription factor; nucleic acid binding	forkhead box P3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.013576603386761	2015
FOXP3	50943	AlteredExpression	BEFREE	Collectively, our findings indicate that HO-1 exhibits anti-inflammatory activity in the mouse model of NEA via inhibition of the p-STAT3-ROR&gamma;t pathway, regulating kinetics of ROR&gamma;t and <span class= gene  id= 24097973-13-186-191 >Foxp3</span> expression, thus providing a possible novel therapeutic target in <span class= disease  id= 24097973-13-258-267 >asthmatic</span> patients.	24097973	transcription factor; nucleic acid binding	forkhead box P3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.013576603386761	2014
IL15	3600	AlteredExpression	BEFREE	In the present study we have evaluated the expression of <span class= gene  id= 11742275-5-57-62 >IL-15</span> mRNA and protein in bronchial biopsy specimens obtained from patients with sarcoidosis (n = 8), tuberculosis (n = 7), chronic bronchitis (n = 10), and <span class= disease  id= 11742275-5-214-230 >bronchial asthma</span> (n = 8) and compared its expression with that seen in normal control subjects (n = 11).	11742275	signaling molecule	interleukin 15	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.013134049753292	2002
IL13RA1	3597	AlteredExpression	BEFREE	The expression of <span class= gene  id= 21596548-9-18-27 >IL-13R&alpha;(1</span>) was higher in <span class= disease  id= 21596548-9-43-53 >asthmatics</span> compared to controls, and correlated to the BLTs.	21596548	defense/immunity protein; signaling molecule	interleukin 13 receptor subunit alpha 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.012910480126392	2011
CCL17	6361	AlteredExpression	BEFREE	In addition, bronchoalveolar lavage fluid from <span class= disease  id= 11306430-9-47-56 >asthmatic</span> subjects after allergen challenge contained significantly increased levels of <span class= gene  id= 11306430-9-135-139 >TARC</span>, suggesting that TARC production by bronchial epithelial cells may play a role in the pathogenesis of allergic asthma.	11306430	signaling molecule	C-C motif chemokine ligand 17	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.012752423034121	2001
CCL17	6361	AlteredExpression	BEFREE	Expression of sDC OX40L and <span class= gene  id= 25813919-9-28-33 >CCL17</span> mRNA was increased in <span class= disease  id= 25813919-9-56-65 >asthmatic</span> cases (P = .003 and P = .0001, respectively). sHBEC TSLP mRNA expression was strongly associated with sDC OX40L mRNA expression (R = 0.65, P = .001) and less strongly with sDC <span class= gene  id= 25813919-9-242-247 >CCL17</span> mRNA expression. sHBEC IL33 mRNA expression was associated with sDC OX40L mRNA expression (R = 0.42, P = .04) but not sDC <span class= gene  id= 25813919-9-370-375 >CCL17</span> mRNA expression.	25813919	signaling molecule	C-C motif chemokine ligand 17	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.012752423034121	2014
CCL17	6361	AlteredExpression	LHGDN	The effects of house dust mite allergen and the cytokines IL-4 and TGF-beta on <span class=gene id=17023689>TARC</span> expression in 16HBE cells and primary <span class=disease id=17023689>bronchial asthma</span> epithelium, was examined.	17023689	signaling molecule	C-C motif chemokine ligand 17	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.012752423034121	2007
CCL17	6361	AlteredExpression	BEFREE	Although the total numbers of cells expressing CCR4, CCR8, and CXCR3 did not significantly differ in the asthmatics and controls, there was evidence of selective infiltration of CD4(+)/CCR4(+) T cells in the <span class= disease  id= 15944327-6-208-217 >asthmatic</span> biopsies which correlated with <span class= gene  id= 15944327-6-249-253 >TARC</span> and MDC expression and airway obstruction.	15944327	signaling molecule	C-C motif chemokine ligand 17	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.012752423034121	2005
CCL17	6361	AlteredExpression	BEFREE	This study does <span class= negexp >not support</span> the existence in human <span class= disease  id= 22981793-8-51-57 >asthma</span> of the full M2 phenotype described to date but points to upregulation of <span class= gene  id= 22981793-8-131-136 >CCL17</span> in both patients with mild and those with moderate <span class= disease  id= 22981793-8-188-194 >asthma</span>, providing a further source for this ligand of CCR4(+) cells that contributes to airways inflammation.	22981793	signaling molecule	C-C motif chemokine ligand 17	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.012752423034121	2012
CCL17	6361	AlteredExpression	LHGDN	Elevated bronchial mucosal expression of TARC/CCL17 is implicated in asthma pathogenesis; its action is partly through selective development and retention, or recruitment of T helper type 2, not Th1, receptor-bearing cells.	15944327	signaling molecule	C-C motif chemokine ligand 17	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.012752423034121	2005
TAC1	6863	AlteredExpression	BEFREE	Evidence suggested LIF is related to the higher expression of <span class= gene  id= 17392578-2-62-74 >neurokinin-1</span> receptor (NK-1R) in <span class= disease  id= 17392578-2-95-101 >asthma</span>.	17392578	signaling molecule	tachykinin precursor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.012202969465695	2007
TAC1	6863	AlteredExpression	LHGDN	The contents of plasma neurokinin A (NKA) were significantly higher during the asthma attack stage of children, and the higher was the level of NKA, the more severe the attack.	14749007	signaling molecule	tachykinin precursor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.012202969465695	2003
TAC1	6863	AlteredExpression	LHGDN	Sputum <span class=gene id=18507649>NKA</span> is up-regulated during acute <span class=disease id=18507649>asthma</span> exacerbation and it positively correlates to its severity.	18507649	signaling molecule	tachykinin precursor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.012202969465695	2009
CHI3L1	1116	AlteredExpression	BEFREE	Our results suggest that CCL18 and <span class= gene  id= 23331560-9-35-41 >YKL-40</span> levels and CHIT1 activity are enhanced in allergic airway inflammation and thus may contribute to airway remodelling in <span class= disease  id= 23331560-9-162-168 >asthma</span>.	23331560	hydrolase	chitinase 3 like 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011667871274586	2012
CHI3L1	1116	AlteredExpression	BEFREE	Although <span class= gene  id= 19414556-2-9-15 >YKL-40</span> is expressed in exaggerated quantities and correlates with disease activity in <span class= disease  id= 19414556-2-95-101 >asthma</span> and many other disorders, the biological properties of BRP-39/<span class= gene  id= 19414556-2-164-170 >YKL-40</span> have only been rudimentarily defined.	19414556	hydrolase	chitinase 3 like 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011667871274586	2009
CHI3L1	1116	AlteredExpression	LHGDN	CHI3L1 is a susceptibility gene for asthma, bronchial hyperresponsiveness, and reduced lung function, and elevated circulating YKL-40 levels are a biomarker for asthma and decline in lung function.	18403759	hydrolase	chitinase 3 like 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011667871274586	2008
TGFB2	7042	AlteredExpression	BEFREE	<span class= gene  id= 22227417-10-0-6 >TGF-&beta;2</span> levels increased significantly in <span class= disease  id= 22227417-10-41-50 >asthmatic</span> cultures after IL-4/IL-13 stimulation.	22227417	signaling molecule	transforming growth factor beta 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011653515897269	2011
TGFB2	7042	AlteredExpression	BEFREE	<span class= gene  id= 24875618-12-0-6 >TGF-&beta;2</span> activity was increased in cocultures of HLFs with AECs from <span class= disease  id= 24875618-12-67-76 >asthmatic</span> patients (P &lt; .05), whereas PGES2 was downregulated in AEC-HLF cocultures (2.2-fold, P &lt; .006).	24875618	signaling molecule	transforming growth factor beta 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011653515897269	2014
CCL26	10344	AlteredExpression	BEFREE	ST2L expression was increased in severe <span class= disease  id= 25091434-8-40-46 >asthma</span> (P = .02) and associated with multiple indicators of TH2-like inflammation, including blood eosinophils (P = .001), exhaled nitric oxide (P = .003), and epithelial CLCA1 (P &lt; .0001) and <span class= gene  id= 25091434-8-233-242 >eotaxin-3</span> (P = .001) mRNA expression.	25091434	signaling molecule	C-C motif chemokine ligand 26	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011551201582644	2014
CCL26	10344	AlteredExpression	BEFREE	<span class= gene  id= 11415932-0-0-9 >Eotaxin-3</span> but <span class= negexp >not eotaxin gene expression is upregulated in</span> <span class= disease  id= 11415932-0-60-70 >asthmatics</span> 24 hours after allergen challenge.	11415932	signaling molecule	C-C motif chemokine ligand 26	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011551201582644	2001
PLF	450095	AlteredExpression	BEFREE	We aimed to determine the relationship between serum periostin levels and <span class= gene  id= 23791506-3-74-92 >pulmonary function</span> decline in <span class= disease  id= 23791506-3-104-113 >asthmatic</span> patients on inhaled corticosteroid (ICS) treatment.	23791506	null	Pulmonary function	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01153852493695	2013
PLF	450095	AlteredExpression	BEFREE	Our data suggest a gene-by-environment interaction between CD14 genotypes and ETS, which affects <span class= gene  id= 15879416-11-97-115 >pulmonary function</span> and IgE levels among Latinos with <span class= disease  id= 15879416-11-150-156 >asthma</span>.	15879416	null	Pulmonary function	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01153852493695	2005
PLF	450095	AlteredExpression	BEFREE	An inverse and strict correlation between sputum HMGB1 levels and <span class= gene  id= 26250770-9-66-84 >pulmonary function</span> indices also were observed in children with mild (FEV1%, r = -0.86544, P &lt; .0001; FEF25%-75%, r = -0.53948, P &lt; .05), moderate (FEV1%, r = -0.99548, P &lt; .0001; FEF25%-75%, r = -0.48668, P &lt; .05), and severe (FEV1%, r = -0.90191, P &lt; .0001; FEF25%-75%, r = -0.66777, P &lt; .05) <span class= disease  id= 26250770-9-360-366 >asthma</span>.	26250770	null	Pulmonary function	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01153852493695	2015
PLF	450095	AlteredExpression	BEFREE	We aimed to determine whether sputum amphiregulin is expressed at elevated levels in patients with <span class= disease  id= 19447920-2-99-105 >asthma</span> or eosinophilic bronchitis (EB), and whether it is associated with eosinophilic inflammation, <span class= gene  id= 19447920-2-200-218 >pulmonary function</span>, and bronchial hyperresponsiveness in children.	19447920	null	Pulmonary function	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01153852493695	2009
CXCR3	2833	AlteredExpression	BEFREE	In contrast to <span class= disease  id= 11390417-6-15-21 >asthma</span>, T cells infiltrating the airways of patients with chronic obstructive pulmonary disease and pulmonary sarcoidosis produce IFN-gamma and express high levels of <span class= gene  id= 11390417-6-182-187 >CXCR3</span>, while lacking CCR4 and CCR8 expression.	11390417	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-X-C motif chemokine receptor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011378789113056	2001
CXCR3	2833	AlteredExpression	BEFREE	Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C <span class= gene  id= 10570327-0-127-147 >chemokine receptor 3</span> expression in bronchial biopsies from atopic and nonatopic (Intrinsic) <span class= disease  id= 10570327-0-219-229 >asthmatics</span>.	10570327	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-X-C motif chemokine receptor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011378789113056	1999
STAT3	6774	AlteredExpression	BEFREE	This <span class= disease  id= 17919711-5-5-11 >asthma</span>-associated alteration was both subset specific because no change was seen in CD4(+)CD161(-)CD25(+) (regulatory T cells) and CD4(+)CD161(-)CD25(-) subsets and isoform specific because phospho-STAT5 and phospho-<span class= gene  id= 17919711-5-221-226 >STAT3</span> levels were unchanged.	17919711	transcription factor; nucleic acid binding	signal transducer and activator of transcription 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011327631955743	2007
GATA3	2625	AlteredExpression	BEFREE	Major transcription factors controlling T(H)1 and T(H)2 development, such as T-box transcription factor and <span class= gene  id= 19038437-1-108-113 >GATA3</span>, might be centrally involved in <span class= disease  id= 19038437-1-146-152 >asthma</span> and atopic diseases.	19038437	transcription factor; nucleic acid binding	GATA binding protein 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011067260548847	2008
GATA3	2625	AlteredExpression	BEFREE	Four polymorphisms SCCA1 promoter that were in linkage disequilibrium were associated with skin test positivity in <span class= disease  id= 23199842-10-115-124 >asthmatic</span> children and showed higher promoter activity and higher binding of GATA-2 and <span class= gene  id= 23199842-10-203-209 >GATA-3</span> after IL-4 + IL-13 stimulation.	23199842	transcription factor; nucleic acid binding	GATA binding protein 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011067260548847	2012
GATA3	2625	AlteredExpression	BEFREE	The expression level of <span class= gene  id= 15947486-9-24-30 >GATA-3</span> may <span class= negexp >not be an essential factor</span> to cause IL-5 hyperproduction in <span class= disease  id= 15947486-9-95-111 >bronchial asthma</span>, though GATA-3 is crucially involved in IL-5 gene transcription in human peripheral CD4+ T cells.	15947486	transcription factor; nucleic acid binding	GATA binding protein 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011067260548847	2005
GATA3	2625	AlteredExpression	BEFREE	The results of this study provide the first evidence of increased <span class= gene  id= 9949310-10-66-72 >GATA-3</span> gene expression in association with IL-5 mRNA+ cells in <span class= disease  id= 9949310-10-129-138 >asthmatic</span> airways.	9949310	transcription factor; nucleic acid binding	GATA binding protein 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011067260548847	1999
GATA3	2625	AlteredExpression	BEFREE	We report using p62-/- mice and cells that p62 acts downstream TCR activation, and is important for Th2 polarization and <span class= disease  id= 16874300-4-121-127 >asthma</span>, playing a significant role in the control of the sustained activation of NF-kappaB and late synthesis of <span class= gene  id= 16874300-4-234-239 >GATA3</span> and IL-4 by participating in the activation of the IKK complex.	16874300	transcription factor; nucleic acid binding	GATA binding protein 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011067260548847	2006
GATA3	2625	AlteredExpression	BEFREE	We studied the silencing of the <span class= gene  id= 17878900-2-32-38 >GATA-3</span> gene expression using RNA interference (RNAi) delivered by a lentiviral vector, to evaluate the therapeutic role of <span class= gene  id= 17878900-2-155-161 >GATA-3</span> short hairpin RNAs (shRNAs) in a murine model of <span class= disease  id= 17878900-2-211-217 >asthma</span>.	17878900	transcription factor; nucleic acid binding	GATA binding protein 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011067260548847	2008
GATA3	2625	AlteredExpression	BEFREE	We demonstrate here that peroxisome proliferator-activated receptors (PPARs), PPAR-alpha and PPAR-gamma, which have been shown recently to be involved in the regulation of various cell types within the immune system, decrease antigen-induced airway hyperresponsiveness, lung inflammation, eosinophilia, cytokine production, and <span class= gene  id= 12900517-2-328-334 >GATA-3</span> expression as well as serum levels of antigen-specific IgE in a murine model of human <span class= disease  id= 12900517-2-421-427 >asthma</span>.	12900517	transcription factor; nucleic acid binding	GATA binding protein 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.011067260548847	2003
CHRM3	1131	AlteredExpression	BEFREE	The results of the study suggest that the differential expression of the ADRB2 and <span class= gene  id= 22192964-10-83-88 >CHRM3</span> genes is associated with <span class= disease  id= 22192964-10-114-120 >asthma</span> and COPD clinical subtypes.	22192964	receptor	cholinergic receptor muscarinic 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01105290517153	2011
CLCA1	1179	AlteredExpression	BEFREE	Because of its involvement in other airway diseases, such as <span class= disease  id= 22731784-2-61-67 >asthma</span>, we hypothesized that Ca²?-activated Cl? channel 1 (<span class= gene  id= 22731784-2-120-125 >CLCA1</span>) was associated with overproduction of mucus in the airways of smokers and COPD patients.	22731784	transporter	chloride channel accessory 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01089484807926	2012
CLCA1	1179	AlteredExpression	BEFREE	ST2L expression was increased in severe <span class= disease  id= 25091434-8-40-46 >asthma</span> (P = .02) and associated with multiple indicators of TH2-like inflammation, including blood eosinophils (P = .001), exhaled nitric oxide (P = .003), and epithelial <span class= gene  id= 25091434-8-211-216 >CLCA1</span> (P &lt; .0001) and eotaxin-3 (P = .001) mRNA expression.	25091434	transporter	chloride channel accessory 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01089484807926	2014
CLCA1	1179	AlteredExpression	BEFREE	A calcium-activated chloride channel (<span class= gene  id= 11842292-0-38-44 >HCLCA1</span>) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with <span class= disease  id= 11842292-0-147-153 >asthma</span>.	11842292	transporter	chloride channel accessory 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01089484807926	2002
CLCA1	1179	AlteredExpression	BEFREE	By using gene expression microarrays, we found that chloride channel, calcium-activated, family member 1 (<span class= gene  id= 17898169-5-106-111 >CLCA1</span>), periostin, and serine peptidase inhibitor, clade B (ovalbumin), member 2 (serpinB2) were up-regulated in <span class= disease  id= 17898169-5-219-225 >asthma</span> but not in smokers.	17898169	transporter	chloride channel accessory 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.01089484807926	2007
NOD2	64127	AlteredExpression	BEFREE	Polymorphisms in the identified chitin receptors, <span class= gene  id= 24722226-7-50-54 >NOD2</span> and TLR9, predispose individuals to inflammatory conditions and dysregulated expression of chitinases and chitinase-like binding proteins, whose activity is essential to generate IL-10-inducing fungal chitin particles in vitro, have also been linked to inflammatory conditions and <span class= disease  id= 24722226-7-336-342 >asthma</span>.	24722226	transcription factor; nucleic acid binding	nucleotide binding oligomerization domain containing 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.010727021230004	2014
NOD2	64127	AlteredExpression	BEFREE	The situation is complicated further by the fact that WT <span class= gene  id= 23794710-4-57-61 >NOD2</span> and WT RIP2 activity has been implicated in diseases such as <span class= disease  id= 23794710-4-123-129 >asthma</span>, inflammatory arthritis and MS.	23794710	transcription factor; nucleic acid binding	nucleotide binding oligomerization domain containing 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.010727021230004	2013
MUC5AC	4586	AlteredExpression	LHGDN	Pendrin induced expression of <span class=gene id=18424749>MUC5AC</span>, a major product of mucus in <span class=disease id=18424749>asthma</span> and COPD, in airway epithelial cells	18424749	cell adhesion molecule; extracellular matrix protein	mucin 5AC, oligomeric mucus/gel-forming	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.010568964137734	2008
MUC5AC	4586	AlteredExpression	BEFREE	Pendrin induced expression of <span class= gene  id= 18424749-5-30-36 >MUC5AC</span>, a major product of mucus in <span class= disease  id= 18424749-5-66-72 >asthma</span> and COPD, in airway epithelial cells.	18424749	cell adhesion molecule; extracellular matrix protein	mucin 5AC, oligomeric mucus/gel-forming	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.010568964137734	2008
MUC5AC	4586	AlteredExpression	BEFREE	Mice lacking functional NADPH oxidases due to knockout of p47 and mice with epithelial-targeted transgenic expression of a CaMKII inhibitory peptide or wild-type mice treated with inhaled KN-93, an experimental small-molecule CaMKII antagonist, were protected against increases in ICl, <span class= gene  id= 23884469-5-286-292 >MUC5AC</span> expression, and <span class= disease  id= 23884469-5-309-331 >airway hyperreactivity</span> to inhaled methacholine.	23884469	cell adhesion molecule; extracellular matrix protein	mucin 5AC, oligomeric mucus/gel-forming	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.010568964137734	2014
MUC5AC	4586	AlteredExpression	BEFREE	Because an epidermal growth factor receptor (EGFR) cascade induces <span class= gene  id= 11698473-2-67-73 >MUC5AC</span> mucin in airways, and because EGFR is up-regulated in <span class= disease  id= 11698473-2-128-137 >asthmatic</span> airways, we examined the effect of eosinophils on MUC5AC mucin production in NCI-H292 cells (a human airway epithelial cell line that produces mucins).	11698473	cell adhesion molecule; extracellular matrix protein	mucin 5AC, oligomeric mucus/gel-forming	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.010568964137734	2001
MUC5AC	4586	AlteredExpression	BEFREE	AGR2 expression increased together with <span class= gene  id= 22403803-9-40-46 >MUC5AC</span> expression in airway epithelium from  Th2-high  <span class= disease  id= 22403803-9-95-105 >asthmatics</span>.	22403803	cell adhesion molecule; extracellular matrix protein	mucin 5AC, oligomeric mucus/gel-forming	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.010568964137734	2013
MUC5AC	4586	AlteredExpression	BEFREE	<span class= gene  id= 11179133-8-0-6 >MUC5AC</span> was the predominant mucin gene expressed in healthy subjects and subjects with <span class= disease  id= 11179133-8-86-92 >asthma</span>, and <span class= gene  id= 11179133-8-98-104 >MUC5AC</span> protein was increased in the subjects with <span class= disease  id= 11179133-8-148-154 >asthma</span>.	11179133	cell adhesion molecule; extracellular matrix protein	mucin 5AC, oligomeric mucus/gel-forming	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.010568964137734	2001
VCAM1	7412	AlteredExpression	BEFREE	IL-4 mediates important proinflammatory functions in <span class= disease  id= 11398072-1-53-59 >asthma</span>, including induction of the IgE isotype switch, increased expression of <span class= gene  id= 11398072-1-132-165 >vascular cell adhesion molecule 1</span> and promotion of eosinophil transmigration across the endothelium, stimulation of mucus production, and T(H)2 lymphocyte differentiation, leading to release of IL-4, IL-5, IL-9, and IL-13.	11398072	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	vascular cell adhesion molecule 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.010554608760417	2001
IL3	3562	AlteredExpression	BEFREE	Further assessment made in 15 of the 24 acute <span class= disease  id= 8835120-6-46-56 >asthmatics</span> 7 days after systemic steroid treatment revealed a significant reduction in GM-CSF expression (P &lt; 0.05) but <span class= negexp >not for</span> <span class= gene  id= 8835120-6-174-178 >IL-3</span>.	8835120	signaling molecule	interleukin 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009968353411995	1996
IL3	3562	AlteredExpression	BEFREE	There were increased proportions of cells positive for <span class= gene  id= 8360390-6-55-59 >IL-3</span> (p &lt; 0.05), IL-4 (p &lt; 0.005), IL-5 (p &lt; 0.005), and GM-CSF (p &lt; 0.005) mRNA in BAL fluid from patients with symptomatic <span class= disease  id= 8360390-6-180-186 >asthma</span> when compared with that from subjects <span class= negexp >free of</span> symptoms, but <span class= negexp >no difference</span> between the groups in numbers of cells expressing IL-2 and interferon-gamma mRNA.	8360390	signaling molecule	interleukin 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009968353411995	1993
IL3	3562	AlteredExpression	BEFREE	Glucocorticoid therapy of <span class= disease  id= 7742019-13-26-36 >asthmatics</span> is associated with a reduction in the percentages of CD4 T-LC expressing <span class= gene  id= 7742019-13-110-114 >IL-3</span>, IL-5, and GM-CSF mRNA and secretion of the corresponding proteins.	7742019	signaling molecule	interleukin 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009968353411995	1995
IL3	3562	AlteredExpression	BEFREE	<span class= gene  id= 21036386-14-0-4 >IL-3</span> can induce basophils to express high levels of amphiregulin, which may contribute to tissue remodeling during type 2 immune responses such as <span class= disease  id= 21036386-14-147-153 >asthma</span>.	21036386	signaling molecule	interleukin 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009968353411995	2010
CXCL10	3627	AlteredExpression	BEFREE	Although corticosteroids can downregulate the expression of some <span class= disease  id= 15696082-12-65-71 >asthma</span>-associated chemokines, such as eotaxin, MCP-3, and MCP-4, they can also upregulate the expression of other chemokines, including IL-8, <span class= gene  id= 15696082-12-207-212 >IP-10</span>, and MCP-2.	15696082	signaling molecule	C-X-C motif chemokine ligand 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00984709809972	2005
CXCL10	3627	AlteredExpression	BEFREE	CpdA inhibited production of fluticasone-resistant chemokines CCL5, CX3CL1, and <span class= gene  id= 25897650-8-80-86 >CXCL10</span> at protein and mRNA levels in both <span class= disease  id= 25897650-8-122-131 >asthmatic</span> and healthy cells.	25897650	signaling molecule	C-X-C motif chemokine ligand 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00984709809972	2016
CXCL10	3627	AlteredExpression	LHGDN	Elevated bronchial mucosal expression of IP-10/CXCL10 is implicated in asthma pathogenesis; its action is partly through selective development and retention, or recruitment of T helper type 2, not Th1, receptor-bearing cells.	15944327	signaling molecule	C-X-C motif chemokine ligand 10	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00984709809972	2005
HPGDS	27306	AlteredExpression	BEFREE	The protein levels of Gc, hemopexin, and haptoglobin-b were increased, whereas the a1- antitrypsin and <span class= gene  id= 21169467-7-103-128 >glutathione S-transferase</span> levels were decreased in subjects with <span class= disease  id= 21169467-7-168-174 >asthma</span>.	21169467	null	hematopoietic prostaglandin D synthase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009615437447459	2011
HPGDS	27306	AlteredExpression	BEFREE	Downregulation of <span class= gene  id= 21570714-0-18-43 >glutathione S-transferase</span> pi in <span class= disease  id= 21570714-0-50-56 >asthma</span> contributes to enhanced oxidative stress.	21570714	null	hematopoietic prostaglandin D synthase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009615437447459	2011
SFTPD	6441	AlteredExpression	BEFREE	Expression of <span class= gene  id= 25848896-0-14-34 >surfactant protein D</span> in airways of <span class= disease  id= 25848896-0-49-59 >asthmatics</span> and interleukin-13 modulation of <span class= gene  id= 25848896-0-93-113 >surfactant protein D</span> in human models of airway epithelium.	25848896	defense/immunity protein; surfactant	surfactant protein D	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009521214158194	2015
IL2RA	3559	AlteredExpression	BEFREE	Our findings also suggest that treatment with inhaled glucocorticosteroids in <span class= disease  id= 19392991-11-78-88 >asthmatics</span> might increase this FOXP3 protein expression within the CD4(+)<span class= gene  id= 19392991-11-151-155 >CD25</span>(high) T-cell population.	19392991	receptor	interleukin 2 receptor subunit alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009484412378199	2010
IL2RA	3559	AlteredExpression	BEFREE	The six IL-5 mRNA-positive asthmatics tended to have more severe disease than the negative <span class= disease  id= 2022726-11-91-101 >asthmatics</span>, as assessed by symptoms and lung function, and showed a significant increase in the degree of infiltration of the bronchial mucosa by secreting (EG2+) eosinophils and activated (<span class= gene  id= 2022726-11-281-285 >CD25</span>+) T lymphocytes.	2022726	receptor	interleukin 2 receptor subunit alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009484412378199	1991
IL2RA	3559	AlteredExpression	BEFREE	Experiments revealed raised proportions of activated CD4+ T cells as assessed by expression of HLA-DR and <span class= gene  id= 11422132-6-106-110 >CD25</span>+ expression in the <span class= disease  id= 11422132-6-130-139 >asthmatic</span> samples.	11422132	receptor	interleukin 2 receptor subunit alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009484412378199	2001
IL2RA	3559	AlteredExpression	BEFREE	Impaired Ca²? regulation of CD4?<span class= gene  id= 21576985-0-32-36 >CD25</span>? regulatory T cells from pediatric <span class= disease  id= 21576985-0-72-78 >asthma</span>.	21576985	receptor	interleukin 2 receptor subunit alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009484412378199	2010
IL2RA	3559	AlteredExpression	BEFREE	The percentages of both CD4 and CD8 T lymphocytes expressing HLA-DR and <span class= gene  id= 11826234-8-72-76 >CD25</span> were elevated in the <span class= disease  id= 11826234-8-98-108 >asthmatics</span> as compared with controls, and significantly reduced in association with de novo or augmented inhaled glucocorticoid therapy.	11826234	receptor	interleukin 2 receptor subunit alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009484412378199	2002
IGHE	3497	AlteredExpression	BEFREE	Regulation of low affinity <span class= gene  id= 1401914-0-27-30 >IgE</span> receptor (CD23) expression on mononuclear phagocytes in normal and <span class= disease  id= 1401914-0-98-107 >asthmatic</span> subjects.	1401914	null	immunoglobulin heavy constant epsilon	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009326355285928	1992
IGHE	3497	AlteredExpression	BEFREE	The dendritic cell high-affinity <span class= gene  id= 26503747-0-33-36 >IgE</span> receptor is overexpressed in both <span class= disease  id= 26503747-0-71-77 >asthma</span> and severe COPD.	26503747	null	immunoglobulin heavy constant epsilon	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009326355285928	2015
IGHE	3497	AlteredExpression	BEFREE	Particularly, the expression of high affinity <span class= gene  id= 22580035-3-46-49 >IgE</span> receptor (Fc?RI) has been noted in primary human ASM cells in vitro and in vivo within bronchial biopsies of allergic <span class= disease  id= 22580035-3-168-177 >asthmatic</span> subjects.	22580035	null	immunoglobulin heavy constant epsilon	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009326355285928	2012
IGHE	3497	AlteredExpression	BEFREE	This antibody directly inhibits the activation of the high affinity <span class= gene  id= 20444694-6-68-71 >IgE</span> receptor FcepsilonRI on mast cells and basophils by cross-linking FcepsilonRI with the inhibitory receptor FcgammaRIIb, an approach that has strong therapeutic potential for <span class= disease  id= 20444694-6-246-252 >asthma</span> and other allergic diseases.	20444694	null	immunoglobulin heavy constant epsilon	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009326355285928	2010
IGHE	3497	AlteredExpression	LHGDN	A highly significant association of the newly studied (GAAGGA) (n) hexanucleotide repeat with asthma (p = 3x10 (-6)), log (10) TsIgE (p = 0.006) and eotaxin levels (p = 0.004) was observed.	17220216	null	immunoglobulin heavy constant epsilon	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009326355285928	2007
IL16	3603	AlteredExpression	BEFREE	Sputum samples from <span class= disease  id= 10572065-12-20-29 >asthmatic</span> subjects were found to have higher levels of <span class= gene  id= 10572065-12-75-80 >IL-16</span> than were samples from subjects with other pulmonary inflammatory diseases.	10572065	signaling molecule	interleukin 16	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009144173059356	2000
IL16	3603	AlteredExpression	BEFREE	Increased expression of <span class= gene  id= 10932073-0-24-29 >IL-16</span> immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with <span class= disease  id= 10932073-0-119-125 >asthma</span>.	10932073	signaling molecule	interleukin 16	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.009144173059356	2000
C5AR1	728	AlteredExpression	LHGDN	determination of whether the levels of complement factors C3a, C4a, and C5a are elevated at the site of inflammation in chronic obstructive pulmonary disease and in asthma	15039137	receptor	complement C5a receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008971760589768	2004
MMP1	4312	AlteredExpression	BEFREE	Exposure or colonization by SA in the airway may enhance the remodeling of tissue through a TGF-&alpha;-dependent induction of <span class= gene  id= 25180535-10-121-126 >MMP-1</span> expression, and may thereby promote remodeling in airway diseases in which SA is implicated, such as <span class= disease  id= 25180535-10-228-234 >asthma</span> and chronic rhinosinusitis.	25180535	null	matrix metallopeptidase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008645876648242	2016
MMP1	4312	AlteredExpression	BEFREE	We conclude that cells contained in the bronchial secretions from <span class= disease  id= 14968124-7-66-76 >asthmatics</span> express higher amounts of mRNA for <span class= gene  id= 14968124-7-112-117 >MMP-1</span> and TIMP-1, perhaps related to an increased expression of MCP-1, which might contribute to the extracellular matrix changes observed during airway remodelling.	14968124	null	matrix metallopeptidase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008645876648242	2004
MMP1	4312	AlteredExpression	BEFREE	These findings correlated clinically to the significantly higher plasma/serum <span class= gene  id= 24469321-7-78-83 >MMP-1</span> level in <span class= disease  id= 24469321-7-93-102 >asthmatic</span> patients.	24469321	null	matrix metallopeptidase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008645876648242	2014
MMP1	4312	AlteredExpression	BEFREE	Extra-cellular matrix proteins induce <span class= gene  id= 24587395-0-38-64 >matrix metalloproteinase-1</span> (<span class= gene  id= 24587395-0-66-71 >MMP-1</span>) activity and increase airway smooth muscle contraction in <span class= disease  id= 24587395-0-131-137 >asthma</span>.	24587395	null	matrix metallopeptidase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008645876648242	2014
CD28	940	AlteredExpression	BEFREE	Selective blockade of NF-kappaB by novel mutated IkappaBalpha suppresses CD3/<span class= gene  id= 18070230-0-77-81 >CD28</span>-induced activation of memory CD4+ T cells in <span class= disease  id= 18070230-0-127-133 >asthma</span>.	18070230	signaling molecule	CD28 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00859471949093	2008
LEP	3952	AlteredExpression	BEFREE	Serum levels of <span class= gene  id= 19725899-2-16-22 >leptin</span>, adiponectin, mite allergen-specific and total immunoglobulin E, eosinophil cationic protein (ECP), and pro- and anti-inflammatory cytokines were analysed in 97 non-<span class= disease  id= 19725899-2-188-197 >asthmatic</span> children presenting with persistent AR and in 64 controls.	19725899	null	leptin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008422307021342	2011
NPS	594857	AlteredExpression	LHGDN	Because remodeling of airway epithelium is a feature of chronic asthma, the up-regulation of MMP10 and TIMP3 by NPS-NPSR1 signaling may be of relevance in the pathogenesis of asthma.	16926187	null	neuropeptide S	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008422307021342	2006
C3AR1	719	AlteredExpression	LHGDN	determination of whether the levels of complement factors C3a, C4a, and C5a are elevated at the site of inflammation in chronic obstructive pulmonary disease and in asthma	15039137	receptor	complement C3a receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008371149864029	2004
C3AR1	719	AlteredExpression	BEFREE	These results demonstrate the expression of <span class= gene  id= 11160252-9-44-48 >C3aR</span> and C5aR by cells endogenous to the lung, and, given the participation of bronchial epithelial and smooth muscle cells in the pathology of diseases such as sepsis and <span class= disease  id= 11160252-9-216-222 >asthma</span>, the data suggest a role for these receptors during lung inflammation.	11160252	receptor	complement C3a receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008371149864029	2001
IFNA1	3439	AlteredExpression	BEFREE	<span class= gene  id= 24450586-8-0-3 >IFN</span>-&alpha;1, <span class= gene  id= 24450586-8-8-11 >IFN</span>-&beta;1 and IFN-&gamma; mRNA levels correlated with the peak <span class= disease  id= 24450586-8-62-68 >Asthma</span> Index (r = 0.58, P &lt; 0.001; r = 0.57, P = 0.001; and r = 0.51, P = 0.004, respectively).	24450586	signaling molecule	interferon alpha 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008161935614446	2014
IFNA1	3439	AlteredExpression	BEFREE	Type III <span class= gene  id= 18564328-0-9-12 >IFN</span>-lambda mRNA expression in sputum of adult and school-aged <span class= disease  id= 18564328-0-71-81 >asthmatics</span>.	18564328	signaling molecule	interferon alpha 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008161935614446	2009
IFNA1	3439	AlteredExpression	BEFREE	Our data demonstrate that both <span class= gene  id= 20382746-11-31-34 >IFN</span>s and mitogens stimulate protein synthesis but have differential effects on cell size and contractile protein expression and suggest that combined effects of <span class= gene  id= 20382746-11-192-195 >IFN</span>s and mitogens may contribute to ASM cell growth, contractile protein expression, and ASM remodeling in <span class= disease  id= 20382746-11-299-305 >asthma</span>.	20382746	signaling molecule	interferon alpha 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008161935614446	2010
IRAK3	11213	AlteredExpression	BEFREE	Our data indicate that epithelial <span class= gene  id= 22154382-13-34-40 >IRAK-M</span> overexpression in T(H)2 cytokine-exposed airways inhibits TLR2 signaling, providing a novel mechanism for the increased susceptibility of infections in <span class= disease  id= 22154382-13-193-202 >asthmatic</span> patients.	22154382	null	interleukin 1 receptor associated kinase 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008096423079816	2011
CCL1	6346	AlteredExpression	BEFREE	The numbers of cells within the bronchial epithelium and submucosa expressing mRNA for TSLP, TARC/CCL17, MDC/CCL22, and IP-10/CXCL10, but not I-TAC/CXCL11 and I-309/<span class= gene  id= 15944327-4-165-169 >CCL1</span>, were significantly increased in <span class= disease  id= 15944327-4-203-213 >asthmatics</span> as compared with controls (p &lt;/= 0.018).	15944327	signaling molecule	C-C motif chemokine ligand 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008096423079816	2005
CCL1	6346	AlteredExpression	BEFREE	CCR8, the receptor for <span class= gene  id= 17641040-2-23-27 >CCL1</span>, is expressed by approximately 70% of CD4(+) T lymphocytes recruited to the <span class= disease  id= 17641040-2-104-113 >asthmatic</span> airways, and the number of CCR8-expressing cells is increased 3-fold in the airways of <span class= disease  id= 17641040-2-201-210 >asthmatic</span> subjects compared with normal volunteers.	17641040	signaling molecule	C-C motif chemokine ligand 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.008096423079816	2007
ADORA2A	135	AlteredExpression	LHGDN	stimulation with IL-4, IL-13 &amp; subsequent stimulation with AMP/NECA decreased A2AR expression accompanied by increased histamine secretion; results suggest role for decreased A (2A) R expression in enhanced adenosine responsiveness as observed in asthma	18442791	receptor	adenosine A2a receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.007872853452916	2008
ADORA2A	135	AlteredExpression	LHGDN	Activation of the A (2A) receptor might have a beneficial effect by inhibiting inflammatory cell influx and downregulating inflammatory cell activation in asthma and COPD, respectively.	16339780	receptor	adenosine A2a receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.007872853452916	2006
IL21	59067	AlteredExpression	LHGDN	study provides evidence that IL21 is associated with atopic asthma, TsIgE and serum IL-21 levels	18802358	null	interleukin 21	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.007821696295603	2008
CXCR2	3579	AlteredExpression	BEFREE	A signature of 6 genes, including Charcot-Leydon crystal protein (CLC); carboxypeptidase A3 (CPA3); deoxyribonuclease I-like 3 (DNASE1L3); IL-1&beta; (IL1B); alkaline phosphatase, tissue-nonspecific isozyme (ALPL); and <span class= gene  id= 24582314-8-214-248 >chemokine (C-X-C motif) receptor 2</span> (<span class= gene  id= 24582314-8-250-255 >CXCR2</span>), was reproducible and could significantly (P &lt; .0001) discriminate eosinophilic asthma from other phenotypes, including patients with noneosinophilic <span class= disease  id= 24582314-8-407-413 >asthma</span> (AUC, 89.6%), paucigranulocytic <span class= disease  id= 24582314-8-446-452 >asthma</span> (AUC, 92.6%), or neutrophilic <span class= disease  id= 24582314-8-483-489 >asthma</span> (AUC, 91.4%) and healthy control subjects (AUC, 97.6%), as well as discriminating patients with neutrophilic <span class= disease  id= 24582314-8-599-605 >asthma</span> from those with paucigranulocytic asthma (AUC, 85.7%) and healthy control subjects (AUC, 90.8).	24582314	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-X-C motif chemokine receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00777053913829	2013
SLC26A4	5172	AlteredExpression	BEFREE	Factors inducing an up-regulation of <span class= gene  id= 22116359-3-37-44 >pendrin</span> in the kidney and the lung may have an impact on the pathogenesis of hypertension, chronic obstructive pulmonary disease (COPD) and <span class= disease  id= 22116359-3-177-183 >asthma</span>.	22116359	null	solute carrier family 26 member 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.007663639203332	2011
SLC26A4	5172	AlteredExpression	LHGDN	<span class=gene id=18424749>Pendrin</span> induced expression of MUC5AC, a major product of mucus in <span class=disease id=18424749>asthma</span> and COPD, in airway epithelial cells	18424749	null	solute carrier family 26 member 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.007663639203332	2008
SLC26A4	5172	AlteredExpression	BEFREE	STAT6 links IL-4/IL-13 stimulation with <span class= gene  id= 21814192-0-40-47 >pendrin</span> expression in <span class= disease  id= 21814192-0-62-68 >asthma</span> and chronic obstructive pulmonary disease.	21814192	null	solute carrier family 26 member 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.007663639203332	2011
SLC26A4	5172	AlteredExpression	BEFREE	Additionally, <span class= gene  id= 24429826-3-14-21 >pendrin</span> up-regulation could play a role in the pathogenesis of several diseases including <span class= disease  id= 24429826-3-104-120 >bronchial asthma</span> and chronic obstructive pulmonary disease (COPD).	24429826	null	solute carrier family 26 member 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.007663639203332	2013
EGFR	1956	AlteredExpression	BEFREE	These findings suggest a sequence of events by which <span class= gene  id= 11179132-9-53-57 >EGFR</span> activation is involved in mucin expression in <span class= disease  id= 11179132-9-104-113 >asthmatic</span> airway epithelium.	11179132	null	epidermal growth factor receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.007337755261807	2001
EGFR	1956	AlteredExpression	BEFREE	Amphiregulin is a member of the family of <span class= gene  id= 26047642-3-42-74 >epidermal growth factor receptor</span> (<span class= gene  id= 26047642-3-76-80 >EGFR</span>) agonists with cell growth and proinflammatory roles and increased expression in the lungs of <span class= disease  id= 26047642-3-175-181 >asthma</span> patients.	26047642	null	epidermal growth factor receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.007337755261807	2015
EGFR	1956	AlteredExpression	LHGDN	The effects of house dust mite allergen and the cytokines IL-4 and TGF-beta on TARC expression in 16HBE cells and primary bronchial asthma epithelium, was examined.	17023689	null	epidermal growth factor receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.007337755261807	2007
EGFR	1956	AlteredExpression	BEFREE	Because an <span class= gene  id= 11698473-2-11-43 >epidermal growth factor receptor</span> (<span class= gene  id= 11698473-2-45-49 >EGFR</span>) cascade induces MUC5AC mucin in airways, and because <span class= gene  id= 11698473-2-104-108 >EGFR</span> is up-regulated in <span class= disease  id= 11698473-2-128-137 >asthmatic</span> airways, we examined the effect of eosinophils on MUC5AC mucin production in NCI-H292 cells (a human airway epithelial cell line that produces mucins).	11698473	null	epidermal growth factor receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.007337755261807	2001
IL19	29949	AlteredExpression	LHGDN	Elevated IL-19 serum levels in asthmatic patients are positively correlated with levels of IL-4 and IL-13, and suggest that IL-19 may play a role in the pathogenesis of asthma.	15557163	signaling molecule	interleukin 19	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00678830169338	2005
IL19	29949	AlteredExpression	BEFREE	Potentiation of <span class= gene  id= 18539194-0-16-21 >IL-19</span> expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in <span class= disease  id= 18539194-0-105-111 >asthma</span>.	18539194	signaling molecule	interleukin 19	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00678830169338	2008
IL19	29949	AlteredExpression	BEFREE	Human <span class= disease  id= 22583192-9-6-12 >Asthma</span> Gene Array showed an increased <span class= gene  id= 22583192-9-44-49 >IL-19</span> gene expression in NP from patients with CRS in comparison with normal subjects.	22583192	signaling molecule	interleukin 19	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00678830169338	2012
IL19	29949	AlteredExpression	BEFREE	<span class= gene  id= 15557163-0-0-5 >IL-19</span> induced Th2 cytokines and was up-regulated in <span class= disease  id= 15557163-0-52-58 >asthma</span> patients.	15557163	signaling molecule	interleukin 19	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00678830169338	2005
FCER2	2208	AlteredExpression	BEFREE	As assessed by shift in mean fluorescence, instillation of allergen in the <span class= disease  id= 1401914-9-75-84 >asthmatic</span>'s airway further up-regulated <span class= gene  id= 1401914-9-115-129 >Fc epsilon RII</span> on alveolar macrophages by 151 +/- 7%.	1401914	cell adhesion molecule; defense/immunity protein; receptor	Fc fragment of IgE receptor II	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006737144536068	1992
TRPV1	7442	AlteredExpression	BEFREE	Functional <span class= gene  id= 24210884-13-11-16 >TRPV1</span> channels are present in the human airway epithelium and overexpressed in the airways of patients with refractory <span class= disease  id= 24210884-13-130-136 >asthma</span>.	24210884	transporter	transient receptor potential cation channel subfamily V member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006737144536068	2013
TRPV1	7442	AlteredExpression	BEFREE	Blocking of 13-S-HODE activity or disruption of <span class= gene  id= 23443229-7-48-53 >TRPV1</span> activity attenuated airway injury and <span class= disease  id= 23443229-7-92-98 >asthma</span> mimicking features in murine allergic airway inflammation.	23443229	transporter	transient receptor potential cation channel subfamily V member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006737144536068	2013
TRPV1	7442	AlteredExpression	BEFREE	Our data suggest that genetically determined level of <span class= gene  id= 20639579-9-54-59 >TRPV1</span> activity is relevant for <span class= disease  id= 20639579-9-85-91 >asthma</span> pathophysiology.	20639579	transporter	transient receptor potential cation channel subfamily V member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006737144536068	2010
TRPV1	7442	AlteredExpression	BEFREE	The levels of <span class= gene  id= 25585038-8-14-19 >TRPV1</span> gene expression and Th1/Th2 cytokines have a close relationship with <span class= disease  id= 25585038-8-89-95 >asthma</span> onset in children, which provides theoretical evidences for molecular targeted treatment in children with <span class= disease  id= 25585038-8-202-218 >bronchial asthma</span>.	25585038	transporter	transient receptor potential cation channel subfamily V member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006737144536068	2014
CXCR4	7852	AlteredExpression	BEFREE	The <span class= gene  id= 23632297-6-4-22 >chemokine receptor</span> expression profile was determined on Treg cells recruited into the human airway after bronchoscopic segmental allergen challenge of <span class= disease  id= 23632297-6-155-164 >asthmatic</span> patients.	23632297	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-X-C motif chemokine receptor 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006737144536068	2013
PTGS1	5742	AlteredExpression	BEFREE	<span class= gene  id= 18753249-0-0-5 >COX-1</span>, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive <span class= disease  id= 18753249-0-89-95 >asthma</span>.	18753249	oxidoreductase	prostaglandin-endoperoxide synthase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006513574909167	2008
PTGS1	5742	AlteredExpression	BEFREE	The immunosuppressive activity of PMN-MDSCs was diminished in both allergen-challenged <span class= gene  id= 24948368-11-87-92 >COX-1</span> KO mice and patients with AIA, probably through an EP4-mediated signaling pathway, indicating that activation of PMN-MDSCs might be a promising therapeutic strategy for <span class= disease  id= 24948368-11-262-268 >asthma</span>, particularly AIA.	24948368	oxidoreductase	prostaglandin-endoperoxide synthase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006513574909167	2014
PTGS1	5742	AlteredExpression	BEFREE	Alternative splicing of <span class= gene  id= 17508966-0-24-40 >cyclooxygenase-1</span> gene: altered expression in leucocytes from patients with <span class= disease  id= 17508966-0-99-115 >bronchial asthma</span> and association with aspirin-induced 15-HETE release.	17508966	oxidoreductase	prostaglandin-endoperoxide synthase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006513574909167	2007
PTGS1	5742	AlteredExpression	BEFREE	Our aim was to investigate the expression of <span class= gene  id= 17622692-3-45-50 >COX-1</span> and COX-2 mRNA in primary human bronchial epithelial cells (HBEC) isolated from <span class= disease  id= 17622692-3-131-141 >asthmatics</span> and non-<span class= disease  id= 17622692-3-150-160 >asthmatics</span>.	17622692	oxidoreductase	prostaglandin-endoperoxide synthase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006513574909167	2007
CCL18	6362	AlteredExpression	BEFREE	Our results suggest that <span class= gene  id= 23331560-9-25-30 >CCL18</span> and YKL-40 levels and CHIT1 activity are enhanced in allergic airway inflammation and thus may contribute to airway remodelling in <span class= disease  id= 23331560-9-162-168 >asthma</span>.	23331560	signaling molecule	C-C motif chemokine ligand 18	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006513574909167	2012
IL9R	3581	AlteredExpression	BEFREE	Functional expression of <span class= gene  id= 11160343-0-25-38 >IL-9 receptor</span> by human neutrophils from <span class= disease  id= 11160343-0-65-74 >asthmatic</span> donors: role in IL-8 release.	11160343	receptor	interleukin 9 receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006462417751855	2001
IL9R	3581	AlteredExpression	BEFREE	Although the level of <span class= gene  id= 10629460-8-22-27 >IL-9R</span> mRNA expression did not differ in any of the groups (P &gt;.05), <span class= gene  id= 10629460-8-90-95 >IL-9R</span> immunoreactivity was significantly higher in <span class= disease  id= 10629460-8-141-150 >asthmatic</span> compared with control subjects.	10629460	receptor	interleukin 9 receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006462417751855	2000
IL9R	3581	AlteredExpression	BEFREE	We demonstrate significant increases in IL-9 (P &lt;.001) and <span class= gene  id= 11842292-6-59-64 >IL-9R</span> (P &lt;.05) immunoreactivity, as well as increased expression of HCLCA1 mRNA (P &lt;.001), in the epithelium of <span class= disease  id= 11842292-6-171-180 >asthmatic</span> patients compared with that found in control subjects.	11842292	receptor	interleukin 9 receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006462417751855	2002
CRP	1401	AlteredExpression	LHGDN	Serum hs-<span class=gene id=17650829>CRP</span> levels may be related to the state of <span class=disease id=17650829>asthma</span> exacerbation and allergic inflammation.	17650829	null	C-reactive protein	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006290005282267	2007
ADAM8	101	AlteredExpression	BEFREE	ADAM8 mRNA (P = 0.035) and <span class= gene  id= 24147597-8-27-33 >sADAM8</span> protein (P = 0.002) levels were significantly higher in severe <span class= disease  id= 24147597-8-97-103 >asthma</span> compared with controlled <span class= disease  id= 24147597-8-129-135 >asthma</span>.	24147597	null	ADAM metallopeptidase domain 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006238848124954	2013
ADAM8	101	AlteredExpression	BEFREE	Increased expression of ADAM33 and <span class= gene  id= 17339047-0-35-40 >ADAM8</span> with disease progression in <span class= disease  id= 17339047-0-69-75 >asthma</span>.	17339047	null	ADAM metallopeptidase domain 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006238848124954	2006
ADAM8	101	AlteredExpression	BEFREE	Because genetic studies have shown that ADAM-33 gene polymorphisms are associated with <span class= disease  id= 17088949-3-87-93 >asthma</span>, we designed this study to assess mRNA expression profile of several ADAM and ADAMTS proteases in sputum from patients with <span class= disease  id= 17088949-3-218-224 >asthma</span> and to investigate the relationship between expression of these proteases and <span class= disease  id= 17088949-3-303-309 >asthma</span>-associated inflammation and airway obstruction. mRNA expression profile of selected ADAM and ADAMTS proteinases (<span class= gene  id= 17088949-3-423-429 >ADAM-8</span>, -9, -10, -12, -15, -17, and -33; ADAMTS-1, -2, -15, -16, -17, -18, and -19), their physiological inhibitors TIMP-1 and TIMP-3, and RECK, a membrane-anchored MMP activity regulator, was obtained by RT-PCR analysis performed on cells collected by sputum induction from 21 patients with mild to moderate <span class= disease  id= 17088949-3-732-738 >asthma</span> and 17 healthy individuals. mRNA levels of <span class= gene  id= 17088949-3-782-788 >ADAM-8</span>, ADAM-9, ADAM-12, TIMP-1, and TIMP-3 were significantly increased, whereas mRNA levels coding for ADAMTS-1, ADAMTS-15, and RECK were significantly decreased in patients with asthma compared with control patients.	17088949	null	ADAM metallopeptidase domain 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006238848124954	2006
TIMP1	7076	AlteredExpression	BEFREE	We conclude that cells contained in the bronchial secretions from <span class= disease  id= 14968124-7-66-76 >asthmatics</span> express higher amounts of mRNA for MMP-1 and <span class= gene  id= 14968124-7-122-128 >TIMP-1</span>, perhaps related to an increased expression of MCP-1, which might contribute to the extracellular matrix changes observed during airway remodelling.	14968124	null	TIMP metallopeptidase inhibitor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.006238848124954	2004
ALOX15	246	AlteredExpression	BEFREE	<span class= disease  id= 24571371-6-0-6 >Asthma</span>-specific and smoking-related increases (&gt;1.5-fold expression) in <span class= gene  id= 24571371-6-72-100 >arachidonate 15-lipoxygenase</span> and gamma-glutamyltransferase transcripts were demonstrated.	24571371	oxidoreductase	arachidonate 15-lipoxygenase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005964121340741	2014
ALOX15	246	AlteredExpression	BEFREE	<span class= gene  id= 23528921-0-0-18 >12/15-lipoxygenase</span> expressed in non-epithelial cells causes airway epithelial injury in <span class= disease  id= 23528921-0-88-94 >asthma</span>.	23528921	oxidoreductase	arachidonate 15-lipoxygenase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005964121340741	2013
CCL22	6367	AlteredExpression	LHGDN	Elevated bronchial mucosal expression of MDC/CCL22 is implicated in asthma pathogenesis; its action is partly through selective development and retention, or recruitment of T helper type 2, not Th1, receptor-bearing cells.	15944327	signaling molecule	C-C motif chemokine ligand 22	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005964121340741	2005
CCL22	6367	AlteredExpression	BEFREE	Although the total numbers of cells expressing CCR4, CCR8, and CXCR3 did not significantly differ in the asthmatics and controls, there was evidence of selective infiltration of CD4(+)/CCR4(+) T cells in the <span class= disease  id= 15944327-6-208-217 >asthmatic</span> biopsies which correlated with TARC and <span class= gene  id= 15944327-6-258-261 >MDC</span> expression and airway obstruction.	15944327	signaling molecule	C-C motif chemokine ligand 22	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005964121340741	2005
RNASE2	6036	AlteredExpression	LHGDN	Data show that uEPX/c levels did not correlate with established markers of asthma severity and eosinophilic airway inflammation in atopic asthmatic children.	17641730	enzyme modulator; nucleic acid binding; hydrolase	ribonuclease A family member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005740551713841	2007
CD69	969	AlteredExpression	BEFREE	Upregulated <span class= gene  id= 17541278-7-12-16 >CD69</span> expression on locally accumulated basophils in <span class= disease  id= 17541278-7-64-80 >bronchial asthma</span> may be attributed at least in part to a combination of local cytokines, especially IL-3, plus exposure to low levels of IgE-crosslinking allergens.	17541278	signaling molecule	CD69 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005740551713841	2007
CD69	969	AlteredExpression	LHGDN	IL-3 is a central inducer of CD69 expression/CD69 expression on locally accumulated basophils in bronchial asthma may be partly due to a combination of local cytokines, especially IL-3, plus IgE-cross-linking allergens.	17541278	signaling molecule	CD69 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005740551713841	2007
CD69	969	AlteredExpression	LHGDN	CD69 transduces a Bcl-2-dependent death signal when ligated by a specific antibody/the function of CD69 appears to be restricted to activated eosinophils, making an ideal target for therapeutic intervention in asthma.	12234263	signaling molecule	CD69 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005740551713841	2002
TLR7	51284	AlteredExpression	BEFREE	These observations <span class= negexp >could not be</span> attributed to alterations in the numbers of dendritic cell (DC) subsets in <span class= disease  id= 25203745-9-107-113 >asthma</span> or baseline expression of the viral RNA sensing receptors <span class= gene  id= 25203745-9-172-176 >TLR7</span>/TLR8.	25203745	extracellular matrix protein; receptor	toll like receptor 7	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005689394556528	2014
TLR8	51311	AlteredExpression	BEFREE	These observations <span class= negexp >could not be</span> attributed to alterations in the numbers of dendritic cell (DC) subsets in <span class= disease  id= 25203745-9-107-113 >asthma</span> or baseline expression of the viral RNA sensing receptors TLR7/<span class= gene  id= 25203745-9-177-181 >TLR8</span>.	25203745	extracellular matrix protein; receptor	toll like receptor 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005689394556528	2014
CDH1	999	AlteredExpression	LHGDN	Rsults suggest that the lower epithelial alpha-catenin, E-cadherin and (or) ZO-1 expression in patients with atopic asthma contributes to a defective airway epithelial barrier and a higher influx of eosinophils in the epithelium.	18418437	null	cadherin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005689394556528	2008
EDNRA	1909	AlteredExpression	BEFREE	Subjects with the diagnosis of <span class= disease  id= 9988131-3-31-37 >asthma</span> or chronic obstructive pulmonary disease showed significantly higher levels (ratio 0.81 +/- 0.04) of endothelin ET(B) receptor mRNA compared to endothelin <span class= gene  id= 9988131-3-193-197 >ET(A</span>) receptor mRNA.	9988131	receptor	endothelin receptor type A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005638237399215	1999
EPHX1	2052	AlteredExpression	BEFREE	Children with high <span class= gene  id= 21183608-10-19-24 >EPHX1</span> activity may have increase risk of <span class= disease  id= 21183608-10-60-66 >asthma</span> and wheezing outcomes, and can be mediated through airway oxidative stress generation.	21183608	null	epoxide hydrolase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005638237399215	2011
PLA2G4A	5321	AlteredExpression	BEFREE	We have previously shown that in rats, sPLA2 and <span class= gene  id= 24204651-2-49-54 >cPLA2</span> play opposing roles in the pathophysiology of ovalbumin (OVA)-induced experimental allergic bronchitis (OVA-EAB), an <span class= disease  id= 24204651-2-172-178 >asthma</span> model: Upon disease induction sPLA2 expression and production of the broncho-constricting CysLTs are elevated, whereas <span class= gene  id= 24204651-2-298-303 >cPLA2</span> expression and the broncho-dilating PGE2 production are suppressed.	24204651	hydrolase	phospholipase A2 group IVA	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005638237399215	2013
IFNA13	3447	AlteredExpression	BEFREE	<span class= gene  id= 24450586-8-0-3 >IFN</span>-&alpha;1, <span class= gene  id= 24450586-8-8-11 >IFN</span>-&beta;1 and IFN-&gamma; mRNA levels correlated with the peak <span class= disease  id= 24450586-8-62-68 >Asthma</span> Index (r = 0.58, P &lt; 0.001; r = 0.57, P = 0.001; and r = 0.51, P = 0.004, respectively).	24450586	signaling molecule	interferon alpha 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005429023149632	2014
IFNA13	3447	AlteredExpression	BEFREE	Type III <span class= gene  id= 18564328-0-9-12 >IFN</span>-lambda mRNA expression in sputum of adult and school-aged <span class= disease  id= 18564328-0-71-81 >asthmatics</span>.	18564328	signaling molecule	interferon alpha 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005429023149632	2009
IFNA13	3447	AlteredExpression	BEFREE	Our data demonstrate that both <span class= gene  id= 20382746-11-31-34 >IFN</span>s and mitogens stimulate protein synthesis but have differential effects on cell size and contractile protein expression and suggest that combined effects of <span class= gene  id= 20382746-11-192-195 >IFN</span>s and mitogens may contribute to ASM cell growth, contractile protein expression, and ASM remodeling in <span class= disease  id= 20382746-11-299-305 >asthma</span>.	20382746	signaling molecule	interferon alpha 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005429023149632	2010
CREB1	1385	AlteredExpression	LHGDN	the expression of p-CREB is related, in asthma, to the persistent inflammation according to the disease severity/expression can be modulated by glucocorticoids in responsive patients.	17573727	null	cAMP responsive element binding protein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005414667772315	2007
EDNRB	1910	AlteredExpression	BEFREE	Altered ratio of endothelin ET(A)- and <span class= gene  id= 9988131-0-39-43 >ET(B</span>) receptor mRNA in bronchial biopsies from patients with <span class= disease  id= 9988131-0-100-106 >asthma</span> and chronic airway obstruction.	9988131	receptor	endothelin receptor type B	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005414667772315	1999
CHRM2	1129	AlteredExpression	BEFREE	One immunological component of <span class= disease  id= 12948933-1-31-37 >asthma</span> is believed to be the interaction of eosinophils with parasympathetic cholinergic nerves and a consequent inhibition of acetylcholine <span class= gene  id= 12948933-1-172-194 >muscarinic M2 receptor</span> activity, leading to enhanced acetylcholine release and bronchoconstriction.	12948933	receptor	cholinergic receptor muscarinic 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005363510615002	2003
IL13RA2	3598	AlteredExpression	BEFREE	Immunohistochemistry demonstrated that both subunits of <span class= gene  id= 10699178-6-56-62 >IL-13R</span> are prominently expressed in bronchial epithelium and smooth muscle from <span class= disease  id= 10699178-6-136-145 >asthmatic</span> subjects.	10699178	defense/immunity protein; signaling molecule	interleukin 13 receptor subunit alpha 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005363510615002	2000
TACR2	6865	AlteredExpression	BEFREE	Relationship between <span class= gene  id= 16961715-0-21-42 >neurokinin 2 receptor</span> gene polymorphisms and serum vascular endothelial growth factor levels in patients with toluene diisocyanate-induced <span class= disease  id= 16961715-0-160-166 >asthma</span>.	16961715	receptor	tachykinin receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005363510615002	2007
VIP	7432	AlteredExpression	BEFREE	Since we observed, in asthmatic patients, an increase in both FKN and <span class= gene  id= 16424217-9-70-73 >VIP</span> expression by airway smooth muscle and a positive correlation between <span class= gene  id= 16424217-9-144-147 >VIP</span> staining and mast cell infiltration of the smooth muscle layer, we conclude that HASMC-derived FKN may contribute to mast cell recruitment in <span class= disease  id= 16424217-9-290-296 >asthma</span>.	16424217	signaling molecule	vasoactive intestinal peptide	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.005088783830789	2006
F2RL1	2150	AlteredExpression	BEFREE	<span class= gene  id= 18077203-2-0-5 >PAR-2</span> expression is known to be upregulated in respiratory epithelium subsequent to inflammation in <span class= disease  id= 18077203-2-100-106 >asthma</span> and chronic obstructive pulmonary disease (COPD).	18077203	null	F2R like trypsin receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004930726738519	2007
F2RL1	2150	AlteredExpression	BEFREE	Peripheral blood eosinophils isolated from <span class= disease  id= 15467372-6-43-52 >asthmatic</span> individuals were activated using various concentrations of tryptase- and <span class= gene  id= 15467372-6-126-155 >protease-activated receptor-2</span> (<span class= gene  id= 15467372-6-157-162 >PAR-2</span>)-activating peptides (<span class= gene  id= 15467372-6-185-190 >PAR-2</span> AP).	15467372	null	F2R like trypsin receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004930726738519	2004
F2RL1	2150	AlteredExpression	BEFREE	Increased <span class= gene  id= 26658828-0-10-39 >Protease-Activated Receptor-2</span> (<span class= gene  id= 26658828-0-41-46 >PAR-2</span>) Expression on CD14++CD16+ Peripheral Blood Monocytes of Patients with Severe <span class= disease  id= 26658828-0-125-131 >Asthma</span>.	26658828	null	F2R like trypsin receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004930726738519	2015
F2RL1	2150	AlteredExpression	BEFREE	We determined the influence of chronic smoking and <span class= disease  id= 12589358-2-51-57 >asthma</span> on the expression of PAR-1 and <span class= gene  id= 12589358-2-89-94 >PAR-2</span> receptors on alveolar macrophages (AMs).	12589358	null	F2R like trypsin receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004930726738519	2003
F2RL1	2150	AlteredExpression	BEFREE	<span class= gene  id= 24551046-0-0-29 >Protease activated receptor-2</span> expression and function in <span class= disease  id= 24551046-0-57-66 >asthmatic</span> bronchial smooth muscle.	24551046	null	F2R like trypsin receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004930726738519	2013
IL17F	112744	AlteredExpression	BEFREE	Identification of a novel <span class= gene  id= 11591768-0-26-40 >cytokine, ML-1</span>, and its expression in subjects with <span class= disease  id= 11591768-0-78-84 >asthma</span>.	11591768	signaling molecule	interleukin 17F	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004604842796993	2001
NFE2L2	4780	AlteredExpression	BEFREE	Our findings implicate a potential therapeutic value for artesunate in the treatment of <span class= disease  id= 22634146-13-88-94 >asthma</span> via the amelioration of oxidative damage in allergic airways, and it may act by suppressing pro-oxidants and restoring the activities and expression of antioxidants via activation of <span class= gene  id= 22634146-13-278-282 >Nrf2</span>.	22634146	transcription factor; cytoskeletal protein; protease; nucleic acid binding; hydrolase	nuclear factor, erythroid 2 like 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004604842796993	2012
NFE2L2	4780	AlteredExpression	BEFREE	Thiol redox disturbances in children with severe <span class= disease  id= 21514635-0-49-55 >asthma</span> are associated with posttranslational modification of the transcription factor <span class= gene  id= 21514635-0-135-178 >nuclear factor (erythroid-derived 2)-like 2</span>.	21514635	transcription factor; cytoskeletal protein; protease; nucleic acid binding; hydrolase	nuclear factor, erythroid 2 like 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004604842796993	2011
CCR1	1230	AlteredExpression	BEFREE	A CCL chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via <span class= gene  id= 24560857-0-79-83 >CCR1</span>, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of <span class= disease  id= 24560857-0-173-179 >asthma</span>.	24560857	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-C motif chemokine receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004381273170092	2014
CCR1	1230	AlteredExpression	LHGDN	<span class=gene id=18178867>CCR1</span> might be involved in the pathogenesis of <span class=disease id=18178867>asthma</span>, through the activation of airway smooth muscle cells by its ligands.	18178867	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-C motif chemokine receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004381273170092	2008
CCR1	1230	AlteredExpression	BEFREE	Expression and regulation of <span class= gene  id= 18178867-0-29-33 >CCR1</span> by airway smooth muscle cells in <span class= disease  id= 18178867-0-67-73 >asthma</span>.	18178867	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-C motif chemokine receptor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004381273170092	2008
ISG20	3669	AlteredExpression	BEFREE	Impaired Ca²? regulation of CD4?<span class= gene  id= 21576985-0-32-36 >CD25</span>? regulatory T cells from pediatric <span class= disease  id= 21576985-0-72-78 >asthma</span>.	21576985	nucleic acid binding	interferon stimulated exonuclease gene 20	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004120901763197	2010
ISG20	3669	AlteredExpression	BEFREE	The six IL-5 mRNA-positive asthmatics tended to have more severe disease than the negative <span class= disease  id= 2022726-11-91-101 >asthmatics</span>, as assessed by symptoms and lung function, and showed a significant increase in the degree of infiltration of the bronchial mucosa by secreting (EG2+) eosinophils and activated (<span class= gene  id= 2022726-11-281-285 >CD25</span>+) T lymphocytes.	2022726	nucleic acid binding	interferon stimulated exonuclease gene 20	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004120901763197	1991
ISG20	3669	AlteredExpression	BEFREE	Experiments revealed raised proportions of activated CD4+ T cells as assessed by expression of HLA-DR and <span class= gene  id= 11422132-6-106-110 >CD25</span>+ expression in the <span class= disease  id= 11422132-6-130-139 >asthmatic</span> samples.	11422132	nucleic acid binding	interferon stimulated exonuclease gene 20	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004120901763197	2001
ISG20	3669	AlteredExpression	BEFREE	Our findings also suggest that treatment with inhaled glucocorticosteroids in <span class= disease  id= 19392991-11-78-88 >asthmatics</span> might increase this FOXP3 protein expression within the CD4(+)<span class= gene  id= 19392991-11-151-155 >CD25</span>(high) T-cell population.	19392991	nucleic acid binding	interferon stimulated exonuclease gene 20	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004120901763197	2010
ISG20	3669	AlteredExpression	BEFREE	The percentages of both CD4 and CD8 T lymphocytes expressing HLA-DR and <span class= gene  id= 11826234-8-72-76 >CD25</span> were elevated in the <span class= disease  id= 11826234-8-98-108 >asthmatics</span> as compared with controls, and significantly reduced in association with de novo or augmented inhaled glucocorticoid therapy.	11826234	nucleic acid binding	interferon stimulated exonuclease gene 20	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004120901763197	2002
CHIT1	1118	AlteredExpression	BEFREE	Acidic mammalian chitinase (AMCase) and <span class= gene  id= 18845328-2-40-55 >chitotriosidase</span> (<span class= gene  id= 18845328-2-57-62 >CHIT1</span>) have chitinolytic activity, but relatively little is known about their expression in human <span class= disease  id= 18845328-2-155-161 >asthma</span>.	18845328	hydrolase	chitinase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	2008
CHIT1	1118	AlteredExpression	BEFREE	Our results suggest that CCL18 and YKL-40 levels and <span class= gene  id= 23331560-9-53-58 >CHIT1</span> activity are enhanced in allergic airway inflammation and thus may contribute to airway remodelling in <span class= disease  id= 23331560-9-162-168 >asthma</span>.	23331560	hydrolase	chitinase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	2012
DUSP1	1843	AlteredExpression	BEFREE	DEX-stimulated recruitment of GR and histone H4 acetylation at the glucocorticoid response element 4.6 kbp upstream of the <span class= gene  id= 24418482-11-123-128 >MKP-1</span> gene were significantly lower in monocytes from patients with SR <span class= disease  id= 24418482-11-194-200 >asthma</span> compared with those from patients with SS <span class= disease  id= 24418482-11-243-249 >asthma</span>.	24418482	null	dual specificity phosphatase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	2013
DUSP1	1843	AlteredExpression	BEFREE	Bronchial biopsies from allergen-challenged atopic <span class= disease  id= 21827450-4-51-60 >asthmatic</span> subjects taking inhaled budesonide or placebo were subjected to gene expression analysis using real-time reverse transcriptase-PCR for the corticosteroid-inducible genes (official gene symbols with aliases in parentheses): TSC22D3 [glucocorticoid-induced leucine zipper (GILZ)], <span class= gene  id= 21827450-4-340-370 >dual-specificity phosphatase-1</span> (MAPK phosphatase-1), both anti-inflammatory effectors, and FKBP5 [FK506-binding protein 51 (FKBP51)], a regulator of GR function.	21827450	null	dual specificity phosphatase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	2012
FOS	2353	AlteredExpression	BEFREE	These mediators are downstream targets for the transcription factors <span class= gene  id= 11488985-3-69-88 >activator protein-1</span> (<span class= gene  id= 11488985-3-90-94 >AP-1</span>) and nuclear factor-kappaB (NF-kappaB), which control the expression of most immunomodulatory genes and whose activity and expression are elevated in <span class= disease  id= 11488985-3-245-251 >asthma</span>.	11488985	null	Fos proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	2001
FOS	2353	AlteredExpression	BEFREE	Inflammation in <span class= disease  id= 16452600-2-16-22 >asthma</span> is characterised by the increased expression of multiple inflammatory genes regulated by pro-inflammatory transcription factors, such as nuclear factor-kappaB and <span class= gene  id= 16452600-2-186-205 >activator protein-1</span>, which bind to and activate coactivator molecules that acetylate core histones and switch on gene transcription.	16452600	null	Fos proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	2006
FOS	2353	AlteredExpression	BEFREE	NF-kappaB and <span class= gene  id= 9701442-6-14-18 >AP-1</span>) results in the optimal expression of particular genes, resulting in the specific inflammatory pattern seen in <span class= disease  id= 9701442-6-130-139 >asthmatic</span> airways.	9701442	null	Fos proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	1998
FOS	2353	AlteredExpression	BEFREE	There may be an abnormal activation of <span class= gene  id= 8541027-7-39-43 >AP-1</span> in steroid-resistant <span class= disease  id= 8541027-7-65-71 >asthma</span>, and high concentrations of beta 2-agonists may induce a secondary resistance by an interaction between the transcription factor CREB and the glucocorticoid receptor.	8541027	null	Fos proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	1996
JUND	3727	AlteredExpression	BEFREE	These mediators are downstream targets for the transcription factors <span class= gene  id= 11488985-3-69-88 >activator protein-1</span> (<span class= gene  id= 11488985-3-90-94 >AP-1</span>) and nuclear factor-kappaB (NF-kappaB), which control the expression of most immunomodulatory genes and whose activity and expression are elevated in <span class= disease  id= 11488985-3-245-251 >asthma</span>.	11488985	transcription factor; nucleic acid binding	JunD proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	2001
JUND	3727	AlteredExpression	BEFREE	There may be an abnormal activation of <span class= gene  id= 8541027-7-39-43 >AP-1</span> in steroid-resistant <span class= disease  id= 8541027-7-65-71 >asthma</span>, and high concentrations of beta 2-agonists may induce a secondary resistance by an interaction between the transcription factor CREB and the glucocorticoid receptor.	8541027	transcription factor; nucleic acid binding	JunD proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	1996
JUND	3727	AlteredExpression	BEFREE	NF-kappaB and <span class= gene  id= 9701442-6-14-18 >AP-1</span>) results in the optimal expression of particular genes, resulting in the specific inflammatory pattern seen in <span class= disease  id= 9701442-6-130-139 >asthmatic</span> airways.	9701442	transcription factor; nucleic acid binding	JunD proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	1998
JUND	3727	AlteredExpression	BEFREE	Inflammation in <span class= disease  id= 16452600-2-16-22 >asthma</span> is characterised by the increased expression of multiple inflammatory genes regulated by pro-inflammatory transcription factors, such as nuclear factor-kappaB and <span class= gene  id= 16452600-2-186-205 >activator protein-1</span>, which bind to and activate coactivator molecules that acetylate core histones and switch on gene transcription.	16452600	transcription factor; nucleic acid binding	JunD proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	2006
PTGDS	5730	AlteredExpression	BEFREE	Significantly increased levels of <span class= gene  id= 16911359-9-34-38 >PGDS</span> and conversely decreased levels of PGES were observed in <span class= disease  id= 16911359-9-96-106 >asthmatics</span> as compared with non-<span class= disease  id= 16911359-9-128-138 >asthmatics</span>.	16911359	transfer/carrier protein; isomerase	prostaglandin D2 synthase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	2007
STAT1	6772	AlteredExpression	BEFREE	We propose that: (i) IL-4- and IL-13-stimulated SCCA gene expression is mediated via <span class= gene  id= 15677460-8-85-91 >STAT-1</span> and STAT-6 activation, and (ii) by suppressing the production, and most likely by interfering with the signaling of these cytokines, UG inhibits SCCA gene expression associated with airway inflammation in <span class= disease  id= 15677460-8-297-303 >asthma</span>.	15677460	transcription factor; nucleic acid binding	signal transducer and activator of transcription 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	2005
STAT1	6772	AlteredExpression	BEFREE	Individuals with <span class= disease  id= 10820280-4-17-23 >asthma</span> have higher than normal NO concentrations and increased NOSII mRNA and protein due to transcriptional regulation through activation of <span class= gene  id= 10820280-4-159-164 >Stat1</span>.	10820280	transcription factor; nucleic acid binding	signal transducer and activator of transcription 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.004055389228567	2000
FGF2	2247	AlteredExpression	BEFREE	Interleukin-1beta (IL-1beta) and <span class= gene  id= 20082309-1-33-63 >basic fibroblast growth factor</span> (<span class= gene  id= 20082309-1-65-69 >bFGF</span>) are important regulators of proliferation, and their expression is increased in lungs of patients with <span class= disease  id= 20082309-1-174-180 >asthma</span>, idiopathic pulmonary fibrosis (IPF), or chronic obstructive pulmonary disease (COPD).	20082309	signaling molecule	fibroblast growth factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003831819601666	2010
SERPINB3	6317	AlteredExpression	LHGDN	Uteroglobin suppresses <span class=gene id=15677460>SCCA</span> gene expression associated with airway inflammation in <span class=disease id=15677460>asthma</span>	15677460	enzyme modulator	serpin family B member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003831819601666	2005
SERPINB3	6317	AlteredExpression	BEFREE	We propose that: (i) IL-4- and IL-13-stimulated <span class= gene  id= 15677460-8-48-52 >SCCA</span> gene expression is mediated via STAT-1 and STAT-6 activation, and (ii) by suppressing the production, and most likely by interfering with the signaling of these cytokines, UG inhibits <span class= gene  id= 15677460-8-237-241 >SCCA</span> gene expression associated with airway inflammation in <span class= disease  id= 15677460-8-297-303 >asthma</span>.	15677460	enzyme modulator	serpin family B member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003831819601666	2005
TNFSF4	7292	AlteredExpression	BEFREE	Expression of sDC <span class= gene  id= 25813919-9-18-23 >OX40L</span> and CCL17 mRNA was increased in <span class= disease  id= 25813919-9-56-65 >asthmatic</span> cases (P = .003 and P = .0001, respectively). sHBEC TSLP mRNA expression was strongly associated with sDC <span class= gene  id= 25813919-9-172-177 >OX40L</span> mRNA expression (R = 0.65, P = .001) and less strongly with sDC CCL17 mRNA expression. sHBEC IL33 mRNA expression was associated with sDC <span class= gene  id= 25813919-9-316-321 >OX40L</span> mRNA expression (R = 0.42, P = .04) but not sDC CCL17 mRNA expression.	25813919	signaling molecule	tumor necrosis factor superfamily member 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003831819601666	2014
TNFSF4	7292	AlteredExpression	BEFREE	Detection and characterization of <span class= gene  id= 15100674-0-34-45 >OX40 ligand</span> expression in human airway smooth muscle cells: a possible role in <span class= disease  id= 15100674-0-113-119 >asthma</span>?	15100674	signaling molecule	tumor necrosis factor superfamily member 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003831819601666	2004
CCL13	6357	AlteredExpression	BEFREE	Although corticosteroids can downregulate the expression of some <span class= disease  id= 15696082-12-65-71 >asthma</span>-associated chemokines, such as eotaxin, MCP-3, and <span class= gene  id= 15696082-12-123-128 >MCP-4</span>, they can also upregulate the expression of other chemokines, including IL-8, IP-10, and MCP-2.	15696082	signaling molecule	C-C motif chemokine ligand 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003780662444354	2005
CCL13	6357	AlteredExpression	BEFREE	Our findings demonstrate that <span class= gene  id= 10934112-8-30-35 >MCP-4</span> is upregulated in the airways of patients with <span class= disease  id= 10934112-8-83-89 >asthma</span> and suggest that <span class= gene  id= 10934112-8-107-112 >MCP-4</span> plays a role in the recruitment of eosinophils into the airways of patients with <span class= disease  id= 10934112-8-194-200 >asthma</span>.	10934112	signaling molecule	C-C motif chemokine ligand 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003780662444354	2000
CCL13	6357	AlteredExpression	BEFREE	<span class= gene  id= 9062350-7-0-5 >MCP-4</span> mRNA was found in cells collected in bronchoalveolar lavage of <span class= disease  id= 9062350-7-69-78 >asthmatic</span> and nonasthmatic subjects and was prominently expressed in human lung and heart.	9062350	signaling molecule	C-C motif chemokine ligand 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003780662444354	1997
CCL13	6357	AlteredExpression	BEFREE	Eotaxin and <span class= gene  id= 10069883-0-12-42 >monocyte chemotactic protein-4</span> mRNA expression in small airways of <span class= disease  id= 10069883-0-79-88 >asthmatic</span> and nonasthmatic individuals.	10069883	signaling molecule	C-C motif chemokine ligand 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003780662444354	1999
CCL13	6357	AlteredExpression	BEFREE	Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and <span class= gene  id= 10570327-0-111-116 >MCP-4</span>), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) <span class= disease  id= 10570327-0-219-229 >asthmatics</span>.	10570327	signaling molecule	C-C motif chemokine ligand 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003780662444354	1999
SERPINB4	6318	AlteredExpression	LHGDN	Uteroglobin suppresses SCCA gene expression associated with airway inflammation in asthma	15677460	enzyme modulator	serpin family B member 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003557092817453	2005
EGR1	1958	AlteredExpression	BEFREE	FCER2 (CD23) <span class= disease  id= 24010859-0-13-19 >asthma</span>-related single nucleotide polymorphisms yields increased IgE binding and <span class= gene  id= 24010859-0-93-98 >Egr-1</span> expression in human B cells.	24010859	null	early growth response 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00350593566014	2014
FCGR3A	2214	AlteredExpression	BEFREE	Finally we showed that human CD14(+)<span class= gene  id= 24358127-9-36-40 >CD16</span>(+) intermediate monocytes, which are found in increased numbers in patients with allergies and <span class= disease  id= 24358127-9-136-152 >bronchial asthma</span>, expressed high levels of miR-124 and exhibited other properties of M2-like cells.	24358127	cell adhesion molecule	Fc fragment of IgG receptor IIIa	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00350593566014	2013
IL11	3589	AlteredExpression	BEFREE	<span class= gene  id= 10669841-0-0-5 >IL-11</span> expression is increased in severe <span class= disease  id= 10669841-0-40-46 >asthma</span>: association with epithelial cells and eosinophils.	10669841	null	interleukin 11	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00350593566014	2000
TLR3	7098	AlteredExpression	BEFREE	Furthermore, uninfected cells from severe therapy resistant <span class= disease  id= 23212197-5-60-69 >asthmatic</span> children showed lower levels of <span class= gene  id= 23212197-5-102-122 >Toll-like receptor-3</span> mRNA and reduced retinoic acid inducible gene and melanoma differentiation-associated gene 5 mRNA after RV stimulation.	23212197	extracellular matrix protein; receptor	toll like receptor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00350593566014	2014
TLR3	7098	AlteredExpression	BEFREE	<span class= gene  id= 24131248-0-0-4 >TLR3</span> and MDA5 signalling, although not expression, is impaired in <span class= disease  id= 24131248-0-66-75 >asthmatic</span> epithelial cells in response to rhinovirus infection.	24131248	extracellular matrix protein; receptor	toll like receptor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00350593566014	2013
SOCS3	9021	AlteredExpression	BEFREE	The genetic-gene expression network identified the <span class= gene  id= 23209423-9-51-56 >SOCS3</span> pathway as one of the key drivers of <span class= disease  id= 23209423-9-94-100 >asthma</span>.	23209423	signaling molecule	suppressor of cytokine signaling 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00350593566014	2012
SMAD2	4087	AlteredExpression	LHGDN	activation of TGF-beta1/<span class=gene id=12170265>Smad2</span> signaling is associated with airway remodeling in <span class=disease id=12170265>asthma</span>	12170265	transcription factor	SMAD family member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00328236603324	2002
NOX4	50507	AlteredExpression	BEFREE	LTC4 inhibitors, commonly used for <span class= disease  id= 26656251-8-35-41 >asthma</span>, could find broad clinical use in major human pathologies associated with ER stress-activated <span class= gene  id= 26656251-8-136-140 >NOX4</span>.	26656251	oxidoreductase	NADPH oxidase 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00328236603324	2015
CAMP	820	AlteredExpression	LHGDN	Induced-sputum innate immune factor levels discriminate inflammatory changes in cystic fibrosis, COPD, and asthma.	16236890	defense/immunity protein; enzyme modulator	cathelicidin antimicrobial peptide	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00328236603324	2005
CAMP	820	AlteredExpression	BEFREE	In multivariate regression models a significant positive correlation between serum vitamin D levels and the expression of vitamin D-regulated targets, cytochrome P450, family 24, subfamily a (cyp24a) expression by PBMCs (P = .0084, pediatric <span class= disease  id= 22330698-7-242-248 >asthma</span> group only) and serum <span class= gene  id= 22330698-7-271-276 >LL-37</span> levels (P = .0006 in the pediatric group but P = .0067 in the adult <span class= disease  id= 22330698-7-345-351 >asthma</span> group), was found.	22330698	defense/immunity protein; enzyme modulator	cathelicidin antimicrobial peptide	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.00328236603324	2012
FKBP4	2288	AlteredExpression	BEFREE	Dexamethasone-induced <span class= gene  id= 20853021-0-22-28 >FKBP51</span> expression in peripheral blood mononuclear cells could play a role in predicting the response of <span class= disease  id= 20853021-0-126-136 >asthmatics</span> to treatment with corticosteroids.	20853021	isomerase; calcium-binding protein; chaperone	FK506 binding protein 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003231208875927	2010
FKBP4	2288	AlteredExpression	BEFREE	Association of eosinophilic inflammation with <span class= gene  id= 23762334-0-46-52 >FKBP51</span> expression in sputum cells in <span class= disease  id= 23762334-0-83-89 >asthma</span>.	23762334	isomerase; calcium-binding protein; chaperone	FK506 binding protein 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003231208875927	2013
FKBP4	2288	AlteredExpression	BEFREE	Expression of the corticosteroid-induced genes, GILZ and <span class= gene  id= 21827450-9-57-63 >FKBP51</span>, is up-regulated in the airways of allergen-challenged <span class= disease  id= 21827450-9-119-128 >asthmatic</span> subjects taking inhaled budesonide.	21827450	isomerase; calcium-binding protein; chaperone	FK506 binding protein 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003231208875927	2012
FKBP5	2289	AlteredExpression	BEFREE	Association of eosinophilic inflammation with <span class= gene  id= 23762334-0-46-52 >FKBP51</span> expression in sputum cells in <span class= disease  id= 23762334-0-83-89 >asthma</span>.	23762334	isomerase; calcium-binding protein; chaperone	FK506 binding protein 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003231208875927	2013
FKBP5	2289	AlteredExpression	BEFREE	Dexamethasone-induced <span class= gene  id= 20853021-0-22-28 >FKBP51</span> expression in peripheral blood mononuclear cells could play a role in predicting the response of <span class= disease  id= 20853021-0-126-136 >asthmatics</span> to treatment with corticosteroids.	20853021	isomerase; calcium-binding protein; chaperone	FK506 binding protein 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003231208875927	2010
FKBP5	2289	AlteredExpression	BEFREE	Expression of the corticosteroid-induced genes, GILZ and <span class= gene  id= 21827450-9-57-63 >FKBP51</span>, is up-regulated in the airways of allergen-challenged <span class= disease  id= 21827450-9-119-128 >asthmatic</span> subjects taking inhaled budesonide.	21827450	isomerase; calcium-binding protein; chaperone	FK506 binding protein 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003231208875927	2012
IL17RB	55540	AlteredExpression	BEFREE	The expression of <span class= gene  id= 24247484-8-18-25 >IL-17RB</span> on eosinophils was significantly higher in allergic <span class= disease  id= 24247484-8-78-88 >asthmatics</span> (43.08%, range 33.96-59.98%) than in atopic nonasthmatics (11.98%, range 6.33-27.11%, p = 0.002) and normal controls (17.70%, range 10.97-38.9%, p = 0.01).	24247484	null	interleukin 17 receptor B	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003231208875927	2013
SELP	6403	AlteredExpression	BEFREE	Comparison of the intracellular free calcium concentration ([Ca2+]i) in platelets as an indicator of platelet activation, <span class= gene  id= 9498966-2-122-127 >CD62P</span> expression on platelets, and the chemokine regulated upon activation in normal T cells expressed and presumably secreted (RANTES) level in platelet-rich buffer supernatants between <span class= disease  id= 9498966-2-309-319 >asthmatics</span> and normal subjects.	9498966	null	selectin P	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003231208875927	1998
COX2	4513	AlteredExpression	BEFREE	<span class= gene  id= 25180620-7-0-5 >COX-2</span> mRNA stability was increased in <span class= disease  id= 25180620-7-38-47 >asthmatic</span> cells.	25180620	oxidoreductase	cytochrome c oxidase subunit II	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003021994626344	2016
COX2	4513	AlteredExpression	BEFREE	We therefore examined the expression of <span class= gene  id= 10390414-5-40-45 >COX-2</span> messenger RNA (mRNA) in healthy nasal mucosa (n = 11) and in nasal polyps from both patients with AIAR (n = 8) and those with aspirin-tolerant <span class= disease  id= 10390414-5-189-195 >asthma</span>/rhinitis (ATAR) (n = 20).	10390414	oxidoreductase	cytochrome c oxidase subunit II	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003021994626344	1999
COX2	4513	AlteredExpression	BEFREE	COX-1, and not <span class= gene  id= 18753249-0-15-20 >COX-2</span> activity, regulates airway function: relevance to aspirin-sensitive <span class= disease  id= 18753249-0-89-95 >asthma</span>.	18753249	oxidoreductase	cytochrome c oxidase subunit II	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003021994626344	2008
COX2	4513	AlteredExpression	BEFREE	Our aim was to investigate the expression of COX-1 and <span class= gene  id= 17622692-3-55-60 >COX-2</span> mRNA in primary human bronchial epithelial cells (HBEC) isolated from <span class= disease  id= 17622692-3-131-141 >asthmatics</span> and non-<span class= disease  id= 17622692-3-150-160 >asthmatics</span>.	17622692	oxidoreductase	cytochrome c oxidase subunit II	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003021994626344	2007
COX2	4513	AlteredExpression	BEFREE	PAR-2 activation, PGE2, and <span class= gene  id= 12754192-0-28-33 >COX-2</span> in human <span class= disease  id= 12754192-0-43-52 >asthmatic</span> and nonasthmatic airway smooth muscle cells.	12754192	oxidoreductase	cytochrome c oxidase subunit II	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003021994626344	2003
CFL1	1072	AlteredExpression	BEFREE	Expression of nonmuscle <span class= gene  id= 17088134-0-24-33 >cofilin-1</span> and steroid responsiveness in severe <span class= disease  id= 17088134-0-71-77 >asthma</span>.	17088134	cytoskeletal protein	cofilin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003007639249027	2006
CFL1	1072	AlteredExpression	LHGDN	Increased expression may be important in the regulation of glucocorticoid sensitivity in peripheral blood lymphocytes of patients with severe treatment-insensitive asthma.	17088134	cytoskeletal protein	cofilin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003007639249027	2006
ELANE	1991	AlteredExpression	LHGDN	Neutrophil derived elastase (NE) upregulates TGF-beta1 gene expression and release via My88/IRAK/NF-kappaB pathway, possibly through activation of TLR4, and shed light on a potential role of neutrophils in the pathogenesis of asthma.	16690986	protease; hydrolase	elastase, neutrophil expressed	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003007639249027	2006
ETS1	2113	AlteredExpression	BEFREE	Taken together, these data demonstrate that TNF-alpha increases MMP-9 and tenascin expression in bronchial fibroblasts via the transcription factor <span class= gene  id= 14734780-12-148-153 >Ets-1</span>, and suggest a role for <span class= gene  id= 14734780-12-178-183 >Ets-1</span> in airway remodeling in <span class= disease  id= 14734780-12-208-214 >asthma</span>.	14734780	transcription factor; signaling molecule; nucleic acid binding	ETS proto-oncogene 1, transcription factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003007639249027	2004
ETS1	2113	AlteredExpression	LHGDN	<span class=gene id=14734780>Ets-1</span> expression is increased in <span class=disease id=14734780>asthma</span> and contributes to enhanced expression of TNF-alpha-induced matrix metalloproteinase-9 and tenascin in bronchial fibroblasts activated ex vivo.	14734780	transcription factor; signaling molecule; nucleic acid binding	ETS proto-oncogene 1, transcription factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003007639249027	2004
MMP2	4313	AlteredExpression	LHGDN	in vitro findings suggest that the environment within the airways of patients with <span class=disease id=17189319>asthma</span> enhances <span class=gene id=17189319>MMP-2</span> and -14 protein and activity by a complex interaction of transcriptional and posttranscriptional mechanisms, which may contribute to ASM migration.	17189319	null	matrix metallopeptidase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003007639249027	2007
TAGLN	6876	AlteredExpression	BEFREE	Myosin, <span class= gene  id= 19011151-0-8-18 >transgelin</span>, and myosin light chain kinase: expression and function in <span class= disease  id= 19011151-0-78-84 >asthma</span>.	19011151	cytoskeletal protein	transgelin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003007639249027	2009
TAGLN	6876	AlteredExpression	LHGDN	Selective overexpression of airway smooth muscle genes in asthmatic airways leads to increased Vmax, thus contributing to the airway hyperresponsiveness observed in asthma.	19011151	cytoskeletal protein	transgelin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003007639249027	2009
RIPK2	8767	AlteredExpression	BEFREE	The situation is complicated further by the fact that WT NOD2 and WT <span class= gene  id= 23794710-4-69-73 >RIP2</span> activity has been implicated in diseases such as <span class= disease  id= 23794710-4-123-129 >asthma</span>, inflammatory arthritis and MS.	23794710	transferase; kinase	receptor interacting serine/threonine kinase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.003007639249027	2013
CSF3	1440	AlteredExpression	BEFREE	Apolipoprotein A-I (apoA-I) is an important component of high-density lipoprotein particles that mediates reverse cholesterol transport out of cells by interacting with the ATP-binding cassette transporter 1 (ABCA1). apoA-I has also been shown to attenuate neutrophilic airway inflammation in experimental ovalbumin (OVA)-induced <span class= disease  id= 24813055-1-330-336 >asthma</span> by reducing the expression of <span class= gene  id= 24813055-1-367-404 >granulocyte colony-stimulating factor</span> (<span class= gene  id= 24813055-1-406-411 >G-CSF</span>).	24813055	signaling molecule	colony stimulating factor 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002956482091714	2015
IL17RA	23765	AlteredExpression	BEFREE	In a baseline cross-sectional study, we previously showed that IL-25 plasma levels and IL-25 receptor (IL-25R: IL-17RA, IL-17RB, and <span class= gene  id= 27685606-2-133-140 >IL-17RA</span>/RB) expression on mature blood eosinophils are increased in atopic <span class= disease  id= 27685606-2-208-218 >asthmatics</span> compared to normal nonatopic controls.	27685606	null	interleukin 17 receptor A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002956482091714	2016
IL17RA	23765	AlteredExpression	BEFREE	<span class= gene  id= 24247484-9-0-7 >IL-17RA</span> expression was also significantly higher in the allergic <span class= disease  id= 24247484-9-65-74 >asthmatic</span> group.	24247484	null	interleukin 17 receptor A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002956482091714	2013
CXCL1	2919	AlteredExpression	BEFREE	Cysteine oxidation was present in children with difficult-to-treat <span class= disease  id= 25748343-8-67-73 >asthma</span> and accompanied by increased reactive oxygen species generation and increased CCL3 and <span class= gene  id= 25748343-8-161-166 >CXCL1</span> mRNA expression.	25748343	signaling molecule	C-X-C motif chemokine ligand 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002956482091714	2015
HP	3240	AlteredExpression	BEFREE	The protein levels of Gc, hemopexin, and <span class= gene  id= 21169467-7-41-52 >haptoglobin</span>-b were increased, whereas the a1- antitrypsin and glutathione S-transferase levels were decreased in subjects with <span class= disease  id= 21169467-7-168-174 >asthma</span>.	21169467	protease; enzyme modulator; hydrolase; signaling molecule; calcium-binding protein; receptor	haptoglobin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002956482091714	2011
CCL15	6359	AlteredExpression	BEFREE	CC-chemokine <span class= gene  id= 23258953-0-13-18 >CCL15</span> expression and possible implications for the pathogenesis of IgE-related severe <span class= disease  id= 23258953-0-99-105 >asthma</span>.	23258953	signaling molecule	C-C motif chemokine ligand 15	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002956482091714	2012
CRLF2	64109	AlteredExpression	BEFREE	Expression of <span class= gene  id= 20236697-4-14-27 >TSLP receptor</span> (<span class= gene  id= 20236697-4-29-34 >TSLPR</span>) and its response to inhaled corticosteroids was evaluated on bronchial biopsy specimens of healthy control subjects and <span class= disease  id= 20236697-4-156-165 >asthmatic</span> patients by means of immunohistochemistry.	20236697	defense/immunity protein; signaling molecule	cytokine receptor-like factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002956482091714	2010
STAT5A	6776	AlteredExpression	BEFREE	We demonstrate <span class= gene  id= 22970180-12-15-21 >STAT5A</span> gene expression is decreased whereas CRIP1 gene expression is elevated in the AECs from <span class= disease  id= 22970180-12-110-119 >asthmatic</span> compared to both healthy and atopic subjects.	22970180	transcription factor; nucleic acid binding	signal transducer and activator of transcription 5A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002956482091714	2012
RUNX1	861	AlteredExpression	BEFREE	We conclude that 1) SNPs in <span class= gene  id= 21803869-9-28-33 >RUNX1</span> are associated with airway responsiveness in <span class= disease  id= 21803869-9-79-88 >asthmatic</span> children and these associations are modified by IUS exposure, 2) IUS tended to increase the expression of <span class= gene  id= 21803869-9-195-200 >RUNX1</span> in early human development, and 3) a murine IUS model showed that the effects of developmental cigarette smoke exposure persisted for at least 2 wk after birth.	21803869	transcription factor; nucleic acid binding	runt related transcription factor 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002956482091714	2011
NFKB1	4790	AlteredExpression	BEFREE	The current study demonstrates that following airway exposure with an <span class= disease  id= 24227776-9-70-76 >asthma</span>-relevant allergen, activation of classical and alternative <span class= gene  id= 24227776-9-136-141 >NF-&kappa;B</span> pathways occurs within the airway epithelium and may coordinately contribute to allergic inflammation, AHR, and fibrotic airway remodeling.	24227776	transcription factor; nucleic acid binding	nuclear factor kappa B subunit 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002747267842131	2014
MAPK1	5594	AlteredExpression	BEFREE	The IL12B gene encodes the <span class= gene  id= 15007350-1-27-30 >p40</span> chain of IL-12, a proinflammatory cytokine that antagonizes TH2 expression and hence may play a critical role in the pathogenesis of airway inflammation observed in <span class= disease  id= 15007350-1-196-202 >asthma</span>.	15007350	transferase; kinase	mitogen-activated protein kinase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002747267842131	2004
MAPK1	5594	AlteredExpression	BEFREE	In summary, bronchial epithelial cell changes in <span class= disease  id= 17392578-7-49-55 >asthma</span> are induced by LIF which promotes the expression of NK-1R, and JAK/STAT pathway and MAPK/<span class= gene  id= 17392578-7-145-148 >ERK</span> pathway may participate in this process.	17392578	transferase; kinase	mitogen-activated protein kinase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002747267842131	2007
MAPK1	5594	AlteredExpression	BEFREE	These data indicate that HRV-induced activation of the MEK/<span class= gene  id= 22461694-10-59-62 >ERK</span> MAPK pathway and Fra-1 expression are necessary for the upregulation of MMP-9 and can be modulated by two distinct but commonly used <span class= disease  id= 22461694-10-196-202 >asthma</span> pharmacotherapies.	22461694	transferase; kinase	mitogen-activated protein kinase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002747267842131	2012
CTNNA1	1495	AlteredExpression	LHGDN	Rsults suggest that the lower epithelial <span class=gene id=18418437>alpha-catenin</span>, E-cadherin and (or) ZO-1 expression in patients with atopic <span class=disease id=18418437>asthma</span> contributes to a defective airway epithelial barrier and a higher influx of eosinophils in the epithelium.	18418437	cell adhesion molecule; cytoskeletal protein	catenin alpha 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2008
EFNA1	1942	AlteredExpression	LHGDN	This study demonstrates for the first time significantly reduced <span class=gene id=14707054>ephrin-A1</span> expression in T cells of <span class=disease id=14707054>asthma</span> patients.	14707054	signaling molecule	ephrin A1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2004
FPR2	2358	AlteredExpression	LHGDN	Our results indicate that severe asthma is characterized by decreased airway LXA4 levels and luekocyte AKX receptor availability.	18583575	receptor	formyl peptide receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2008
HEXB	3074	AlteredExpression	LHGDN	Elevated activity of beta-hexosaminidase observed in subjects with asthma suggests that the beta-hex isozyme could take part in airway inflammation and remodeling in asthma.	18204279	hydrolase	hexosaminidase subunit beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2008
ITGA4	3676	AlteredExpression	LHGDN	These data suggest that during a respiratory virus infection activated CD8+ T cells from asthmatic subjects may produce excess type 2 cytokines and may contribute to asthma exacerbation by augmenting allergic inflammation.	16001979	null	integrin subunit alpha 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2005
MYH11	4629	AlteredExpression	LHGDN	Selective overexpression of airway smooth muscle genes in asthmatic airways leads to increased Vmax, thus contributing to the airway hyperresponsiveness observed in asthma.	19011151	cell junction protein; cytoskeletal protein; enzyme modulator	myosin heavy chain 11	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2009
PMCH	5367	AlteredExpression	LHGDN	expression of <span class=gene id=17640905>PMCH</span> by activated Th2 cells in vivo may directly link allergic inflammation to energy homeostasis and may contribute to the association between <span class=disease id=17640905>asthma</span> and obesity	17640905	signaling molecule	pro-melanin concentrating hormone	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2007
BAX	581	AlteredExpression	LHGDN	Bax expression is reduced in airway epithelial cells of even mild asthmatic subjects and suggest that restoring Bax expression may provide a clinical approach for restoring the normal numbers of epithelial cells &amp; reduced mucous hypersecretion in asthma.	18390829	signaling molecule	BCL2 associated X, apoptosis regulator	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2008
BCL2L1	598	AlteredExpression	LHGDN	In addition, B cell lymphoma leukemia (Bcl) -x (L), an antiapoptotic regulator, was also highly expressed in macrophages from smokers compared with nonsmokers and subjects with asthma.	12204872	signaling molecule	BCL2 like 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2002
BDKRB1	623	AlteredExpression	LHGDN	We suggest that increased expression of B1 receptor in the human airway following a URI could increase the risk of an exacerbation of asthma by contributing to increased inflammation in the airway.	18039525	receptor	bradykinin receptor B1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2007
BMPR1B	658	AlteredExpression	LHGDN	there was significant down-regulation of ALK-6 (activin receptor-like kinase 6) expression in asthma patients at baseline; allergy challenge was associated with upregulation	18292470	transferase; kinase; receptor	bone morphogenetic protein receptor type 1B	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2008
BMPR2	659	AlteredExpression	LHGDN	there was significant down-regulation of BMPRII (<span class=gene id=18292470>bone morphogenetic protein receptor type II</span>) expression in <span class=disease id=18292470>asthma</span> patients at baseline	18292470	transferase; kinase; receptor	bone morphogenetic protein receptor type 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2008
TJP1	7082	AlteredExpression	LHGDN	Rsults suggest that the lower epithelial alpha-catenin, E-cadherin and (or) ZO-1 expression in patients with atopic asthma contributes to a defective airway epithelial barrier and a higher influx of eosinophils in the epithelium.	18418437	cell junction protein	tight junction protein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2008
C4A	720	AlteredExpression	LHGDN	determination of whether the levels of complement factors C3a, C4a, and C5a are elevated at the site of inflammation in chronic obstructive pulmonary disease and in asthma	15039137	defense/immunity protein; signaling molecule; enzyme modulator	complement C4A (Rodgers blood group)	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2004
XDH	7498	AlteredExpression	LHGDN	The activity of XO was determined in lymphocytes, eosinophils and blood serum in patients with bronchial asthma.	12774669	oxidoreductase	xanthine dehydrogenase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2003
TNFRSF14	8764	AlteredExpression	LHGDN	sHVEM levels were elevated in sera of patients with allergic asthma, atopic dermatitis and rheumatoid arthritis	14749527	receptor	TNF receptor superfamily member 14	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2003
ACVR1	90	AlteredExpression	LHGDN	there was significant down-regulation of <span class=gene id=18292470>ALK-2</span> expression in <span class=disease id=18292470>asthma</span> patients at baseline; allergy challenge was associated with upregulation	18292470	transferase; kinase; receptor	activin A receptor type 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002732912464814	2008
IL23R	149233	AlteredExpression	BEFREE	In this study, we show that in an allergen-induced <span class= disease  id= 19935773-3-51-57 >asthma</span> model, mice with transgenic overexpression of <span class= gene  id= 19935773-3-104-110 >IL-23R</span> exhibited increased airway infiltration of eosinophils and Th2 cytokine production, whereas those deficient in IL-23 displayed reduced airway inflammation.	19935773	defense/immunity protein; signaling molecule	interleukin 23 receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002681755307501	2010
IL7	3574	AlteredExpression	BEFREE	Thymic stromal lymphopoietin (TSLP), an <span class= gene  id= 21966427-1-40-43 >IL7</span>-like cytokine produced by bronchial epithelial cells is upregulated in <span class= disease  id= 21966427-1-115-121 >asthma</span> and induces dendritic cell maturation supporting a Th2 response.	21966427	signaling molecule	interleukin 7	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002681755307501	2011
CXCL9	4283	AlteredExpression	BEFREE	Bronchoalveolar lavage cells from 87 participants were evaluated for IL-27 mRNA and protein alone and in association with epithelial CCL26 (a marker of type 2 activation) in relation to <span class= disease  id= 25312760-5-186-192 >asthma</span> severity and <span class= gene  id= 25312760-5-206-211 >CXCL9</span> mRNA.	25312760	signaling molecule	C-X-C motif chemokine ligand 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002681755307501	2014
PDGFRA	5156	AlteredExpression	BEFREE	There was also an autocrine effect of lower PDGF-AA and higher <span class= gene  id= 16804324-11-63-73 >PDGFRalpha</span> expression that might lead to airway remodeling causing the severity of <span class= disease  id= 16804324-11-146-152 >asthma</span>.	16804324	null	platelet derived growth factor receptor alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002681755307501	2006
PON1	5444	AlteredExpression	BEFREE	Gene expression profiling of experimental <span class= disease  id= 19556304-0-42-48 >asthma</span> reveals a possible role of <span class= gene  id= 19556304-0-76-89 >paraoxonase-1</span> in the disease.	19556304	null	paraoxonase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002681755307501	2009
PPBP	5473	AlteredExpression	BEFREE	<span class= gene  id= 25193981-4-0-4 >PPBP</span> expression by monocyte-derived macrophages from patients with ABPA or CCPA and <span class= disease  id= 25193981-4-84-93 >asthmatic</span> and healthy controls (10 individuals per group) was analyzed using reverse-transcription polymerase chain reaction.	25193981	signaling molecule	pro-platelet basic protein	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002681755307501	2015
CCL8	6355	AlteredExpression	BEFREE	Although corticosteroids can downregulate the expression of some <span class= disease  id= 15696082-12-65-71 >asthma</span>-associated chemokines, such as eotaxin, MCP-3, and MCP-4, they can also upregulate the expression of other chemokines, including IL-8, IP-10, and <span class= gene  id= 15696082-12-218-223 >MCP-2</span>.	15696082	signaling molecule	C-C motif chemokine ligand 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002681755307501	2005
TLR5	7100	AlteredExpression	BEFREE	Therefore, the decreased activation of TLR4 and <span class= gene  id= 19067129-5-48-52 >TLR5</span> in <span class= disease  id= 19067129-5-56-65 >asthmatic</span> patients might contribute to the immunopathological mechanisms of <span class= disease  id= 19067129-5-132-138 >asthma</span> by reducing the release of Th1 and anti-inflammatory cytokines.	19067129	extracellular matrix protein; receptor	toll like receptor 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002681755307501	2008
TNFRSF1B	7133	AlteredExpression	BEFREE	Also, <span class= gene  id= 10627863-8-6-11 >TNFR2</span> is up-regulated in both SSA non-atopic and SRA atopic as compared to non-<span class= disease  id= 10627863-8-85-94 >asthmatic</span> controls.	10627863	receptor	TNF receptor superfamily member 1B	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002681755307501	2000
MUC5B	727897	AlteredExpression	BEFREE	In silico cloning of mouse <span class= gene  id= 11587997-0-27-32 >Muc5b</span> gene and upregulation of its expression in mouse <span class= disease  id= 11587997-0-82-88 >asthma</span> model.	11587997	cell adhesion molecule; extracellular matrix protein	mucin 5B, oligomeric mucus/gel-forming	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002681755307501	2001
IL17D	53342	AlteredExpression	BEFREE	<span class= gene  id= 21535180-0-0-5 >IL-22</span> mRNA in peripheral blood mononuclear cells from allergic rhinitic and <span class= disease  id= 21535180-0-76-85 >asthmatic</span> pediatric patients.	21535180	signaling molecule	interleukin 17D	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002472541057918	2011
IL17D	53342	AlteredExpression	BEFREE	IL-17 and <span class= gene  id= 24349168-13-10-15 >IL-22</span> were increased in both normal and <span class= disease  id= 24349168-13-50-59 >asthmatic</span> conditions with a significantly higher amount in <span class= disease  id= 24349168-13-109-119 >asthmatics</span> compared to controls.	24349168	signaling molecule	interleukin 17D	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002472541057918	2013
IL17D	53342	AlteredExpression	BEFREE	The PAH-induced <span class= gene  id= 25860963-9-16-21 >IL-22</span> levels in <span class= disease  id= 25860963-9-32-41 >asthmatic</span> patients were significantly higher than in healthy subjects.	25860963	signaling molecule	interleukin 17D	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002472541057918	2015
KNG1	3827	AlteredExpression	BEFREE	When we compared results in <span class= disease  id= 12754192-4-28-37 >asthmatic</span> and nonasthmatic muscle cells, both trypsin and <span class= gene  id= 12754192-4-86-96 >bradykinin</span> induced less PGE2 from <span class= disease  id= 12754192-4-120-129 >asthmatic</span> ASM cells, and <span class= gene  id= 12754192-4-145-155 >bradykinin</span> induced significantly less COX-2 mRNA in <span class= disease  id= 12754192-4-197-206 >asthmatic</span> cells.	12754192	null	kininogen 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002197814273705	2003
KNG1	3827	AlteredExpression	BEFREE	<span class= gene  id= 26588817-0-0-10 >Bradykinin</span> B2 receptor expression in the bronchial mucosa of allergic <span class= disease  id= 26588817-0-70-80 >asthmatics</span>: the role of NF-kB.	26588817	null	kininogen 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002197814273705	2015
KNG1	3827	AlteredExpression	BEFREE	Increased levels of <span class= gene  id= 12532104-1-20-30 >bradykinin</span> and IL-8 have been detected within the airways of individuals with active symptoms of allergic rhinitis and <span class= disease  id= 12532104-1-139-145 >asthma</span>.	12532104	null	kininogen 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002197814273705	2003
PDE4A	5141	AlteredExpression	BEFREE	&beta;2-Agonists upregulate <span class= gene  id= 22101762-0-23-27 >PDE4</span> mRNA but <span class= negexp >not protein or activity in human airway smooth muscle cells from</span> <span class= disease  id= 22101762-0-102-111 >asthmatic</span> and nonasthmatic volunteers.	22101762	hydrolase	phosphodiesterase 4A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002197814273705	2012
PDE4A	5141	AlteredExpression	BEFREE	Over the last decade, inhibitors of <span class= gene  id= 10730545-8-36-40 >PDE4</span> (a cAMP-specific family that negatively regulates the function of almost all pro-inflammatory and immune cells, and exerts widespread anti-inflammatory activity in animal models of <span class= disease  id= 10730545-8-222-228 >asthma</span>) have been developed with the view to reducing the adverse effects profile associated with non-selective inhibitors such as theophylline.	10730545	hydrolase	phosphodiesterase 4A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.002197814273705	2000
AHR	196	AlteredExpression	BEFREE	Development of <span class= disease  id= 24365139-16-15-21 >asthma</span> was dependent on NK cells and associated with increased transcription from <span class= gene  id= 24365139-16-97-122 >aryl hydrocarbon receptor</span>- and oxidative stress-regulated genes.	24365139	transcription factor; receptor	aryl hydrocarbon receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2013
AHR	196	AlteredExpression	BEFREE	TCDD-Induced Activation of <span class= gene  id= 26938767-0-27-52 >Aryl Hydrocarbon Receptor</span> Inhibits Th17 Polarization and Regulates Non-Eosinophilic Airway Inflammation in <span class= disease  id= 26938767-0-134-140 >Asthma</span>.	26938767	transcription factor; receptor	aryl hydrocarbon receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2016
HDAC2	3066	AlteredExpression	BEFREE	Glucocorticoids suppress the multiple inflammatory genes that are activated in chronic inflammatory diseases, such as <span class= disease  id= 20188830-3-118-124 >asthma</span>, by reversing histone acetylation of activated inflammatory genes through binding of liganded glucocorticoid receptors (GR) to coactivator molecules and recruitment of histone deacetylase-2 (<span class= gene  id= 20188830-3-316-321 >HDAC2</span>) to the activated transcription complex.	20188830	oxidoreductase; nucleic acid binding; hydrolase	histone deacetylase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2010
HDAC2	3066	AlteredExpression	BEFREE	<span class= gene  id= 18234319-7-0-5 >HDAC2</span> expression and activity is reduced in lung macrophages, biopsy specimens, and blood cells from patients with severe <span class= disease  id= 18234319-7-122-128 >asthma</span> and smoking-induced <span class= disease  id= 18234319-7-149-155 >asthma</span>, as well as in patients with chronic obstructive pulmonary disease, perhaps accounting for the enhanced inflammation and reduced steroid responsiveness seen in these patients.	18234319	oxidoreductase; nucleic acid binding; hydrolase	histone deacetylase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2007
HDAC2	3066	AlteredExpression	BEFREE	HDAC1 and <span class= gene  id= 22156779-10-10-15 >HDAC2</span> expression was <span class= negexp >not downregulated in severe</span> <span class= disease  id= 22156779-10-59-65 >asthma</span>.	22156779	oxidoreductase; nucleic acid binding; hydrolase	histone deacetylase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2012
HDAC2	3066	AlteredExpression	BEFREE	<span class= gene  id= 23360759-6-0-5 >HDAC2</span> appears to mediate the action of steroids to switch off activated inflammatory genes, but in patients with COPD, patients with severe asthma, and smokers with <span class= disease  id= 23360759-6-165-171 >asthma</span>, HDAC2 activity and expression are reduced by oxidative stress through activation of phosphoinositide 3-kinase &delta;.	23360759	oxidoreductase; nucleic acid binding; hydrolase	histone deacetylase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2012
HDAC2	3066	AlteredExpression	BEFREE	Inhibition of <span class= gene  id= 20538962-0-14-35 >histone deacetylase 2</span> expression by elevated glucocorticoid receptor beta in steroid-resistant <span class= disease  id= 20538962-0-109-115 >asthma</span>.	20538962	oxidoreductase; nucleic acid binding; hydrolase	histone deacetylase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2010
HDAC2	3066	AlteredExpression	BEFREE	Corticosteroids suppress the multiple inflammatory genes that are activated in <span class= disease  id= 16452600-3-79-88 >asthmatic</span> airways, mainly by reversing histone acetylation of activated inflammatory genes through binding of glucocorticoid receptors to coactivators and recruitment of <span class= gene  id= 16452600-3-249-270 >histone deacetylase 2</span> to the activated transcription complex.	16452600	oxidoreductase; nucleic acid binding; hydrolase	histone deacetylase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2006
PIK3CA	5290	AlteredExpression	BEFREE	Silencing of <span class= gene  id= 22556157-11-13-18 >p110&alpha;</span> or -&delta;, but not p110&beta;, resulted in comparable attenuation of TNF-&alpha;-induced CD38 expression in <span class= disease  id= 22556157-11-112-121 >asthmatic</span> and nonasthmatic cells.	22556157	transferase; kinase	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2012
PIK3CB	5291	AlteredExpression	BEFREE	We hypothesized that <span class= gene  id= 22556157-4-21-25 >PI3K</span>s mediate CD38 expression and are involved in the differential induction of CD38 by TNF-&alpha; in <span class= disease  id= 22556157-4-118-127 >asthmatic</span> HASM cells.	22556157	transferase; kinase	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2012
PIK3CD	5293	AlteredExpression	BEFREE	We hypothesized that <span class= gene  id= 22556157-4-21-25 >PI3K</span>s mediate CD38 expression and are involved in the differential induction of CD38 by TNF-&alpha; in <span class= disease  id= 22556157-4-118-127 >asthmatic</span> HASM cells.	22556157	transferase; kinase	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2012
PIK3CG	5294	AlteredExpression	BEFREE	We hypothesized that <span class= gene  id= 22556157-4-21-25 >PI3K</span>s mediate CD38 expression and are involved in the differential induction of CD38 by TNF-&alpha; in <span class= disease  id= 22556157-4-118-127 >asthmatic</span> HASM cells.	22556157	transferase; kinase	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001923087489492	2012
EPHB2	2048	AlteredExpression	BEFREE	In summary, bronchial epithelial cell changes in <span class= disease  id= 17392578-7-49-55 >asthma</span> are induced by LIF which promotes the expression of NK-1R, and JAK/STAT pathway and MAPK/<span class= gene  id= 17392578-7-145-148 >ERK</span> pathway may participate in this process.	17392578	null	EPH receptor B2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	2007
EPHB2	2048	AlteredExpression	BEFREE	These data indicate that HRV-induced activation of the MEK/<span class= gene  id= 22461694-10-59-62 >ERK</span> MAPK pathway and Fra-1 expression are necessary for the upregulation of MMP-9 and can be modulated by two distinct but commonly used <span class= disease  id= 22461694-10-196-202 >asthma</span> pharmacotherapies.	22461694	null	EPH receptor B2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	2012
FN1	2335	AlteredExpression	BEFREE	<span class= gene  id= 24875618-11-0-11 >Fibronectin</span> expression by HLFs cocultured with AECs from <span class= disease  id= 24875618-11-57-66 >asthmatic</span> patients was significantly greater than that by HLFs alone.	24875618	signaling molecule	fibronectin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	2014
FOSB	2354	AlteredExpression	BEFREE	NF-kappaB and <span class= gene  id= 9701442-6-14-18 >AP-1</span>) results in the optimal expression of particular genes, resulting in the specific inflammatory pattern seen in <span class= disease  id= 9701442-6-130-139 >asthmatic</span> airways.	9701442	null	FosB proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	1998
FOSB	2354	AlteredExpression	BEFREE	There may be an abnormal activation of <span class= gene  id= 8541027-7-39-43 >AP-1</span> in steroid-resistant <span class= disease  id= 8541027-7-65-71 >asthma</span>, and high concentrations of beta 2-agonists may induce a secondary resistance by an interaction between the transcription factor CREB and the glucocorticoid receptor.	8541027	null	FosB proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	1996
FOSB	2354	AlteredExpression	BEFREE	Inflammation in <span class= disease  id= 16452600-2-16-22 >asthma</span> is characterised by the increased expression of multiple inflammatory genes regulated by pro-inflammatory transcription factors, such as nuclear factor-kappaB and <span class= gene  id= 16452600-2-186-205 >activator protein-1</span>, which bind to and activate coactivator molecules that acetylate core histones and switch on gene transcription.	16452600	null	FosB proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	2006
FOSB	2354	AlteredExpression	BEFREE	These mediators are downstream targets for the transcription factors <span class= gene  id= 11488985-3-69-88 >activator protein-1</span> (<span class= gene  id= 11488985-3-90-94 >AP-1</span>) and nuclear factor-kappaB (NF-kappaB), which control the expression of most immunomodulatory genes and whose activity and expression are elevated in <span class= disease  id= 11488985-3-245-251 >asthma</span>.	11488985	null	FosB proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	2001
JUN	3725	AlteredExpression	BEFREE	NF-kappaB and <span class= gene  id= 9701442-6-14-18 >AP-1</span>) results in the optimal expression of particular genes, resulting in the specific inflammatory pattern seen in <span class= disease  id= 9701442-6-130-139 >asthmatic</span> airways.	9701442	transcription factor; nucleic acid binding	Jun proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	1998
JUN	3725	AlteredExpression	BEFREE	Inflammation in <span class= disease  id= 16452600-2-16-22 >asthma</span> is characterised by the increased expression of multiple inflammatory genes regulated by pro-inflammatory transcription factors, such as nuclear factor-kappaB and <span class= gene  id= 16452600-2-186-205 >activator protein-1</span>, which bind to and activate coactivator molecules that acetylate core histones and switch on gene transcription.	16452600	transcription factor; nucleic acid binding	Jun proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	2006
JUN	3725	AlteredExpression	BEFREE	There may be an abnormal activation of <span class= gene  id= 8541027-7-39-43 >AP-1</span> in steroid-resistant <span class= disease  id= 8541027-7-65-71 >asthma</span>, and high concentrations of beta 2-agonists may induce a secondary resistance by an interaction between the transcription factor CREB and the glucocorticoid receptor.	8541027	transcription factor; nucleic acid binding	Jun proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	1996
JUN	3725	AlteredExpression	BEFREE	These mediators are downstream targets for the transcription factors <span class= gene  id= 11488985-3-69-88 >activator protein-1</span> (<span class= gene  id= 11488985-3-90-94 >AP-1</span>) and nuclear factor-kappaB (NF-kappaB), which control the expression of most immunomodulatory genes and whose activity and expression are elevated in <span class= disease  id= 11488985-3-245-251 >asthma</span>.	11488985	transcription factor; nucleic acid binding	Jun proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	2001
JUNB	3726	AlteredExpression	BEFREE	Inflammation in <span class= disease  id= 16452600-2-16-22 >asthma</span> is characterised by the increased expression of multiple inflammatory genes regulated by pro-inflammatory transcription factors, such as nuclear factor-kappaB and <span class= gene  id= 16452600-2-186-205 >activator protein-1</span>, which bind to and activate coactivator molecules that acetylate core histones and switch on gene transcription.	16452600	transcription factor; nucleic acid binding	JunB proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	2006
JUNB	3726	AlteredExpression	BEFREE	These mediators are downstream targets for the transcription factors <span class= gene  id= 11488985-3-69-88 >activator protein-1</span> (<span class= gene  id= 11488985-3-90-94 >AP-1</span>) and nuclear factor-kappaB (NF-kappaB), which control the expression of most immunomodulatory genes and whose activity and expression are elevated in <span class= disease  id= 11488985-3-245-251 >asthma</span>.	11488985	transcription factor; nucleic acid binding	JunB proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	2001
JUNB	3726	AlteredExpression	BEFREE	NF-kappaB and <span class= gene  id= 9701442-6-14-18 >AP-1</span>) results in the optimal expression of particular genes, resulting in the specific inflammatory pattern seen in <span class= disease  id= 9701442-6-130-139 >asthmatic</span> airways.	9701442	transcription factor; nucleic acid binding	JunB proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	1998
JUNB	3726	AlteredExpression	BEFREE	There may be an abnormal activation of <span class= gene  id= 8541027-7-39-43 >AP-1</span> in steroid-resistant <span class= disease  id= 8541027-7-65-71 >asthma</span>, and high concentrations of beta 2-agonists may induce a secondary resistance by an interaction between the transcription factor CREB and the glucocorticoid receptor.	8541027	transcription factor; nucleic acid binding	JunB proto-oncogene, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	1996
CD34	947	AlteredExpression	BEFREE	We conclude that there is increased expression of IL-5 on blood <span class= gene  id= 11724761-10-64-68 >CD34</span>(+) cells of patients with <span class= disease  id= 11724761-10-95-101 >asthma</span> and that this expression may auto-regulate eosinophilic colony formation from these progenitor cells.	11724761	null	CD34 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001648360705279	2002
EGF	1950	AlteredExpression	BEFREE	Amphiregulin and HB-<span class= gene  id= 22247333-4-20-23 >EGF</span> were expressed in airway epithelium of patients with <span class= disease  id= 22247333-4-77-83 >asthma</span>.	22247333	extracellular matrix protein; receptor	epidermal growth factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2012
IFNB1	3456	AlteredExpression	BEFREE	TLR3-induced TSLP, TNF&alpha;, CXCL8, and <span class= gene  id= 22543056-7-36-40 >IFN&beta;</span> mRNA and protein levels were dose-dependently and non-selectively inhibited by capsazepine, equally in cells from <span class= disease  id= 22543056-7-155-164 >asthmatic</span> and COPD donors.	22543056	signaling molecule	interferon beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2012
IFNB1	3456	AlteredExpression	BEFREE	Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus <span class= gene  id= 20627922-0-95-110 >interferon-beta</span> in bronchial epithelial cells from donors with <span class= disease  id= 20627922-0-158-164 >asthma</span>.	20627922	signaling molecule	interferon beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2010
IFNB1	3456	AlteredExpression	BEFREE	After IAV infection, viral levels were increased 2-fold in hBECs from <span class= disease  id= 25216987-5-70-79 >asthmatic</span> subjects compared with nonasthmatic control subjects (P &lt; .05) and this increase occurred in concert with increased IFN-?1 levels and <span class= negexp >no significant difference</span> in <span class= gene  id= 25216987-5-243-248 >IFNB1</span>, 2'-5'-oligoadenylate synthetase 1, or myxovirus (influenza virus) resistance 1mRNA levels.	25216987	signaling molecule	interferon beta 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2014
SLC52A1	55065	AlteredExpression	BEFREE	<span class= gene  id= 18077203-2-0-5 >PAR-2</span> expression is known to be upregulated in respiratory epithelium subsequent to inflammation in <span class= disease  id= 18077203-2-100-106 >asthma</span> and chronic obstructive pulmonary disease (COPD).	18077203	receptor	solute carrier family 52 member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2007
SLC52A1	55065	AlteredExpression	BEFREE	In conclusion, we have demonstrated that <span class= disease  id= 24551046-11-41-50 >asthmatic</span> BSM cells express increased baseline levels of functional <span class= gene  id= 24551046-11-109-114 >PAR-2</span>.	24551046	receptor	solute carrier family 52 member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2013
SLC52A1	55065	AlteredExpression	BEFREE	We determined the influence of chronic smoking and <span class= disease  id= 12589358-2-51-57 >asthma</span> on the expression of PAR-1 and <span class= gene  id= 12589358-2-89-94 >PAR-2</span> receptors on alveolar macrophages (AMs).	12589358	receptor	solute carrier family 52 member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2003
PLA2G10	8399	AlteredExpression	BEFREE	We have previously shown that in rats, <span class= gene  id= 24204651-2-39-44 >sPLA2</span> and cPLA2 play opposing roles in the pathophysiology of ovalbumin (OVA)-induced experimental allergic bronchitis (OVA-EAB), an <span class= disease  id= 24204651-2-172-178 >asthma</span> model: Upon disease induction <span class= gene  id= 24204651-2-209-214 >sPLA2</span> expression and production of the broncho-constricting CysLTs are elevated, whereas cPLA2 expression and the broncho-dilating PGE2 production are suppressed.	24204651	hydrolase	phospholipase A2 group X	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2013
PLA2G10	8399	AlteredExpression	BEFREE	This study found that TGM2, a mediator that is novel to <span class= disease  id= 20052409-10-56-62 >asthma</span> pathogenesis, is overexpressed in <span class= disease  id= 20052409-10-97-106 >asthmatic</span> airways and functions to increase <span class= gene  id= 20052409-10-141-150 >sPLA(2)-X</span> enzymatic activity.	20052409	hydrolase	phospholipase A2 group X	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2009
NR1I2	8856	AlteredExpression	BEFREE	We determined the influence of chronic smoking and <span class= disease  id= 12589358-2-51-57 >asthma</span> on the expression of <span class= gene  id= 12589358-2-79-84 >PAR-1</span> and <span class= gene  id= 12589358-2-89-94 >PAR-2</span> receptors on alveolar macrophages (AMs).	12589358	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 1 group I member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2003
NR1I2	8856	AlteredExpression	BEFREE	In conclusion, we have demonstrated that <span class= disease  id= 24551046-11-41-50 >asthmatic</span> BSM cells express increased baseline levels of functional <span class= gene  id= 24551046-11-109-114 >PAR-2</span>.	24551046	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 1 group I member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2013
NR1I2	8856	AlteredExpression	BEFREE	<span class= gene  id= 18077203-2-0-5 >PAR-2</span> expression is known to be upregulated in respiratory epithelium subsequent to inflammation in <span class= disease  id= 18077203-2-100-106 >asthma</span> and chronic obstructive pulmonary disease (COPD).	18077203	transcription factor; receptor; nucleic acid binding	nuclear receptor subfamily 1 group I member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001373633921066	2007
MAPK14	1432	AlteredExpression	BEFREE	ASMCs of patients with severe <span class= disease  id= 22947346-10-30-36 >asthma</span> are corticosteroid insensitive; this might be secondary to heightened <span class= gene  id= 22947346-10-107-143 >p38 mitogen-activated protein kinase</span> levels.	22947346	transferase; kinase	mitogen-activated protein kinase 14	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2012
ALRH	260328	AlteredExpression	BEFREE	<span class= gene  id= 21764573-10-0-17 >Allergic rhinitis</span>, chronic rhinitis and chronic rhinosinusitis were associated with different risk factor patterns and symptom expression of <span class= disease  id= 21764573-10-141-147 >asthma</span>.	21764573	null	Allergic rhinitis	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2011
IFNL1	282618	AlteredExpression	BEFREE	Finally, both IL-28 and <span class= gene  id= 18564328-9-24-29 >IL-29</span> mRNA levels are higher in <span class= disease  id= 18564328-9-56-65 >asthmatic</span> children than in <span class= disease  id= 18564328-9-83-92 >asthmatic</span> adults.	18564328	null	interferon lambda 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2009
IFNL1	282618	AlteredExpression	BEFREE	After IAV infection, viral levels were increased 2-fold in hBECs from <span class= disease  id= 25216987-5-70-79 >asthmatic</span> subjects compared with nonasthmatic control subjects (P &lt; .05) and this increase occurred in concert with increased <span class= gene  id= 25216987-5-196-202 >IFN-?1</span> levels and <span class= negexp >no significant difference</span> in IFNB1, 2'-5'-oligoadenylate synthetase 1, or myxovirus (influenza virus) resistance 1mRNA levels.	25216987	null	interferon lambda 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2014
ISYNA1	51477	AlteredExpression	BEFREE	BNP stimulated the release of acetylcholine (210.7 &plusmn; 11.1%) from BEAS-2B cells that in turn increased MYPT1 and <span class= gene  id= 24074453-10-112-116 >iNOS</span> gene/protein expression and enhanced NO levels in <span class= disease  id= 24074453-10-167-176 >asthmatic</span> ASM supernatant (35.0 &plusmn; 13.0%).	24074453	null	inositol-3-phosphate synthase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2014
IL23A	51561	AlteredExpression	BEFREE	IL-6, IL-1&beta;, TGF-&beta; and <span class= gene  id= 24349168-14-23-28 >IL-23</span> were significantly elevated in fibroblasts from <span class= disease  id= 24349168-14-77-86 >asthmatic</span> subjects upon co-culture with CD4(+)T cells.	24349168	signaling molecule	interleukin 23 subunit alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2013
IL23A	51561	AlteredExpression	BEFREE	In this study, we show that in an allergen-induced <span class= disease  id= 19935773-3-51-57 >asthma</span> model, mice with transgenic overexpression of IL-23R exhibited increased airway infiltration of eosinophils and Th2 cytokine production, whereas those deficient in <span class= gene  id= 19935773-3-222-227 >IL-23</span> displayed reduced airway inflammation.	19935773	signaling molecule	interleukin 23 subunit alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2010
PLA2G2A	5320	AlteredExpression	BEFREE	We have previously shown that in rats, <span class= gene  id= 24204651-2-39-44 >sPLA2</span> and cPLA2 play opposing roles in the pathophysiology of ovalbumin (OVA)-induced experimental allergic bronchitis (OVA-EAB), an <span class= disease  id= 24204651-2-172-178 >asthma</span> model: Upon disease induction <span class= gene  id= 24204651-2-209-214 >sPLA2</span> expression and production of the broncho-constricting CysLTs are elevated, whereas cPLA2 expression and the broncho-dilating PGE2 production are suppressed.	24204651	hydrolase	phospholipase A2 group IIA	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2013
ACTB	60	AlteredExpression	BEFREE	The median (IQR) T-bet expression after normalization with <span class= gene  id= 17302903-7-59-69 >beta-actin</span> was suppressed in <span class= disease  id= 17302903-7-88-98 >asthmatics</span> versus controls [<span class= disease  id= 17302903-7-116-126 >asthmatics</span> 0 x 71 (0 x 59) versus controls 1 x 07 (1 x 14), P=0 x 03].The median (IQR) of plasma RANTES was elevated, whereas IP-10 was suppressed in <span class= disease  id= 17302903-7-266-276 >asthmatics</span> versus controls (RANTES: 13658 x 0 (13673 x 3) versus 6299 x 5 (19407 x 8) pg/ml, P=0 x 03; IP-10: 1047 x 6 (589 x 8) versus 1306 x 4 (759 x 9) pg/ml, P=0 x 001).	17302903	cytoskeletal protein	actin beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2007
ACTB	60	AlteredExpression	BEFREE	The SCF/<span class= gene  id= 15813808-7-8-18 >beta-actin</span> mRNA ratios were significantly higher in ASA-hypersensitive (AH) <span class= disease  id= 15813808-7-84-94 >asthmatics</span> (median 0.97, range: 0.8-1.5) when compared with ASA-tolerant (AT) patients (median 0.5, range: 0.1-0.7; P &lt; 0.001).	15813808	cytoskeletal protein	actin beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2005
ACTB	60	AlteredExpression	BEFREE	<span class= gene  id= 12200519-0-0-10 >beta-Actin</span> and GAPDH housekeeping gene expression in <span class= disease  id= 12200519-0-53-62 >asthmatic</span> airways is variable and not suitable for normalising mRNA levels.	12200519	cytoskeletal protein	actin beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2002
SPP1	6696	AlteredExpression	BEFREE	There was a further significant increase of <span class= gene  id= 19076536-7-44-47 >OPN</span> expression in patients with nasal polyps (NPs) and <span class= disease  id= 19076536-7-99-105 >asthma</span>.	19076536	null	secreted phosphoprotein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2009
POTEF	728378	AlteredExpression	BEFREE	The SCF/<span class= gene  id= 15813808-7-8-18 >beta-actin</span> mRNA ratios were significantly higher in ASA-hypersensitive (AH) <span class= disease  id= 15813808-7-84-94 >asthmatics</span> (median 0.97, range: 0.8-1.5) when compared with ASA-tolerant (AT) patients (median 0.5, range: 0.1-0.7; P &lt; 0.001).	15813808	null	POTE ankyrin domain family member F	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2005
POTEF	728378	AlteredExpression	BEFREE	<span class= gene  id= 12200519-0-0-10 >beta-Actin</span> and GAPDH housekeeping gene expression in <span class= disease  id= 12200519-0-53-62 >asthmatic</span> airways is variable and not suitable for normalising mRNA levels.	12200519	null	POTE ankyrin domain family member F	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2002
POTEF	728378	AlteredExpression	BEFREE	The median (IQR) T-bet expression after normalization with <span class= gene  id= 17302903-7-59-69 >beta-actin</span> was suppressed in <span class= disease  id= 17302903-7-88-98 >asthmatics</span> versus controls [<span class= disease  id= 17302903-7-116-126 >asthmatics</span> 0 x 71 (0 x 59) versus controls 1 x 07 (1 x 14), P=0 x 03].The median (IQR) of plasma RANTES was elevated, whereas IP-10 was suppressed in <span class= disease  id= 17302903-7-266-276 >asthmatics</span> versus controls (RANTES: 13658 x 0 (13673 x 3) versus 6299 x 5 (19407 x 8) pg/ml, P=0 x 03; IP-10: 1047 x 6 (589 x 8) versus 1306 x 4 (759 x 9) pg/ml, P=0 x 001).	17302903	null	POTE ankyrin domain family member F	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2007
CD38	952	AlteredExpression	BEFREE	Differential induction of <span class= gene  id= 20693316-0-26-30 >CD38</span> expression by TNF-{alpha} in <span class= disease  id= 20693316-0-60-69 >asthmatic</span> airway smooth muscle cells.	20693316	lyase; hydrolase	CD38 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2011
CD38	952	AlteredExpression	BEFREE	In HASM cells, regulation of <span class= gene  id= 22556157-13-29-33 >CD38</span> expression occurs by specific class I PI3K isoforms, independent of NF-&kappa;B or AP-1 activation, and PI3K signaling may <span class= negexp >not be involved</span> in the differential elevation of <span class= gene  id= 22556157-13-200-204 >CD38</span> in <span class= disease  id= 22556157-13-208-217 >asthmatic</span> HASM cells.	22556157	lyase; hydrolase	CD38 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.001098907136852	2012
CEL	1056	AlteredExpression	BEFREE	Cyclosporin A, apoptosis of <span class= gene  id= 12952249-0-28-31 >BAL</span> T-cells and expression of Bcl-2 in <span class= disease  id= 12952249-0-67-77 >asthmatics</span>.	12952249	hydrolase	carboxyl ester lipase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2004
CEL	1056	AlteredExpression	BEFREE	Activation of peripheral blood CD4 but not CD8 T-LC and a Th2-type pattern of elevated cytokine mRNA expression in <span class= gene  id= 7742019-2-115-118 >BAL</span> fluid T-LC have been observed in <span class= disease  id= 7742019-2-152-162 >asthmatics</span>, but the principal source (CD4 or CD8 T-LC) of these cytokines is unknown.	7742019	hydrolase	carboxyl ester lipase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	1995
SLC27A5	10998	AlteredExpression	BEFREE	Activation of peripheral blood CD4 but not CD8 T-LC and a Th2-type pattern of elevated cytokine mRNA expression in <span class= gene  id= 7742019-2-115-118 >BAL</span> fluid T-LC have been observed in <span class= disease  id= 7742019-2-152-162 >asthmatics</span>, but the principal source (CD4 or CD8 T-LC) of these cytokines is unknown.	7742019	ligase	solute carrier family 27 member 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	1995
SLC27A5	10998	AlteredExpression	BEFREE	Cyclosporin A, apoptosis of <span class= gene  id= 12952249-0-28-31 >BAL</span> T-cells and expression of Bcl-2 in <span class= disease  id= 12952249-0-67-77 >asthmatics</span>.	12952249	ligase	solute carrier family 27 member 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2004
CCR4	1233	AlteredExpression	BEFREE	Activation of <span class= gene  id= 20099827-2-14-18 >CCR4</span> by CKLF1 plays an important role in diseases such as <span class= disease  id= 20099827-2-72-78 >asthma</span> and multiple sclerosis.	20099827	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-C motif chemokine receptor 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2010
CPA3	1359	AlteredExpression	BEFREE	IEMC density was 2-fold higher than normal in subjects with T(H)2-high <span class= disease  id= 20451039-8-71-77 >asthma</span> compared with that seen in subjects with T(H)2-low <span class= disease  id= 20451039-8-129-135 >asthma</span> or healthy control subjects (P = .015 for both comparisons), and these cells were characterized by expression of tryptases and <span class= gene  id= 20451039-8-263-267 >CPA3</span> but not chymase.	20451039	protease; hydrolase	carboxypeptidase A3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2010
CPA3	1359	AlteredExpression	BEFREE	Genes related to epithelial repair and mast cell infiltration including beta-tryptase and <span class= gene  id= 20052409-6-90-109 >carboxypeptidase A3</span> were upregulated by exercise challenge in the <span class= disease  id= 20052409-6-156-162 >asthma</span> group with EIB.	20052409	protease; hydrolase	carboxypeptidase A3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2009
DECR1	1666	AlteredExpression	BEFREE	Changes in <span class= gene  id= 22982469-0-11-16 >NADPH</span> oxidase mRNA level can be detected in blood at inhaled corticosteroid treated <span class= disease  id= 22982469-0-95-104 >asthmatic</span> children.	22982469	oxidoreductase	2,4-dienoyl-CoA reductase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2012
DECR1	1666	AlteredExpression	BEFREE	Mice lacking functional <span class= gene  id= 23884469-5-24-29 >NADPH</span> oxidases due to knockout of p47 and mice with epithelial-targeted transgenic expression of a CaMKII inhibitory peptide or wild-type mice treated with inhaled KN-93, an experimental small-molecule CaMKII antagonist, were protected against increases in ICl, MUC5AC expression, and <span class= disease  id= 23884469-5-309-331 >airway hyperreactivity</span> to inhaled methacholine.	23884469	oxidoreductase	2,4-dienoyl-CoA reductase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2014
ABCA1	19	AlteredExpression	BEFREE	<span class= gene  id= 9105087-0-0-14 >Membrane-bound</span> and soluble alpha IL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic <span class= disease  id= 9105087-0-100-110 >asthmatics</span>.	9105087	transporter	ATP binding cassette subfamily A member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	1997
ABCA1	19	AlteredExpression	BEFREE	These findings suggest that <span class= gene  id= 24813055-8-28-33 >ABCA1</span> expressed by vascular endothelial cells and alveolar macrophages may play important roles in attenuating the severity of neutrophilic airway inflammation in <span class= disease  id= 24813055-8-191-197 >asthma</span>.	24813055	transporter	ATP binding cassette subfamily A member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2015
FCGR3B	2215	AlteredExpression	BEFREE	Finally we showed that human CD14(+)<span class= gene  id= 24358127-9-36-40 >CD16</span>(+) intermediate monocytes, which are found in increased numbers in patients with allergies and <span class= disease  id= 24358127-9-136-152 >bronchial asthma</span>, expressed high levels of miR-124 and exhibited other properties of M2-like cells.	24358127	cell adhesion molecule	Fc fragment of IgG receptor IIIb	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2013
AKR1B1	231	AlteredExpression	BEFREE	<span class= gene  id= 19752229-0-0-16 >Aldose reductase</span> inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced <span class= disease  id= 19752229-0-116-122 >asthma</span> in mice.	19752229	oxidoreductase	aldo-keto reductase family 1 member B	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2009
GAPDH	2597	AlteredExpression	BEFREE	The expression levels of the beta-actin and <span class= gene  id= 18417509-7-44-84 >glyceraldehyde-3-phosphate dehydrogenase</span> genes were significantly different between the three groups of patients, with atopic <span class= disease  id= 18417509-7-170-180 >asthmatics</span> showing the highest expression levels for both genes.	18417509	oxidoreductase	glyceraldehyde-3-phosphate dehydrogenase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2009
GAPDH	2597	AlteredExpression	BEFREE	beta-Actin and <span class= gene  id= 12200519-0-15-20 >GAPDH</span> housekeeping gene expression in <span class= disease  id= 12200519-0-53-62 >asthmatic</span> airways is variable and not suitable for normalising mRNA levels.	12200519	oxidoreductase	glyceraldehyde-3-phosphate dehydrogenase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2002
GAPDH	2597	AlteredExpression	BEFREE	Using quantitative polymerase chain reaction analysis, we determined the messenger RNA (mRNA) expression of eotaxin, eotaxin-2, and eotaxin-3 relative to <span class= gene  id= 11415932-3-154-159 >GAPDH</span> mRNA expression in bronchial biopsies and bronchoalveolar lavage fluid (BALF) cells obtained from subjects with mild <span class= disease  id= 11415932-3-277-283 >asthma</span>, asthmatic subjects 24 h after allergen challenge, and normal control subjects.	11415932	oxidoreductase	glyceraldehyde-3-phosphate dehydrogenase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2001
TIPARP	25976	AlteredExpression	BEFREE	<span class= gene  id= 21276008-0-0-6 >PARP-1</span> deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine <span class= disease  id= 21276008-0-101-107 >asthma</span> model.	21276008	nucleic acid binding	TCDD inducible poly(ADP-ribose) polymerase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2011
TIPARP	25976	AlteredExpression	BEFREE	In the present study, we provide evidence for the first time that <span class= gene  id= 26205779-10-66-72 >PARP-1</span> is activated in human <span class= disease  id= 26205779-10-95-101 >asthma</span> and that its inhibition is effective in blocking established <span class= disease  id= 26205779-10-163-169 >asthma</span> in mice.	26205779	nucleic acid binding	TCDD inducible poly(ADP-ribose) polymerase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2015
HSPA4	3308	AlteredExpression	BEFREE	In addition, increased circulating <span class= gene  id= 19821156-15-35-40 >Hsp70</span> levels observed in <span class= disease  id= 19821156-15-60-69 >asthmatic</span> pregnant patients might play a connecting role in the pathomechanism of <span class= disease  id= 19821156-15-142-151 >asthmatic</span> inflammation and obstetrical/perinatal complications.	19821156	null	heat shock protein family A (Hsp70) member 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2009
HSPA4	3308	AlteredExpression	BEFREE	Expression of <span class= gene  id= 11022984-8-14-19 >HSP70</span> gene in PBMC of <span class= disease  id= 11022984-8-36-45 >asthmatic</span> and chronic bronchitis patients was different, indicating that HSP, especially <span class= gene  id= 11022984-8-125-130 >HSP70</span>, might be involved in the pathogenesis of <span class= disease  id= 11022984-8-173-179 >asthma</span>.	11022984	null	heat shock protein family A (Hsp70) member 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2001
FAS	355	AlteredExpression	BEFREE	<span class= gene  id= 11207646-8-0-3 >FAS</span> and FASL were not differentially expressed, but FAST kinase was over-expressed in AN and <span class= disease  id= 11207646-8-93-95 >AA</span>.	11207646	receptor	Fas cell surface death receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2001
FAS	355	AlteredExpression	BEFREE	It has been suggested that expression of the <span class= gene  id= 9761749-3-45-48 >Fas</span> receptor and its ligand (FasL) in airway epithelium may modulate the inflammatory response commonly found in <span class= disease  id= 9761749-3-158-167 >asthmatic</span> lungs.	9761749	receptor	Fas cell surface death receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	1998
LGALS9	3965	AlteredExpression	BEFREE	Reduced expression of galectin-1 and <span class= gene  id= 23121677-0-37-47 >galectin-9</span> by leucocytes in <span class= disease  id= 23121677-0-65-71 >asthma</span> patients.	23121677	cell adhesion molecule; signaling molecule	galectin 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2013
MIR155	406947	AlteredExpression	BEFREE	Cyclooxygenase-2 and <span class= gene  id= 25180620-0-21-33 >microRNA-155</span> expression are elevated in <span class= disease  id= 25180620-0-61-70 >asthmatic</span> airway smooth muscle cells.	25180620	null	microRNA 155	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2016
KITLG	4254	AlteredExpression	BEFREE	In asthmatic patients treated with glucocorticoids, a significant decrease of SCF mRNA, protein levels and mast cell numbers was observed as compared with untreated <span class= disease  id= 16499642-9-165-174 >asthmatic</span> patients (1.1 pg/microg mRNA; 62.0+/-10.3 pg/mL <span class= gene  id= 16499642-9-223-226 >SCF</span> protein and 39+/-13 mast cells/mm(2); P&lt;0.05), reaching levels comparable to those of the control group.	16499642	cell adhesion molecule; signaling molecule	KIT ligand	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2006
COX1	4512	AlteredExpression	BEFREE	Our aim was to investigate the expression of <span class= gene  id= 17622692-3-45-50 >COX-1</span> and COX-2 mRNA in primary human bronchial epithelial cells (HBEC) isolated from <span class= disease  id= 17622692-3-131-141 >asthmatics</span> and non-<span class= disease  id= 17622692-3-150-160 >asthmatics</span>.	17622692	oxidoreductase	cytochrome c oxidase subunit I	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2007
COX1	4512	AlteredExpression	BEFREE	<span class= gene  id= 18753249-0-0-5 >COX-1</span>, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive <span class= disease  id= 18753249-0-89-95 >asthma</span>.	18753249	oxidoreductase	cytochrome c oxidase subunit I	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2008
COX1	4512	AlteredExpression	BEFREE	The immunosuppressive activity of PMN-MDSCs was diminished in both allergen-challenged <span class= gene  id= 24948368-11-87-92 >COX-1</span> KO mice and patients with AIA, probably through an EP4-mediated signaling pathway, indicating that activation of PMN-MDSCs might be a promising therapeutic strategy for <span class= disease  id= 24948368-11-262-268 >asthma</span>, particularly AIA.	24948368	oxidoreductase	cytochrome c oxidase subunit I	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2014
CPA4	51200	AlteredExpression	BEFREE	Genes related to epithelial repair and mast cell infiltration including beta-tryptase and <span class= gene  id= 20052409-6-90-109 >carboxypeptidase A3</span> were upregulated by exercise challenge in the <span class= disease  id= 20052409-6-156-162 >asthma</span> group with EIB.	20052409	protease; hydrolase	carboxypeptidase A4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2009
CPA4	51200	AlteredExpression	BEFREE	Previously, we found that mast cell tryptases and <span class= gene  id= 20451039-1-50-69 >carboxypeptidase A3</span> (CPA3) are differentially expressed in the airway epithelium in <span class= disease  id= 20451039-1-134-143 >asthmatic</span> subjects.	20451039	protease; hydrolase	carboxypeptidase A4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2010
PLG	5340	AlteredExpression	BEFREE	These results show that enhancing uPA/<span class= gene  id= 19098125-9-38-45 >plasmin</span> activity lessens the airway remodeling in a murine <span class= disease  id= 19098125-9-97-103 >asthma</span> model.	19098125	protease; hydrolase	plasminogen	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2009
PPARA	5465	AlteredExpression	BEFREE	<span class= gene  id= 16312170-4-0-4 >PPAR</span>-y gene expression was evaluated at baseline and 24 hours later in <span class= disease  id= 16312170-4-71-80 >asthmatic</span> patients and controls using real-time polymerase chain reaction.	16312170	transcription factor; receptor; nucleic acid binding	peroxisome proliferator activated receptor alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2005
ANO1	55107	AlteredExpression	BEFREE	Increased expression of the human <span class= gene  id= 11956057-0-34-60 >Ca2+-activated Cl- channel</span> 1 (CaCC1) gene in the <span class= disease  id= 11956057-0-83-92 >asthmatic</span> airway.	11956057	null	anoctamin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2002
ANO1	55107	AlteredExpression	BEFREE	A <span class= gene  id= 11842292-0-2-36 >calcium-activated chloride channel</span> (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with <span class= disease  id= 11842292-0-147-153 >asthma</span>.	11842292	null	anoctamin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2002
LTB4R2	56413	AlteredExpression	BEFREE	These findings indicate that <span class= gene  id= 23603839-10-29-33 >BLT2</span> has a protective role in allergic airway inflammation and that diminished <span class= gene  id= 23603839-10-108-112 >BLT2</span> expression in CD4(+) T cells may contribute to the pathophysiology of <span class= disease  id= 23603839-10-183-189 >asthma</span>.	23603839	receptor	leukotriene B4 receptor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2013
S100A8	6279	AlteredExpression	BEFREE	The concentrations of <span class= gene  id= 25973752-11-22-28 >S100A8</span> and S100A9 were significantly elevated in <span class= disease  id= 25973752-11-71-80 >asthmatic</span> bronchoalveolar lavage fluid (BALF) when compared to normal BALF (p&lt;0.01), but not in serum.	25973752	signaling molecule; calcium-binding protein	S100 calcium binding protein A8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2015
S100A8	6279	AlteredExpression	BEFREE	Quantitative real-time RT-PCR confirmed that the genes related (<span class= gene  id= 19187333-11-64-70 >S100A8</span> and GAS6) and unrelated to infections (CD200 and RBP7) were differentially expressed during <span class= disease  id= 19187333-11-163-169 >asthma</span> exacerbation (P&lt;0.01).	19187333	signaling molecule; calcium-binding protein	S100 calcium binding protein A8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2009
IFIH1	64135	AlteredExpression	BEFREE	Expression of Toll-like receptor (TLR) 3, TLR7, TLR8, retinoic acid-inducible gene I (RIG-I), <span class= gene  id= 22657407-7-94-136 >melanoma differentiation-associated gene 5</span> (<span class= gene  id= 22657407-7-138-143 >MDA-5</span>), TIR domain-containing adapter-inducing IFN-&beta; (TRIF), myeloid differentiation primary response gene 88 (MyD88), caspase recruitment domain adaptor inducing IFN-&beta; (CARDIF), IL-1 receptor-associated kinase 4 (IRAK4), I&kappa;B kinase &beta; (IKKB), I&kappa;B kinase &iota; (IKKI), interferon regulatory factors 3 and 7, and rhinovirus induction of expression of the virus-inducible molecules TLR3, TLR7, RIG-I, and MDA-5 were not impaired in these interferon-deficient BAL cells in <span class= disease  id= 22657407-7-603-612 >asthmatic</span> patients.	22657407	null	interferon induced with helicase C domain 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2012
IFIH1	64135	AlteredExpression	BEFREE	Furthermore, uninfected cells from severe therapy resistant <span class= disease  id= 23212197-5-60-69 >asthmatic</span> children showed lower levels of Toll-like receptor-3 mRNA and reduced retinoic acid inducible gene and <span class= gene  id= 23212197-5-173-215 >melanoma differentiation-associated gene 5</span> mRNA after RV stimulation.	23212197	null	interferon induced with helicase C domain 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2014
IFIH1	64135	AlteredExpression	BEFREE	Impaired antiviral responses in <span class= disease  id= 24131248-10-32-41 >asthmatic</span> pBECs are not due to deficient expression of PRRs; <span class= gene  id= 24131248-10-93-97 >MDA5</span> and TLR3, but an inability to later activate types I and III interferon immune responses to RV infection, potentially increasing susceptibility to the effects of RV infection.	24131248	null	interferon induced with helicase C domain 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2013
YY1	7528	AlteredExpression	BEFREE	We also studied ovalbumin-driven allergic immune responses in a mouse model of <span class= disease  id= 18423564-5-79-85 >asthma</span> and <span class= gene  id= 18423564-5-90-94 >YY-1</span> expression in lung tissue from human <span class= disease  id= 18423564-5-132-141 >asthmatic</span> subjects.	18423564	transcription factor	YY1 transcription factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2008
PARP9	83666	AlteredExpression	BEFREE	Cyclosporin A, apoptosis of <span class= gene  id= 12952249-0-28-31 >BAL</span> T-cells and expression of Bcl-2 in <span class= disease  id= 12952249-0-67-77 >asthmatics</span>.	12952249	nucleic acid binding	poly(ADP-ribose) polymerase family member 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2004
PARP9	83666	AlteredExpression	BEFREE	Activation of peripheral blood CD4 but not CD8 T-LC and a Th2-type pattern of elevated cytokine mRNA expression in <span class= gene  id= 7742019-2-115-118 >BAL</span> fluid T-LC have been observed in <span class= disease  id= 7742019-2-152-162 >asthmatics</span>, but the principal source (CD4 or CD8 T-LC) of these cytokines is unknown.	7742019	nucleic acid binding	poly(ADP-ribose) polymerase family member 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	1995
TP63	8626	AlteredExpression	BEFREE	The epithelium of <span class= disease  id= 26315281-1-18-28 >asthmatics</span> is characterized by reduced expression of E-cadherin and increased expression of the basal cell markers ck-5 and <span class= gene  id= 26315281-1-142-145 >p63</span> that is indicative of a relatively undifferentiated repairing epithelium.	26315281	transcription factor	tumor protein p63	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2015
TP63	8626	AlteredExpression	BEFREE	We previously reported increased numbers of basal cells expressing the transcription factor <span class= gene  id= 23837456-3-92-95 >p63</span> in the airway epithelium of patients with <span class= disease  id= 23837456-3-138-144 >asthma</span>.	23837456	transcription factor	tumor protein p63	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2014
TP63	8626	AlteredExpression	BEFREE	The IL12B gene encodes the <span class= gene  id= 15007350-1-27-30 >p40</span> chain of IL-12, a proinflammatory cytokine that antagonizes TH2 expression and hence may play a critical role in the pathogenesis of airway inflammation observed in <span class= disease  id= 15007350-1-196-202 >asthma</span>.	15007350	transcription factor	tumor protein p63	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2004
ATG5	9474	AlteredExpression	BEFREE	Furthermore, <span class= gene  id= 22536318-10-13-17 >Atg5</span> expression was increased in nasal epithelium of acute <span class= disease  id= 22536318-10-72-82 >asthmatics</span> compared to stable asthmatics and non-<span class= disease  id= 22536318-10-121-130 >asthmatic</span> controls.	22536318	membrane traffic protein	autophagy related 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2012
CD44	960	AlteredExpression	BEFREE	Furthermore, drug treatment stimulated the expression of <span class= gene  id= 22865625-11-57-61 >CD44</span> receptors in <span class= disease  id= 22865625-11-75-84 >asthmatic</span> ASMCs.	22865625	null	CD44 molecule (Indian blood group)	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000824180352639	2013
RAMP1	10267	AlteredExpression	BEFREE	Expression of functional <span class= gene  id= 20933260-0-25-62 >receptor activity modifying protein 1</span> by airway epithelial cells with dysregulation in <span class= disease  id= 20933260-0-112-118 >asthma</span>.	20933260	receptor	receptor activity modifying protein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2010
CDKN1C	1028	AlteredExpression	BEFREE	Immunostaining usually occurred in the cytoplasm of columnar cells; however, in severe asthma, nuclear staining was also evident in the proliferative, basal cell compartment. p21(waf) expression was significantly higher in <span class= disease  id= 12495933-3-223-232 >asthmatic</span> versus nonasthmatic epithelium and was unaffected by corticosteroid treatment; proliferating cell nuclear antigen was not significantly different in any group. p21(waf), but not p27(kip1), mRNA and protein were induced by treatment of bronchial epithelial cells in vitro with transforming growth factor (TGF)-beta or H2O2, but not by dexamethasone, which induced p57(<span class= gene  id= 12495933-3-600-604 >kip2</span>).	12495933	enzyme modulator	cyclin dependent kinase inhibitor 1C	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2003
CIB2	10518	AlteredExpression	BEFREE	Immunostaining usually occurred in the cytoplasm of columnar cells; however, in severe asthma, nuclear staining was also evident in the proliferative, basal cell compartment. p21(waf) expression was significantly higher in <span class= disease  id= 12495933-3-223-232 >asthmatic</span> versus nonasthmatic epithelium and was unaffected by corticosteroid treatment; proliferating cell nuclear antigen was not significantly different in any group. p21(waf), but not p27(kip1), mRNA and protein were induced by treatment of bronchial epithelial cells in vitro with transforming growth factor (TGF)-beta or H2O2, but not by dexamethasone, which induced p57(<span class= gene  id= 12495933-3-600-604 >kip2</span>).	12495933	calcium-binding protein; phosphatase; hydrolase	calcium and integrin binding family member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2003
KAT5	10524	AlteredExpression	BEFREE	We have previously shown that in rats, sPLA2 and <span class= gene  id= 24204651-2-49-54 >cPLA2</span> play opposing roles in the pathophysiology of ovalbumin (OVA)-induced experimental allergic bronchitis (OVA-EAB), an <span class= disease  id= 24204651-2-172-178 >asthma</span> model: Upon disease induction sPLA2 expression and production of the broncho-constricting CysLTs are elevated, whereas <span class= gene  id= 24204651-2-298-303 >cPLA2</span> expression and the broncho-dilating PGE2 production are suppressed.	24204651	transcription factor; transferase; nucleic acid binding	lysine acetyltransferase 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2013
AGR2	10551	AlteredExpression	BEFREE	The pro-oncogenic protein anterior gradient 2 (<span class= gene  id= 22945652-3-47-51 >AGR2</span>) is a case in point; <span class= gene  id= 22945652-3-73-77 >AGR2</span> has been shown using a range of expression platforms to be involved in <span class= disease  id= 22945652-3-149-155 >asthma</span>, inflammatory bowel disease, cell transformation, cancer drug resistance and metastatic growth.	22945652	oxidoreductase; surfactant	anterior gradient 2, protein disulphide isomerase family member	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2013
CKAP4	10970	AlteredExpression	BEFREE	We previously reported increased numbers of basal cells expressing the transcription factor <span class= gene  id= 23837456-3-92-95 >p63</span> in the airway epithelium of patients with <span class= disease  id= 23837456-3-138-144 >asthma</span>.	23837456	nucleic acid binding; hydrolase	cytoskeleton associated protein 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2014
CKAP4	10970	AlteredExpression	BEFREE	The epithelium of <span class= disease  id= 26315281-1-18-28 >asthmatics</span> is characterized by reduced expression of E-cadherin and increased expression of the basal cell markers ck-5 and <span class= gene  id= 26315281-1-142-145 >p63</span> that is indicative of a relatively undifferentiated repairing epithelium.	26315281	nucleic acid binding; hydrolase	cytoskeleton associated protein 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2015
TMED1	11018	AlteredExpression	BEFREE	<span class= gene  id= 25091434-8-0-4 >ST2L</span> expression was increased in severe <span class= disease  id= 25091434-8-40-46 >asthma</span> (P = .02) and associated with multiple indicators of TH2-like inflammation, including blood eosinophils (P = .001), exhaled nitric oxide (P = .003), and epithelial CLCA1 (P &lt; .0001) and eotaxin-3 (P = .001) mRNA expression.	25091434	transfer/carrier protein; membrane traffic protein	transmembrane p24 trafficking protein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2014
CCR8	1237	AlteredExpression	BEFREE	<span class= gene  id= 17641040-2-0-4 >CCR8</span>, the receptor for CCL1, is expressed by approximately 70% of CD4(+) T lymphocytes recruited to the <span class= disease  id= 17641040-2-104-113 >asthmatic</span> airways, and the number of <span class= gene  id= 17641040-2-141-145 >CCR8</span>-expressing cells is increased 3-fold in the airways of <span class= disease  id= 17641040-2-201-210 >asthmatic</span> subjects compared with normal volunteers.	17641040	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-C motif chemokine receptor 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2007
CREBBP	1387	AlteredExpression	BEFREE	In contrast, although there was no change in the site of HAT (<span class= gene  id= 12153977-7-62-82 >CREB binding protein</span> and p300/<span class= gene  id= 12153977-7-92-112 >CREB binding protein</span>-associated factor) expression, HAT activity was increased in subjects with <span class= disease  id= 12153977-7-188-194 >asthma</span>.	12153977	transcription factor; transferase; nucleic acid binding	CREB binding protein	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2002
CREBBP	1387	AlteredExpression	BEFREE	To evaluate the expression of <span class= gene  id= 17573727-3-30-33 >CBP</span> and of phospho-CREB (p-CREB) in bronchial biopsies and in peripheral blood mononuclear cells (PBMC) of controls (C), untreated (UA), inhaled steroid treated (ICS) and steroid-dependent asthmatic (<span class= disease  id= 17573727-3-230-233 >SDA</span>) patients.	17573727	transcription factor; transferase; nucleic acid binding	CREB binding protein	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2007
CTSG	1511	AlteredExpression	BEFREE	Systemic expression of DEFA1,1B,3,4,<span class= gene  id= 21785157-7-36-40 >CTSG</span> and ELA2 was significantly higher in the neutrophilic asthma (<span class= disease  id= 21785157-7-103-105 >NA</span>) phenotype.	21785157	protease; hydrolase	cathepsin G	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2011
TSC22D3	1831	AlteredExpression	BEFREE	Immunostaining of bronchial biopsies revealed <span class= gene  id= 21827450-8-46-50 >GILZ</span> expression in the airways epithelium and smooth muscle of <span class= disease  id= 21827450-8-109-118 >asthmatic</span> subjects.	21827450	transcription factor	TSC22 domain family member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2012
TSC22D3	1831	AlteredExpression	BEFREE	Dexamethasone's trans-activation of <span class= gene  id= 23160983-9-36-40 >GILZ</span> and trans-repression of NF-kB-driven IL-6 expression were both inhibited by IL2?+?4; IL17?+?IL23 antagonized Dex trans-repression in PBMC from <span class= disease  id= 23160983-9-184-194 >asthmatics</span>.	23160983	transcription factor	TSC22 domain family member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2012
F2R	2149	AlteredExpression	BEFREE	We determined the influence of chronic smoking and <span class= disease  id= 12589358-2-51-57 >asthma</span> on the expression of <span class= gene  id= 12589358-2-79-84 >PAR-1</span> and PAR-2 receptors on alveolar macrophages (AMs).	12589358	null	coagulation factor II thrombin receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2003
GATA1	2623	AlteredExpression	BEFREE	Finally, although no consistent expression changes were observed across all subjects in response to house dust mite antigen stimulation, we observed subtle differences in gene expression (e.g., <span class= gene  id= 22246175-7-194-199 >GATA1</span> and GATA2) in BAL cells related to the <span class= disease  id= 22246175-7-239-245 >asthma</span> and atopy phenotype.	22246175	transcription factor; nucleic acid binding	GATA binding protein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2012
GATA2	2624	AlteredExpression	BEFREE	Four polymorphisms SCCA1 promoter that were in linkage disequilibrium were associated with skin test positivity in <span class= disease  id= 23199842-10-115-124 >asthmatic</span> children and showed higher promoter activity and higher binding of <span class= gene  id= 23199842-10-192-198 >GATA-2</span> and GATA-3 after IL-4 + IL-13 stimulation.	23199842	transcription factor; nucleic acid binding	GATA binding protein 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2012
IL37	27178	AlteredExpression	BEFREE	Anti-inflammatory activity of <span class= gene  id= 26454413-0-30-35 >IL-37</span> in <span class= disease  id= 26454413-0-39-48 >asthmatic</span> children: Correlation with inflammatory cytokines TNF-&alpha;, IL-&beta;, IL-6 and IL-17A.	26454413	signaling molecule	interleukin 37	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2015
IL37	27178	AlteredExpression	BEFREE	This study demonstrates that <span class= gene  id= 25557042-10-29-34 >IL-37</span> is able to ablate a TH2 cell-directed allergic inflammatory response and the hallmarks of experimental <span class= disease  id= 25557042-10-138-144 >asthma</span> in mice, suggesting that <span class= gene  id= 25557042-10-170-175 >IL-37</span> may be critical for <span class= disease  id= 25557042-10-196-202 >asthma</span> pathogenesis.	25557042	signaling molecule	interleukin 37	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2014
HAS2	3037	AlteredExpression	BEFREE	<span class= gene  id= 24875618-10-0-4 >HAS2</span> expression by HLFs cocultured with AECs from <span class= disease  id= 24875618-10-50-59 >asthmatic</span> patients was 2.5-fold higher than that by HLFs cocultured with AECs from healthy subjects (P &lt; .002).	24875618	transferase	hyaluronan synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2014
HAS2	3037	AlteredExpression	BEFREE	<span class= gene  id= 21570715-11-0-21 >Hyaluronan synthase 2</span> mRNA was markedly increased in <span class= disease  id= 21570715-11-53-62 >asthmatic</span> fibroblasts.	21570715	transferase	hyaluronan synthase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2011
HDAC1	3065	AlteredExpression	BEFREE	There was <span class= negexp >no difference</span> in the site of <span class= gene  id= 12153977-5-39-44 >HDAC1</span>-HDAC6 expression between normal subjects and subjects with <span class= disease  id= 12153977-5-104-110 >asthma</span>, but subjects with <span class= disease  id= 12153977-5-130-136 >asthma</span> had reduced HDAC enzymatic activity and reduced <span class= gene  id= 12153977-5-185-190 >HDAC1</span> and HDAC2 protein expression, as measured by Western blotting.	12153977	oxidoreductase; nucleic acid binding; hydrolase	histone deacetylase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2002
HDAC1	3065	AlteredExpression	BEFREE	Glucocorticoid receptor &beta; and <span class= gene  id= 22156779-0-30-51 >histone deacetylase 1</span> and 2 expression in the airways of severe <span class= disease  id= 22156779-0-94-100 >asthma</span>.	22156779	oxidoreductase; nucleic acid binding; hydrolase	histone deacetylase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2012
HRH1	3269	AlteredExpression	BEFREE	<span class= gene  id= 23448392-8-0-4 >HRH1</span> was differentially expressed in adults with <span class= disease  id= 23448392-8-49-55 >asthma</span> vs. controls (p = 0.04), and EDN1 was differentially expressed in children with <span class= disease  id= 23448392-8-136-142 >asthma</span> vs. controls 12-18 years old (p = 0.03).	23448392	receptor	histamine receptor H1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2013
HSPB1	3315	AlteredExpression	BEFREE	We report that in <span class= disease  id= 12482203-5-18-27 >asthmatic</span> subjects the basal epithelium cells express a high level of <span class= gene  id= 12482203-5-88-93 >Hsp27</span> but no apoptotic morphology.	12482203	chaperone	heat shock protein family B (small) member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2003
HSPB2	3316	AlteredExpression	BEFREE	We report that in <span class= disease  id= 12482203-5-18-27 >asthmatic</span> subjects the basal epithelium cells express a high level of <span class= gene  id= 12482203-5-88-93 >Hsp27</span> but no apoptotic morphology.	12482203	chaperone	heat shock protein family B (small) member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2003
ITGAM	3684	AlteredExpression	BEFREE	Then the effect of HMGB1 on the receptor of advanced glycation end products (RAGE) expressions on <span class= gene  id= 22909167-5-98-103 >CD11b</span>-CD11c(+) cells isolated from a murine model of <span class= disease  id= 22909167-5-151-157 >asthma</span> were measured to elucidate the mechanisms involved.	22909167	null	integrin subunit alpha M	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2013
ITGB4	3691	AlteredExpression	BEFREE	An ovalbumin (OVA)-challenged <span class= disease  id= 20364299-6-30-36 >asthma</span> model was used to investigate <span class= gene  id= 20364299-6-67-72 >ITGB4</span> expression after antigen exposure in vivo.	20364299	cell adhesion molecule; extracellular matrix protein; receptor	integrin subunit beta 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2010
RPSA	3921	AlteredExpression	BEFREE	<span class= gene  id= 10627863-9-0-5 >LAMR1</span> is down-regulated in CD4+ T cells of SRA compared to non-<span class= disease  id= 10627863-9-63-72 >asthmatic</span> individuals, irrespective of their atopic status.	10627863	nucleic acid binding	ribosomal protein SA	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2000
RPSA	3921	AlteredExpression	BEFREE	The IL12B gene encodes the <span class= gene  id= 15007350-1-27-30 >p40</span> chain of IL-12, a proinflammatory cytokine that antagonizes TH2 expression and hence may play a critical role in the pathogenesis of airway inflammation observed in <span class= disease  id= 15007350-1-196-202 >asthma</span>.	15007350	nucleic acid binding	ribosomal protein SA	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2004
LIF	3976	AlteredExpression	BEFREE	Serum <span class= gene  id= 10400851-7-6-9 >LIF</span> levels were higher in atopic patients with mild <span class= disease  id= 10400851-7-58-64 >asthma</span> than in nonatopic normal donors.	10400851	signaling molecule	leukemia inhibitory factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	1999
LIF	3976	AlteredExpression	BEFREE	In summary, bronchial epithelial cell changes in <span class= disease  id= 17392578-7-49-55 >asthma</span> are induced by <span class= gene  id= 17392578-7-71-74 >LIF</span> which promotes the expression of NK-1R, and JAK/STAT pathway and MAPK/ERK pathway may participate in this process.	17392578	signaling molecule	leukemia inhibitory factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2007
MIR19A	406979	AlteredExpression	BEFREE	Thus, upregulation of <span class= gene  id= 25362490-5-22-29 >miR-19a</span> in <span class= disease  id= 25362490-5-33-39 >asthma</span> may be an indicator and a cause of increased TH2 cytokine production in the airways.	25362490	null	microRNA 19a	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2014
MMP7	4316	AlteredExpression	BEFREE	However, chronic disordered epithelial expression of <span class= gene  id= 20624652-14-53-58 >MMP-7</span> in patients with <span class= disease  id= 20624652-14-76-82 >asthma</span> might increase mFasL cleavage and contribute to airway epithelial damage and inflammation.	20624652	null	matrix metallopeptidase 7	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2010
CD200	4345	AlteredExpression	BEFREE	Quantitative real-time RT-PCR confirmed that the genes related (S100A8 and GAS6) and unrelated to infections (<span class= gene  id= 19187333-11-110-115 >CD200</span> and RBP7) were differentially expressed during <span class= disease  id= 19187333-11-163-169 >asthma</span> exacerbation (P&lt;0.01).	19187333	null	CD200 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2009
MUSK	4593	AlteredExpression	BEFREE	We studied the effect of maternal fatty acid desaturase (<span class= gene  id= 26283408-2-57-61 >FADS</span>) genotype and breast milk LCPUFA levels on infants' blood T-cell profiles and ex vivo-produced cytokines after anti-CD3/CD28 stimulation of peripheral blood mononuclear cells in 6-month-old infants from the Copenhagen Prospective Study of <span class= disease  id= 26283408-2-301-307 >Asthma</span> in Childhood birth cohort.	26283408	null	muscle associated receptor tyrosine kinase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2016
OSM	5008	AlteredExpression	BEFREE	<span class= gene  id= 25840724-7-0-3 >OSM</span> levels were also increased in bronchoalveolar lavage fluid of allergic <span class= disease  id= 25840724-7-75-84 >asthmatic</span> patients after segmental allergen challenge and in esophageal biopsy specimens from patients with eosinophilic esophagitis.	25840724	signaling molecule	oncostatin M	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2015
SERPINB2	5055	AlteredExpression	BEFREE	Gene expression levels of CLCA1 and periostin, but not <span class= gene  id= 24075231-5-55-63 >SerpinB2</span>, were significantly higher than normal in sputum cells from <span class= disease  id= 24075231-5-124-133 >asthmatic</span> subjects.	24075231	enzyme modulator	serpin family B member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2013
SERPINB2	5055	AlteredExpression	BEFREE	By using gene expression microarrays, we found that chloride channel, calcium-activated, family member 1 (CLCA1), periostin, and serine peptidase inhibitor, clade B (ovalbumin), member 2 (<span class= gene  id= 17898169-5-188-196 >serpinB2</span>) were up-regulated in <span class= disease  id= 17898169-5-219-225 >asthma</span> but not in smokers.	17898169	enzyme modulator	serpin family B member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2007
PCNA	5111	AlteredExpression	BEFREE	Immunostaining usually occurred in the cytoplasm of columnar cells; however, in severe asthma, nuclear staining was also evident in the proliferative, basal cell compartment. p21(waf) expression was significantly higher in <span class= disease  id= 12495933-3-223-232 >asthmatic</span> versus nonasthmatic epithelium and was unaffected by corticosteroid treatment; <span class= gene  id= 12495933-3-312-346 >proliferating cell nuclear antigen</span> was not significantly different in any group. p21(waf), but not p27(kip1), mRNA and protein were induced by treatment of bronchial epithelial cells in vitro with transforming growth factor (TGF)-beta or H2O2, but not by dexamethasone, which induced p57(kip2).	12495933	nucleic acid binding	proliferating cell nuclear antigen	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2003
CKLF	51192	AlteredExpression	BEFREE	Compound 41 blocked the calcium mobilization and chemotaxis induced by <span class= gene  id= 20099827-5-71-76 >CKLF1</span>-C27 and reduced the <span class= disease  id= 20099827-5-97-106 >asthmatic</span> pathologic changes in lung tissue of human <span class= gene  id= 20099827-5-150-155 >CKLF1</span>-transfected mice.	20099827	null	chemokine like factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2010
PPIA	5478	AlteredExpression	BEFREE	The suitability of using the <span class= gene  id= 23110234-8-29-33 >PPIA</span> gene as the HKG for such studies was questioned due to its low expression in <span class= disease  id= 23110234-8-111-121 >asthmatics</span>.	23110234	isomerase	peptidylprolyl isomerase A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2012
RETN	56729	AlteredExpression	BEFREE	We show here that T(h)2 cell-mediated inflammation in murine <span class= disease  id= 24150243-4-61-67 >asthma</span> models induces the expression of some markers of alternatively activated macrophage such as arginase 1 and <span class= gene  id= 24150243-4-175-183 >resistin</span>-like molecule-&alpha; in iDCs by a mechanism depending on the intrinsic expression of STAT6.	24150243	null	resistin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2014
PTPN7	5778	AlteredExpression	BEFREE	Bronchial biopsies from allergen-challenged atopic <span class= disease  id= 21827450-4-51-60 >asthmatic</span> subjects taking inhaled budesonide or placebo were subjected to gene expression analysis using real-time reverse transcriptase-PCR for the corticosteroid-inducible genes (official gene symbols with aliases in parentheses): TSC22D3 [glucocorticoid-induced leucine zipper (GILZ)], <span class= gene  id= 21827450-4-340-370 >dual-specificity phosphatase-1</span> (MAPK phosphatase-1), both anti-inflammatory effectors, and FKBP5 [FK506-binding protein 51 (FKBP51)], a regulator of GR function.	21827450	phosphatase; hydrolase	protein tyrosine phosphatase, non-receptor type 7	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2012
RAPSN	5913	AlteredExpression	BEFREE	We studied the effect of maternal fatty acid desaturase (<span class= gene  id= 26283408-2-57-61 >FADS</span>) genotype and breast milk LCPUFA levels on infants' blood T-cell profiles and ex vivo-produced cytokines after anti-CD3/CD28 stimulation of peripheral blood mononuclear cells in 6-month-old infants from the Copenhagen Prospective Study of <span class= disease  id= 26283408-2-301-307 >Asthma</span> in Childhood birth cohort.	26283408	enzyme modulator; transmembrane receptor regulatory/adaptor protein	receptor associated protein of the synapse	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2016
RELA	5970	AlteredExpression	BEFREE	Furthermore, chromatin immunoprecipitation studies detected increased binding of NF-kappaB <span class= gene  id= 19734226-5-91-94 >p65</span> and RNA polymerase II to the CXCL8 promoter of <span class= disease  id= 19734226-5-142-151 >asthmatic</span> HASM cells both in the presence and absence of TNF-alpha stimulation.	19734226	transcription factor; nucleic acid binding	RELA proto-oncogene, NF-kB subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2009
RPE65	6121	AlteredExpression	BEFREE	The epithelium of <span class= disease  id= 26315281-1-18-28 >asthmatics</span> is characterized by reduced expression of E-cadherin and increased expression of the basal cell markers ck-5 and <span class= gene  id= 26315281-1-142-145 >p63</span> that is indicative of a relatively undifferentiated repairing epithelium.	26315281	oxidoreductase	RPE65, retinoid isomerohydrolase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2015
RPE65	6121	AlteredExpression	BEFREE	We previously reported increased numbers of basal cells expressing the transcription factor <span class= gene  id= 23837456-3-92-95 >p63</span> in the airway epithelium of patients with <span class= disease  id= 23837456-3-138-144 >asthma</span>.	23837456	oxidoreductase	RPE65, retinoid isomerohydrolase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2014
S100A9	6280	AlteredExpression	BEFREE	The concentrations of S100A8 and <span class= gene  id= 25973752-11-33-39 >S100A9</span> were significantly elevated in <span class= disease  id= 25973752-11-71-80 >asthmatic</span> bronchoalveolar lavage fluid (BALF) when compared to normal BALF (p&lt;0.01), but not in serum.	25973752	signaling molecule; calcium-binding protein	S100 calcium binding protein A9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2015
SCD	6319	AlteredExpression	BEFREE	We studied the effect of maternal <span class= gene  id= 26283408-2-34-55 >fatty acid desaturase</span> (FADS) genotype and breast milk LCPUFA levels on infants' blood T-cell profiles and ex vivo-produced cytokines after anti-CD3/CD28 stimulation of peripheral blood mononuclear cells in 6-month-old infants from the Copenhagen Prospective Study of <span class= disease  id= 26283408-2-301-307 >Asthma</span> in Childhood birth cohort.	26283408	null	stearoyl-CoA desaturase	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2016
CCL3	6348	AlteredExpression	BEFREE	The aims of this study were to examine the expression of the <span class= gene  id= 18178867-4-61-65 >CCL3</span> receptor, CCR1, on human airway smooth muscle cells (ASMC) and to document the regulation of this receptor by cytokines involved in <span class= disease  id= 18178867-4-198-204 >asthma</span> pathogenesis.	18178867	signaling molecule	C-C motif chemokine ligand 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2008
GORASP1	64689	AlteredExpression	BEFREE	Furthermore, chromatin immunoprecipitation studies detected increased binding of NF-kappaB <span class= gene  id= 19734226-5-91-94 >p65</span> and RNA polymerase II to the CXCL8 promoter of <span class= disease  id= 19734226-5-142-151 >asthmatic</span> HASM cells both in the presence and absence of TNF-alpha stimulation.	19734226	null	golgi reassembly stacking protein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2009
WNK1	65125	AlteredExpression	BEFREE	Furthermore, chromatin immunoprecipitation studies detected increased binding of NF-kappaB <span class= gene  id= 19734226-5-91-94 >p65</span> and RNA polymerase II to the CXCL8 promoter of <span class= disease  id= 19734226-5-142-151 >asthmatic</span> HASM cells both in the presence and absence of TNF-alpha stimulation.	19734226	transferase; kinase	WNK lysine deficient protein kinase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2009
SMN1	6606	AlteredExpression	BEFREE	Monoclonal antibody inhibition of TGF&beta;2 led to similar expression of &alpha;-<span class= gene  id= 25849331-12-71-74 >SMA</span> between healthy and <span class= disease  id= 25849331-12-95-104 >asthmatic</span> BEC-HLF co-cultures.	25849331	null	survival of motor neuron 1, telomeric	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2015
SMN1	6606	AlteredExpression	BEFREE	However, these observations were exclusively accompanied by increased expression of alpha-<span class= gene  id= 16430780-10-90-93 >SMA</span> in patients with mild <span class= disease  id= 16430780-10-116-122 >asthma</span>.	16430780	null	survival of motor neuron 1, telomeric	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2006
SMN2	6607	AlteredExpression	BEFREE	However, these observations were exclusively accompanied by increased expression of alpha-<span class= gene  id= 16430780-10-90-93 >SMA</span> in patients with mild <span class= disease  id= 16430780-10-116-122 >asthma</span>.	16430780	null	survival of motor neuron 2, centromeric	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2006
SMN2	6607	AlteredExpression	BEFREE	Monoclonal antibody inhibition of TGF&beta;2 led to similar expression of &alpha;-<span class= gene  id= 25849331-12-71-74 >SMA</span> between healthy and <span class= disease  id= 25849331-12-95-104 >asthmatic</span> BEC-HLF co-cultures.	25849331	null	survival of motor neuron 2, centromeric	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2015
SYT1	6857	AlteredExpression	BEFREE	Furthermore, chromatin immunoprecipitation studies detected increased binding of NF-kappaB <span class= gene  id= 19734226-5-91-94 >p65</span> and RNA polymerase II to the CXCL8 promoter of <span class= disease  id= 19734226-5-142-151 >asthmatic</span> HASM cells both in the presence and absence of TNF-alpha stimulation.	19734226	membrane traffic protein	synaptotagmin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2009
TNFAIP3	7128	AlteredExpression	BEFREE	Genes associated with activation of the LPS signaling pathway (early growth response 1, dual-specificity phosphatase 2, molecule possessing ankyrin repeats induced by LPS, and <span class= gene  id= 18774390-8-176-203 >TNF-alpha-induced protein 3</span>) were significantly increased in BAL samples from subjects with CR <span class= disease  id= 18774390-8-271-277 >asthma</span> (P &lt; .05).	18774390	nucleic acid binding; hydrolase	TNF alpha induced protein 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2008
TYRP1	7306	AlteredExpression	BEFREE	Seven (8%) of the 92 serum samples from patients with <span class= disease  id= 15679724-11-54-70 >bronchial asthma</span> showed IgE-binding to the recombinant clone <span class= gene  id= 15679724-11-115-124 >B protein</span>.	15679724	null	tyrosinase related protein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2005
UVRAG	7405	AlteredExpression	BEFREE	We previously reported increased numbers of basal cells expressing the transcription factor <span class= gene  id= 23837456-3-92-95 >p63</span> in the airway epithelium of patients with <span class= disease  id= 23837456-3-138-144 >asthma</span>.	23837456	null	UV radiation resistance associated	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2014
UVRAG	7405	AlteredExpression	BEFREE	The epithelium of <span class= disease  id= 26315281-1-18-28 >asthmatics</span> is characterized by reduced expression of E-cadherin and increased expression of the basal cell markers ck-5 and <span class= gene  id= 26315281-1-142-145 >p63</span> that is indicative of a relatively undifferentiated repairing epithelium.	26315281	null	UV radiation resistance associated	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2015
CALCA	796	AlteredExpression	BEFREE	Epithelial cell expression of <span class= gene  id= 20933260-1-30-40 >calcitonin</span> gene-related peptide (CGRP) is a feature of provoked <span class= disease  id= 20933260-1-94-100 >asthma</span>.	20933260	signaling molecule	calcitonin related polypeptide alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2010
FLAD1	80308	AlteredExpression	BEFREE	We studied the effect of maternal fatty acid desaturase (<span class= gene  id= 26283408-2-57-61 >FADS</span>) genotype and breast milk LCPUFA levels on infants' blood T-cell profiles and ex vivo-produced cytokines after anti-CD3/CD28 stimulation of peripheral blood mononuclear cells in 6-month-old infants from the Copenhagen Prospective Study of <span class= disease  id= 26283408-2-301-307 >Asthma</span> in Childhood birth cohort.	26283408	transferase	flavin adenine dinucleotide synthetase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2016
CD276	80381	AlteredExpression	BEFREE	<span class= gene  id= 26108069-0-0-5 >B7-H3</span> expression in children with <span class= disease  id= 26108069-0-34-40 >asthma</span> exacerbation.	26108069	null	CD276 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2016
FOSL1	8061	AlteredExpression	BEFREE	These data indicate that HRV-induced activation of the MEK/ERK MAPK pathway and <span class= gene  id= 22461694-10-80-85 >Fra-1</span> expression are necessary for the upregulation of MMP-9 and can be modulated by two distinct but commonly used <span class= disease  id= 22461694-10-196-202 >asthma</span> pharmacotherapies.	22461694	null	FOS like 1, AP-1 transcription factor subunit	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2012
CAV1	857	AlteredExpression	BEFREE	Roxithromycin suppresses airway remodeling and modulates the expression of <span class= gene  id= 25479721-0-75-85 >caveolin-1</span> and phospho-p42/p44MAPK in <span class= disease  id= 25479721-0-113-122 >asthmatic</span> rats.	25479721	membrane traffic protein; enzyme modulator; transmembrane receptor regulatory/adaptor protein; structural protein	caveolin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2014
HSPB3	8988	AlteredExpression	BEFREE	We report that in <span class= disease  id= 12482203-5-18-27 >asthmatic</span> subjects the basal epithelium cells express a high level of <span class= gene  id= 12482203-5-88-93 >Hsp27</span> but no apoptotic morphology.	12482203	chaperone	heat shock protein family B (small) member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2003
IL32	9235	AlteredExpression	BEFREE	Airway inflammatory diseases such as chronic obstructive pulmonary disease (COPD) and <span class= disease  id= 25157456-1-86-92 >asthma</span> are associated with elevated expression of <span class= gene  id= 25157456-1-136-150 >interleukin-32</span> (<span class= gene  id= 25157456-1-152-157 >IL-32</span>), a recently described cytokine that appears to play a critical role in inflammation.	25157456	null	interleukin 32	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000549453568426	2014
HDAC6	10013	AlteredExpression	BEFREE	There was <span class= negexp >no difference</span> in the site of HDAC1-<span class= gene  id= 12153977-5-45-50 >HDAC6</span> expression between normal subjects and subjects with <span class= disease  id= 12153977-5-104-110 >asthma</span>, but subjects with asthma had reduced HDAC enzymatic activity and reduced HDAC1 and HDAC2 protein expression, as measured by Western blotting.	12153977	oxidoreductase; nucleic acid binding; hydrolase	histone deacetylase 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2002
RABEPK	10244	AlteredExpression	BEFREE	The IL12B gene encodes the <span class= gene  id= 15007350-1-27-30 >p40</span> chain of IL-12, a proinflammatory cytokine that antagonizes TH2 expression and hence may play a critical role in the pathogenesis of airway inflammation observed in <span class= disease  id= 15007350-1-196-202 >asthma</span>.	15007350	null	Rab9 effector protein with kelch motifs	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2004
CDKN1A	1026	AlteredExpression	BEFREE	FCS + TGF-&beta; inhibited p21(<span class= gene  id= 23944957-6-26-30 >WAF1</span>) and p27(kip1) expression, and increased microRNA-221 (miR-221) expression in ASMCs from individuals with severe <span class= disease  id= 23944957-6-144-150 >asthma</span>. miR-221, and not miR-222, mimics the increased proliferation and IL-6 release induced by FCS + TGF in healthy ASM, whereas in patients with severe <span class= disease  id= 23944957-6-299-305 >asthma</span>, the inhibition of miR-221, but not miR-222, inhibited proliferation and IL-6 release. miR-221 inhibition led to the increased expression of FCS + TGF-&beta;-induced p21(WAF1) and p27(kip1).	23944957	enzyme modulator	cyclin dependent kinase inhibitor 1A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
CDKN1B	1027	AlteredExpression	BEFREE	FCS + TGF-&beta; inhibited p21(WAF1) and p27(<span class= gene  id= 23944957-6-40-44 >kip1</span>) expression, and increased microRNA-221 (miR-221) expression in ASMCs from individuals with severe <span class= disease  id= 23944957-6-144-150 >asthma</span>. miR-221, and not miR-222, mimics the increased proliferation and IL-6 release induced by FCS + TGF in healthy ASM, whereas in patients with severe <span class= disease  id= 23944957-6-299-305 >asthma</span>, the inhibition of miR-221, but not miR-222, inhibited proliferation and IL-6 release. miR-221 inhibition led to the increased expression of FCS + TGF-&beta;-induced p21(WAF1) and p27(<span class= gene  id= 23944957-6-485-489 >kip1</span>).	23944957	enzyme modulator	cyclin dependent kinase inhibitor 1B	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
LANCL1	10314	AlteredExpression	BEFREE	The IL12B gene encodes the <span class= gene  id= 15007350-1-27-30 >p40</span> chain of IL-12, a proinflammatory cytokine that antagonizes TH2 expression and hence may play a critical role in the pathogenesis of airway inflammation observed in <span class= disease  id= 15007350-1-196-202 >asthma</span>.	15007350	null	LanC like 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2004
RACK1	10399	AlteredExpression	BEFREE	Elevated <span class= gene  id= 25048599-0-9-42 >receptor for activated C kinase 1</span> expression is involved in intracellular Ca2+ influx and potentially associated with compromised regulatory T cell function in patients with <span class= disease  id= 25048599-0-183-189 >asthma</span>.	25048599	null	receptor for activated C kinase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
CEBPA	1050	AlteredExpression	BEFREE	Impaired translation of <span class= gene  id= 19121862-0-24-60 >CCAAT/enhancer binding protein alpha</span> mRNA in bronchial smooth muscle cells of <span class= disease  id= 19121862-0-102-111 >asthmatic</span> patients.	19121862	transcription factor; nucleic acid binding	CCAAT/enhancer binding protein alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2008
CIB1	10519	AlteredExpression	BEFREE	FCS + TGF-&beta; inhibited p21(WAF1) and p27(<span class= gene  id= 23944957-6-40-44 >kip1</span>) expression, and increased microRNA-221 (miR-221) expression in ASMCs from individuals with severe <span class= disease  id= 23944957-6-144-150 >asthma</span>. miR-221, and not miR-222, mimics the increased proliferation and IL-6 release induced by FCS + TGF in healthy ASM, whereas in patients with severe <span class= disease  id= 23944957-6-299-305 >asthma</span>, the inhibition of miR-221, but not miR-222, inhibited proliferation and IL-6 release. miR-221 inhibition led to the increased expression of FCS + TGF-&beta;-induced p21(WAF1) and p27(<span class= gene  id= 23944957-6-485-489 >kip1</span>).	23944957	calcium-binding protein; phosphatase; hydrolase	calcium and integrin binding 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
ANP32B	10541	AlteredExpression	BEFREE	Unlike other inflammatory diseases including autoimmune diseases and <span class= disease  id= 21765951-6-69-75 >asthma</span>, the circulating levels of BAFF, <span class= gene  id= 21765951-6-109-114 >APRIL</span> and TWEAK were not elevated in AE or SE patients compared with HCs and did <span class= negexp >not correlate</span> with the disease severity or systemic IgE levels in AE patients.	21765951	enzyme modulator	acidic nuclear phosphoprotein 32 family member B	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2011
ERN2	10595	AlteredExpression	BEFREE	We found that <span class= gene  id= 23168839-3-14-19 >IRE1&beta;</span> is also expressed in HBE, <span class= negexp >is absent</span> in human alveolar cells, and is upregulated in cystic fibrosis and <span class= disease  id= 23168839-3-123-132 >asthmatic</span> HBE.	23168839	transferase; kinase	endoplasmic reticulum to nucleus signaling 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2013
POSTN	10631	AlteredExpression	BEFREE	Expression of TSLP, IL33, and <span class= gene  id= 25813919-8-30-35 >POSTN</span> mRNA was increased in sHBECs in <span class= disease  id= 25813919-8-68-77 >asthmatic</span> cases (P = .001, P = .05, and P = .04, respectively).	25813919	cell adhesion molecule; signaling molecule	periostin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
UTS2	10911	AlteredExpression	BEFREE	We found that both <span class= gene  id= 22270542-9-19-22 >UII</span> and TGF-&beta;1 were upregulated in <span class= disease  id= 22270542-9-54-60 >asthma</span> lung tissues.	22270542	signaling molecule	urotensin 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
RAB40B	10966	AlteredExpression	BEFREE	Expression of <span class= gene  id= 25863981-8-14-17 >RAR</span>-related orphan receptor A (RORA), which has been linked to <span class= disease  id= 25863981-8-77-83 >asthma</span> in genome-wide association studies, was significantly upregulated in patients with <span class= disease  id= 25863981-8-167-169 >SA</span>.	25863981	null	RAB40B, member RAS oncogene family	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
EBNA1BP2	10969	AlteredExpression	BEFREE	The IL12B gene encodes the <span class= gene  id= 15007350-1-27-30 >p40</span> chain of IL-12, a proinflammatory cytokine that antagonizes TH2 expression and hence may play a critical role in the pathogenesis of airway inflammation observed in <span class= disease  id= 15007350-1-196-202 >asthma</span>.	15007350	null	EBNA1 binding protein 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2004
CHEK1	1111	AlteredExpression	BEFREE	Vitamin D has also been implicated in <span class= disease  id= 22532985-3-38-44 >asthma</span> through its effects on the obesity, bacillus Calmettee Gu&eacute;rin (BCG) vaccination and high vitamin D level, vitamin D supplement, checkpoint protein kinase 1 (<span class= gene  id= 22532985-3-202-206 >Chk1</span>), plasminogen activator inhibitor-1 (PAI-1) and gamma delta T cells (gdT).	22532985	transferase; kinase	checkpoint kinase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
AKAP13	11214	AlteredExpression	BEFREE	Mice lacking functional NADPH oxidases due to knockout of <span class= gene  id= 23884469-5-58-61 >p47</span> and mice with epithelial-targeted transgenic expression of a CaMKII inhibitory peptide or wild-type mice treated with inhaled KN-93, an experimental small-molecule CaMKII antagonist, were protected against increases in ICl, MUC5AC expression, and <span class= disease  id= 23884469-5-309-331 >airway hyperreactivity</span> to inhaled methacholine.	23884469	null	A-kinase anchoring protein 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
PRRT2	112476	AlteredExpression	BEFREE	Hence, new molecules capable of modulating the expression or biological activity of <span class= gene  id= 22830352-9-84-87 >PKC</span>-? are being developed and tested for their potential as novel therapy for several T-cells mediated disease conditions such as multiple sclerosis, rheumatoid arthritis, <span class= disease  id= 22830352-9-256-262 >asthma</span>, inflammatory bowel disease and organ transplantation, etc.	22830352	null	proline rich transmembrane protein 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
RBP7	116362	AlteredExpression	BEFREE	Quantitative real-time RT-PCR confirmed that the genes related (S100A8 and GAS6) and unrelated to infections (CD200 and <span class= gene  id= 19187333-11-120-124 >RBP7</span>) were differentially expressed during <span class= disease  id= 19187333-11-163-169 >asthma</span> exacerbation (P&lt;0.01).	19187333	null	retinol binding protein 7	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
CCR7	1236	AlteredExpression	BEFREE	<span class= gene  id= 10627863-0-0-4 >CCR7</span> (<span class= gene  id= 10627863-0-6-10 >EBI1</span>) receptor down-regulation in <span class= disease  id= 10627863-0-40-46 >asthma</span>: differential gene expression in human CD4+ T lymphocytes.	10627863	cell adhesion molecule; phosphatase; hydrolase; defense/immunity protein; receptor	C-C motif chemokine receptor 7	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2000
COL3A1	1281	AlteredExpression	BEFREE	COL1A1 and <span class= gene  id= 24875618-9-11-17 >COL3A1</span> expression by HLFs cocultured with AECs from <span class= disease  id= 24875618-9-63-72 >asthmatic</span> patients was greater than that by HLFs cocultured with AECs from healthy subjects (2.2-fold, P &lt; .02; 10.8-fold, P &lt; .02).	24875618	null	collagen type III alpha 1 chain	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
COL4A3	1285	AlteredExpression	BEFREE	This indicates that while CTSD possesses the potential to directly regulate <span class= gene  id= 23483898-10-76-85 >tumstatin</span>, and thus angiogenesis through this mechanism however, it is <span class= negexp >not likely to be involved</span> in the dysregulation of <span class= gene  id= 23483898-10-197-206 >tumstatin</span> found in <span class= disease  id= 23483898-10-216-225 >asthmatic</span> airways.	23483898	null	collagen type IV alpha 3 chain	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2013
CLDN7	1366	AlteredExpression	BEFREE	<span class= gene  id= 21624620-0-0-9 >Claudin-1</span> expression in airway smooth muscle exacerbates airway remodeling in <span class= disease  id= 21624620-0-78-87 >asthmatic</span> subjects.	21624620	cell junction protein	claudin 7	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2011
CR1	1378	AlteredExpression	BEFREE	Expression of <span class= gene  id= 10779280-0-14-18 >CD35</span> (<span class= gene  id= 10779280-0-20-23 >CR1</span>) and CD11b (CR3) on circulating neutrophils and eosinophils from allergic <span class= disease  id= 10779280-0-98-107 >asthmatic</span> children.	10779280	null	complement C3b/C4b receptor 1 (Knops blood group)	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2000
CRIP1	1396	AlteredExpression	BEFREE	We demonstrate STAT5A gene expression is decreased whereas <span class= gene  id= 22970180-12-59-64 >CRIP1</span> gene expression is elevated in the AECs from <span class= disease  id= 22970180-12-110-119 >asthmatic</span> compared to both healthy and atopic subjects.	22970180	cytoskeletal protein; nucleic acid binding	cysteine rich protein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
CRYGC	1420	AlteredExpression	BEFREE	A <span class= gene  id= 24560857-0-2-5 >CCL</span> chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of <span class= disease  id= 24560857-0-173-179 >asthma</span>.	24560857	null	crystallin gamma C	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
PWAR1	145624	AlteredExpression	BEFREE	We determined the influence of chronic smoking and <span class= disease  id= 12589358-2-51-57 >asthma</span> on the expression of <span class= gene  id= 12589358-2-79-84 >PAR-1</span> and PAR-2 receptors on alveolar macrophages (AMs).	12589358	null	Prader Willi/Angelman region RNA 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2003
VCAN	1462	AlteredExpression	BEFREE	We also measured mRNA for <span class= gene  id= 19076933-7-26-34 >versican</span>, a matrix proteoglycan, known to be upregulated in the <span class= disease  id= 19076933-7-90-99 >asthmatic</span> airway wall.	19076933	extracellular matrix protein	versican	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
CTGF	1490	AlteredExpression	BEFREE	Expression of <span class= gene  id= 12502478-0-14-45 >connective tissue growth factor</span> in <span class= disease  id= 12502478-0-49-58 >asthmatic</span> airway smooth muscle cells.	12502478	signaling molecule	connective tissue growth factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2003
PLB1	151056	AlteredExpression	BEFREE	In vitro studies using recombinant human enzymes reveal that TGM2 augments the enzymatic activity of secreted <span class= gene  id= 20052409-9-110-127 >phospholipase A(2</span>) (PLA(2)) group X (sPLA(2)-X), an enzyme recently implicated in <span class= disease  id= 20052409-9-192-198 >asthma</span> pathogenesis.	20052409	null	phospholipase B1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
CUX1	1523	AlteredExpression	BEFREE	Expression levels of <span class= gene  id= 22556157-10-21-25 >p110</span> isoforms &alpha;, &beta;, and &delta; were comparable in nonasthmatic and <span class= disease  id= 22556157-10-83-92 >asthmatic</span> HASM cells.	22556157	transcription factor; nucleic acid binding	cut like homeobox 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
CYBB	1536	AlteredExpression	BEFREE	The relative expression of <span class= gene  id= 22982469-8-27-31 >CYBB</span> was significantly lower (p&lt;0.05) in patients treated with a low daily dose of inhaled corticosteroid (ICS), than in <span class= disease  id= 22982469-8-148-158 >asthmatics</span> not receiving ICS therapy.	22982469	oxidoreductase	cytochrome b-245 beta chain	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
CD55	1604	AlteredExpression	BEFREE	This was consistent with our finding of relative downregulation of <span class= gene  id= 19843653-9-67-71 >CD55</span> in <span class= disease  id= 19843653-9-75-84 >asthmatic</span> compared with normal subjects.	19843653	null	CD55 molecule (Cromer blood group)	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2010
DEFA1	1667	AlteredExpression	BEFREE	Systemic expression of <span class= gene  id= 21785157-7-23-28 >DEFA1</span>,1B,3,4,CTSG and ELA2 was significantly higher in the neutrophilic asthma (<span class= disease  id= 21785157-7-103-105 >NA</span>) phenotype.	21785157	null	defensin alpha 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2011
A2M	2	AlteredExpression	BEFREE	Differences in elastase-binding activity of alpha 1-protease inhibitor and <span class= gene  id= 7682483-0-75-96 >alpha 2-macroglobulin</span> for <span class= disease  id= 7682483-0-101-107 >asthma</span> patients and control subjects with various alpha 1-protease inhibitor phenotypes.	7682483	defense/immunity protein; signaling molecule; enzyme modulator	alpha-2-macroglobulin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	1993
CRYGEP	200575	AlteredExpression	BEFREE	A <span class= gene  id= 24560857-0-2-5 >CCL</span> chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of <span class= disease  id= 24560857-0-173-179 >asthma</span>.	24560857	null	crystallin gamma E, pseudogene	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
MARK2	2011	AlteredExpression	BEFREE	We determined the influence of chronic smoking and <span class= disease  id= 12589358-2-51-57 >asthma</span> on the expression of <span class= gene  id= 12589358-2-79-84 >PAR-1</span> and PAR-2 receptors on alveolar macrophages (AMs).	12589358	transferase; kinase	microtubule affinity regulating kinase 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2003
F3	2152	AlteredExpression	BEFREE	Immunohistochemical staining of endobronchial biopsies identified epithelial localization of <span class= gene  id= 22828416-10-93-95 >TF</span> with increased expression in <span class= disease  id= 22828416-10-125-131 >asthma</span>.	22828416	defense/immunity protein; receptor	coagulation factor III, tissue factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
FLT1	2321	AlteredExpression	BEFREE	In parallel, BALF concentrations of soluble <span class= gene  id= 26869672-6-44-50 >VEGFR1</span> and IL-18 were significantly reduced in severe asthmatics in vivo and inversely correlated with angiogenesis.Activin-A is overexpressed and has anti-angiogenic effects in vitro that are not propagated in vivo, where reduced basal expression of its receptors is observed particularly in severe <span class= disease  id= 26869672-6-344-350 >asthma</span>.	26869672	null	fms related tyrosine kinase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
SRRM2	23524	AlteredExpression	BEFREE	Repression of COX-2 and IL-1&beta; expression by miR-146a correlated with reduced abundance of the <span class= gene  id= 25217662-8-94-113 >RNA-binding protein</span> human antigen R. These results demonstrate that miR-146a and miR-146b expression is inducible in hASMCs by proinflammatory cytokines and that miR-146a expression is greater in <span class= disease  id= 25217662-8-290-299 >asthmatic</span> cells.	25217662	null	serine/arginine repetitive matrix 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
ALOX15B	247	AlteredExpression	BEFREE	Expression of <span class= gene  id= 22409990-10-14-31 >15-lipoxygenase 2</span> was increased in epithelium from patients with severe <span class= disease  id= 22409990-10-86-92 >asthma</span>, whereas expression levels of MUC5AC, MUC5B, 5-lipoxygenase, and 15-lipoxygeanse 1 were similar to those of patients with mild <span class= disease  id= 22409990-10-220-226 >asthma</span>.	22409990	oxidoreductase	arachidonate 15-lipoxygenase, type B	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
FUCA1	2517	AlteredExpression	BEFREE	The regulation of <span class= gene  id= 24469468-2-18-23 >FUCA1</span> and FUCA2 gene expression and enzyme activity in response to <span class= disease  id= 24469468-2-85-91 >asthma</span>-associated Th2 cytokines and, for contrast, Th1 cytokine IFN-&gamma;, were investigated in a human airway cell line.	24469468	null	fucosidase, alpha-L- 1, tissue	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
FUCA2	2519	AlteredExpression	BEFREE	The regulation of FUCA1 and <span class= gene  id= 24469468-2-28-33 >FUCA2</span> gene expression and enzyme activity in response to <span class= disease  id= 24469468-2-85-91 >asthma</span>-associated Th2 cytokines and, for contrast, Th1 cytokine IFN-&gamma;, were investigated in a human airway cell line.	24469468	null	fucosidase, alpha-L- 2, plasma	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
GAB1	2549	AlteredExpression	BEFREE	The siRNA knockdown of <span class= gene  id= 25586491-8-23-27 >GAB1</span> in the BEAS-2B cell line resulted in a decrease in the NFkB level, suggesting a novel regulatory path of the pro-inflammatory factor NFkB by <span class= gene  id= 25586491-8-169-173 >GAB1</span> in <span class= disease  id= 25586491-8-177-183 >asthma</span>.	25586491	transmembrane receptor regulatory/adaptor protein	GRB2 associated binding protein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
TXN2	25828	AlteredExpression	BEFREE	Among the identified proteins, the increased expression of the messenger RNA of phosphodiesterase 4C and <span class= gene  id= 17550934-10-105-118 >thioredoxin-2</span> and the decreased expression of the messenger RNA of glutathione S-transferase M3 were confirmed by RT-PCR in the <span class= disease  id= 17550934-10-233-242 >asthmatic</span> patients.	17550934	oxidoreductase	thioredoxin 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2007
GAS6	2621	AlteredExpression	BEFREE	Quantitative real-time RT-PCR confirmed that the genes related (S100A8 and <span class= gene  id= 19187333-11-75-79 >GAS6</span>) and unrelated to infections (CD200 and RBP7) were differentially expressed during <span class= disease  id= 19187333-11-163-169 >asthma</span> exacerbation (P&lt;0.01).	19187333	extracellular matrix protein	growth arrest specific 6	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
FBXO8	26269	AlteredExpression	BEFREE	Pharmacological inhibition revealed that although dual proliferative pathways control ASM growth in cells from non-<span class= disease  id= 18338817-8-115-125 >asthmatics</span> stimulated with 10% <span class= gene  id= 18338817-8-146-149 >FBS</span> to an equal extent ([(3)H]-thymidine incorporation reduced to 57.2 +/- 6.9% by the PI 3-kinase inhibitor LY294002 and 57.8 +/- 1.1% by the ERK-pathway inhibitor U0126); in <span class= disease  id= 18338817-8-322-332 >asthmatics</span>, the presence of a strong proliferative stimulus (10% <span class= gene  id= 18338817-8-387-390 >FBS</span>) reduces ERK activation resulting in a shift to the PI 3-kinase pathway.	18338817	enzyme modulator	F-box protein 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2008
EHF	26298	AlteredExpression	BEFREE	Genetic linkage studies suggest that ESE-2 and <span class= gene  id= 18475289-3-47-52 >ESE-3</span>, which encode epithelium-specific Ets-domain-containing transcription factors, are candidate <span class= disease  id= 18475289-3-146-152 >asthma</span> susceptibility genes.	18475289	transcription factor; signaling molecule; nucleic acid binding	ETS homologous factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2008
RNU1-1	26871	AlteredExpression	BEFREE	Since endogenous GCs reportedly attenuate the airway <span class= disease  id= 19251840-3-53-62 >asthmatic</span> response to allergen exposure, we investigated whether airway smooth muscle (ASM) exhibits cytokine-induced changes in 11beta-<span class= gene  id= 19251840-3-189-193 >HSD1</span> expression that enable the ASM to regulate its own bioavailability of GC and, accordingly, the protective effect of GR signaling on airway function under proasthmatic conditions.	19251840	null	RNA, U1 small nuclear 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
GIF	2694	AlteredExpression	BEFREE	Effect of bacterial endotoxin LPS on expression of <span class= gene  id= 17884733-0-51-54 >INF</span>-gamma and IL-5 in T-lymphocytes from <span class= disease  id= 17884733-0-92-102 >asthmatics</span>.	17884733	transfer/carrier protein; transporter	gastric intrinsic factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2007
LAT	27040	AlteredExpression	BEFREE	Our results demonstrated that the expression of <span class= gene  id= 23360572-4-48-51 >LAT</span> mRNA in peripheral blood T cells from patients with <span class= disease  id= 23360572-4-104-110 >asthma</span> decreased, as compared to healthy controls.	23360572	null	linker for activation of T-cells	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2013
SLC39A1	27173	AlteredExpression	BEFREE	Serum zinc levels were significantly lower in <span class= disease  id= 19598279-9-46-55 >asthmatic</span> infants (P &lt; 0.01); Expression of ZnT-1, ZnT-3, ZnT-5, <span class= gene  id= 19598279-9-111-116 >ZIP-1</span> mRNA were not significantly different between two groups, but expression of ZIP-2 mRNA was significantly higher (P &lt; 0.01) in the asthmatic group than the control group.	19598279	transporter; transmembrane receptor regulatory/adaptor protein	solute carrier family 39 member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
RBMS3	27303	AlteredExpression	BEFREE	Repression of COX-2 and IL-1&beta; expression by miR-146a correlated with reduced abundance of the <span class= gene  id= 25217662-8-94-113 >RNA-binding protein</span> human antigen R. These results demonstrate that miR-146a and miR-146b expression is inducible in hASMCs by proinflammatory cytokines and that miR-146a expression is greater in <span class= disease  id= 25217662-8-290-299 >asthmatic</span> cells.	25217662	null	RNA binding motif single stranded interacting protein 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
EIF3K	27335	AlteredExpression	BEFREE	We speculate that it may be possible to manipulate smooth <span class= gene  id= 9817732-5-58-73 >muscle-specific</span> gene expression in <span class= disease  id= 9817732-5-93-99 >asthma</span> or pulmonary arterial hypertension as an eventual therapy.	9817732	null	eukaryotic translation initiation factor 3 subunit K	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	1998
IFNL2	282616	AlteredExpression	BEFREE	Finally, both <span class= gene  id= 18564328-9-14-19 >IL-28</span> and IL-29 mRNA levels are higher in <span class= disease  id= 18564328-9-56-65 >asthmatic</span> children than in <span class= disease  id= 18564328-9-83-92 >asthmatic</span> adults.	18564328	null	interferon lambda 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
ANG	283	AlteredExpression	BEFREE	Expression of vascular endothelial growth factor, basic fibroblast growth factor, and <span class= gene  id= 11174196-0-86-96 >angiogenin</span> immunoreactivity in <span class= disease  id= 11174196-0-117-126 >asthmatic</span> airways and its relationship to angiogenesis.	11174196	enzyme modulator; nucleic acid binding; hydrolase	angiogenin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2001
PDIA3	2923	AlteredExpression	BEFREE	Here we show that <span class= gene  id= 26435004-12-18-23 >ERp57</span> levels are increased in the airway epithelium of <span class= disease  id= 26435004-12-73-82 >asthmatic</span> patients and in mice with allergic airways disease.	26435004	null	protein disulfide isomerase family A member 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
SLC39A2	29986	AlteredExpression	BEFREE	Overexpression of <span class= gene  id= 19598279-0-18-23 >Zip-2</span> mRNA in the leukocytes of <span class= disease  id= 19598279-0-50-59 >asthmatic</span> infants.	19598279	transporter; transmembrane receptor regulatory/adaptor protein	solute carrier family 39 member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
ANXA1	301	AlteredExpression	BEFREE	LPS induced significant expression of <span class= gene  id= 25634111-8-38-43 >ANXA1</span> and LTA4H in <span class= disease  id= 25634111-8-57-67 >asthmatics</span> when compared to COPD patients and healthy subjects.	25634111	null	annexin A1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
APC	324	AlteredExpression	BEFREE	<span class= gene  id= 25312757-3-0-3 >DP2</span> protein expression was assessed in bronchial biopsy specimens from <span class= disease  id= 25312757-3-71-80 >asthmatic</span> patients (n = 22) and healthy control subjects (n = 10) by using immunohistochemistry and in primary epithelial cells by using flow cytometry, immunofluorescence, and quantitative RT-PCR.	25312757	null	APC, WNT signaling pathway regulator	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
HPX	3263	AlteredExpression	BEFREE	The protein levels of Gc, <span class= gene  id= 21169467-7-26-35 >hemopexin</span>, and haptoglobin-b were increased, whereas the a1- antitrypsin and glutathione S-transferase levels were decreased in subjects with <span class= disease  id= 21169467-7-168-174 >asthma</span>.	21169467	transfer/carrier protein	hemopexin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2011
HSPA1L	3305	AlteredExpression	BEFREE	Here we investigated possible associations with other polymorphic susceptibility/resistance genes located within the major histocompatibility complex, i.e., the genes coding the major 70-kDa heat-shock proteins (HSP; Hsp70) hsp70-1, hsp70-2, and <span class= gene  id= 10221440-2-246-255 >hsp70-HOM</span>, whose products are overexpressed in the bronchi of <span class= disease  id= 10221440-2-308-317 >asthmatic</span> patients.	10221440	null	heat shock protein family A (Hsp70) member 1 like	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	1999
C1orf228	339541	AlteredExpression	BEFREE	The IL12B gene encodes the <span class= gene  id= 15007350-1-27-30 >p40</span> chain of IL-12, a proinflammatory cytokine that antagonizes TH2 expression and hence may play a critical role in the pathogenesis of airway inflammation observed in <span class= disease  id= 15007350-1-196-202 >asthma</span>.	15007350	null	chromosome 1 open reading frame 228	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2004
FASLG	356	AlteredExpression	BEFREE	FAS and <span class= gene  id= 11207646-8-8-12 >FASL</span> were not differentially expressed, but FAST kinase was over-expressed in AN and <span class= disease  id= 11207646-8-93-95 >AA</span>.	11207646	signaling molecule	Fas ligand	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2001
AQP4	361	AlteredExpression	BEFREE	The top-ranked predicted target of the highly down-regulated miRNA-203 in <span class= disease  id= 22679274-10-74-83 >asthmatic</span> cells was the aquaporin gene <span class= gene  id= 22679274-10-113-117 >AQP4</span>.	22679274	transporter	aquaporin 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
ING1	3621	AlteredExpression	BEFREE	Mice lacking functional NADPH oxidases due to knockout of <span class= gene  id= 23884469-5-58-61 >p47</span> and mice with epithelial-targeted transgenic expression of a CaMKII inhibitory peptide or wild-type mice treated with inhaled KN-93, an experimental small-molecule CaMKII antagonist, were protected against increases in ICl, MUC5AC expression, and <span class= disease  id= 23884469-5-309-331 >airway hyperreactivity</span> to inhaled methacholine.	23884469	transcription factor; nucleic acid binding	inhibitor of growth family member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
JAK3	3718	AlteredExpression	BEFREE	These data underline (1) the pivotal role of the gamma c chain, CD40/CD40L, <span class= gene  id= 12207328-10-76-80 >JAK3</span> and IL-13 in the inflammatory-like activation of lung myofibroblasts, (2) the cell-type restraint effects of IL-13 on these cells, and (3) the potential usefulness of <span class= gene  id= 12207328-10-248-252 >JAK3</span> inhibitors in the treatment of <span class= disease  id= 12207328-10-284-290 >asthma</span>.	12207328	transferase; kinase	Janus kinase 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2002
ENTPD8	377841	AlteredExpression	BEFREE	We studied total ectonucleotidase activity in leukocytes from patients suffering from <span class= disease  id= 26405014-3-86-92 >asthma</span> exacerbation and explored the expression of <span class= gene  id= 26405014-3-137-148 >E-NTPDase 1</span>, 2, 3, and 8, and E-NPP1, 2, and 3, in their polymorphonuclear cells by immunofluorescence and qPCR.	26405014	phosphatase; hydrolase	ectonucleoside triphosphate diphosphohydrolase 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
KLK1	3816	AlteredExpression	BEFREE	In conclusion, ROS-induced GC metaplasia in normal human bronchial epithelial cells is associated with HA depolymerization and EGF processing by <span class= gene  id= 16424381-11-145-147 >TK</span> followed by EGFR signaling, suggesting that increases in <span class= gene  id= 16424381-11-205-207 >TK</span> activity could contribute to GC metaplasia and mucus hypersecretion in diseases such as <span class= disease  id= 16424381-11-296-302 >asthma</span> and chronic bronchitis.	16424381	protease; enzyme modulator; hydrolase; signaling molecule; calcium-binding protein; receptor	kallikrein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2006
RHOA	387	AlteredExpression	BEFREE	These data indicate that Mfge8 binding to integrin receptors on ASM opposes the effect of allergic inflammation on <span class= gene  id= 23269839-10-115-119 >RhoA</span> activity and identify a pathway for specific inhibition of ASM hypercontractility in <span class= disease  id= 23269839-10-205-211 >asthma</span>.	23269839	enzyme modulator	ras homolog family member A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2013
MIR140	406932	AlteredExpression	BEFREE	Basal and TNF-&alpha;-induced expression of <span class= gene  id= 22773691-5-38-45 >miR-140</span>-3p was determined in nonasthmatic ASM (NAASM) and <span class= disease  id= 22773691-5-96-105 >asthmatic</span> ASM (AASM) cells.	22773691	null	microRNA 140	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
MIR145	406937	AlteredExpression	BEFREE	We found that <span class= gene  id= 26197891-3-14-21 >miR-145</span> was aberrantly more highly expressed in ASM cells exposed to cytokine stimulation that mimic the airway conditions of patients with <span class= disease  id= 26197891-3-154-160 >asthma</span>.	26197891	null	microRNA 145	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
MIR146A	406938	AlteredExpression	BEFREE	Repression of COX-2 and IL-1&beta; expression by <span class= gene  id= 25217662-8-44-52 >miR-146a</span> correlated with reduced abundance of the RNA-binding protein human antigen R. These results demonstrate that <span class= gene  id= 25217662-8-162-170 >miR-146a</span> and miR-146b expression is inducible in hASMCs by proinflammatory cytokines and that <span class= gene  id= 25217662-8-256-264 >miR-146a</span> expression is greater in <span class= disease  id= 25217662-8-290-299 >asthmatic</span> cells.	25217662	null	microRNA 146a	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
MIR192	406967	AlteredExpression	BEFREE	Decreased <span class= gene  id= 23170939-0-10-17 >miR-192</span> expression in peripheral blood of <span class= disease  id= 23170939-0-52-61 >asthmatic</span> individuals undergoing an allergen inhalation challenge.	23170939	null	microRNA 192	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
MIR203A	406986	AlteredExpression	BEFREE	The top-ranked predicted target of the highly down-regulated <span class= gene  id= 22679274-10-61-70 >miRNA-203</span> in <span class= disease  id= 22679274-10-74-83 >asthmatic</span> cells was the aquaporin gene AQP4.	22679274	null	microRNA 203a	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
SMAD7	4092	AlteredExpression	BEFREE	Expression of <span class= gene  id= 12464953-0-14-19 >Smad7</span> in bronchial epithelial cells is inversely correlated to basement membrane thickness and airway hyperresponsiveness in patients with <span class= disease  id= 12464953-0-153-159 >asthma</span>.	12464953	transcription factor	SMAD family member 7	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2003
MCAM	4162	AlteredExpression	BEFREE	Up-regulated <span class= gene  id= 23256918-12-13-18 >MUC18</span> expression in lungs (eg, in alveolar macrophages) of COPD and <span class= disease  id= 23256918-12-81-87 >asthma</span> patients may contribute to excessive inflammation during disease exacerbations.	23256918	cell adhesion molecule; receptor	melanoma cell adhesion molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
MIP	4284	AlteredExpression	BEFREE	Because severe asthma is characterized by neutrophilic inflammation, we investigated the relationship between EGFR activation and production of IL-8 and macrophage inhibitory protein-1 alpha (<span class= gene  id= 12580917-3-192-195 >MIP</span>-1alpha) using in vitro culture models and examined the association between epithelial expression of IL-8 and EGFR in bronchial biopsies from <span class= disease  id= 12580917-3-337-346 >asthmatic</span> subjects.	12580917	transporter	major intrinsic protein of lens fiber	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2003
ACHE	43	AlteredExpression	BEFREE	We previously demonstrated that, at concentrations that do <span class= negexp >not inhibit</span> <span class= gene  id= 23377347-2-71-91 >acetylcholinesterase</span> activity, the OP parathion causes <span class= disease  id= 23377347-2-126-148 >airway hyperreactivity</span> in guinea pigs as a result of functional loss of inhibitory M2 muscarinic receptors on parasympathetic nerves.	23377347	hydrolase	acetylcholinesterase (Cartwright blood group)	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2013
MMP8	4317	AlteredExpression	BEFREE	Airway obstruction correlates with <span class= gene  id= 12429813-0-35-48 >collagenase-2</span> (<span class= gene  id= 12429813-0-50-55 >MMP-8</span>) expression and activation in <span class= disease  id= 12429813-0-86-102 >bronchial asthma</span>.	12429813	null	matrix metallopeptidase 8	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2002
MIR148B	442892	AlteredExpression	BEFREE	<span class= gene  id= 23534973-6-0-8 >miR-148b</span> levels were significantly increased in airway epithelial cells from <span class= disease  id= 23534973-6-77-86 >asthmatic</span> subjects with an <span class= disease  id= 23534973-6-104-113 >asthmatic</span> mother compared with those seen in <span class= disease  id= 23534973-6-149-158 >asthmatic</span> subjects without an <span class= disease  id= 23534973-6-179-188 >asthmatic</span> mother, and +3142 genotypes were associated with sHLA-G concentrations in bronchoalveolar lavage fluid among <span class= disease  id= 23534973-6-298-307 >asthmatic</span> subjects with an <span class= disease  id= 23534973-6-325-334 >asthmatic</span> mother but not among those with a nonasthmatic mother.	23534973	null	microRNA 148b	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2013
MSD	4434	AlteredExpression	BEFREE	The study was undertaken to investigate the influence of once-daily treatment with montelukast (Singulair; <span class= gene  id= 15705989-1-107-110 >MSD</span>; Glattbrugg, Switzerland) on levels of exhaled nitric oxide (eNO) and lung function in preschool children with <span class= disease  id= 15705989-1-222-228 >asthma</span>.	15705989	null	microcephaly with spastic diplegia (Paine syndrome)	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2005
PPP1R12A	4659	AlteredExpression	BEFREE	BNP stimulated the release of acetylcholine (210.7 &plusmn; 11.1%) from BEAS-2B cells that in turn increased <span class= gene  id= 24074453-10-102-107 >MYPT1</span> and iNOS gene/protein expression and enhanced NO levels in <span class= disease  id= 24074453-10-167-176 >asthmatic</span> ASM supernatant (35.0 &plusmn; 13.0%).	24074453	enzyme modulator	protein phosphatase 1 regulatory subunit 12A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
OAS1	4938	AlteredExpression	BEFREE	After IAV infection, viral levels were increased 2-fold in hBECs from <span class= disease  id= 25216987-5-70-79 >asthmatic</span> subjects compared with nonasthmatic control subjects (P &lt; .05) and this increase occurred in concert with increased IFN-?1 levels and <span class= negexp >no significant difference</span> in IFNB1, <span class= gene  id= 25216987-5-250-283 >2'-5'-oligoadenylate synthetase 1</span>, or myxovirus (influenza virus) resistance 1mRNA levels.	25216987	defense/immunity protein; transferase; nucleic acid binding	2'-5'-oligoadenylate synthetase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
ODC1	4953	AlteredExpression	BEFREE	This study demonstrates that the expression of arginase I and <span class= gene  id= 17291856-14-62-65 >ODC</span> is increased in airways of smoking compared with nonsmoking <span class= disease  id= 17291856-14-126-135 >asthmatic</span> subjects and in vitro by nicotine.	17291856	lyase	ornithine decarboxylase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2006
ALDH7A1	501	AlteredExpression	BEFREE	Total monocyte cyclic AMP <span class= gene  id= 11429397-8-26-29 >PDE</span> activity remained unaffected following challenge of <span class= disease  id= 11429397-8-82-91 >asthmatic</span> subjects with either house dust mite or cat dander and was inhibited in a concentration-dependent manner by rolipram (0.01 - 100 microM) both before and after allergen challenge.	11429397	oxidoreductase	aldehyde dehydrogenase 7 family member A1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2001
OXT	5020	AlteredExpression	BEFREE	Taken together, we show that cytokines modulate the expression of functional <span class= gene  id= 20670427-14-77-85 >oxytocin</span> receptors in HASMCs suggesting a potential role for inflammation-induced changes in oxytocin receptor signaling in the regulation of airway hyper-responsiveness in <span class= disease  id= 20670427-14-250-256 >asthma</span>.	20670427	signaling molecule	oxytocin/neurophysin I prepropeptide	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2010
MBL3P	50639	AlteredExpression	BEFREE	<span class= gene  id= 17845414-7-0-3 >MBL</span> levels and genotype have <span class= negexp >no significant relationship</span> with serum IgE, pulmonary functions, and the severity of <span class= disease  id= 17845414-7-114-120 >asthma</span>.	17845414	null	mannose-binding lectin family member 3, pseudogene	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2007
PDGFRB	5159	AlteredExpression	BEFREE	Furthermore, the baseline fibroblast expression of <span class= gene  id= 15753901-7-51-61 >PDGFR-beta</span> was significantly greater in patients with severe <span class= disease  id= 15753901-7-112-118 >asthma</span> compared with the other groups.	15753901	null	platelet derived growth factor receptor beta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2005
ENPP1	5167	AlteredExpression	BEFREE	Decreased expression of ectonucleotidase E-<span class= gene  id= 26405014-0-43-47 >NPP1</span> in leukocytes from subjects with severe <span class= disease  id= 26405014-0-88-94 >asthma</span> exacerbation.	26405014	phosphatase; hydrolase	ectonucleotide pyrophosphatase/phosphodiesterase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
PLEK	5341	AlteredExpression	BEFREE	Mice lacking functional NADPH oxidases due to knockout of <span class= gene  id= 23884469-5-58-61 >p47</span> and mice with epithelial-targeted transgenic expression of a CaMKII inhibitory peptide or wild-type mice treated with inhaled KN-93, an experimental small-molecule CaMKII antagonist, were protected against increases in ICl, MUC5AC expression, and <span class= disease  id= 23884469-5-309-331 >airway hyperreactivity</span> to inhaled methacholine.	23884469	cytoskeletal protein	pleckstrin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
PNN	5411	AlteredExpression	BEFREE	Cytokine gene expression and sputum <span class= gene  id= 19797135-8-36-54 >neutrophil protein</span> production did <span class= negexp >not differ between</span> <span class= disease  id= 19797135-8-89-95 >asthma</span> subtypes.	19797135	null	pinin, desmosome associated protein	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2010
PRG2	5553	AlteredExpression	BEFREE	Additionally, IL-13, IL-10 and <span class= gene  id= 24450586-9-31-61 >eosinophil major basic protein</span> mRNA levels were greater in patients with <span class= disease  id= 24450586-9-104-110 >asthma</span> exacerbations compared to non-exacerbating patients (P = 0.03, P = 0.06 and P = 0.02, respectively), and IL-13 mRNA correlated with the peak <span class= disease  id= 24450586-9-252-258 >Asthma</span> Index (P = 0.006).	24450586	defense/immunity protein; extracellular matrix protein	proteoglycan 2, pro eosinophil major basic protein	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
PRKD1	5587	AlteredExpression	BEFREE	To investigate whether the downstream protein ankyrin-rich membrane spanning (ARMS), a novel transmembrane substrate of <span class= gene  id= 20934630-2-120-136 >protein kinase D</span> (Kidins220), is activated in the pathogenesis of <span class= disease  id= 20934630-2-186-192 >asthma</span>.	20934630	null	protein kinase D1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2010
NSFL1C	55968	AlteredExpression	BEFREE	Mice lacking functional NADPH oxidases due to knockout of <span class= gene  id= 23884469-5-58-61 >p47</span> and mice with epithelial-targeted transgenic expression of a CaMKII inhibitory peptide or wild-type mice treated with inhaled KN-93, an experimental small-molecule CaMKII antagonist, were protected against increases in ICl, MUC5AC expression, and <span class= disease  id= 23884469-5-309-331 >airway hyperreactivity</span> to inhaled methacholine.	23884469	membrane traffic protein	NSFL1 cofactor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
PNO1	56902	AlteredExpression	BEFREE	Repression of COX-2 and IL-1&beta; expression by miR-146a correlated with reduced abundance of the <span class= gene  id= 25217662-8-94-113 >RNA-binding protein</span> human antigen R. These results demonstrate that miR-146a and miR-146b expression is inducible in hASMCs by proinflammatory cytokines and that miR-146a expression is greater in <span class= disease  id= 25217662-8-290-299 >asthmatic</span> cells.	25217662	null	partner of NOB1 homolog	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
PSMD7	5713	AlteredExpression	BEFREE	The IL12B gene encodes the <span class= gene  id= 15007350-1-27-30 >p40</span> chain of IL-12, a proinflammatory cytokine that antagonizes TH2 expression and hence may play a critical role in the pathogenesis of airway inflammation observed in <span class= disease  id= 15007350-1-196-202 >asthma</span>.	15007350	null	proteasome 26S subunit, non-ATPase 7	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2004
PTAFR	5724	AlteredExpression	BEFREE	Comparison of <span class= gene  id= 9363928-0-14-49 >platelet-activating factor receptor</span> mRNA levels in peripheral blood eosinophils from normal subjects and atopic <span class= disease  id= 9363928-0-126-135 >asthmatic</span> patients.	9363928	receptor	platelet activating factor receptor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	1997
PTBP1	5725	AlteredExpression	BEFREE	Repression of COX-2 and IL-1&beta; expression by miR-146a correlated with reduced abundance of the <span class= gene  id= 25217662-8-94-113 >RNA-binding protein</span> human antigen R. These results demonstrate that miR-146a and miR-146b expression is inducible in hASMCs by proinflammatory cytokines and that miR-146a expression is greater in <span class= disease  id= 25217662-8-290-299 >asthmatic</span> cells.	25217662	null	polypyrimidine tract binding protein 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
MIR146B	574447	AlteredExpression	BEFREE	Repression of COX-2 and IL-1&beta; expression by miR-146a correlated with reduced abundance of the RNA-binding protein human antigen R. These results demonstrate that miR-146a and <span class= gene  id= 25217662-8-175-183 >miR-146b</span> expression is inducible in hASMCs by proinflammatory cytokines and that miR-146a expression is greater in <span class= disease  id= 25217662-8-290-299 >asthmatic</span> cells.	25217662	null	microRNA 146b	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
NUFIP2	57532	AlteredExpression	BEFREE	In real-time quantitative polymerase chain reaction analysis, subjects homozygous for the haplotype overtransmitted to <span class= disease  id= 15879417-8-119-125 >asthma</span>-affected offspring showed significantly increased level of cytoplasmic <span class= gene  id= 15879417-8-197-223 >FMRP interacting protein 2</span> gene expression in lymphocytes compared with ones heterozygous for the haplotype (p = 0.038).	15879417	null	NUFIP2, FMR1 interacting protein 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2005
RAB27A	5873	AlteredExpression	BEFREE	This SNP belongs to member of RAS oncogene family (<span class= gene  id= 25431337-7-51-57 >RAB27A</span>) and was associated with an expression quantitative trait locus for <span class= gene  id= 25431337-7-126-132 >RAB27A</span> in lymphoblastoid cell lines from <span class= disease  id= 25431337-7-167-177 >asthmatics</span>.	25431337	null	RAB27A, member RAS oncogene family	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
RARA	5914	AlteredExpression	BEFREE	Expression of <span class= gene  id= 25863981-8-14-17 >RAR</span>-related orphan receptor A (RORA), which has been linked to <span class= disease  id= 25863981-8-77-83 >asthma</span> in genome-wide association studies, was significantly upregulated in patients with <span class= disease  id= 25863981-8-167-169 >SA</span>.	25863981	transcription factor; receptor; nucleic acid binding	retinoic acid receptor alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
RPLP0	6175	AlteredExpression	BEFREE	B2M and <span class= gene  id= 23110234-7-8-13 >RPLP0</span> were identified as the most optimal HKGs in gene expression studies involving human blood CD4(+) T cells derived from normal, depressive <span class= disease  id= 23110234-7-151-161 >asthmatics</span> and non-depressive <span class= disease  id= 23110234-7-181-191 >asthmatics</span>.	23110234	nucleic acid binding	ribosomal protein lateral stalk subunit P0	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
MIR483	619552	AlteredExpression	BEFREE	The level of <span class= gene  id= 25531302-7-13-20 >miR-483</span>-5p in serum was significantly associated with other atopic conditions, such as rhinitis and/or <span class= disease  id= 25531302-7-116-122 >asthma</span>.	25531302	null	microRNA 483	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
S100A1	6271	AlteredExpression	BEFREE	We speculate that the high levels of <span class= gene  id= 21418345-9-37-41 >S100</span>/calgranulins found in bronchoalveolar lavage fluid of <span class= disease  id= 21418345-9-96-106 >asthmatics</span> and of OVA-treated TG S100A12 mice do <span class= negexp >not significantly mediate</span> pulmonary inflammation.	21418345	signaling molecule; calcium-binding protein	S100 calcium binding protein A1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2011
S100B	6285	AlteredExpression	BEFREE	We speculate that the high levels of <span class= gene  id= 21418345-9-37-41 >S100</span>/calgranulins found in bronchoalveolar lavage fluid of <span class= disease  id= 21418345-9-96-106 >asthmatics</span> and of OVA-treated TG S100A12 mice do <span class= negexp >not significantly mediate</span> pulmonary inflammation.	21418345	signaling molecule; calcium-binding protein	S100 calcium binding protein B	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2011
CLEC11A	6320	AlteredExpression	BEFREE	Mice lacking functional NADPH oxidases due to knockout of <span class= gene  id= 23884469-5-58-61 >p47</span> and mice with epithelial-targeted transgenic expression of a CaMKII inhibitory peptide or wild-type mice treated with inhaled KN-93, an experimental small-molecule CaMKII antagonist, were protected against increases in ICl, MUC5AC expression, and <span class= disease  id= 23884469-5-309-331 >airway hyperreactivity</span> to inhaled methacholine.	23884469	signaling molecule; extracellular matrix protein	C-type lectin domain family 11 member A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
CXCL11	6373	AlteredExpression	BEFREE	We used in situ hybridization and immunohistochemistry to examine the expression and cellular provenance of TSLP, Th2-attracting (thymus and activation-regulated chemokine (TARC)/CCL17, macrophage-derived chemokine (MDC)/CCL22, I-309/CCL1) and Th1-attracting (IFN-gamma-inducible protein 10 (IP-10)/CXCL10, IFN-inducible T cell alpha-chemoattractant (I-TAC)/<span class= gene  id= 15944327-3-358-364 >CXCL11</span>) chemokines and expression of their receptors CCR4, CCR8, and CXCR3 in bronchial biopsies from 20 <span class= disease  id= 15944327-3-463-473 >asthmatics</span> and 15 normal controls.	15944327	signaling molecule	C-X-C motif chemokine ligand 11	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2005
SDC4	6385	AlteredExpression	BEFREE	ASMC <span class= gene  id= 22268118-11-5-15 >syndecan-4</span> production during Th1 inflammatory conditions may regulate chemokine activity and mast cell recruitment to the ASM in <span class= disease  id= 22268118-11-134-140 >asthma</span>.	22268118	cell adhesion molecule; defense/immunity protein; cytoskeletal protein; signaling molecule; extracellular matrix protein	syndecan 4	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
ARHGEF28	64283	AlteredExpression	BEFREE	The situation is complicated further by the fact that WT NOD2 and WT <span class= gene  id= 23794710-4-69-73 >RIP2</span> activity has been implicated in diseases such as <span class= disease  id= 23794710-4-123-129 >asthma</span>, inflammatory arthritis and MS.	23794710	enzyme modulator	Rho guanine nucleotide exchange factor 28	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2013
FBRS	64319	AlteredExpression	BEFREE	Pharmacological inhibition revealed that although dual proliferative pathways control ASM growth in cells from non-<span class= disease  id= 18338817-8-115-125 >asthmatics</span> stimulated with 10% <span class= gene  id= 18338817-8-146-149 >FBS</span> to an equal extent ([(3)H]-thymidine incorporation reduced to 57.2 +/- 6.9% by the PI 3-kinase inhibitor LY294002 and 57.8 +/- 1.1% by the ERK-pathway inhibitor U0126); in <span class= disease  id= 18338817-8-322-332 >asthmatics</span>, the presence of a strong proliferative stimulus (10% <span class= gene  id= 18338817-8-387-390 >FBS</span>) reduces ERK activation resulting in a shift to the PI 3-kinase pathway.	18338817	null	fibrosin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2008
SLC30A5	64924	AlteredExpression	BEFREE	Serum zinc levels were significantly lower in asthmatic infants (P &lt; 0.01); Expression of ZnT-1, ZnT-3, <span class= gene  id= 19598279-9-104-109 >ZnT-5</span>, ZIP-1 mRNA were not significantly different between two groups, but expression of ZIP-2 mRNA was significantly higher (P &lt; 0.01) in the <span class= disease  id= 19598279-9-247-256 >asthmatic</span> group than the control group.	19598279	transporter	solute carrier family 30 member 5	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
TFDP2	7029	AlteredExpression	BEFREE	<span class= gene  id= 25312757-3-0-3 >DP2</span> protein expression was assessed in bronchial biopsy specimens from <span class= disease  id= 25312757-3-71-80 >asthmatic</span> patients (n = 22) and healthy control subjects (n = 10) by using immunohistochemistry and in primary epithelial cells by using flow cytometry, immunofluorescence, and quantitative RT-PCR.	25312757	transcription factor; nucleic acid binding	transcription factor Dp-2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
TFF2	7032	AlteredExpression	BEFREE	Moreover, <span class= gene  id= 22329990-5-10-14 >TFF2</span> messenger RNA expression is significantly increased in nasal mucosal brushings during <span class= disease  id= 22329990-5-101-107 >asthma</span> exacerbations in children.	22329990	signaling molecule	trefoil factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
TGFA	7039	AlteredExpression	BEFREE	Exposure or colonization by SA in the airway may enhance the remodeling of tissue through a <span class= gene  id= 25180535-10-92-97 >TGF-&alpha;</span>-dependent induction of MMP-1 expression, and may thereby promote remodeling in airway diseases in which SA is implicated, such as <span class= disease  id= 25180535-10-228-234 >asthma</span> and chronic rhinosinusitis.	25180535	signaling molecule	transforming growth factor alpha	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2016
TP53	7157	AlteredExpression	BEFREE	We sought to assess apoptosis of eosinophils, macrophages, and T lymphocytes in bronchial biopsy specimens from <span class= disease  id= 10200002-3-112-121 >asthmatic</span> subjects and to examine its regulation by evaluating the expression of B-cell lymphoma leukemia-2 (Bcl-2) and <span class= gene  id= 10200002-3-232-235 >P53</span> proteins.	10200002	transcription factor	tumor protein p53	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	1999
TRAF2	7186	AlteredExpression	BEFREE	The tumour necrosis factor pathway was activated in AN and <span class= disease  id= 11207646-9-59-61 >AA</span> with increased cytokine and receptor levels and increased <span class= gene  id= 11207646-9-120-125 >TRAF2</span>, an intracellular signalling product.	11207646	signaling molecule	TNF receptor associated factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2001
VTN	7448	AlteredExpression	BEFREE	<span class= gene  id= 25768308-0-0-11 >Vitronectin</span> expression in the airways of subjects with <span class= disease  id= 25768308-0-55-61 >asthma</span> and chronic obstructive pulmonary disease.	25768308	cell adhesion molecule	vitronectin	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
WNT7A	7476	AlteredExpression	BEFREE	<span class= gene  id= 26655831-5-0-5 >Wnt7a</span> mRNA expression was prominent in induced sputum from patients with <span class= disease  id= 26655831-5-73-79 >asthma</span> compared with that from healthy controls.	26655831	signaling molecule	Wnt family member 7A	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
YWHAZ	7534	AlteredExpression	BEFREE	In vitro studies using recombinant human enzymes reveal that TGM2 augments the enzymatic activity of secreted <span class= gene  id= 20052409-9-110-127 >phospholipase A(2</span>) (PLA(2)) group X (sPLA(2)-X), an enzyme recently implicated in <span class= disease  id= 20052409-9-192-198 >asthma</span> pathogenesis.	20052409	chaperone	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
SLC30A1	7779	AlteredExpression	BEFREE	Serum zinc levels were significantly lower in <span class= disease  id= 19598279-9-46-55 >asthmatic</span> infants (P &lt; 0.01); Expression of <span class= gene  id= 19598279-9-90-95 >ZnT-1</span>, ZnT-3, ZnT-5, ZIP-1 mRNA were not significantly different between two groups, but expression of ZIP-2 mRNA was significantly higher (P &lt; 0.01) in the asthmatic group than the control group.	19598279	transporter	solute carrier family 30 member 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
SLC52A2	79581	AlteredExpression	BEFREE	We determined the influence of chronic smoking and <span class= disease  id= 12589358-2-51-57 >asthma</span> on the expression of <span class= gene  id= 12589358-2-79-84 >PAR-1</span> and PAR-2 receptors on alveolar macrophages (AMs).	12589358	receptor	solute carrier family 52 member 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2003
CASP9	842	AlteredExpression	BEFREE	Activation of Bcl-2-<span class= gene  id= 26938720-0-20-29 >Caspase-9</span> Apoptosis Pathway in the Testis of <span class= disease  id= 26938720-0-65-74 >Asthmatic</span> Mice.	26938720	protease; enzyme modulator; hydrolase	caspase 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2016
RECK	8434	AlteredExpression	BEFREE	Because genetic studies have shown that ADAM-33 gene polymorphisms are associated with <span class= disease  id= 17088949-3-87-93 >asthma</span>, we designed this study to assess mRNA expression profile of several ADAM and ADAMTS proteases in sputum from patients with <span class= disease  id= 17088949-3-218-224 >asthma</span> and to investigate the relationship between expression of these proteases and <span class= disease  id= 17088949-3-303-309 >asthma</span>-associated inflammation and airway obstruction. mRNA expression profile of selected ADAM and ADAMTS proteinases (ADAM-8, -9, -10, -12, -15, -17, and -33; ADAMTS-1, -2, -15, -16, -17, -18, and -19), their physiological inhibitors TIMP-1 and TIMP-3, and <span class= gene  id= 17088949-3-562-566 >RECK</span>, a membrane-anchored MMP activity regulator, was obtained by RT-PCR analysis performed on cells collected by sputum induction from 21 patients with mild to moderate asthma and 17 healthy individuals. mRNA levels of ADAM-8, ADAM-9, ADAM-12, TIMP-1, and TIMP-3 were significantly increased, whereas mRNA levels coding for ADAMTS-1, ADAMTS-15, and <span class= gene  id= 17088949-3-912-916 >RECK</span> were significantly decreased in patients with <span class= disease  id= 17088949-3-963-969 >asthma</span> compared with control patients.	17088949	null	reversion inducing cysteine rich protein with kazal motifs	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2006
MAK16	84549	AlteredExpression	BEFREE	Repression of COX-2 and IL-1&beta; expression by miR-146a correlated with reduced abundance of the <span class= gene  id= 25217662-8-94-113 >RNA-binding protein</span> human antigen R. These results demonstrate that miR-146a and miR-146b expression is inducible in hASMCs by proinflammatory cytokines and that miR-146a expression is greater in <span class= disease  id= 25217662-8-290-299 >asthmatic</span> cells.	25217662	null	MAK16 homolog	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2014
CTNNAL1	8727	AlteredExpression	BEFREE	In the present study, we observed the temporal and spatial distribution of <span class= gene  id= 17647259-3-75-82 >CTNNAL1</span> expression in mouse lung tissue with the OVA-sensitized <span class= disease  id= 17647259-3-139-145 >asthma</span> model and found that the level of CTNNAL1 mRNA showed a prominent <span class= negexp >negative correlation</span> with pulmonary resistance (R(L)).	17647259	cell adhesion molecule; cytoskeletal protein	catenin alpha like 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2008
TNFSF13	8741	AlteredExpression	BEFREE	Unlike other inflammatory diseases including autoimmune diseases and <span class= disease  id= 21765951-6-69-75 >asthma</span>, the circulating levels of BAFF, <span class= gene  id= 21765951-6-109-114 >APRIL</span> and TWEAK were not elevated in AE or SE patients compared with HCs and did <span class= negexp >not correlate</span> with the disease severity or systemic IgE levels in AE patients.	21765951	null	tumor necrosis factor superfamily member 13	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2011
KAT2B	8850	AlteredExpression	BEFREE	Sputum macrophages had increased expression of <span class= gene  id= 24355018-13-47-52 >KAT2B</span> in eosinophilic compared with paucigranulocytic <span class= disease  id= 24355018-13-101-107 >asthma</span>.	24355018	transferase; nucleic acid binding	lysine acetyltransferase 2B	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2013
VNN1	8876	AlteredExpression	BEFREE	<span class= gene  id= 25910714-0-0-7 >Vanin-1</span> expression and methylation discriminate pediatric <span class= disease  id= 25910714-0-58-64 >asthma</span> corticosteroid treatment response.	25910714	hydrolase	vanin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
CLDN1	9076	AlteredExpression	BEFREE	<span class= gene  id= 21624620-0-0-9 >Claudin-1</span> expression in airway smooth muscle exacerbates airway remodeling in <span class= disease  id= 21624620-0-78-87 >asthmatic</span> subjects.	21624620	cell junction protein	claudin 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2011
AIFM1	9131	AlteredExpression	BEFREE	DNA ladder and immunochemistry showed significant increase in apoptotic index of the <span class= disease  id= 26938720-10-85-94 >asthmatic</span> testis, whereas a decrease in mRNA expression of Bcl-2 and increases in Bax, BNIP3, caspase-9, and <span class= gene  id= 26938720-10-194-197 >AIF</span> were observed in the <span class= disease  id= 26938720-10-219-225 >asthma</span> group.	26938720	oxidoreductase	apoptosis inducing factor mitochondria associated 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2016
CD2	914	AlteredExpression	BEFREE	Transgenic overexpression of Batf under the control of the <span class= gene  id= 24290279-10-59-62 >CD2</span> promoter/enhancer augmented lung inflammation and IgE levels in the setting of experimental <span class= disease  id= 24290279-10-155-161 >asthma</span>.	24290279	cell adhesion molecule; defense/immunity protein; signaling molecule; transferase; kinase; receptor	CD2 molecule	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2013
MYOM2	9172	AlteredExpression	BEFREE	IRAK-<span class= gene  id= 22154382-9-5-14 >M protein</span> levels were increased in <span class= disease  id= 22154382-9-40-49 >asthmatic</span> airway epithelium.	22154382	cell adhesion molecule; extracellular matrix protein	myomesin 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2011
ARHGEF2	9181	AlteredExpression	BEFREE	The IL12B gene encodes the <span class= gene  id= 15007350-1-27-30 >p40</span> chain of IL-12, a proinflammatory cytokine that antagonizes TH2 expression and hence may play a critical role in the pathogenesis of airway inflammation observed in <span class= disease  id= 15007350-1-196-202 >asthma</span>.	15007350	enzyme modulator	Rho/Rac guanine nucleotide exchange factor 2	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2004
TMPRSS11D	9407	AlteredExpression	BEFREE	Targeting histone deacetylase activity in rheumatoid arthritis and <span class= disease  id= 18983693-0-67-73 >asthma</span> as prototypes of inflammatory disease: should we keep our <span class= gene  id= 18983693-0-132-135 >HAT</span>s on?	18983693	protease; enzyme modulator; hydrolase; signaling molecule; calcium-binding protein; receptor	transmembrane protease, serine 11D	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
ORMDL1	94101	AlteredExpression	BEFREE	Baseline expression of <span class= gene  id= 26011647-10-23-29 >ORMDL1</span> (P = 1.7 &times; 10(-6) ) and ORMDL2 (P = 4.9 &times; 10(-5) ) was significantly higher in PBMC from <span class= disease  id= 26011647-10-119-129 >asthmatics</span>, while induction of ORMDLs upon stimulation was stronger in nonasthmatics.	26011647	null	ORMDL sphingolipid biosynthesis regulator 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
ADAMTS1	9510	AlteredExpression	BEFREE	Because genetic studies have shown that ADAM-33 gene polymorphisms are associated with asthma, we designed this study to assess mRNA expression profile of several ADAM and ADAMTS proteases in sputum from patients with <span class= disease  id= 17088949-3-218-224 >asthma</span> and to investigate the relationship between expression of these proteases and asthma-associated inflammation and airway obstruction. mRNA expression profile of selected ADAM and ADAMTS proteinases (ADAM-8, -9, -10, -12, -15, -17, and -33; <span class= gene  id= 17088949-3-464-472 >ADAMTS-1</span>, -2, -15, -16, -17, -18, and -19), their physiological inhibitors TIMP-1 and TIMP-3, and RECK, a membrane-anchored MMP activity regulator, was obtained by RT-PCR analysis performed on cells collected by sputum induction from 21 patients with mild to moderate asthma and 17 healthy individuals. mRNA levels of ADAM-8, ADAM-9, ADAM-12, TIMP-1, and TIMP-3 were significantly increased, whereas mRNA levels coding for ADAMTS-1, ADAMTS-15, and RECK were significantly decreased in patients with asthma compared with control patients.	17088949	protease; enzyme modulator; hydrolase; extracellular matrix protein	ADAM metallopeptidase with thrombospondin type 1 motif 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2006
ENTPD1	953	AlteredExpression	BEFREE	We studied total ectonucleotidase activity in leukocytes from patients suffering from <span class= disease  id= 26405014-3-86-92 >asthma</span> exacerbation and explored the expression of <span class= gene  id= 26405014-3-137-148 >E-NTPDase 1</span>, 2, 3, and 8, and E-NPP1, 2, and 3, in their polymorphonuclear cells by immunofluorescence and qPCR.	26405014	phosphatase; hydrolase	ectonucleoside triphosphate diphosphohydrolase 1	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2015
CLOCK	9575	AlteredExpression	BEFREE	In the present study, we examine circadian timing in the lung, determine the cellular localization of core <span class= gene  id= 18787022-3-107-112 >clock</span> proteins in both mouse and human lung tissue, and establish the effects of glucocorticoids (widely used in the treatment of <span class= disease  id= 18787022-3-237-243 >asthma</span>) on the pulmonary clock.	18787022	transcription factor	clock circadian regulator	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2009
SART3	9733	AlteredExpression	BEFREE	Expression levels of <span class= gene  id= 22556157-10-21-25 >p110</span> isoforms &alpha;, &beta;, and &delta; were comparable in nonasthmatic and <span class= disease  id= 22556157-10-83-92 >asthmatic</span> HASM cells.	22556157	null	squamous cell carcinoma antigen recognized by T-cells 3	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
HDAC9	9734	AlteredExpression	BEFREE	These data do <span class= negexp >not support</span> upregulated GR&beta; and resultant reduced <span class= gene  id= 22156779-11-64-68 >HDAC</span> expression as the principal mechanism of steroid resistance in severe <span class= disease  id= 22156779-11-139-145 >asthma</span>.	22156779	oxidoreductase; nucleic acid binding; hydrolase	histone deacetylase 9	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	2012
PCLAF	9768	AlteredExpression	BEFREE	We compared expression levels of mRNA for the <span class= gene  id= 9363928-2-46-49 >PAF</span> receptor (PAF-R) in peripheral blood eosinophils from atopic <span class= disease  id= 9363928-2-111-120 >asthmatic</span> patients with those from normal healthy subjects using a relative quantification method based on the reverse transcription-polymerase chain reaction (RT-PCR).	9363928	null	PCNA clamp associated factor	C0004096	Asthma	Abnormality of the immune system; Abnormality of the respiratory system	C0004096	Asthma	Disease or Syndrome	D001249	Immune System Diseases ; Respiratory Tract Diseases	disease of anatomical entity	disease	null	disease	0.000274726784213	1997
